<!--
Primary care
Bone and joint - 551
URTI - 667
Gastro -
UTI - 1058
Skin - 1339
Eye - 1835
Meningitis
GEnital
LRTI
Health care associated
Parasites
General guidance
Intermediate care
Sepsis
UTI
Skin
LRTI
Gastro
URTI
Genital
Bone
Meningitis
Eye
Healthcare associated
Parasites
General Guidance
Hospital care
A&E adults
A&E paeds
Inpatient adults
Inpatient children
General guidance
Prophylaxis
--><!-- Font Awesome icons (free version)--><script src="https://use.fontawesome.com/releases/v5.13.0/js/all.js" crossorigin="anonymous" type="text/javascript"></script><!-- Google fonts-->
<link href="https://fonts.googleapis.com/css?family=Montserrat:400,700" rel="stylesheet" type="text/css" />
<link href="https://fonts.googleapis.com/css?family=Lato:400,700,400italic,700italic" rel="stylesheet" type="text/css" /><!-- Core theme CSS (includes Bootstrap)-->
<link href="https://www.tamesideandglossopccg.org/getmedia/72509ea0-1785-47cf-a42c-291a4847ca0c/styles.css" rel="stylesheet" />
<header class="masthead bg-primary text-white text-center mt-2 px-0" id="page-top">
<style type="text/css">.modal {
    position: fixed;
    top: 0;
    left: 0;
    z-index: 1050;
    display: none;
    width: 100%;
    height: 100%;
    overflow: hidden;
    outline: 0;
    overflow-y:auto;
    }
</style>
<div class="container d-flex align-items-center flex-column"><!-- Masthead Heading-->
<h3 class="mb-0">Antibiotic guidelines</h3>
<!-- Masthead Subheading-->

<p class="font-weight-light mb-0">These guidelines are maintained jointly between Tameside and Glossop ICFT Antibiotic pharmacist&nbsp;and microbiologists and the CCG antibiotic pharmacist. Their contact details can be found at the bottom of the page. For any general website feedback please use the feedback button at the bottom of the page.</p>
</div>
</header>
<marquee behavior="scroll" direction="left" id="marquee">v1.1 last updated 5-January-2021.</marquee> <!--Scrolling bar showing info of version number and last updates etc--> <!--Primary and Urgent care Guidelines section--> <!--This is a whole section as shown by the section tag, you could copy and past this copying everything from <section> to the next </section> tag. Any green &apos;id&apos; tags have to be unique and for example to primarGuidelines tells the browser to move to this section when you click primary care on the navigation menu. So if you were to add a new section you would need to copy and paste this section, change the id to something different such as &apos;emergencyGuidelines&apos; and then add a new navigation link pointing to this section.-->

<section class="page-section1 portfolio" id="primaryGuidelines">
<div class="container"><!-- Portfolio Section Heading-->
<h2 class="page-section-heading text-center text-uppercase text-secondary mb-0">Primary / Urgent Care Guidelines</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>
<!--This shows the two button Managing Infections and General Guidance. the rest of the code deals with making it look like a button and also setting it to show and hide the below content. It defaults to hidden and is shown when you click a button. the &apos;data-target&apos; tag which is followed by #managingInfections is needed to identify the div which will show and hide when the button is clicked. if adding a new section to this you would copy all the text for a button including the <button> and </button> tag. Change the text in white to show what is displayed on the page and then change the &apos;data-target&apos; info from #managingInfectionsPC to an alternative such as &apos;#infectionsEmergency&apos; this then needs to match the id in the portfolio grid items below.-->

<div class="column text-center"><button class="btn btn-primary mr-3 ml-2 mb-3" onclick="closePCGC()" type="button">Managing Infections</button><button class="btn btn-primary mb-3" onclick="closePCMI()" type="button">General Guidance</button></div>

<hr /><!-- Portfolio Grid Items--><!--The first div has an id managingInfections so the button with that as the data-target will know which to show and hide. The rest of the code is creating the views you see for each clinical area.-->
<div class="row hide pb-2" id="managingInfectionsPC" style="display:none"><!-- Portfolio Item 1-->
<div class="col-xs-8 col-md-4 mb-3"><!--Data-target here which is PCBone is unique for each item we make in this section and refers to the modal which opens when clicked. This modal is constructed at the end of the code after the footer section. -->
<div class="portfolio-item mx-auto" data-target="#PCBone" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><img alt="bone" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/2e370b23-53da-4c83-b6b9-d65e16dce746/bone" />
<p class="text-center">Bone and Joint</p>
</div>
</div>
<!-- Portfolio Item 2--><!--Item 2 and 3 are the same as above but have a unique portfolioModal number.-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCURT" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="lungs" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/74b391a7-b4f3-4e19-af16-df14ee925e24/lungs" />
<p class="text-center">Upper Respiratory Tract</p>
</div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCUTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="urinary" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/0e95e4ac-8285-44e5-999f-3f90abc15229/urinary" />
<p class="text-center">Urinary Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 4-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCSkin" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="skin" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/3c0a1bd9-6e4b-45b1-81ee-fafed1fd2cdc/skin" />
<p class="text-center">Skin &amp; Soft Tissue Infections</p>
</div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCEye" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="eye" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/63d5374d-cc02-4805-8bde-7fdc834d0f81/eye" />
<p class="text-center">Opthamology Infections</p>
</div>
</div>
<!-- Portfolio Item 6-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCmen" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="meningitis" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/ea425690-7e1c-453c-bee1-547a29e66590/meningitis" />
<p class="text-center">Meningitis</p>
</div>
</div>
<!-- Portfolio Item 7-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCGT" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="genital" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/586836a9-d8e5-45eb-833f-04f398fd55ae/gender" />
<p class="text-center">Genital Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 8-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCLRT" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="lungs" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/74b391a7-b4f3-4e19-af16-df14ee925e24/lungs" />
<p class="text-center">Lower Respiratory Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 9-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCHCAI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="healthcareinfections" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/ba3aa27c-64b5-4e5a-bf19-9fcfd748793f/hospital" />
<p class="text-center">Healthcare Associated Infections</p>
</div>
</div>
<!-- Portfolio Item 10-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCParasite" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="parasites" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/f62bf192-0e6a-4b4d-9766-6a2b08f5c9eb/parasite" />
<p class="text-center">Parasites</p>
</div>
</div>
<!-- Portfolio Item 11-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCGastro" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="gastrointestinal" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/13f64820-31fb-4905-8613-d3771fc1b614/Intestines" />
<p class="text-center">Gastrointestinal</p>
</div>
</div>
</div>

<div class="row hide text-center" id="PCGeneralGuidelines" style="display:none"><!-- Portfolio Item 1-->
<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCIntro" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Introduction</button></div>
</div>
<!-- Portfolio Item 2-->

<div class="col-xs-8 col-md-4 mb-3 ">
<div class="portfolio-item mx-auto" data-target="#PCAims" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Aims of the Guidelines</button></div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCPrinciples" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Principles of Treatment</button></div>
</div>
<!-- Portfolio Item 4-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCReferences" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">References</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCFurtherReading" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Further Reading</button></div>
</div>
</div>
</div>
</section>
<!--Intermediate care Guidelines-->

<section class="page-section1 portfolio" id="interGuidelines">
<div class="container"><!-- Portfolio Section Heading-->
<h2 class="page-section-heading text-center text-uppercase text-secondary mb-0">Intermediate Care Guidelines</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<div class="column text-center"><button class="btn btn-primary mr-3 ml-2 mb-3" onclick="closeICGC()" type="button">Managing Infections</button><button class="btn btn-primary mb-3" onclick="closeICMI()" type="button">General Guidance</button></div>

<hr /><!-- Portfolio Grid Items-->
<div class="row collapse hide" id="managingInfectionsIC" style="display:none"><!-- Portfolio Item 1-->
<div class="col-xs-8 col-md-4 mb-3"><!--Data-target here which is portfolioModal1 is unique for each item we make in this section and refers to the modal which opens when clicked. This modal is constructed at the end of the code after the footer section. -->
<div class="portfolio-item mx-auto" data-target="#ICBone" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="bone" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/2e370b23-53da-4c83-b6b9-d65e16dce746/bone" />
<p class="text-center">Bone and Joint</p>
</div>
</div>
<!-- Portfolio Item 2--><!--Item 2 and 3 are the same as above but have a unique portfolioModal number.-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#ICURTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="lungs" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/74b391a7-b4f3-4e19-af16-df14ee925e24/lungs" />
<p class="text-center">Upper Respiratory Tract</p>
</div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#ICUTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="urinary" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/0e95e4ac-8285-44e5-999f-3f90abc15229/urinary" />
<p class="text-center">Urinary Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 4-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#ICSkin" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="skin" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/3c0a1bd9-6e4b-45b1-81ee-fafed1fd2cdc/skin" />
<p class="text-center">Skin &amp; Soft Tissue Infections</p>
</div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCEye" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="eye" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/63d5374d-cc02-4805-8bde-7fdc834d0f81/eye" />
<p class="text-center">Opthamology Infections</p>
</div>
</div>
<!-- Portfolio Item 6-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCMen" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="meningitis" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/ea425690-7e1c-453c-bee1-547a29e66590/meningitis" />
<p class="text-center">Meningitis</p>
</div>
</div>
<!-- Portfolio Item 7-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#ICGTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="genitalinfections" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/586836a9-d8e5-45eb-833f-04f398fd55ae/gender" />
<p class="text-center">Genital Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 8-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#ICLRTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="lungs" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/74b391a7-b4f3-4e19-af16-df14ee925e24/lungs" />
<p class="text-center">Lower Respiratory Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 9-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCHCAI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="healthcareinfections" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/ba3aa27c-64b5-4e5a-bf19-9fcfd748793f/hospital" />
<p class="text-center">Healthcare Associated Infections</p>
</div>
</div>
<!-- Portfolio Item 10-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCParasite" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="parasites" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/f62bf192-0e6a-4b4d-9766-6a2b08f5c9eb/parasite" />
<p class="text-center">Parasites</p>
</div>
</div>
<!-- Portfolio Item 11-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#ICGastro" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="gastronintestinal" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/13f64820-31fb-4905-8613-d3771fc1b614/Intestines" />
<p class="text-center">Gastrointestinal</p>
</div>
</div>
<!--Portfolio Item 12-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#ICSepsis" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="healthcareinfections" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/bb33cdeb-9999-4a9f-8de6-91eca8507650/blood_1" />
<p class="text-center">Sepsis Syndrome</p>
</div>
</div>
</div>
</div>

<div class="container">
<div class="row collapse hide text-center" id="ICGeneralGuidelines" style="display:none"><!-- Portfolio Item 1-->
<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCIntro" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Introduction</button></div>
</div>
<!-- Portfolio Item 2-->

<div class="col-xs-8 col-md-4 mb-3 ">
<div class="portfolio-item mx-auto" data-target="#PCAims" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Aims of the Guidelines</button></div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCPrinciples" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Principles of Treatment</button></div>
</div>
<!-- Portfolio Item 4-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCReferences" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">References</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#PCFurtherReading" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Further Reading</button></div>
</div>
</div>
</div>
</section>
<!--Hospital guidelines-->

<section class="page-section1 portfolio" id="hospGuidelines">
<div class="container"><!-- Portfolio Section Heading-->
<h2 class="page-section-heading text-center text-uppercase text-secondary mb-0">Hospital Guidelines</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<div class="column text-center"><button aria-controls="managingInfectionsH" aria-expanded="false" class="btn btn-primary mr-3 ml-3 mb-3" data-target="#managingInfectionsH" data-toggle="collapse" type="button">Hospital Guidelines</button></div>

<hr /><!-- Portfolio Grid Items-->
<div class="row collapse hide text-center" id="managingInfectionsH"><!-- Portfolio Item 1-->
<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdults" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">A&amp;E Adults</button></div>
</div>
<!-- Portfolio Item 2--><!--Item 2 and 3 are the same as above but have a unique portfolioModal number.-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaeds" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">A&amp;E Paediatrics</button></div>
</div>
<!-- Adult Inpatients-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto">
<div class="column text-center"><button aria-controls="AdInHC" aria-expanded="false" class="btn btn-primary general" data-target="#AdInHC" data-toggle="collapse" onclick="onlyAdInpat()" type="button">Adult Inpatients</button></div>
</div>
</div>
<!-- Paed Inpatients-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto">
<div class="column text-center"><button aria-controls="PaedInHC" aria-expanded="false" class="btn btn-primary general" data-target="#PaedInHC" data-toggle="collapse" onclick="onlyPaedInpat()" type="button">Paediatric Inpatients</button></div>
</div>
</div>
<!-- General Guidance-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto">
<div class="column text-center"><button aria-controls="HCGeneralGuidelines" aria-expanded="false" class="btn btn-primary general" data-target="#HCGeneralGuidelines" data-toggle="collapse" onclick="onlyHospGuide()" type="button">General Guidance</button></div>
</div>
</div>
<!-- Prophylaxis-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto">
<div class="column text-center"><button aria-controls="HCProphylaxis" aria-expanded="false" class="btn btn-primary general" data-target="#HCProphylaxis" data-toggle="collapse" onclick="onlyProph()" type="button">Prophylaxis</button></div>
</div>
</div>
</div>
</div>
<!--Adult inpatient section button-->

<div class="container">
<div class="row collapse hide pb-2" id="AdInHC" style="display:none">
<div class="col-lg-12">
<h3 class="text-center">Adult Inpatients</h3>

<hr /></div>
<!-- Portfolio Item 1-->

<div class="col-xs-8 col-md-4 mb-3"><!--Data-target here which is PCBone is unique for each item we make in this section and refers to the modal which opens when clicked. This modal is constructed at the end of the code after the footer section. -->
<div class="portfolio-item mx-auto" data-target="#HCAdBlood" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><img alt="healthcareinfections" class="img-fluid" height="400px" src="https://www.tamesideandglossopccg.org/getmedia/bb33cdeb-9999-4a9f-8de6-91eca8507650/blood_1" width="400px" />
<p class="text-center">Bloodstream Infections and Sepsis Syndrome</p>
</div>
</div>
<!-- Portfolio Item 2--><!--Item 2 and 3 are the same as above but have a unique portfolioModal number.-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdBoneJoint" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="bone" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/2e370b23-53da-4c83-b6b9-d65e16dce746/bone" />
<p class="text-center">Bone and Joint Infections</p>
</div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdCardio" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="cardiovascular" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/9133a0ea-414b-472b-9895-601344959b08/cardio" />
<p class="text-center">Cardiovascular Infections</p>
</div>
</div>
<!-- Portfolio Item 4-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdCNS" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="meningitis" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/ea425690-7e1c-453c-bee1-547a29e66590/meningitis" />
<p class="text-center">Central Nervous System Infections</p>
</div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdDental" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="Dental" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/5f2f8f65-f8bd-4c7d-865b-e19a89d32f8a/tooth_1" />
<p class="text-center">Dental Infections</p>
</div>
</div>
<!-- Portfolio Item 6-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdENT" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="ent" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/d2fb7630-0091-4097-9a9b-c47ce73a956d/ent" />
<p class="text-center">Ear, Nose &amp; Throat Infections</p>
</div>
</div>
<!-- Portfolio Item 7-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdEye" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="eye" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/63d5374d-cc02-4805-8bde-7fdc834d0f81/eye" />
<p class="text-center">Opthamology Infections</p>
</div>
</div>
<!-- Portfolio Item 8-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdFungal" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="fungal" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/8286ed6e-9fbd-493a-bc19-4c2423821745/virus" />
<p class="text-center">Fungal Infections</p>
</div>
</div>
<!-- Portfolio Item 9-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdGastro" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="gastroinfections" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/13f64820-31fb-4905-8613-d3771fc1b614/Intestines" />
<p class="text-center">Gastrointestinal Tract / Intra-abdominal Infections</p>
</div>
</div>
<!-- Portfolio Item 10-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdGynae" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="gynaecology" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/90d514cb-69a6-426d-b815-591b026fbe45/uterus_1" />
<p class="text-center">Gynaecological Infections</p>
</div>
</div>
<!-- Portfolio Item 11-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdHead" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="head" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/060bc0a5-a7c8-41f6-aa32-9092bcdb969c/head" />
<p class="text-center">Head &amp; Neck Infections</p>
</div>
</div>
<!-- Portfolio Item 12-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdObstetric" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="obstetrics" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/7bc2934a-ab0b-4f83-8dfa-71839f93c048/baby" />
<p class="text-center">Obstetric Infections</p>
</div>
</div>
<!-- Portfolio Item 13-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdResp" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="lungs" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/74b391a7-b4f3-4e19-af16-df14ee925e24/lungs" />
<p class="text-center">Respiratory Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 14-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdSTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="genitalinfections" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/586836a9-d8e5-45eb-833f-04f398fd55ae/gender" />
<p class="text-center">Sexually Transmitted Infections</p>
</div>
</div>
<!-- Portfolio Item 15-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdSkin" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="skin" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/3c0a1bd9-6e4b-45b1-81ee-fafed1fd2cdc/skin" />
<p class="text-center">Skin and Soft Tissue Infections</p>
</div>
</div>
<!-- Portfolio Item 16-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCAdUTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="urinary" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/0e95e4ac-8285-44e5-999f-3f90abc15229/urinary" />
<p class="text-center">Urinary Tract Infections</p>
</div>
</div>
</div>
</div>
<!--Paeditric inpatient section button-->

<div class="container">
<div class="row collapse hide pb-2" id="PaedInHC" style="display:none">
<div class="col-lg-12">
<h3 class="text-center">Paediatric Inpatients</h3>

<hr /></div>
<!-- Portfolio Item 1-->

<div class="col-xs-8 col-md-4 mb-3"><!--Data-target here which is PCBone is unique for each item we make in this section and refers to the modal which opens when clicked. This modal is constructed at the end of the code after the footer section. -->
<div class="portfolio-item mx-auto" data-target="#HCPaedBlood" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><img alt="healthcareinfections" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/bb33cdeb-9999-4a9f-8de6-91eca8507650/blood_1" />
<p class="text-center">Bloodstream Infections and Sepsis Syndrome</p>
</div>
</div>
<!-- Portfolio Item 2--><!--Item 2 and 3 are the same as above but have a unique portfolioModal number.-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedBoneJoint" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="bone" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/2e370b23-53da-4c83-b6b9-d65e16dce746/bone" />
<p class="text-center">Bone and Joint Infections</p>
</div>
</div>
<!-- Portfolio Item 4-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedCNS" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="meningitis" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/ea425690-7e1c-453c-bee1-547a29e66590/meningitis" />
<p class="text-center">Central Nervous System Infections</p>
</div>
</div>
<!-- Portfolio Item 6-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedENT" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="ent" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/d2fb7630-0091-4097-9a9b-c47ce73a956d/ent" />
<p class="text-center">Ear, Nose &amp; Throat Infections</p>
</div>
</div>
<!-- Portfolio Item 7-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedEye" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="eye" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/63d5374d-cc02-4805-8bde-7fdc834d0f81/eye" />
<p class="text-center">Opthamology Infections</p>
</div>
</div>
<!-- Portfolio Item 9-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedGastro" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="gastronintestinal" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/13f64820-31fb-4905-8613-d3771fc1b614/Intestines" />
<p class="text-center">Gastrointestinal Tract / Intra-abdominal Infections</p>
</div>
</div>
<!-- Portfolio Item 13-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedResp" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="lungs" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/74b391a7-b4f3-4e19-af16-df14ee925e24/lungs" />
<p class="text-center">Respiratory Tract Infections</p>
</div>
</div>
<!-- Portfolio Item 15-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedSkin" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="skin" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/3c0a1bd9-6e4b-45b1-81ee-fafed1fd2cdc/skin" />
<p class="text-center">Skin and Soft Tissue Infections</p>
</div>
</div>
<!-- Portfolio Item 16-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPaedUTI" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<img alt="urinary" class="img-fluid" src="https://www.tamesideandglossopccg.org/getmedia/0e95e4ac-8285-44e5-999f-3f90abc15229/urinary" />
<p class="text-center">Urinary Tract Infections</p>
</div>
</div>
</div>
</div>
<!--Hospital General Guidance-->

<div class="container">
<div class="row collapse hide pb-2" id="HCGeneralGuidelines" style="display:none">
<div class="col-lg-12">
<h3 class="text-center">General Guidance</h3>

<hr /></div>
<!-- Portfolio Item 1-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCEditors" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Editors</button></div>
</div>
<!-- Portfolio Item 2-->

<div class="col-xs-8 col-md-4 mb-3 ">
<div class="portfolio-item mx-auto" data-target="#HCLatest" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Latest Updates</button></div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCObjectives" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Objectives</button></div>
</div>
<!-- Portfolio Item 4-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCDecCDiff" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Decreasing Clostridium Difficile</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCResistantOrgs" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Preventing Resistant Organisms</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPenAllergy" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Penicillin Allergy</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCApRx" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Appropriate Prescribing</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCDrugMonitoring" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Therapeutic Drug Monitoring</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCPropbiotics" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Probiotics</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCIVOral" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">IV to Oral Switch</button></div>
</div>
<!-- Portfolio Item 5-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCReferences" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">References</button></div>
</div>
</div>
</div>
<!--Prophylaxis-->

<div class="container">
<div class="row collapse hide pb-2" id="HCProphylaxis" style="display:none">
<div class="col-lg-12">
<h3 class="text-center">Prophylaxis</h3>

<hr /></div>
<!-- Portfolio Item 1-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCMedProph" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">Medical Prophylaxis</button></div>
</div>
<!-- Portfolio Item 2-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#MRSAERAD" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the button we use for this view--><button class="btn btn-primary general">MRSA Eradication</button></div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCProphObsGynae" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Obstetrics and Gynaecology</button></div>
</div>
<!-- Portfolio Item 3-->

<div class="col-xs-8 col-md-4 mb-3">
<div class="portfolio-item mx-auto" data-target="#HCProphSurg" data-toggle="modal">
<div class="portfolio-item-caption d-flex align-items-center justify-content-center h-100 w-100">
<div class="portfolio-item-caption-content text-center text-white">&nbsp;</div>
</div>
<!--This is the image we use for this view--><button class="btn btn-primary general">Surgical Prophylaxis</button></div>
</div>
</div>
</div>
</section>
<!-- Footer-->

<footer class="footer text-center" id="footer">
<div class="container">
<div class="row"><!-- Footer About Text-->
<div class="col-md-6">
<h4>Feedback</h4>

<div class="col-md-12">
<p>For feedback on this webpage please contact Danny Jebb</p>
<a class="btn btn-primary mb-2" href="mailto:tgccg.medsqueries@nhs.net?subject=Website%20Feedback">Website feedback</a></div>

<div class="col-md-12">
<p>For feedback on the content of this webpage please contact Saarah Niazi-Ali</p>
<a class="btn btn-primary mb-2" href="mailto:s.niazi-ali@nhs.net?subject=Website%20Feedback">Content feedback</a></div>
</div>

<div class="col-md-6">
<h4 class="text-uppercase mb-4">Contacts</h4>
<a class="btn btn-primary mb-2" href="contacts.html">Team Contact List</a><br />
<a class="btn btn-primary mb-2" href="https://www.tamesideandglossopccg.org/antibiotic-guidelines/version-history">Version History</a></div>
</div>

<div class="col-md-12 mb-5 mb-lg-0">
<div>Icons made by <a href="https://www.flaticon.com/authors/srip" title="srip">srip</a> from <a href="https://www.flaticon.com/" title="Flaticon">www.flaticon.com</a></div>
</div>
</div>
</footer>
<!--  Modals--> <!-- Bone and Joint section-->

<div aria-hidden="true" aria-labelledby="BoneAndJointLabel" class="portfolio-modal modal fade " id="PCBone" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="BoneAndJointLabel">Bone and Joint</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4><a href="#iob" id="PCBoneSection">Infected Olecrenon Bursitis</a></h4>

<h4><a href="#osteomyelitis">Osteomyelitis</a></h4>
<br />
<!--Infective oclernon bursitis-->
<div class="text-left border border-info rounded" id="iobSection">
<h2 class="text-center" id="iob">Infected Olecrenon Bursitis</h2>

<p>Bursitis occurs when the bursa is irritated and inflamed and is generally classified as.&nbsp;</p>

<p>Non-septic (most common) - sterile inflammation resulting from various causes including trauma or overuse.&nbsp;</p>

<p>Septic - infection resulting from seeding of the bursal sac with micro-organisms, usually bacteria.&nbsp; Olecranon bursitis is more common in:</p>

<ul>
    <li>Athletes who play sports which involve repetitive overhead throwing or elbow flexion and extension.</li>
    <li>People in jobs which involve risk of regular elbow trauma or pressure on the bursa. For example gardeners and mechanics.</li>
    <li>Young or middle-aged men.&nbsp;</li>
</ul>

<p>Most cases of olecranon bursitis resolve without complications; however, recurrent episodes may occur especially after recurrent minor trauma.</p>
<!--Start accordian-->

<div id="accordionIob">
<div class="card">
<div class="card-header" id="iobTreatment">
<h5 class="mb-0"><button aria-controls="collapseIobTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseIobTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="iobTreatment" class="collapse" data-parent="#accordionIob" id="collapseIobTreatment">
<div class="card-body text-left">
<p>1st choice - <span style="color:#330099"><strong>Flucloxacillin 1g QDS 5 days</strong></span></p>

<p>2nd choice - <span style="color:#990066"><strong>Clindamycin 450mg QDS for 5 days</strong></span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Osteomyelitis-->
<div class="text-left border border-info rounded">
<h2 class="text-center" id="osteomyelitis">Osteomyelitis</h2>

<p>Osteomyelitis could be suspected if the following are seen:</p>

<ul>
    <li>Wound probing to bone</li>
    <li>sequestrated bone removed from wound</li>
    <li>static ulceration not responding to treatment (first address soft tissue infection, mechanical causes, ischaemia, co-morbidities)</li>
    <li>history of soft tissue infection increases suspicion</li>
    <li>&ldquo;Sausage toe&rdquo;</li>
</ul>
<!--Accordion-->

<div id="accordion1">
<div class="card">
<div class="card-header" id="osteoManagement">
<h5 class="mb-0"><button aria-controls="collapseOsteoManagement" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseOsteoManagement" data-toggle="collapse" type="button">Management</button></h5>
</div>

<div aria-labelledby="osteoManagement" class="collapse" data-parent="#accordion1" id="collapseOsteoManagement">
<div class="card-body text-left">
<ul>
    <li>Arrange x-ray to rule out osteomyelitis</li>
    <li>Collect and send any bone fragments to microbiology for culture and sensitivity</li>
    <li>Whilst results of x-ray awaited, treat any signs or symptoms of soft tissue infection using the CCG guidelines.&nbsp; If the infection does not respond to treatment liaise with microbiology.</li>
    <li>Refer patient to High Risk Foot Team for assessment and treatment plan advice (email:&nbsp; <a href="mailto:tga-tr.cids@nhs.net" target="_blank">tga-tr.cids@nhs.net</a>)</li>
</ul>

<p><strong>If radiology report diagnoses osteomyelitis:&nbsp; </strong></p>

<p>Liaise with microbiology around individualised treatment plan for patient.</p>

<p><strong>Dr H Sacho </strong>0161 922 4086 or contact via hospital switchboard (0161 922 6000)</p>

<p><strong>Dr P F Unsworth </strong>0161 922 6500 or contact via hospital switchboard</p>

<p>Monitor patient&rsquo;s wound at least weekly until healing achieved/ conservative plan set</p>

<p><strong>Please Note:</strong></p>

<p>Patient may need MRI to affected area if complex case/lack of clarity</p>
</div>
</div>
</div>
<!--Treatment-->

<div class="card">
<div class="card-header" id="osteoTreatment">
<h5 class="mb-0"><button aria-controls="collapseOsteoTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseOsteoTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="osteoTreatment" class="collapse" data-parent="#accordion1" id="collapseOsteoTreatment">
<div class="card-body text-left">
<p><strong><span style="color:#0000FF">Flucloxacillin 1g QDS</span></strong></p>

<p><u><strong><span style="color:#000000">Penicillin allergy</span></strong></u></p>

<p><strong><font color="#800080">Clindamycin 450mg QDS</font></strong></p>

<p>Typical treatment duration:</p>

<p><span style="color:#FF0000">4 weeks for septic arthritis and 6 weeks for osteomyelitis</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCBoneSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Upper Respiratory infections-->

<div aria-hidden="true" class="portfolio-modal modal fade " id="PCURT" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="URTI">Upper Respiratory Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<div id="acuteCoughtSection"><!-- Portfolio Modal - Acute Cough-->
<h4><a href="#acuteCough">Acute Cough</a></h4>

<h4><a href="#acuteRhin">Acute Rhinosinusitis</a></h4>

<h4><a href="#flu">Influenza</a></h4>

<h4><a href="#otExt">Otitis Externa</a></h4>

<h4><a href="#otMedia">Otitis Media</a></h4>

<h4><a href="#pertussis">Pertussis (Whooping Cough)</a></h4>

<h4><a href="#pharyngitis">Pharyngitis / Sore Throat / Tonsillitis</a></h4>

<hr class="mt-2 mb-3" />
<div class="text-left border border-info rounded">
<h4 id="acuteCough">Acute Cough</h4>

<h5 class="text-left">Be aware that an acute cough:</h5>

<ul class="text-left ">
    <li>is usually self-limiting and gets better within 3 to 4 weeks without antibiotics</li>
    <li>is most commonly caused by a viral upper respiratory tract infection, such as a cold or flu</li>
    <li>can also be caused by acute bronchitis, a lower respiratory tract infection, which is usually a viral infection but can be bacterial</li>
    <li>can also have other infective or non-infective causes.</li>
</ul>
<!--Accordian-->

<div id="accordionAc">
<div class="card">
<div class="card-header" id="acManagement">
<h5 class="mb-0"><button aria-controls="collapseAcuteCoughManagement" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseAcuteCoughManagement" data-toggle="collapse" type="button">Management</button></h5>
</div>

<div aria-labelledby="acManagement" class="collapse" data-parent="#accordionAc" id="collapseAcuteCoughManagement">
<div class="card-body text-left">
<p>Be aware that some people may wish to try the following self-care treatments, which have limited evidence of some benefit for the relief of cough symptoms:</p>

<ul>
    <li>honey (in people aged over 1 year)</li>
    <li>pelargonium (a herbal medicine; in people aged 12 and over)</li>
    <li>over-the-counter cough medicines containing the expectorant guaifenesin (in people aged 12 and over)</li>
    <li>over-the-counter cough medicines containing cough suppressants, except codeine, (in people aged 12 and over who do not have a persistent cough, such as in asthma, or excessive secretions).</li>
</ul>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="acTreatment">
<h5 class="mb-0"><button aria-controls="collapseAcuteCoughTx" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseAcuteCoughTx" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="acTreatment" class="collapse" data-parent="#accordionAc" id="collapseAcuteCoughTx">
<div class="card-body text-left">
<p>For people with an acute cough who are identified at a face-to-face clinical examination as systemically very unwell, offer an immediate antibiotic prescription&nbsp;</p>

<p>Be aware that people with an acute cough may be at higher risk of complications if they:</p>

<ul>
    <li>have a pre-existing comorbidity, such as significant heart, lung, renal, liver or neuromuscular disease, immunosuppression or cystic fibrosis</li>
    <li>are young children who were born prematurely</li>
    <li>are older than 65 years with 2 or more of the following criteria, or older than 80 years with 1 or more of the following criteria:  hospitalisation in previous year  type 1 or type 2 diabetes  history of congestive heart failure  current use of oral corticosteroids.</li>
</ul>

<p><span style="color:#c0392b"><u><strong>Reassess</strong></u></span> people with an acute cough if their symptoms worsen rapidly or significantly, taking account of:</p>

<ul>
    <li>alternative diagnoses, such as pneumonia</li>
    <li>any symptoms or signs suggesting a more serious illness or condition, such as cardiorespiratory failure or sepsis</li>
    <li>previous antibiotic use, which may have led to resistant bacteria.</li>
</ul>

<p><span style="color:#0000ff"><strong>Doxycycline 200 mg on first day, then 100 mg once a day</strong></span>&nbsp;</p>

<p><strong><span style="color:#660099">Amoxicillin 500mg - 1g three times a day</span></strong>&nbsp;</p>

<p><span style="color:#66cc00"><strong>Clarithromycin 500 mg twice a day</strong>&nbsp;</span></p>

<p>Review at day 3 and do not exceed total duration of treatment by 5 days in total</p>
</div>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Influenza-->
<div class="text-left border border-info rounded" id="influenzaSection">
<hr class="mt-2 mb-3" />
<h4 id="flu">Influenza</h4>

<div class="text-left">
<p>For further information on management of seasonal influenza please see <a href="https://cks.nice.org.uk/influenza-seasonal#!scenarioclarification" target="_blank">NICE guidance</a></p>

<p>Please note this service is provided by Public Health Laboratory Manchester</p>

<p><strong><strong>Influenza diagnostic service for General Practice </strong></strong></p>

<p><strong><strong>INTRODUCTION</strong></strong></p>

<ul>
    <li>Public Health Laboratory Manchester provides a testing service for respiratory viral infections, including Influenza.</li>
    <li>Primary Care leads will be notified by email once the enhanced service is operational. This will be when Influenza is circulating, either nationally (by CMO notification) or locally, whichever is sooner.</li>
</ul>

<p><strong><strong>SAMPLES</strong></strong></p>

<ul>
    <li>If patients are producing sputum, please collect a sample in sputum pot.</li>
    <li>For patients who are not producing sputum: Please send nose and throat swabs, combined in a single vial of virus transport medium (VTM). Please use one flocked swab to swab the nose and another one to swab the throat and then place both in a single vial of VTM.</li>
    <li>If virus transport medium is not available, specimens can be taken using dry cotton or Dacron-tipped swabs but they should <strong><strong>not </strong></strong>be sent in charcoal transport medium.</li>
</ul>

<p><strong><strong>REQUESTS</strong></strong></p>

<ul>
    <li>Respiratory virus testing, including Influenza can be requested on GP ICE.</li>
</ul>

<p><strong><strong>RESULTS </strong></strong></p>

<ul>
    <li>Between Monday and Friday routine respiratory virus results will generally be available within 24 hours of receipt in the laboratory. Results for samples received after 09.00 on Saturday or during Sunday will be available on the following Monday.</li>
    <li>Positive results will be telephoned to the requesting location during the following hours: 08.30-17.00 Monday to Friday and 08.30 to 12.30 on Saturday.</li>
    <li>A dedicated mobile phone number (07973 870099) will be available (08:30 to 17:00 seven days a week) for chasing urgent results.</li>
</ul>

<p><strong><strong>ADDITIONAL CONTACT DETAILS</strong></strong></p>

<ul>
    <li>For further information during normal working hours (Mon-Fri 9am-5pm and Saturday 09.00-12.30) please contact the laboratory (0161 2768854 Option 1).</li>
    <li>Outside of normal working hours the duty consultant virologist can be contacted for urgent clinical and operational advice via the hospital switchboard (01612761234).</li>
</ul>
</div>
<!--Accordion-->

<div id="accordionFlu">
<div class="card-header" id="fluPrevention">
<h5 class="mb-0"><button aria-controls="collapseFluPrevention" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseFluPrevention" data-toggle="collapse" type="button">Prevention</button></h5>
</div>

<div aria-labelledby="fluPrevention" class="collapse" data-parent="#accordionFlu" id="collapseFluPrevention">
<div class="card-body text-left">
<p>The current Department of Health advice should be followed.</p>

<p>Annual vaccination is essential for all those at risk of influenza.</p>
</div>
</div>

<div class="card-header" id="fluTreatment">
<h5 class="mb-0"><button aria-controls="collapseFluTx" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseFluTx" data-toggle="collapse">Treatment</button></h5>
</div>

<div aria-labelledby="fluTreatment" class="collapse" data-parent="#accordionFlu" id="collapseFluTx">
<div class="card-body text-left">
<p>Treatment is recommended when all of the following apply:</p>

<ul>
    <li>Influenza is known to be circulating in the community (indicated by national surveillance schemes).</li>
    <li>The patient is in an &lsquo;at-risk&rsquo; group.</li>
    <li>The patient presents with influenza-like illness and can begin treatment within 48 hours of the onset of symptoms.</li>
</ul>

<p><span style="color:#0000FF"><strong>Oseltamivir 75mg BD for 5 days</strong></span></p>

<p><strong>or</strong></p>

<p><strong><span style="color:#800080">Zanamivir 10 mg (2 inhalations via diskhaler) BD for 5 days </span></strong>(caution in asthma and COPD; there is a risk of bronchospasm so a short- acting bronchodilator should be available).</p>
</div>
</div>

<div class="card-header" id="fluProphylaxis">
<h5 class="mb-0"><button aria-controls="collapseFluProphylaxis" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseFluProphylaxis" data-toggle="collapse" type="button">Prophylaxis</button></h5>
</div>

<div aria-labelledby="fluProphylaxis" class="collapse" data-parent="#accordionFlu" id="collapseFluProphylaxis">
<div class="card-body text-left">
<ul>
    <li><span style="color:#000000">Prophylaxis is normally not considered in at-risk groups who have been vaccinated against seasonal influenza at least 14 days before exposure.&nbsp;</span></li>
    <li><span style="color:#000000">Prescribe an antiviral drug for post-exposure prophylaxis if all of the following circumstances apply:&nbsp;</span>
    <ul>
        <li><span style="color:#000000">The national surveillance scheme indicates that influenza is circulating.</span></li>
        <li><span style="color:#000000">The person has been exposed to a person (in the same household or residential setting) with&nbsp;an influenza-like illness.</span></li>
        <li><span style="color:#000000">The person is in an &#39;at risk&#39; group&nbsp;</span> <span style="color:#000000">(see below for more information)&nbsp;and has not been&nbsp;adequately protected by vaccination, that is:</span>
        <ul>
            <li><span style="color:#000000">They have not been vaccinated since the previous influenza season.</span></li>
            <li><span style="color:#000000">The vaccination is not well matched to the circulating strain.</span></li>
            <li><span style="color:#000000">There has been less than 14 days between vaccination and date of contact with influenza.</span></li>
        </ul>
        </li>
        <li><span style="color:#000000">The person is able to start treatment within 48&nbsp;hours of this contact (for oseltamivir) or 36&nbsp;hours of this contact (for zanamivir).</span>
        <ul>
            <li><span style="color:#000000">Treatment after 48&nbsp;hours of this contact (for oseltamivir) or 36&nbsp;hours of this contact (for zanamivir) is an off-label use and should be done on specialist advice only.</span></li>
        </ul>
        </li>
    </ul>
    </li>
</ul>

<p><span style="color:#000000">Prophylaxis is also recommended for residents in chronic care establishments (regardless of influenza vaccination) using oseltamivir within 48 hours of influenza-like illness being present in the establishment.</span></p>

<p><span style="color:#0000ff"><strong>Oseltamivir 75mg OD for 10 days</strong></span><span style="color:#000000"> (within 48 hours of contact)</span></p>

<p><span style="color:#000000"><strong>or</strong></span></p>

<p><span style="color:#990099"><strong>Zanamivir 10mg (via diskhaler) OD for 10 days</strong></span><span style="color:#000000"> (within 36 hours of contact)</span></p>
</div>
</div>

<div class="card-header" id="fluRisk">
<h5 class="mb-0"><button aria-controls="collapseFluRisk" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseFluRisk" data-toggle="collapse" type="button">At Risk Groups</button></h5>
</div>

<div aria-labelledby="fluRisk" class="collapse" data-parent="#accordionFlu" id="collapseFluRisk">
<div class="card-body text-left">
<ul>
    <li><strong>Chronic respiratory disease</strong>, including:

    <ul>
        <li>Chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis, and bronchopulmonary dysplasia.</li>
        <li>Asthma that requires continuous or repeated use of inhaled corticosteroids or with previous exacerbations requiring hospital admission.</li>
        <li>Children who have previously been admitted to hospital for lower respiratory tract disease.</li>
    </ul>
    </li>
    <li><strong>Chronic heart disease</strong>, including congenital heart disease, hypertension with cardiac complications, chronic heart failure, and individuals requiring regular medication or follow up for ischaemic heart disease.</li>
    <li><strong>Chronic kidney disease</strong>, including nephrotic syndrome, chronic renal failure, and renal transplantation.</li>
    <li><strong>Chronic liver disease</strong>, including cirrhosis, biliary atresia, and chronic hepatitis.</li>
    <li><strong>Chronic neurological disease</strong>, including stroke and transient ischaemic attack.</li>
    <li><strong>Diabetes</strong>, including type&nbsp;1 diabetes and type&nbsp;2 diabetes (requiring oral hypoglycaemic drugs or a controlled diet).</li>
    <li><strong>Immunosuppression</strong>&nbsp;due to disease or treatment, including:
    <ul>
        <li>People undergoing chemotherapy (or radiotherapy) leading to immunosuppression.</li>
        <li>People with asplenia or splenic dysfunction.</li>
        <li>HIV infection (all stages).</li>
        <li>Individuals treated with, or likely to be treated with, systemic steroids for more than 1&nbsp;month at dosages equivalent to 20&nbsp;mg prednisolone daily (at any age) or, for children weighing less than 20&nbsp;kg, a dose of 1&nbsp;mg or more per kg body weight per day.</li>
    </ul>
    </li>
    <li><strong>Morbid obesity (body mass index of 40 or more).</strong></li>
</ul>

<p><strong>Consideration should also be given to:</strong></p>

<ul>
    <li>People living in long-stay residential or nursing homes.</li>
    <li>People who receive a carer&rsquo;s allowance or care for disabled or elderley people, whose welfare may be at risk if the carer falls ill.</li>
</ul>
</div>
</div>
</div>
</div>
<br />
<!--Pertussis-->
<div class="text-left border border-info rounded" id="pertussisSection">
<hr class="mt-2 mb-3" />
<h4 id="pertussis">Pertussis (Whooping Cough)</h4>

<div class="text-left">
<p>There is increased pertussis activity in England and it is advised that the following actions should be taken:</p>

<ul>
    <li>Immunise: all infants must be immunised at the correct time to ensure they are protected as early as possible and prevent spread to vulnerable infants.</li>
    <li>Notify: suspected cases must be reported to PHE North West on 0344 225 0562.</li>
    <li>Treat: follow treatment recommendations by the PHE at: <a href="https://www.gov.uk/government/collections/pertussis-guidance-data-and-analysis" target="_blank">https://www.gov.uk/government/collections/pertussis-guidance-data-and-analysis</a></li>
    <li>Test: the specimen taken will depend on the time of presentation. For patients presenting within 14 days of onset of cough, take a per nasal swab.&nbsp; For patients presenting after 14 days of onset of cough, take blood for serology.</li>
</ul>

<p>Please can the following form also be completed and faxed or emailed to PHE</p>

<p><a href="https://www.gov.uk/government/publications/notifiable-diseases-form-for-registered-medical-practitioners" target="_blank">Registered medical practitioner notification form</a></p>
</div>
</div>
<!--Pharyngitis-->

<div class="text-left border border-info rounded" id="pharyngitisSection">
<hr class="mt-2 mb-3" />
<h4 id="pharyngitis">Pharyngitis / Sore Throat / Tonsillitis</h4>

<div class="text-left">
<p><strong>Avoid antibiotics </strong>as 90% resolve in 7 days&nbsp;without, and pain only reduced by 16 hours.</p>

<p>Use<strong> <a href="https://ctu1.phc.ox.ac.uk/feverpain/index.php" target="_blank">FeverPAIN</a> Score: </strong></p>

<p>Fever in last 24h, Purulence, Attend rapidly under 3d, severely Inflamed tonsils, No cough or coryza</p>

<p><strong>Score 0-1</strong>: 13-18% streptococci, use NO antibiotic strategy;</p>

<p><strong>2-3: </strong>34-40% streptococci, use 3 day back-up antibiotic;</p>

<p><strong>&gt;4:</strong> 62-65% streptococci, use immediate antibiotic if severe, &nbsp;or 48hr short back-up prescription</p>

<p>A positive throat swab culture growing Streptococcus Group A, together with clinical features of acute pharyngotonsillitis almost certainly indicates infection.&nbsp;</p>

<p>If you have taken a throat swab before prescribing antibiotics and it is reported negative for Streptococcus&nbsp;Group A&nbsp;do not prescribe antibiotics, and if antibiotics have already been commenced, discontinue them.</p>

<p>Streptococcus A throat swab POC testing can be a&nbsp;rapid way to determine bacterial vs viral sore throat and consideration should be given to this method of testing especially in the urgent care or walk-in setting.</p>
</div>
<br />
<!--Treatment-->
<div id="accordionPharyngitis">
<div class="card">
<div class="card-header" id="pharyngitisTreatment">
<h5 class="mb-0"><button aria-controls="collapsePharyngitisTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsePharyngitisTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="pharyngitisTreatment" class="collapse" data-parent="#accordionPharyngitis" id="collapsePharyngitisTreatment">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Phenoxymethylpenicillin 500mg QDS</strong></span> or <span style="color:#0000ff"><strong>1g BD (QDS) when severe</strong></span>&nbsp;for 5 days.&nbsp; (10 days for scarlet fever).</p>

<p><u><span style="color:#000000"><strong>Penicillin allergy</strong></span></u></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg BD</strong></span> for 5&nbsp;days. (10 days for scarlet fever).</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Otitis Media-->
<div class="text-left border border-info rounded" id="OtMediaSection">
<hr class="mt-2 mb-3" />
<h4 id="otMedia">Otitis Media</h4>

<div class="text-left">
<p><span style="color:#000000"><strong>Many cases are viral and otitis media resolves in 60% of cases without antibiotics within 24 hours</strong></span>. You need to treat 15 children aged over 2 years to get pain relief in one child, at 2 days. A poor outcome is unlikely if there is no vomiting and the temperature is below 38.5&ordm;C. Recent evidence suggests that antibiotics seem to be most beneficial in children younger than 2 years of age with bilateral acute otitis media, and in children with both acute otitis media and otorrhoea.</p>

<p>The best option is to use pain relief for 24 hours (ibuprofen or paracetamol) before deciding if antibiotics&nbsp; are needed.&nbsp; Consider a delayed prescription to use if symptoms don&rsquo;t improve in 24 hours.</p>

<p>2-3 days treatment may be sufficient so parents can stop the antibiotics before the end of the course if their child has recovered.</p>
</div>

<div id="accordionOtMedia">
<div class="card">
<div class="card-header" id="OtMediaTreatment">
<h5 class="mb-0"><button aria-controls="collapseOtMediaTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseOtMediaTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="OtMediaTreatment" class="collapse" data-parent="#accordionOtMedia" id="collapseOtMediaTreatment">
<div class="card-body text-left">
<p>Treatment for adults (for children see BNF for doses)</p>

<p><span style="color:#0000FF"><strong>Amoxicillin 500mg TDS</strong></span> for 5 days or <span style="color:#0000FF"><strong>1g TDS</strong></span> for 3 days</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg BD</strong></span> for 5 days</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Otitis Externa-->
<div class="text-left border border-info rounded" id="OtExternaSection">
<hr class="mt-2 mb-3" />
<h4 id="otExt">Otitis Externa</h4>

<div class="text-left">
<p>First use aural toilet and analgesics.</p>

<p>Cure rates are similar at 7 days for topical acetic acid or antibiotic +/- steroid.</p>

<p>First line:<span style="color:rgb(0, 0, 255)"> <strong>Acetic acid 2%</strong> </span>(e.g. Earcalm available over the counter)<span style="color:rgb(0, 0, 255)"> <strong>1 spray TDS</strong></span> 7 days</p>

<p>Second line: <span style="color:rgb(0, 0, 255)"><strong>Neomycin sulphate with corticosteroid </strong>(e.g. Otomize ear spray, 1 puff TDS or Betnesol N ear drops 3 drops TDS) 7 days min to 14 days max.</span></p>

<p>Advise patient to apply tragal pressure to help remove&nbsp;the debris.</p>

<p><span style="color:#FF0000"><strong>AVOID IF PERFORATED TYMPANIC MEMBRANE. </strong></span></p>

<p>If cellulitis or disease extending outside the ear canal, start oral antibiotics and refer.</p>
</div>
</div>
<br />
<!--Acute Rhinosinusitis-->
<div class="text-left border border-info rounded" id="acuteRhinosSection">
<hr class="mt-2 mb-3" />
<h4 id="acuteRhin">Acute Rhinosinusitis</h4>

<div class="text-left">
<p><strong>Avoid antibiotics as 80% resolve in 14 days without, and they only offer marginal benefit after 7 days. </strong></p>

<p>Reserve antibiotics for those with severe or persistent (10 days plus) symptoms. Steam inhalations will encourage drainage and can give relief. Use adequate analgesia. Consider delayed or immediate antibiotic when purulent nasal discharge.</p>
</div>

<div id="accordionRhinosinusitis">
<div class="card">
<div class="card-header" id="RhinoTreatment">
<h5 class="mb-0"><button aria-controls="collapseRhinoTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseRhinoTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="RhinoTreatment" class="collapse" data-parent="#accordionRhinosinusitis" id="collapseRhinoTreatment">
<div class="card-body text-left">
<p><strong>Treatment for adults (for children see CBNF for doses) </strong></p>

<p><span style="color:#0000cd"><strong>Amoxicillin 500 mg TDS</strong> </span>for 5&nbsp;days<span style="color:#0000cd"> (<strong>1g if severe</strong>) </span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Doxycycline 200 mg STAT then 100 mg OD </strong></span>for 5&nbsp;days in total.</p>

<p>Doxycycline must <strong>NOT </strong>be prescribed for children under 12 years, or for pregnant or breast-feeding women.</p>

<p>If failure to respond to the above first line antibiotics use</p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav 625 mg TDS</strong> </span>for 5&nbsp;days</p>

<p><u><strong>Penicillin allergy</strong></u></p>

<p><span style="color:#800080"><strong>Clarithromcyin 500 mg BD</strong></span><span style="color:#0000ff"> </span>for 5&nbsp;days</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#URTI"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- UTI section-->

<div aria-hidden="true" aria-labelledby="UrinaryTractLabel" class="portfolio-modal modal fade " id="PCUTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="UrinaryTractLabel">Urinary Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="PCUrine"><a href="#acutePyelonephritis">Acute Pyelonephritis</a></h4>

<h4><a href="#bacterialProstatitis">Bacterial Prostatitis</a></h4>

<h4><a href="#catheterUTI">Catheter-associated UTI</a></h4>

<h4><a href="#recurrentUTI">Recurrent UTI</a></h4>

<h4><a href="#PCuncomplicatedFemales">Uncomplicated UTI in Females</a></h4>

<h4><a href="#childrenUTI">UTI in Children</a></h4>

<h4><a href="#maleUTI">UTI in Males</a></h4>

<h4><a href="#pregnancyUTI">UTI in pregnancy</a></h4>
<br />
<!--Acute pyelonephritis-->
<div class="text-left border border-info rounded" id="pyelonephritisSection">
<h2 class="text-center" id="acutePyelonephritis">Acute Pyelonephritis</h2>

<p>Pyelonephritis is inflammation of the kidney which usually results from bacterial infection. It is important to differentiate pyelonephritis (upper urinary tract infection) from cystitis (lower urinary tract infection) in order to treat the patient appropriately. Pyelonephritis triggers a systemic response and symptoms include: fever, rigors, flank pain, nausea, vomiting and costovertebral angle tenderness, whereas symptoms of cystitis are more localised to the area of infection i.e. the bladder and include dysuria, urinary bladder frequency and urgency,and suprapubic pain.</p>
<!--Start accordian-->

<div id="accordionAcutePye">
<div class="card">
<div class="card-header" id="acutePyeTreatment">
<h5 class="mb-0"><button aria-controls="collapseAcutePyeTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseAcutePyeTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="acutePyeTreatment" class="collapse" data-parent="#accordionAcutePye" id="collapseAcutePyeTreatment">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Cefalexin 1g&nbsp;TDS</strong></span> for 10 days.</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

<p><strong><span style="color:#800080">Ciprofloxacin 500mg BD</span></strong> for 7 days.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Bacterial Prostatitis-->
<div class="text-left border border-info rounded" id="prostatitisSection">
<h2 class="text-center" id="bacterialProstatitis">Bacterial Prostatitis</h2>

<p>Send a MSU off for culture and prescribe empiric antibiotics. Review antibiotic therapy when sensitivity results come back (refer to urologist).</p>
<!--Start accordian-->

<div id="accordionProstatitis">
<div class="card">
<div class="card-header" id="prostatitisTreatment">
<h5 class="mb-0"><button aria-controls="collapseProstatitisTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseProstatitisTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="prostatitisTreatment" class="collapse" data-parent="#accordionProstatitis" id="collapseProstatitisTreatment">
<div class="card-body text-left">
<p><span style="color:#000000"><strong>1st line:</strong></span><span style="color:#800080"><strong> </strong></span><strong><span style="color:#0000ff">Co-trimoxazole 960mg BD</span></strong><span style="color:#3333cc"> </span>for 14&nbsp;days.</p>

<p><span style="color:#000000"><strong>2nd line:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#8e44ad"><strong>Ciprofloxacin 500mg BD</strong> </span>for 14&nbsp;days.</p>

<p><span style="color:#000000"><strong>3rd line:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#e74c3c"><strong>Doxycycline 100mg&nbsp;BD</strong> </span>for 14&nbsp;days.</p>

<p>In sexually active young men consider a diagnosis of Chlamydia trachomatis or gonorrhoea. Refer all men for investigation by a specialist after recovery to exclude a structural cause.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Catheter-associated UTI-->
<div class="text-left border border-info rounded" id="cathUTISection">
<h2 class="text-center" id="catheterUTI">Catheter-associated UTI</h2>

<ul>
    <li>Catheter-associated UTI occurs when bacteria in a catheter bypass the body&#39;s defence mechanisms and enter the bladder.</li>
    <li>The longer a catheter has been in place the more likely bacteria will be found in the urine</li>
    <li>Treatment is only needed for <u><strong>symptomatic</strong></u>&nbsp;catheter-associated UTI (apart from in pregnancy)</li>
    <li>Removing or changing the catheter (especially if it has been in place for longer than 7 days) should be strongly considered.</li>
    <li>Catheters should be&nbsp;reviewed and&nbsp;removed rather than changed if possible</li>
</ul>
<!--Start accordian-->

<div id="accordionCatheterUTI">
<div class="card">
<div class="card-header" id="catheterUTITreatment">
<h5 class="mb-0"><button aria-controls="collapseCatheterUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseCatheterUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="catheterUTITreatment" class="collapse" data-parent="#accordionCatheterUTI" id="collapseCatheterUTITreatment">
<div class="card-body text-left">
<p><span style="background-color:white"><strong>This is not routinely required for every patient</strong>.&nbsp; However, for those patients that are truly symptomatic of a UTI and require a catheter change (rather than just removal)&nbsp;<strong>and</strong>&nbsp;there is concern regarding&nbsp;introduction of bacteria during the change (due to previous medical history or traumatic catheter change),&nbsp;then antibiotics can be given to reduce the incidence of bacteraemia.</span></p>

<p><span style="background-color:white">Any antibiotic therapy for these patients should be based on previous known urine sensitivities and ideally a specimen&nbsp;be sent for urinalysis&nbsp;<strong><u>BEFORE</u></strong>&nbsp;any antibiotic therapy is started for resolution of the UTI.</span></p>

<p><span style="background-color:white">Urine specimens should&nbsp;<strong><u>ALWAYS</u></strong>&nbsp;be taken from the sampling port and&nbsp;<u>NOT</u>&nbsp;the catheter bag.&nbsp;Refer to the <u>Trust Urinary catheterisation and catheter care management adults policy</u> for guidance on best practice.</span></p>

<p><span style="background-color:white"><a data-dismiss="modal" data-target="#HCProphSurg" data-toggle="modal" href="#HCSurgUrinCatheter"> Urinary catheterisation prophylaxis  </a>&nbsp;&nbsp;for those patients with urethritis, where Staph aureus has been isolated, and require a catheter change.</span></p>

<p><span style="background-color:white">For further advice on individual patients contact Urology Specialist Nurses 0161 922 6696, Infection Prevention Nurses on 0161 922 6194 or the Consultant Microbiologist on 0161 922 4086 / 6500.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Recurrent UTI-->
<div class="text-left border border-info rounded" id="recurrentUTISection">
<h2 class="text-center" id="recurrentUTI">Recurrent UTI</h2>

<p>Recurrent urinary tract infection (UTI) in adults is defined as repeated UTI with frequency of 2 or more UTIs in the last 6 months or 3 or more UTIs in the last 12 months.</p>

<p>Comprehensively assess the problem and refer to a specialist urologist or gynaecologist (for female patients).</p>

<p><strong>Behavioural and personal hygiene measures:</strong></p>

<p>Patients <span style="color:#282828"><span style="color:#282828"><span style="color:#282828"><span style="color:#282828">should be given advice about behavioural and personal <span style="color:#282828"><span style="color:#282828">hygiene measures to reduce the risk of UTI, such as:</span></span></span></span></span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- drinking enough fluids to avoid dehydration</span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- </span></span><span style="color:#282828"><span style="color:#282828">not delaying habitual and post-coital urination</span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- wiping from front to back after defaecation</span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- not douching or wearing occlusive underwear.</span></span></p>

<p><strong><span style="color:#000000">Cranberry products and D-mannose:</span></strong></p>

<p><span style="color:#58595b">Some women find these effective, but there is currently poor evidence to support this and patients should be warned about the sugar content of these products if relevant.&nbsp; Cranberry products should be avoided by patients on warfarin.</span></p>
<!--Start accordian-->

<div id="accordionRecurrentUTI">
<div class="card">
<div class="card-header" id="recurrentUTITreatment">
<h5 class="mb-0"><button aria-controls="collapseRecurrentUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseRecurrentUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="catheterUTITreatment" class="collapse" data-parent="#accordionRecurrentUTI" id="collapseRecurrentUTITreatment">
<div class="card-body text-left">
<p><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></p>

<p>If behavioural and personal hygiene measures do not reduce incidence of UTI, antibiotic treatment may be considered from one of the following recommendations below:</p>

<ul>
    <li>Each episode of UTI may be treated by a healthcare professional as it occurs.</li>
    <li>Patient/carer initiated antibiotic treatment is a cost-effective and safer alternative (in terms of avoiding the development of CDI and antibiotic resistance) compared to continuous antibiotic prophylaxis.&nbsp; This&nbsp;entails self-administration of single high-dose antibiotic treatment; however, if symptoms persist, treatment could continue for up to 3 days, but often 1 or 2 days are sufficient.&nbsp; This should be considered in patients who are compos mentis and are capable of recognising the symptoms of UTI. The patient should be counselled on how and when to self-treat.&nbsp; Antibiotics should be reviewed every 6 months.</li>
    <li>Antibiotic prophylaxis with either trimethoprim 100mg or nitrofurantoin 50mg nocte (provided there is sensitivity to these antibiotics) may be considered where it may be impractical for patients or carers to initiate antibiotics appropriately however antibiotics must be reviewed at least every 6 months.&nbsp; The patient should be counselled on adverse effects&nbsp;and&nbsp;the risk of antibiotic resistance developing.</li>
    <li>If related to sexual intercourse consider a single dose of antibiotic post coital (off-label use).&nbsp; Trimethoprim 200mg or nitrofurantoin 100mg stat&nbsp;may be given&nbsp;after taking into account sensitivity results.&nbsp; Antibiotics should be reviewed every 6 months.</li>
</ul>

<p>For patients who develop and continue to have symptoms of UTI whilst taking antibiotic prophylaxis or treating a UTI, they should be advised to seek medical help.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Uncomplicated Female UTI-->
<div class="text-left border border-info rounded" id="PCuncomplicatedFemales">
<h2 class="text-center" id="femaleUTI">Uncomplicated UTI in Females</h2>

<p>If there is fever, flank or back pain then it is likely to be an upper UTI and antibiotic treatment for 7 - 14 days is needed, (see pyelonephritis section).</p>

<p>If symptoms are mild the woman may wish to consider not taking antibiotics and simply increase her fluid intake as UTIs often resolve spontaneously in a few days.</p>

<p>If the woman has more than 3 typical symptoms of a UTI, and no vaginal discharge, then treat empirically with antibiotics as below.</p>

<p>If the woman has 2 or less, or mild symptoms, obtain a urine sample. If the urine is NOT cloudy this gives a 97% negative predictive value, so do not treat unless other risk factors of infection are present.</p>

<p>If urine is cloudy then perform a urine dipstick test containing nitrite and leucocyte esterase impregnated reagent. If the results are negative for leucocytes and nitrites then there is a 95% negative predictive value. If both are positive, or nitrite or leucocyte esterase are positive, then treat.&nbsp; However, if only leucocytes are positive only treat if symptoms are severe and send urine for culture.</p>

<p>DO NOT PERFORM URINE DIPSTICK TESTS IN THOSE OVER THE AGE OF 65 YEARS</p>
<!--Start accordian-->

<div id="accordionFemaleUTI">
<div class="card">
<div class="card-header" id="femaleUTITreatment">
<h5 class="mb-0"><button aria-controls="collapseFemaleUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseFemaleUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="femaleUTITreatment" class="collapse" data-parent="#accordionFemaleUTI" id="collapseFemaleUTITreatment">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Nitrofurantoin 100mg MR BD</span></strong>&nbsp;for 3 days (nitrofurantoin 50mg QDS may be an alternative if supply issues with MR preparations).</p>

<p>Nitrofurantoin is contraindicated in patients with an eGFR of &le;45ml/min; however it maybe used with caution in patients with eGFR 30-44ml/min provided the duration of treatment does not exceed 7 days</p>

<p>OR</p>

<p><span style="color:#800080"><strong>Pivmecillinam 400mg STAT then 200mg TDS</strong></span> for 3 days <strong>(this is a penicillin)</strong></p>

<p>If the above two options are not suitable for patients then please use MSU results to guide treatment or discuss with Microbiologist on 0161 922 4086/6500 or mobile via switch 0161 922 6000</p>

<p>If a patient is penicillin allergic (anaphylaxis) and has poor renal function whereby other antibiotic options can&#39;t be used then<span style="color:#00ff00"><strong>&nbsp;</strong></span><span style="color:#008000"><strong>Fosfomycin (prescribe as <em>Monuril</em>) 3g STAT once only</strong></span> can be given.</p>
</div>
</div>

<div class="card-header" id="femaleUTIResistence">
<h5 class="mb-0"><button aria-controls="collapseFemaleUTIResistence" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseFemaleUTIResistence" data-toggle="collapse" type="button">Resistance within our population</button></h5>
</div>

<div aria-labelledby="femaleUTIResistence" class="collapse" data-parent="#accordionFemaleUTI" id="collapseFemaleUTIResistence">
<div class="card-body text-left">
<p>We have high levels of resistance (50%) to co-amoxiclav of E coli. &nbsp;Pivecillinam has shown to be effective against E coli and is also a recommended choice in the PHE guidelines. The resistance to this drug is low in our local population at 16%. Cephalosporins have high sensitivity rates in Tameside.</p>

<p>Extended - spectrum Beta-lactamase enzymes (ESBLs) in gram-negative bacilli such as E. coli are increasing, and these ESBL-producing E. coli are multi-resistant but remain sensitive to nitrofurantoin. Consider a diagnosis of Chlamydia trachomatis in sexually active young women (in which case urine or endocervical specimens should be submitted for Chlamydia PCR assay).</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--UTI Children-->
<div class="text-left border border-info rounded" id="childrenUTISection">
<h2 class="text-center" id="childrenUTI">UTI in Children</h2>

<p>Send a MSU for culture and rule out or manage associated conditions (e.g. constipation, urinary tract obstruction). In a child over 60 days old with mild symptoms or another possible cause a urine dipstick test can be performed. If negative for nitrites and leucocyte esterase, antibiotics can be delayed until culture results become available. With moderate symptoms start antibiotics and review treatment when the culture results are back.</p>

<p>NICE guidelines also state that the locally agreed choices should be followed.</p>
<!--Start accordian-->

<div id="accordionChildrenUTI">
<div class="card">
<div class="card-header" id="childrenUTITreatment">
<h5 class="mb-0"><button aria-controls="collapseChildrenUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseChildrenUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="childrenUTITreatment" class="collapse" data-parent="#accordionChildrenUTI" id="collapseChildrenUTITreatment">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Trimethoprim </strong></span>dosed as in cBNF for 3 days</p>

<p>An alternative antibiotic should be used if the child is already on trimethoprim prophylaxis (in which case the trimethoprim should be stopped), has had it in the last 3months, or has had previous infections resistant to it e.g.</p>

<p><span style="color:#800080"><strong>Cefalexin</strong></span> dosed as in cBNF for 3 days</p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#B22222"><strong>Nitrofurantoin</strong></span> dosed as in c BNF for 3 days</p>

<p>For children who are 3 months or older and have cystitis or lower UTI NICE guidance CG54 suggests 3 days treatment for lower UTI. However if the child is still unwell after 24 - 48 hours, therapy needs reviewing and if there is no alternative diagnosis, send urine for culture.</p>

<p>For children who are under 3 months or children with upper UTI/pyelonephritis refer immediately to a paediatric specialist.</p>

<p>Infants and children with recurrent UTIs should be referred for assessment by a paediatric specialist.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--UTI Males-->
<div class="text-left border border-info rounded" id="maleUTISection">
<h2 class="text-center" id="maleUTI">UTI in Males</h2>

<p>Always send a MSU off to the lab for culture. Consider a diagnosis of prostatitis and refer if necessary. In sexually active young men with urinary symptoms consider Chlamydia trachomatis and other sexually transmitted infections.</p>

<p>DO NOT PERFORM URINE DIPSTICK TESTS IN THOSE OVER THE AGE OF 65 YEARS</p>
<!--Start accordian-->

<div id="accordionMaleUTI">
<div class="card">
<div class="card-header" id="maleUTITreatment">
<h5 class="mb-0"><button aria-controls="collapseMaleUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseMaleUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="maleUTITreatment" class="collapse" data-parent="#accordionMaleUTI" id="collapseMaleUTITreatment">
<div class="card-body text-left">
<p>1st choice:<strong> <span style="color:#3300ff">Pivmecillinam 400mg STAT</span>&nbsp;</strong>for the first dose followed by<strong><span style="color:#3300ff"> 200mg TDS</span>&nbsp;</strong>thereafter&nbsp;for&nbsp;7 days<strong>.</strong></p>

<p>2nd choice:<span style="color:#8e44ad"><strong> Nitrofurantoin 100mg MR BD</strong></span>&nbsp;for&nbsp;7 days (nitrofurantoin 50mg QDS may be an alternative if supply issues with MR preparations)</p>

<p>Nitrofurantoin is contraindicated in patients with an eGFR of &le;45ml/min however it may be used with caution in patients with eGFR 30-44ml/min provided the duration of treatment does not exceed 7 days.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Pregnancy UTI-->
<div class="text-left border border-info rounded" id="pregnancyUTISection">
<h2 class="text-center" id="pregnancyUTI">UTI in Pregnancy</h2>

<p>A MSU (mid stream urine sample) should be sent off for culture at the first antenatal visit, as asymptomatic bacteriuria can be associated with pyelonephritis and premature delivery. If the patient presents with signs of a UTI send off a MSU for culture.</p>

<p>Treat empirically until sensitivity data comes back. Repeat the MSU 7 days after treatment has been completed to ensure the infection has been eradicate.</p>
<!--Start accordian-->

<div id="accordionPregnancyUTI">
<div class="card">
<div class="card-header" id="pregnancyUTITreatment">
<h5 class="mb-0"><button aria-controls="collapsePregnancyUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsePregnancyUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="pregnancyUTITreatment" class="collapse" data-parent="#accordionPregnancyUTI" id="collapsePregnancyUTITreatment">
<div class="card-body text-left">
<p><u><strong>ORAL TREATMENT:</strong></u></p>

<p><strong>1st line:</strong>&nbsp;<strong><span style="color:#2980b9">Nitrofurantoin 100mg MR BD </span>- </strong><u><strong>AVOID AT TERM (from 37 weeks).</strong></u></p>

<p><strong>2nd line: </strong><span style="color:#8e44ad"><strong>Pivmecillinam 400mg STAT then 200mg TDS</strong></span><strong><span style="color:#8e44ad"> </span>(this is a penicillin-containing antibiotic)</strong></p>

<p><strong>3rd line: </strong><span style="color:#c0392b"><strong>Cefalexin 500mg TDS</strong></span> - <strong>avoid if penicillin allergy anaphylaxis.</strong></p>

<p><strong>Treatment duration is a total of 7 days.</strong></p>
</div>
</div>

<div class="card-header" id="pregnancyUTIResistence">
<h5 class="mb-0"><button aria-controls="collapsePregnancyUTIResistence" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsePregnancyUTIResistence" data-toggle="collapse" type="button">Resistance within our population</button></h5>
</div>

<div aria-labelledby="pregnancyUTIResistence" class="collapse" data-parent="#accordionPregnancyUTI" id="collapsePregnancyUTIResistence">
<div class="card-body text-left">
<p>Cefalexin has been chosen as first line choice as we have high levels of E coli sensitive to this antibiotic in our local population and it also concentrates well in the urine.&nbsp; It is of utmost importance that UTI in pregnancy is treated promptly and effectively. We can be confident that this is the case if cephalexin is used in this population.</p>

<p>Short term use of nitrofurantoin in pregnancy is unlikely to cause problems to the foetus. Nitrofurantoin i s contraindicated in patients with an eGFR of &le;45ml/min however it may be used with caution in patients with eGFR 30-44ml/min provided the duration of treatment does not exceed 7 days.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCUrine"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Primary Care Skin section-->

<div aria-hidden="true" aria-labelledby="SkinLabel" class="portfolio-modal modal fade " id="PCSkin" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="SkinLabel">Skin and Soft Tissue Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="PCSkinTissue"><a href="#PCacne">Acne</a></h4>

<h4><a href="#PCcellulitis">Cellulitis</a></h4>

<h4><a href="#PCchickenpox">Chicken Pox</a></h4>

<h4><a href="#PCderma">Dermatophyte Infection of the Skin</a></h4>

<h4><a href="#PCdiabeticFoot">Diabetic Foot Infection</a></h4>

<h4><a href="#PCfungalNail">Fungal Nail Infections</a></h4>

<h4><a href="#PCHumanbitesSection">Human and Animal Bites</a></h4>

<h4><a href="#PCimpetigo">Impetigo</a></h4>

<h4><a href="#PCinsectBitesSection">Insect Bites and Stings</a></h4>

<h4><a href="#PClegUlcers">Leg Ulcers / Pressure Sores</a></h4>

<h4><a href="#PCscarletFever">Scarlet Fever</a></h4>

<h4><a href="#PCshingles">shingles</a></h4>

<h4><a href="#PCstrepA">Strep Group A</a></h4>
<br />
<!--Insect Bites-->
<div class="text-left border border-info rounded" id="PCinsectBitesSection">
<h2 class="text-center" id="PCInsectBites">Insect Bites and Stings</h2>

<p>Please note that a rapid-onset skin reaction is likely to be an inflammatory or allergic reaction rather than an infection.</p>

<p>Most insect bites or stings will <u><strong>not</strong></u> require antibiotics.</p>

<p>Advise patients:</p>

<ol>
    <li>That skin redness and itching are common and may last for up to 10 days</li>
    <li>Avoid scratching as this may&nbsp;help reduce inflammation and the risk of infection</li>
    <li>They should seek medical help if symptoms worsen significantly at any time or they become systemically unwell</li>
</ol>
<!--Start accordian-->

<div id="PCaccordionInsectBites">
<div class="card">
<div class="card-header" id="PCInsectbitesTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseInsectBitesTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseInsectBitesTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCInsectbitesTreatment" class="collapse" data-parent="#PCaccordionInsectBites" id="PCcollapseInsectBitesTreatment">
<div class="card-body text-left">
<p>Do not routinely offer antibiotics if there are no signs or symptoms of spreading cellulitis.</p>

<p>Be aware that people may wish to consider oral antihistamines (in those over 1 year old) to help relieve itching.</p>

<p>If signs and symptoms of infection treat as <a href="#PCcellulitis">  cellulitis</a> </p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Bites-->
<div class="text-left border border-info rounded" id="PCHumanbitesSection">
<h2 class="text-center" id="PCbites">Human and Animal Bites</h2>

<p><strong><u><span style="color:black">Note:</span></u></strong><strong><u><span style="color:#e74c3c"> see also section below under the heading animal and human bites to the hand including clenched fist injuries.</span></u></strong></p>

<p>Antibiotic prophylaxis is recommended for all wounds under 72 hours old even if there is no sign of infection.&nbsp; Consider if tetanus prophylaxis is needed. Assess the HIV, hepatitis B and C and syphillis risk and if necessary discuss with a Consultant in Communicable Disease Control.</p>

<p>If the skin is not broken just clean it, but if the skin is broken irrigate it with warm, running water. Send the patient to ED&nbsp;if severe.</p>

<p><strong>Check tetanus status</strong>&nbsp;and immunise if necessary.&nbsp; Prophylaxis is advised for puncture wounds, any bite involving the hand, face, foot, joint tendon or ligament, and in immunocompromised, diabetic, asplenic or elderley patients.</p>

<p>If treating an<strong>&nbsp;insect bite</strong>&nbsp;then treat as&nbsp;<u><strong>cellulitis</strong></u>. &nbsp;True cellulitis is a systemic infection and you would expect some systemic signs and symptoms, please ensure an infection is confirmed as all insect bites do not need to be treated with antibiotics. (See <a href="#PCcellulitis" > cellulitis</a> for treatment of infected insect bites)</p>
<!--Start accordian-->

<div id="PCaccordionBites">
<div class="card">
<div class="card-header" id="PCbitesTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseBitesTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseBitesTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCbitesTreatment" class="collapse" data-parent="#PCaccordionBites" id="PCcollapseBitesTreatment">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Co-amoxiclav 625 mg TDS</strong></span> for 5 days
<p><strong><u>Penicillin allergy</u></strong></p>

<p><span style="color:#8e44ad"><strong>Doxycycline 200mg po for the first dose then 100mg po bd</strong></span> for 5 days</p>
</div>
</div>

<div class="card-header" id="PCBitesHand">
<h5 class="mb-0"><button aria-controls="collapsePCBiteHand" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsePCBiteHand" data-toggle="collapse" type="button">Animal and Human Bites to the Hand</button></h5>
</div>

<div aria-labelledby="PCBitesHand" class="collapse" data-parent="#PCaccordionBites" id="collapsePCBiteHand">
<div class="card-body text-left">
<p><span style="color:#333333">Animal and human bites to the hand including clenched fist injuries (&#39;fight-bite&#39;) are at <u>greater risk for development of complications</u> associated with infection particularly septic arthritis, osteomyelitis and tendon sheath infection.</span></p>

<p><span style="color:#333333">These patients would require <u>hospital admission</u> for intravenous antibiotic treatment as well as <u>orthopaedic review</u> with assessment of surgical intervention including joint washout and tissue debridement.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Cellulitis-->
<div class="text-left border border-info rounded" id="PCcellulitisSection">
<h2 class="text-center" id="PCcellulitis">Cellulitis</h2>

<p>True cellulitis is a systemic infection and you would expect some systemic signs and symptoms.</p>

<p>This treatment also applies if there is&nbsp;<strong><u>spreading cellulitis</u></strong>&nbsp;resulting from an insect bite (please ensure an infection is confirmed as all insect bites&nbsp;<u>do not</u>&nbsp;need to be treated with antibiotics).&nbsp;</p>

<p>If there is history of exposure to fresh water, i.e. rivers or streams (Aeromonas hydrophilia) at the site add&nbsp;<strong>ciprofloxacin</strong>&nbsp;(750 mg twice daily 7 days) and if there is history of exposure to salt water (Vibrio vulnificus) add&nbsp;<strong>doxycycline</strong>&nbsp;(200mg stat then 100mg daily 7 days total).</p>

<p>Doxycycline must NOT be prescribed for children under 12 years, or for pregnant or breast-feeding women.</p>

<p>Please refer to the full guidance distributed for the community IV cellulitis pathway</p>
<!--Start accordian-->

<div id="PCaccordionCellulitis">
<div class="card">
<div class="card-header" id="PCcellulitisTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseCellulitisTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseCellulitisTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCcellulitisTreatment" class="collapse" data-parent="#PCaccordionCellulitis" id="PCcollapseCellulitisTreatment">
<div class="card-body text-left">
<p><span style="color:#0000cc"><strong>Flucloxacillin 1g QDS for 5 days</strong></span></p>

<p><strong><u>Penicillin allergy</u></strong></p>

<p><span style="color:#990066"><strong>Clindamycin 450mg QDS for 5 days&nbsp;</strong></span></p>

</div>
</div>

<div class="card-header" id="PCcellulitisFacial">
<h5 class="mb-0"><button aria-controls="PCcollapseCellulitisFacial" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseCellulitisFacial" data-toggle="collapse" type="button">Facial Cellulitis</button></h5>
</div>

<div aria-labelledby="PCcellulitisFacial" class="collapse" data-parent="#PCaccordionCellulitis" id="PCcollapseCellulitisFacial">
<div class="card-body text-left">

                                        <p><span style="color:rgb(0, 0, 255)"><strong>Co-amoxiclav 625 mg TDS</strong></span> <span style="color:rgb(0, 0, 255)"><strong>for&nbsp;10 days.</strong></span></p>

<p>&nbsp;</p>

<p><span style="color:rgb(0, 0, 0)"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:rgb(128, 0, 128)"><strong>Clindamycin 450mg po QDS for 10 days.</strong></span></p>

<p>&nbsp;</p>

<p>If the patient is febrile and acutely ill, refer to hospital for IV treatment.</p>

                                    
</div>
</div>

<div class="card-header" id="PCCommIVTher">
<h5 class="mb-0"><button aria-controls="PCcollapsePCCommIVTher" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePCCommIVTher" data-toggle="collapse" type="button">Community IV Therapy</button></h5>
</div>

<div aria-labelledby="PCCommIVTher" class="collapse" data-parent="#PCaccordionCellulitis" id="PCcollapsePCCommIVTher">
<div class="card-body text-left">

                                    
                                        <table border="1" cellspacing="0" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td colspan="6" style="background-color:#bfbfbf; width:503.25pt">
            <p><strong>Cellulitis Antibiotic Formulary</strong></p>

            <p><strong>(Treat only until acute inflammation disappears)</strong></p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#92d050; width:503.25pt">
            <p><strong>ERON CLASS I</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#bfbfbf; width:170.15pt">
            <p><strong>Antibiotic</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:42.5pt">
            <p><strong>Route</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:120.5pt">
            <p><strong>Dose</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:63.8pt">
            <p><strong>Frequency</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:2.0cm">
            <p><strong>Duration</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:49.6pt">
            <p><strong>Review</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#c6e6a2; width:170.15pt">
            <p>Flucloxacillin</p>
            </td>
            <td style="background-color:#c6e6a2; width:42.5pt">
            <p>Oral</p>
            </td>
            <td style="background-color:#c6e6a2; width:120.5pt">
            <p>1g</p>
            </td>
            <td style="background-color:#c6e6a2; width:63.8pt">
            <p>QDS</p>
            </td>
            <td style="background-color:#c6e6a2; width:2.0cm">
            <p>3 days</p>
            </td>
            <td style="background-color:#c6e6a2; width:49.6pt">
            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#d9d9d9; width:503.25pt">
            <p><strong>In penicillin allergy:</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#c6e6a2; width:170.15pt">
            <p>Clarithromycin</p>
            </td>
            <td style="background-color:#c6e6a2; width:42.5pt">
            <p>Oral</p>
            </td>
            <td style="background-color:#c6e6a2; width:120.5pt">
            <p>500mg</p>
            </td>
            <td style="background-color:#c6e6a2; width:63.8pt">
            <p>B.D.</p>
            </td>
            <td style="background-color:#c6e6a2; width:2.0cm">
            <p>3 days</p>
            </td>
            <td style="background-color:#c6e6a2; width:49.6pt">
            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#ffc000; width:503.25pt">
            <p><strong>ERON CLASS II</strong></p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#bfbfbf; width:503.25pt">
            <p><strong>Oral treatment</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#bfbfbf; width:170.15pt">
            <p><strong>Antibiotic</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:42.5pt">
            <p><strong>Route</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:120.5pt">
            <p><strong>Dose</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:63.8pt">
            <p><strong>Frequency</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:2.0cm">
            <p><strong>Duration</strong></p>
            </td>
            <td style="background-color:#bfbfbf; width:49.6pt">
            <p><strong>Review</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#ffdb69; width:170.15pt">
            <p>Flucloxacillin</p>

            <p>Plus</p>

            <p>Clindamycin</p>
            </td>
            <td style="background-color:#ffdb69; width:42.5pt">
            <p>Oral</p>

            <p>&nbsp;</p>

            <p>Oral</p>
            </td>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>1g</p>

            <p>&nbsp;</p>

            <p>450mg</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>QDS</p>

            <p>&nbsp;</p>

            <p>QDS</p>
            </td>
            <td style="background-color:#ffdb69; width:2.0cm">
            <p>3 days</p>

            <p>&nbsp;</p>

            <p>3 days</p>
            </td>
            <td style="background-color:#ffdb69; width:49.6pt">
            <p>Day 4</p>

            <p>&nbsp;</p>

            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#d9d9d9; width:503.25pt">
            <p>&nbsp;<strong>In penicillin allergy:</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#ffdb69; width:170.15pt">
            <p>Clindamycin</p>
            </td>
            <td style="background-color:#ffdb69; width:42.5pt">
            <p>Oral</p>
            </td>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>450mg</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>QDS</p>
            </td>
            <td style="background-color:#ffdb69; width:2.0cm">
            <p>3 days</p>
            </td>
            <td style="background-color:#ffdb69; width:49.6pt">
            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#bfbfbf; width:503.25pt">
            <p><strong>IV treatment</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#ffdb69; width:170.15pt">
            <p>Flucloxacillin via Elastomeric pump</p>
            </td>
            <td style="background-color:#ffdb69; width:42.5pt">
            <p>IV</p>
            </td>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>8g</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>24 hours</p>
            </td>
            <td style="background-color:#ffdb69; width:2.0cm">
            <p>3 days</p>
            </td>
            <td style="background-color:#ffdb69; width:49.6pt">
            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#ffdb69; width:170.15pt">
            <p>In the case of chemical phlebitis</p>

            <p>From pump-Change to Clindamycin</p>
            </td>
            <td style="background-color:#ffdb69; width:42.5pt">
            <p>&nbsp;</p>

            <p>Oral</p>
            </td>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>&nbsp;</p>

            <p>450mg</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>&nbsp;</p>

            <p>Q.D.S.</p>
            </td>
            <td style="background-color:#ffdb69; width:2.0cm">
            <p>&nbsp;</p>

            <p>3 days</p>
            </td>
            <td style="background-color:#ffdb69; width:49.6pt">
            <p>&nbsp;</p>

            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#d9d9d9; width:503.25pt">
            <p><strong>In penicillin allergy:</strong></p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#ffdb69; width:170.15pt">
            <p>Teicoplanin</p>
            </td>
            <td colspan="5" style="background-color:#ffdb69; width:333.1pt">
            <p>&nbsp;</p>
            </td>
        </tr>
        <tr>
            <td rowspan="2" style="background-color:#ffdb69; width:170.15pt">
            <p>If 50-70kg</p>
            </td>
            <td rowspan="2" style="background-color:#ffdb69; width:42.5pt">
            <p>IV</p>
            </td>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>Day 1 = 800mg</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>Stat</p>
            </td>
            <td rowspan="2" style="background-color:#ffdb69; width:2.0cm">
            <p>3 days</p>
            </td>
            <td rowspan="2" style="background-color:#ffdb69; width:49.6pt">
            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>Day 2 &amp; 3 = 10mg/kg</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>Once daily</p>
            </td>
        </tr>
        <tr>
            <td rowspan="2" style="background-color:#ffdb69; width:170.15pt">
            <p>If &gt; 70kg</p>
            </td>
            <td rowspan="2" style="background-color:#ffdb69; width:42.5pt">
            <p>IV</p>
            </td>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>Day 1 = 12mg/kg</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>Stat</p>
            </td>
            <td rowspan="2" style="background-color:#ffdb69; width:2.0cm">
            <p>3 days</p>
            </td>
            <td rowspan="2" style="background-color:#ffdb69; width:49.6pt">
            <p>Day 4</p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#ffdb69; width:120.5pt">
            <p>Day 2 &amp; 3 = 10mg/kg</p>
            </td>
            <td style="background-color:#ffdb69; width:63.8pt">
            <p>Once daily</p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#ffdb69; width:503.25pt">
            <p>Do pre-dose level before 4<sup>th</sup> dose and if outside the therapeutic range, discuss with Microbiologist/Antibiotic Pharmacist before resuming treatment.</p>
            </td>
        </tr>
        <tr>
            <td colspan="6" style="background-color:#ffdb69; width:503.25pt">
            <p>If eGFR&lt;30ml/min dose of teicoplanin should be obtained from Antibiotic Pharmacist.</p>
            </td>
        </tr>
    </tbody>
</table>

                                    
</div>
</div>


</div>
</div>
</div>
<br />
<!--Dermatophyte-->
<div class="text-left border border-info rounded" id="PCdermatoPhyteSection">
<h2 class="text-center" id="PCderma">Dermatophyte Infection of the Skin</h2>

<p>Take skin scrapings for culture. Topical azoles,<span style="color:#0000ff">&nbsp;<strong>clotrimazole 1 % or miconazole 2 %</strong></span>, are useful if you are not sure if there is Candida or dermatophyte infection.&nbsp; The azoles can take 4&ndash;6 weeks to work. Topical terbinafine 1% although more expensive can work with in a week. Consider oral treatment only if disease is extensive or severe (however, consider referral) or if topical treatment has failed. Discuss scalp infections with a specialist</p>
</div>
<br />
<!--Diabetic foot-->
<div class="text-left border border-info rounded" id="PCdiabeticFootSection">
<h2 class="text-center" id="PCdiabeticFoot">Diabetic Foot Infection</h2>

<p>The recommendations&nbsp;for treatment of DFI&nbsp;have been made following discussion with Abigail Hall (High Risk Foot Team Podiatrist) and Dr Haris Rathur (Consultant for Adult Medicine).</p>

<p>Refer to Diabetes Service</p>

<p>email:&nbsp;<a href="mailto:tga-tr.cids@nhs.net" target="_blank">tga-tr.cids@nhs.net</a>&nbsp;(Contact High Risk Foot Podiatry on 0161 366 2335)</p>

<p><span style="color:#e74c3c"><strong>All patients with Diabetic Foot Ulcers MUST be under the care of a Podiatrist</strong></span></p>
<!--Start accordian-->

<div id="PCaccordionDiabeticFoot">
<div class="card">
<div class="card-header" id="PCdiabeticFootMild">
<h5 class="mb-0"><button aria-controls="PCcollapseDiabeticFootMild" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseDiabeticFootMild" data-toggle="collapse" type="button">Mild Infection</button></h5>
</div>

<div aria-labelledby="PCdiabeticFootMild" class="collapse" data-parent="#PCaccordionCellulitis" id="PCcollapseDiabeticFootMild">
<div class="card-body text-left">
<p>Presence of at least 2 of the following:</p>

<p>local swelling, erythema, local tenderness or pain, local warmth, purulent discharge.</p>

<p>Local infection involving only skin and subcutaneous tissue.  If erythema, must be &lt;2cm around ulcer</p>

<p><span style="color:#0000ff"><strong>Flucloxacillin 1g QDS for a maximum of 5 days </strong></span>(review after 3 days)</p>

<p><u>Penicillin allergy</u></p>

<p><span style="color:#990066"><strong>Clarithromycin 500mg BD for a maximum of 5 days </strong></span>(review after 3 days)</p>
</div>
</div>

<div class="card-header" id="PCdiabeticFootMod">
<h5 class="mb-0"><button aria-controls="PCcollapseDiabeticFootMod" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseDiabeticFootMod" data-toggle="collapse" type="button">Moderate Infection</button></h5>
</div>

<div aria-labelledby="PCdiabeticFootMod" class="collapse" data-parent="#PCaccordionCellulitis" id="PCcollapseDiabeticFootMod">
<div class="card-body text-left">
<p>as above <strong>plus</strong> erythema &gt; 2cm but &lt;5cm, or involving structures deeper than skin and subcutaneous tissues.</p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav 625mg TDS for a maximum of 5 days</strong></span> (review after 3 days)</p>
</div>
</div>

<div class="card-header" id="PCdiabeticFootSev">
<h5 class="mb-0"><button aria-controls="PCcollapseDiabeticFootSev" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseDiabeticFootSev" data-toggle="collapse" type="button">Severe Infection</button></h5>
</div>

<div aria-labelledby="PCdiabeticFootMod" class="collapse" data-parent="#PCaccordionCellulitis" id="PCcollapseDiabeticFootSev">
<div class="card-body text-left">
<p>Spreading cellulitis (&gt; 5cm from the wound), ascending lymphangitis, deep tissue abscess formation with or without systemic inflammatory response syndrome</p>

<p><strong>arrange admittance into hospital for IV antibiotics</strong></p>

<p>Note: Systemic infection may sometimes manifest with sepsis syndrome including&nbsp;fever, vomiting, hypotension, deranged blood glucose levels and confusion.&nbsp; It is important to note that patients with ischaemia and neuropathy may not mount an appropriate inflammatory response, but nevertheless be extremely ill.</p>
</div>
</div>

<div class="card-header" id="PCdiabeticFootRef">
<h5 class="mb-0"><button aria-controls="PCcollapseDiabeticFootRef" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseDiabeticFootRef" data-toggle="collapse" type="button">References</button></h5>
</div>

<div aria-labelledby="PCdiabeticFootRef" class="collapse" data-parent="#PCaccordionCellulitis" id="PCcollapseDiabeticFootRef">
<div class="card-body text-left">
<p>National Institute of Health and Care Excellence (NICE), (2015).&nbsp; <em>Diabetic foot problems: prevention and management, NICE guideline 19.</em>&nbsp; <a href="http://www.nice.org.uk/guidance/ng19/chapter/1-Recommendations#diabetic-foot-infection-2" target="_blank">http://www.nice.org.uk/guidance/ng19/chapter/1-Recommendations#diabetic-foot-infection-2</a></p>

<p>Lipsky, B.A., Berendt, A.R., Cornia, P.B., Pile, J.C., Peters, E.J.G., Armstrong, D.G.&hellip; Senneville, E. (2012) 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections.&nbsp; <em>CID 2012</em>, 54:132-164</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Leg Ulcers-->
<div class="text-left border border-info rounded" id="PClegUlcerSection">
<h2 class="text-center" id="PClegUlcers">Leg Ulcers / Pressure Sores</h2>

<p>Bacteria will always be present and therefore culture swabs of deeper tissues should be taken and not slough or necrotic tissue.&nbsp; Systemic antibiotics are only indicated if there is evidence of clinical infection (e.g. increasing pain, pyrexia, spreading cellulitis, tissue induration, enlarging ulcer).</p>

<p>In the absence of systemic features of infection, only topical treatment&nbsp;<strong><u>without</u></strong>&nbsp;the addition of systemic&nbsp;antibiotic is indicated for these patients</p>

<p>Refer adults with an infected leg ulcer to hospital if they have any symptoms or signs suggesting a more serious illness or condition, such as sepsis, necrotising fasciitis or osteomyelitis.</p>
<!--Start accordian-->

<div id="PCaccordionLegUlcer">
<div class="card">
<div class="card-header" id="PClegUlcersTop">
<h5 class="mb-0"><button aria-controls="PCcollapseLegUlcer" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseLegUlcer" data-toggle="collapse" type="button">Topical Treatment</button></h5>
</div>

<div aria-labelledby="PClegUlcers" class="collapse" data-parent="#PCaccordionLegUlcer" id="PCcollapseLegUlcer">
<div class="card-body text-left">
<p>In consultation with the community tissue viability team, either:</p>

<p><span style="color:#0000ff"><strong>Flamazine (silver sulphadiazine) cream</strong></span><strong> </strong>for <u>non</u>-exudative wounds</p>

<p>Apply at every dressing change</p>

<p>OR</p>

<p><span style="color:#2ecc71"><strong>Medicinal honey (Mesitran soft ointment dressing)</strong></span> for wounds with an exudate</p>

<p>Apply at every dressing change</p>
</div>
</div>

<div class="card-header" id="PClegUlcerSys">
<h5 class="mb-0"><button aria-controls="PCcollapseLegUlcerSys" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseLegUlcerSys" data-toggle="collapse" type="button">Systemic Treatment</button></h5>
</div>

<div aria-labelledby="PClegUlcerSys" class="collapse" data-parent="#PCaccordionLegUlcer" id="PCcollapseLegUlcerSys">
<div class="card-body text-left">
<p>If these ulcers are complicated&nbsp;by systemic features of infection (as above), give:</p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav 625mg TDS</strong></span> for 5 days and <strong><u>then review</u></strong> - if the systemic symptoms of infection have resolved, stop antibiotics and continue topical treatment</p>

<p>For penicillin allergy options please contact Consultant Microbiology on <a href="tel:01619224086"> 0161 922 4086</a>(or mobile via switchboard <a href="tel:01619226000">0161 922 6000</a>)</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Shingles-->
<div class="text-left border border-info rounded" id="PCshinglesSection">
<h2 class="text-center" id="PCshingles">Shingles (Herpes Zoster)</h2>

<p>Antivirals should be started within 72 hours of onset of the rash.</p>

<p>They should be used in adults over 50 years, in the immunocompromised, in anyone with ophthalmic involvement, in anyone in severe, acute pain or with an extensive rash; they can also be used in people who are likely to come in close contact with &ldquo;at risk&rdquo; groups (e.g. immunocompromised, pregnancy).</p>

<p>Specialist advice should be sought for immunocompromised patients.</p>
<!--Start accordian-->

<div id="PCaccordionShingles">
<div class="card">
<div class="card-header" id="PCshinglesTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseShinglesTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseShinglesTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCshinglesTreatment" class="collapse" data-parent="#PCaccordionShingles" id="PCcollapseShinglesTreatment">
<div class="card-body text-left">

                                        <p>1.&nbsp; <span style="color:#0000FF"><strong>Aciclovir 800 mg orally five times a day</strong></span> for 7 days</p>

<p>2.&nbsp;<span style="color:#800080"><strong> Valaciclovir 1g TDS</strong></span> for 7 days</p>

<p><strong>or</strong></p>

<p>3.&nbsp; <span style="color:#B22222"><strong>Famciclovir 250mg TDS</strong></span> for 7 days</p>

<p>Aciclovir is by far the cheapest antiviral. If compliance is an issue valaciclovir or famciclovir can be given less frequently but these drugs are much more expensive (provided aciclovir is prescribed generically).</p>

                                    
</div>
</div>
</div>
</div>
</div>
<br />
<!--Strep A-->
<div class="text-left border border-info rounded" id="PCstrepSection">
<h2 class="text-center" id="PCstrepA">Strep A Group Infection</h2>

<p>Strep Group A infections can be clinically classified into 2 main groups:</p>

<ul>
    <li>Non-invasive and treatable with oral antibiotics in the GP/outpatient setting and includes:
    <ul>
        <li>Pharyngotonsillitis</li>
        <li>Cellulitis</li>
        <li>Skin and wound infections (such as impetigo and chronic leg ulcers)</li>
        <li>Scarlet fever (toxin mediated infection).</li>
    </ul>
    </li>
    <li>Invasive and potentially life-threatening including:
    <ul>
        <li>Necrotizing fasciitis</li>
        <li>Bacteraemia (including bacteraemic pneumonia)</li>
        <li>Facial erysipelas</li>
        <li>Streptococcal toxic shock syndrome.</li>
    </ul>
    </li>
</ul>

<p>Differentiation between non-invasive and invasive Strep Group A infection is important for appropriate clinical management. Because of the potential for non-invasive Strep Group A infections to be become invasive all clinical laboratory&nbsp;<u>culture proven</u>&nbsp;Strep Group A infections must be treated with antibiotics as follows:</p>

<p><strong>Amoxicillin 1g po tds&nbsp;</strong>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a data-dismiss="modal" data-target="#PCURT" data-toggle="modal" href="#PCURT"> Pharyngitis / Tonsillitis</a> section in primary care guidelines.</p>

<p>&nbsp;</p>

<p><u><strong>Penicillin allergy</strong></u></p>

<p><strong>Clarithromycin 500mg BD</strong>&nbsp;for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a data-dismiss="modal" data-target="#PCURT" data-toggle="modal" href="#PCURT"> Pharyngitis / Tonsillitis</a> section in primary care guidelines.</p>

<p>&nbsp;</p>
</div>
<br />
<!--Impetigo-->
<div class="text-left border border-info rounded" id="impetigo">
<h2 class="text-center" id="PCimpetigo">Impetigo</h2>

<p><strong>In those with uncomplicated impetigo</strong></p>

<p>Explain the diagnosis and provide written information.</p>

<ol>
    <li>A patient information leaflet on&nbsp; <a href="http://www.bad.org.uk/for-the-public/patient-information-leaflets" target="_blank"><u>Impetigo</u></a>&nbsp;can be downloaded from the British Association of Dermatologists website at&nbsp; <a href="http://www.bad.org.uk/" target="_blank">www.bad.org.uk</a>.</li>
    <li>Reassure the person that impetigo usually heals completely without scarring, and that serious complications are rare.</li>
    <li>Advise the person that hygiene measures are important to aid healing and stop infection spreading to other areas of the body and to other people.</li>
    <li>Recommend that the person:
    <ul>
        <li>Washes affected areas with soap and water.</li>
        <li>Washes their hands regularly, in particular after touching a patch of impetigo.</li>
        <li>Avoids scratching affected areas.</li>
        <li>Avoids sharing towels, face cloths, and other personal care products and thoroughly cleans potentially contaminated toys and play equipment.</li>
    </ul>
    </li>
    <li>Inform the person of Public Health England exclusion recommendations:
    <ul>
        <li>Children and adults should stay away from school and&nbsp;other childcare facilities&nbsp;or&nbsp;work until lesions are healed, dry and crusted over or 48 hours after initiation of antibiotics.</li>
        <li>Food handlers are required by law to inform employers immediately if they have impetigo.</li>
    </ul>
    </li>
    <li>Ensure optimal treatment of any pre-existing skin conditions such as eczema, head lice, scabies or insect bites.</li>
</ol>

<p>Mupirocin should be reserved for MRSA.&nbsp; If widespread or long standing impetigo use systemic antibiotics.</p>

<p>Do not offer combination treatment with a topical and oral antibiotic to treat impetigo.</p>

<p>Ensure a review is undertaken to ensure sustained improvement or the need to escalate treatment.</p>
<!--Start accordian-->

<div id="PCaccordionImpetigo">
<div class="card">
<div class="card-header" id="PCImpetigoNonBullous">
<h5 class="mb-0"><button aria-controls="PCcollapseImpetigoNonBullous" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseImpetigoNonBullous" data-toggle="collapse" type="button">Localised Non-Bullous Impetigo</button></h5>
</div>

<div aria-labelledby="PCImpetigoNonBullous" class="collapse" data-parent="#PCaccordionImpetigo" id="PCcollapseImpetigoNonBullous">
<div class="card-body text-left">
<p><u>Topical agent</u> -&nbsp;for people with localised non-bullous impetigo who are not systemically unwell or at high risk of complications</p>

<p><span style="color:#0000ff"><strong>Hydrogen peroxide 1% cream</strong></span>&nbsp;(Crytacide) apply 2-3 times a day for 5 days</p>

<p>Although other topical antiseptics are available for treating superficial skin infections, no evidence was found for using them to treat impetigo.&nbsp;</p>

<p>If hydrogen peroxide 1% cream is unsuitable, then fusidic acid 2% (apply TDS for 5 days) may be considered&nbsp;as an&nbsp;alternative</p>
</div>
</div>

<div class="card-header" id="PCImpetigoWidespreadNonBullous">
<h5 class="mb-0"><button aria-controls="PCcollapseImpetigoWidespreadNonBullous" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseImpetigoWidespreadNonBullous" data-toggle="collapse" type="button">Widespread Non-Bullous Impetigo</button></h5>
</div>

<div aria-labelledby="PCImpetigoWidespreadNonBullous" class="collapse" data-parent="#PCaccordionImpetigo" id="PCcollapseImpetigoWidespreadNonBullous">
<div class="card-body text-left">
<p>Offer a short course of a topical or oral antibiotic for people with widespread non-bullous impetigo who are not systemically unwell or at high risk of complications</p>

<p><strong><u>Topical</u></strong></p>

<p><strong><span style="color:#ff0099">Fusidic acid 2% apply TDS for 5 days</span></strong></p>

<p><strong><u>Oral options</u></strong></p>

<p><span style="color:#0000ff"><strong>Flucloxacillin 1g QDS</strong></span> for 5&nbsp;days</p>

<p>Children:</p>

<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td><strong>Age</strong></td>
            <td><strong>Dose</strong></td>
        </tr>
        <tr>
            <td>1 month to 1 year</td>
            <td>62.5mg - 125mg QDS</td>
        </tr>
        <tr>
            <td>2 years to 9 years</td>
            <td>125mg - 250mg QDS</td>
        </tr>
        <tr>
            <td>10 years to 17 years</td>
            <td>250mg - 500mg QDS</td>
        </tr>
    </tbody>
</table>

<p>If child weighs over 50kg use adult doses.</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg BD</strong></span> for 5&nbsp;days</p>
</div>
</div>

<div class="card-header" id="PCImpetigBullous">
<h5 class="mb-0"><button aria-controls="PCcollapseImpetigoBullous" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseImpetigoBullous" data-toggle="collapse" type="button">Bullous Impetigo</button></h5>
</div>

<div aria-labelledby="PCImpetigBullous" class="collapse" data-parent="#PCaccordionImpetigo" id="PCcollapseImpetigoBullous">
<div class="card-body text-left">
<p><strong><u>Bullous impetigo or impetigo in people who are systemically unwell or at high risk of complications</u></strong></p>

<p>Offer a short course of an oral antibiotic for:</p>

<ul>
    <li>all people with bullous impetigo</li>
    <li>people with non-bullous impetigo who are systemically unwell or at high risk of complications.</li>
</ul>

<p><strong><u>Oral options</u></strong></p>

<p><span style="color:#0000ff"><strong>Flucloxacillin 1g QDS</strong></span> for 5&nbsp;days</p>

<p>Children:</p>

<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td><strong>Age</strong></td>
            <td><strong>Dose</strong></td>
        </tr>
        <tr>
            <td>1 month to 1 year</td>
            <td>62.5mg - 125mg QDS</td>
        </tr>
        <tr>
            <td>2 years to 9 years</td>
            <td>125mg - 250mg QDS</td>
        </tr>
        <tr>
            <td>10 years to 17 years</td>
            <td>250mg - 500mg QDS</td>
        </tr>
    </tbody>
</table>

<p>If child weighs over 50kg use adult doses.</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg BD</strong></span> for 5&nbsp;days</p>

<p>(see <a href="https://bnfc.nice.org.uk/" target="_blank">BNFc</a>&nbsp;for doses in children)</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Acne-->
<div class="text-left border border-info rounded" id="acne">
<h2 class="text-center" id="PCacne">Acne</h2>

<p><u><strong>Topical treatment</strong></u></p>

<p>In mild acne initial treatment should consist of topical benzoyl peroxide or a topical retinoid. Topical antibiotics may be used in moderate acne, or where there is treatment failure or intolerance to treatment in mild acne. Topical antibiotics should be used in combination with benzoyl peroxide (if tolerated) as this combination is more effective than using either drug in isolation, and because it limits the development of antibiotic resistance. Topical antibiotics should not be combined with topical retinoids as this combination may promote bacterial resistance.</p>

<p>Topical antibiotic treatment should not be used long-term and should be stopped after 6-8 weeks. Consider switching to benzoyl peroxide at this point.</p>

<p><u><strong>Oral treatment</strong></u></p>

<p>Oral antibiotics may be considered in patients where topical treatment is not tolerated, there is moderate acne on the shoulders or back where it may be extensive or difficult to reach, or if there is a significant risk of scarring or pigment changes. Oral antibiotics may be combined with topical benzoyl peroxide or a topical retinoid, or both if tolerated. Oral and topical antibiotics should not be prescribed for concomitant use. Oral antibiotics may need to continue for 3 months before a response to treatment is seen.</p>
<!--Start accordian-->

<div id="PCaccordionAcne">
<div class="card">
<div class="card-header" id="PCAcne">
<h5 class="mb-0"><button aria-controls="PCcollapseAcne" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseAcne" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCAcne" class="collapse" data-parent="#PCaccordionAcne" id="PCcollapseAcne">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Lymecycline 408mg OD</strong></span></p>

<p>If not tolerated or pregnant/breastfeeding:</p>

<p><span style="color:#800080"><strong>Erythromycin 500mg BD</strong></span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Fungal Nail-->
<div class="text-left border border-info rounded" id="PCFungalNailSection">
<h2 class="text-center" id="PCfungalNail">Fungal Nail Infections</h2>

<p>If you suspect a dermatophyte infection of the proximal fingernail or toenail, take nail clippings for fungal culture. Only start treatment if infection is confirmed by the laboratory. This condition is rare in children so refer them for specialist advice.</p>
<!--Start accordian-->

<div id="PCaccordionFungalNail">
<div class="card">
<div class="card-header" id="PCFungalNail">
<h5 class="mb-0"><button aria-controls="PCcollapseFungalNail" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseFungalNail" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCFungalNail" class="collapse" data-parent="#PCaccordionFungalNail" id="PCcollapseFungalNail">
<div class="card-body text-left">
<p>For superficial infections only</p>

<p><span style="color:#0000FF"><strong>Amorolfine&nbsp;5 % nail lacquer 1&ndash;2 times a week</strong></span> for 6 months (fingers) or 12 months (toes)</p>

<p><strong>or</strong></p>

<p><span style="color:#800080"><strong>Terbinafine 250 mg OD </strong></span>for 6&ndash;12 weeks (fingers) or 3&ndash;6 months (toes)</p>

<p><strong>or</strong></p>

<p>For infections with yeasts and non-dermatophyte moulds use

pulsed <span style="color:#B22222"><strong>Itraconazole 200 mg BD</strong></span> <strong>for 7 days repeated monthly</strong>. For fingernails use 2 courses and for toenails use 3 courses.</p>

<p>Rarely idiosyncratic liver reactions occur with terbinafine.&nbsp; Tell patients to watch for signs of liver toxicity.</p>

<p>Itraconazole should be avoided in patients at risk of heart failure and in patients taking statins (risk of myopathy) and it can also cause liver toxicity.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Chickenpox-->
<div class="text-left border border-info rounded" id="PCchickenPoxSection">
<h2 class="text-center" id="PCchickenpox">Chicken Pox</h2>

<p>Always seek specialist advice for treatment and prophylaxis in pregnant women. For advice during normal working hours, contact the Clinical Virology department at Central Manchester University Hospitals on 0161 276 8853, and for clinical advice out of hours, telephone 0161 276 1234 and ask for the duty Consultant Virologist.</p>

<p>In healthy adults and children with uncomplicated chickenpox no antiviral treatment is recommended. Antivirals are indicated in all patients who are immunocompromised and always seek specialist advice for these patients. If the patient is severely immunocompromised they will need hospital referral for intravenous aciclovir as well as varicella zoster immunoglobulin.&nbsp; Antivirals should be used in an adult with clinical toxicity within 24 hours of onset of the rash using the same doses as in shingles.</p>
<!--Start accordian-->

<div id="PCaccordionChickenPox">
<div class="card">
<div class="card-header" id="PCChickenPox">
<h5 class="mb-0"><button aria-controls="PCcollapseChickenPox" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseChickenPox" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCChickenPox" class="collapse" data-parent="#PCaccordionChickenPox" id="PCcollapseChickenPox">
<div class="card-body text-left"><span style="color:#0000FF"><strong>Aciclovir 800mg orally five times for 7 days</strong></span></div>
</div>
</div>
</div>
</div>
<br />
<!--Scarlet Fever-->
<div class="text-left border border-info rounded" id="PCscarletFeverSection">
<h2 class="text-center" id="PCscarletFever">Scarlet Fever</h2>

<p>See <a data-dismiss="modal" data-target="#PCURT" data-toggle="modal" href="#PCURT"> Tonsillitis </a>section on the Upper Respiratory Infection page</p>
</div>
<!--floating icon--><a class="float" href="#PCSkinTissue"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<br />
<!-- Primary Care Eye section-->
<div aria-hidden="true" aria-labelledby="EyeLabel" class="portfolio-modal modal fade " id="PCEye" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="EyeLabel">Opthamology Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>
<br />
<!--Conjunctivitis-->
<div class="text-left border border-info rounded" id="PCconjunctivitisSection">
<h2 class="text-center" id="PCConjuctivitis">Conjuctivitis</h2>

<div>
<p>Only treat if severe, as most cases are viral or self limiting and 65% tend to resolve on placebo by day 5.&nbsp; Bacterial conjunctivitis is usually unilateral and also self limiting. It is characterised by mucopurulent red eyes and not watery discharge.</p>
</div>
<!--Start accordian-->

<div id="PCaccordionConj">
<div class="card">
<div class="card-header" id="PCConjPox">
<h5 class="mb-0"><button aria-controls="PCcollapseConj" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseConj" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCConjPox" class="collapse" data-parent="#PCaccordionConj" id="PCcollapseConj">
<div class="card-body text-left">
<p>1st choice&nbsp;<span style="color:#0000FF"><strong>Chloramphenicol 0.5 % eye drops 1 drop 2 hourly </strong></span>for <u>2 days</u>, reducing to<span style="color:#0000FF"><strong> 4 hourly</strong></span> as the infection improves</p>

<p><strong>plus </strong></p>

<p><span style="color:#800080"><strong>Chloramphenicol 1% eye ointment at night</strong></span></p>

<p><strong>However treatment with eye drops alone may be sufficient.</strong></p>

<p>2nd choice (ONLY if chloramphenicol not effective or unsuitable)&nbsp;<span style="color:#B22222"><strong>&nbsp;Fusidic acid 1 % eye drops 1 drop BD</strong></span></p>

<p>Continue both for 48 hours after resolution of symptoms</p>

<p><strong>Swab the eye for culture and sensitivity</strong> if the infective conjunctivitis is not resolving after <strong><u>7 days</u> </strong>of treatment. Swab all people who are sexually active for gonococcal and chlamydial infection who have conjunctivitis that persists for 14 days despite treatment.</p>

<p><span style="color:#FF0000"><strong>Please note that there as recently been a <u>significant price increase</u> of fusidic acid eye drops. Please ensure it is only prescribed as a second choice when absolutely necessary and chloramphenicol is not suitable</strong></span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCcon"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Primary Care Meningitis section-->

<div aria-hidden="true" aria-labelledby="MeningitisLabel" class="portfolio-modal modal fade " id="PCMen" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="MeningitisLabel">Meningitis</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>
<br />
<!--Meninigitis-->
<div class="text-left border border-info rounded" id="PCMenSection">
<h2 class="text-center" id="PCmen">Meningitis</h2>

<div>
<p>Rapid transfer to hospital remains the highest priority whether or not penicillin is given &ndash; minutes are precious. Provided it does not cause a delay in admission, benzylpenicillin should be administered as soon as meningococcal disease is suspected. PHE recommends all GPs carry benzylpenicillin and it should be given whilst transfer to hospital is being arranged.</p>

<p>If a patient with suspected meningitis without a non-blanching rash cannot be transferred to hospital urgently, antibiotics should also be given. Benzylpenicillin is the antibiotic of choice however cefotaxime can be given in penicillin allergy. NICE guidance states, &lsquo;a history of a rash following penicillin is not a contraindication.&rsquo; However if there is a clear history of anaphylaxis after a previous dose of penicillin or cephalosporin arrange urgent transfer without administering antibiotics.</p>
</div>
<!--Start accordian-->

<div id="PCaccordionMen">
<div class="card">
<div class="card-header" id="PCmentreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseMen" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseMen" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCMen" class="collapse" data-parent="#PCaccordionMen" id="PCcollapseMen">
<div class="card-body text-left">
<p>Treatment for adults (for children see CBNF for doses)</p>

<p><span style="color:#0000FF"><strong>Benzylpenicillin 1.2g</strong></span> &ndash; ideally IV but IM if a vein cannot be accessed</p>

<p><u><strong>Penicillin allergy (rash)</strong></u></p>

<p><span style="color:#800080"><strong>Cefotaxime 1g </strong></span>&ndash; ideally IV but IM if a vein cannot be accessed</p>

<p><u><strong>Penicillin allergy&nbsp;(Anaphylaxis)</strong></u></p>

<p><strong><span style="color:#B22222">Chloramphenicol 1g - </span></strong>&nbsp;IV</p>
</div>
</div>

<div class="card-header" id="PCmenProph">
<h5 class="mb-0"><button aria-controls="PCcollapseMenProph" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseMenProph" data-toggle="collapse" type="button">Prophylaxis for Close Contacts</button></h5>
</div>

<div aria-labelledby="PCmenProph" class="collapse" data-parent="#PCaccordionMen" id="PCcollapseMenProph">
<div class="card-body text-left">
<p><span style="color:#000000"><u><strong>Indications for antibiotic prophylaxis</strong></u></span></p>

<p><span style="color:#000000">Antibiotic prophylaxis should be offered to the following:</span></p>

<ul>
    <li><span style="color:#000000"><strong>Close contacts </strong>-</span> those who have had prolonged close contact with the case in a household type setting during the seven days before onset of illness. Examples of such contacts would be those living and/or sleeping in the same household, pupils in the same dormitory, boy/girlfriends, or university students sharing a kitchen in a hall of residence.</li>
    <li><span style="color:#000000"><strong>Transient contacts </strong></span>- those who have had transient close contact with a case <span style="color:#000000"> <u><strong>only</strong></u> if </span>they have been <span style="color:#000000"><strong>directly exposed to large particle droplets/secretions from the respiratory tract of a case around the time of admission to hospital.</strong></span></li>
</ul>

<p>Close contact does<span style="color:#000000"> <u><strong>NOT</strong></u> </span>include:</p>

<ul>
    <li>staff and children attending same nursery or crche</li>
    <li>students/pupils in same school/class/tutor group</li>
    <li>work or school colleagues</li>
    <li>friends</li>
    <li>residents of nursing/residential homes</li>
    <li>kissing on cheek or mouth (intimate kissing would normally bring the contact into the close, prolonged contact category)</li>
    <li>food or drink sharing or similar low level of salivary contact</li>
    <li>attending the same social function</li>
    <li>travelling in next seat on same plane, train, bus, or car (in the absence of intense exposure to nasopharyngeal secretions).</li>
</ul>

<p><span style="color:#000000"><u><strong>Prevention of secondary cases</strong></u></span></p>

<p>Chemoprophylaxis should be prescribed following discussion with the specialist team at the PHE North West on 0344 225 0562 within office hours and via Tameside&nbsp;Hospital switchboard out of hours&ndash;ask for the PHE North West on call.</p>

<p>Tameside General Hospital will arrange the supply of antibiotic prophylaxis for household contacts of patients treated there.</p>

<p>For other useful numbers please see <a href="https://www.gov.uk/emergency-contacts-public-health" target="_blank"><span style="color:#0066cc">https://www.gov.uk/emergency-contacts-public-health</span></a></p>

<p><span style="color:#000000"><strong>1st line:</strong></span></p>

<p><strong><span style="color:#000000">Adult:</span><span style="color:#0000ff"> Ciprofloxacin 500mg po as a single dose </span></strong>for an adult.</p>

<p><strong>Neonate:</strong> <span style="color:#0000ff"><strong>Ciprofloxacin 30mg/kg (max. per dose 125mg) po&nbsp;for 1 dose.</strong></span></p>

<p><strong>Child 1 month&ndash;4 years:</strong> <span style="color:#0000ff"><strong>Ciprofloxacin 30mg/kg (max. per dose 125mg) po for 1 dose.</strong></span></p>

<p><strong>Child 5&ndash;11 years:</strong> <span style="color:#0000ff"><strong>Ciprofloxacin 250mg po for 1 dose.</strong></span></p>

<p><strong>Child 12&ndash;17 years:</strong> <strong><span style="color:#0000ff">Ciprofloxacin 500mg po for 1 dose.</span></strong></p>

<p><span style="color:#000000"><strong>Ciprofloxacin in pregnancy</strong></span></p>

<p>A single dose of ciprofloxacin can be used for the prevention of secondary cases of meningococcal meningitis/bacteraemia in pregnancy.</p>

<p><span style="color:#000000"><strong>Or if unable to take ciprofloxacin or if contraindicated,</strong></span></p>

<p><span style="color:#000000"><strong>2nd line:</strong></span></p>

<p><strong>Adult:</strong> <span style="color:#0000ff"><strong>Rifampicin 600mg po every 12 hours for 2 days.</strong></span></p>

<p><strong>Neonate - 11 months: <span style="color:#0000ff">Rifampicin 5mg/kg po every 12 hours for 2 days.</span></strong></p>

<p><strong>Child 1&ndash;11 years: <span style="color:#0000ff">Rifampicin 10mg/kg po every 12 hours (max. per dose 600mg), for 2 days.</span></strong></p>

<p><strong>Child 12&ndash;17 years:</strong> <strong><span style="color:#0000ff">Rifampicin 600mg po every 12 hours for 2 days.</span></strong></p>

<p><span style="color:#000000"><strong>Or if rifampicin is contraindicated,</strong></span></p>

<p><span style="color:#000000"><strong>3rd line:</strong></span><span style="color:#0000ff"><strong> Ceftriaxone 250mg IM stat dose </strong></span>(<strong><span style="color:#0000ff">125mg in a child under 12yrs</span></strong>)</p>

<p>(NB not licensed for this indication).</p>

<p>Further advice can be sought from Greater Manchester Health Protection Unit 0161 786 6710 or via switchboard out of hours.</p>

<p><strong>References:</strong></p>

<p>Public Health England. Guidance for the public health management of meningococcal disease in the UK. February 2018. <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/688835/Public_health_management_of_meningococcal_disease_guidelines.pdf" target="_blank"><span style="color:#0066cc">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/688835/Public_health_management_of_meningococcal_disease_guidelines.pdf</span></a></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCcon"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Genital tract section-->

<div aria-hidden="true" aria-labelledby="GenitalTractLabel" class="portfolio-modal modal fade " id="PCGT" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="GenitalTractLabel">Genital Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<div>
<p>Consider a diagnosis of Chlamydia infection in anyone who is (or has been) sexually active who presents with a genital infection.</p>

<p>To identify Chlamydia infection first catch urine sample after holding urine in bladder for at least 1 hour, can be sent to the laboratory at Tameside General Hospital. A test for Chlamydia on first catch urine is very reliable and the specimen is also tested for gonorrhoea. Gonorrhoea positive cases should be referred for management by a GUM clinic where swabs for culture and sensitivity will betaken and contact tracing will be carried out.</p>

<p><strong><u>Ashton Primary Care Sexual Health Clinic</u></strong></p>

<p><strong>Ashton Primary Care Centre, 193 Old Street, Ashton-under-Lyne, OL6 7SR</strong></p>

<p><strong>0161 342 7101</strong></p>
</div>

<h4 id="PCGTI"><a href="#PCbacterialVaginosis">Bacterial Vaginosis</a></h4>

<h4><a href="#PCcandidiasis">Candidiasis</a></h4>

<h4><a href="#PCchlamydia">Chlamydia</a></h4>

<h4><a href="#PCEpididymo">Epididymo - Orchitis</a></h4>

<h4><a href="#PCGonorrhoea">Gonorrhoea</a></h4>

<h4><a href="#PCInfectBarthCyst">Infected Bartholin&#39;s Cyst/Abcess</a></h4>

<h4><a href="#PCPID">Pelvic Inflammatory Disease</a></h4>

<h4><a href="#PCTrichomoniasis">Trichomoniases</a></h4>
<br />
<!--Bacterial Vaginosis-->
<div class="text-left border border-info rounded" id="PCbacterialVaginosis">
<h2 class="text-center" id="PCBV">Bacterial Vaginosis</h2>

<p>A seven day course of metronidazole is slightly more effective than 2g stat.</p>

<p>Clindamycin gel is expensive but is a useful alternative if metronidazole cannot be tolerated</p>
<!--Start accordian-->

<div id="PCaccordionBV">
<div class="card">
<div class="card-header" id="PCBVTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseBV" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseBV" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCBV" class="collapse" data-parent="#PCaccordionBV" id="PCcollapseBV">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Metronidazole 400mg BD</strong></span> for 7 days</p>

<p>or</p>

<p><span style="color:#008000"><strong>Metronidazole 2g STAT</strong></span></p>

<p>or</p>

<p><span style="color:#800080"><strong>Metronidazole vaginal gel 0.75% 5g</strong></span> nightly for 5 nights</p>

<p>or</p>

<p><span style="color:#B22222"><strong>Clindamycin 2 % vaginal cream 5g </strong></span>nightly for 7 nights (expensive)</p>

<p>During pregnancy /breastfeeding avoid high dose regimens of metronidazole (2g stat dose). During lactation metronidazole enters breast milk and can alter the taste of breast milk, therefore avoid oral treatment in lactating women and use topical treatment instead.</p>
</div>
</div>
</div>
</div>
<br />
<!--Candidiasis-->
<div class="text-left border border-info rounded" id="PCcandidiasis">
<h2 class="text-center" id="PCCandidae">Candidiasis</h2>

<p>Many products are available over the counter, so check whether the patient has already self-treated. Systemic treatments are best reserved for failures of topical treatment and for patients who prefer oral treatment to topical.</p>
<!--Start accordian-->

<div id="PCaccordionCandidae">
<div class="card">
<div class="card-header" id="PCCandidaeTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseCandidae" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseCandidae" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCCandidae" class="collapse" data-parent="#PCaccordionCandidae" id="PCcollapseCandidae">
<div class="card-body text-left">
<p><strong><span style="color:#0000FF">Clotrimazole 10% vaginal cream 5g single dose</span></strong></p>

<p>or</p>

<p><span style="color:#800080"><strong>Clotrimazole pessary 500mg as a single dose</strong></span></p>

<p>If <u>topical treatment fails</u> or the <u>patient prefers oral preparation</u>:</p>

<p><strong><span style="color:#008080">Fluconazole 150mg orally STAT</span></strong></p>

<p><strong>In pregnancy avoid oral azole and use intravaginal treatment for 7 days</strong>:</p>

<p><span style="color:#B22222"><strong>Clotrimazole pessary 100mg </strong></span>at night for 6 nights</p>

<p>(This slightly shorter treatment duration is considered acceptable by PHE as that is the number of pessaries in one original pack of clotrimazole 100mg pessaries).</p>

<p>or</p>

<p><span style="color:#008000"><strong>Miconazole 2% cream 5g BD</strong></span> as intravaginal application for 7 days</p>

<p>In pregnancy the use of an <u>applicator</u> to insert pessaries should be <u>avoided</u> and insertion by hand is preferable.</p>

<p>The patient should be instructed to wash hands before insertion. For intravaginal creams where use of an applicator cannot be avoided, care must be taken to avoid injuring the cervix.</p>
</div>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Chlamydia-->
<div class="text-left border border-info rounded" id="PCchlamydia">
<h2 class="text-center" id="PCChlamydia">Chlamydia</h2>

<p>It is recommended that management of Chlamydia should be undertaken at Ashton Primary Care Sexual Health Clinic.</p>

<p>Treat with a &ldquo;stat&rdquo; dose of azithromycin one hour before or two hours after food. A seven day course of oxytetracycline or erythromycin is cheaper but compliance may be poor.</p>

<p>Also erythromycin is less efficacious than doxycycline and has more side effects. Contacts of chlamydia positive patients should be treated immediately rather than waiting for a positive result. A urine specimen must be taken before treatment is commenced.</p>
<!--Start accordian-->

<div id="PCaccordionChlamydia">
<div class="card">
<div class="card-header" id="PCChlamydiaTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseChlamydia" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseChlamydia" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCChlamydia" class="collapse" data-parent="#PCaccordionChlamydia" id="PCcollapseChlamydia">
<div class="card-body text-left">
<p>1st line:&nbsp;<span style="color:#800080"><strong>Doxycycline 100mg BD </strong></span>for 7 days</p>

<p>2nd line:<span style="color:#0000ff"><strong>Azithromycin 1g STAT</strong></span>,&nbsp;<span style="color:#0000ff"><strong>followed by 500mg once daily&nbsp;</strong></span>for 2 days</p>

<p><u>In pregnancy/breast feeding:</u></p>

<p><span style="color:#008080"><strong>Azithromycin 1g STAT, followed by 500mg once daily&nbsp;</strong></span>for 2 days</p>

<p>Due to the lower cure rate in pregnancy, a test for cure should be performed at least 5 weeks after treatment (6 weeks with azithromycin).</p>

<p>Patients should be advised to avoid sexual contact for a week after treatment, even if using a condom, to prevent the risk of re-infection.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Epididymo-orchitis-->
<div class="text-left border border-info rounded" id="epydidymo">
<h2 class="text-center" id="PCEpididymo">Epididymo-Orchitis</h2>
<!--Start accordian-->

<div id="PCaccordionEpididymo">
<div class="card">
<div class="card-header" id="PCEpididymoTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseEpididymo" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseEpididymo" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCEpididymo" class="collapse" data-parent="#PCaccordionEpididymo" id="PCcollapseEpididymo">
<div class="card-body text-left">
<p><span style="color:#000000"><u>Due to chlamydial infection</u>:</span></p>

<p><span style="color:#0000ff"><strong>Ceftriaxone 500mg IM stat</strong></span><span style="color:#000000"> then </span><span style="color:#0000ff"><strong>Doxycycline 100mg po bd</strong></span><span style="color:#000000"> for <u>14 days.</u></span></p>

<p><span style="color:#000000">Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</span></p>

<p><u>Due to Gram negative&nbsp;enteric organisms (urinary pathogens):</u></p>

<p><u><span style="color:#000000"><strong>1st line:</strong></span></u><span style="color:#0000ff"><strong> Co-trimoxazole 960mg po bd </strong></span><span style="color:#000000">for 10 days.</span></p>

<p><span style="color:#000000"><u><strong>2nd line:</strong></u></span> <span style="color:#8e44ad"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000">for 10 days</span></p>

<p><strong>or</strong></p>

<p><span style="color:#8e44ad"><strong>ofloxacin 200mg po bd</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#000000">for&nbsp;<u>14 days.</u></span></p>

<p><u><strong><span style="color:black">3rd line:</span></strong></u><strong> </strong><strong><span style="color:#e74c3c">Doxycycline 100mg BD</span></strong> <span style="color:#333333">for&nbsp;10 days.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Gonorrhoea-->
<div class="text-left border border-info rounded" id="PCgonorrhoea">
<h2 class="text-center" id="PCGonorrhoea">Gonorrhoea</h2>

<p>Because of varying antibiotic sensitivities gonorrhoea can be difficult to treat, and a test of cure is important. It is recommended that management of gonorrhoea should be undertaken at Ashton Primary Care Sexual Health Clinic, particularly in a climate of emerging antibiotic resistance.</p>
</div>
<br />
<!--InfectbarthCyst-->
<div class="text-left border border-info rounded" id="PCInfectBarthCyst">
<h2 class="text-center" id="PCinfectbarthCyst">Infected Bartholin&#39;s cyst/abscess</h2>
<!--Start accordian-->

<div id="PCaccordionInfectbarthCyst">
<div class="card">
<div class="card-header" id="PCInfectbarthCystTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseInfectbarthCyst" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseInfectbarthCyst" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCInfectbarthCyst" class="collapse" data-parent="#PCaccordionInfectbarthCyst" id="PCcollapseInfectbarthCyst">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Cefalexin 1g TDS&nbsp;</span></strong><span style="color:#000000">plus</span><strong><span style="color:#0000ff"> clindamycin 450mg TDS&nbsp;</span></strong><span style="color:#000000">for 5 days.</span></p>

<p><span style="color:#000000"><strong>Note:</strong> cephalosporins can be given in penicillin allergy with a rash.</span></p>

<p><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis):</u></strong></span></p>

<p><span style="color:#990066"><strong>Co-trimoxazole 960mg BD</strong></span><span style="color:#c0392b"><strong>&nbsp;</strong></span><span style="color:#000000">plus</span><span style="color:#800080"><strong> </strong></span><span style="color:#990066"><strong>clindamycin 450mg BD</strong></span><span style="color:#000000"><strong> </strong>for 5 days.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--PID-->
<div class="text-left border border-info rounded" id="PID">
<h2 class="text-center" id="PCPID">Pelvic Inflammatory Disease</h2>

<p>Take appropriate specimens for chlamydia and gonococci then give a choice of treatment regimen as indicated below. Note that all Gonorrhoea positive cases should be referred for treatment to a GUM clinic.</p>
<!--Start accordian-->

<div id="PCaccordionPID">
<div class="card">
<div class="card-header" id="PCPIDTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapsePID" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePID" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCPID" class="collapse" data-parent="#PCaccordionPID" id="PCcollapsePID">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Ceftriaxone 500mg IM single dose</strong></span></p>

<p><u>followed by </u></p>

<p><strong><span style="color:#c0392b">Metronidazole 400mg BD</span><span style="color:#008000"> </span><span style="color:#000000">plus</span><span style="color:#008000"><strong> </strong></span><span style="color:#c0392b">Doxycycline 100mg BD </span></strong><span style="color:#000000">for 14 days.</span></p>

<p>The above regimen is suitable for patients with penicillin allergy, where the nature of the allergy is a rash.</p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></p>

<p><span style="color:#c0392b"><strong>Metronidazole 400mg BD </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#008000"><strong><strong> </strong></strong></span><span style="color:#c0392b"><strong>Ofloxacin 400mg BD </strong></span><span style="color:#000000">for 14 days.</span></p>

<p>(AVOID this regimen if high risk of gonococcal disease due to quinolone resistance).</p>

<p>Doxycycline must NOT be prescribed for pregnant or breast - feeding women</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Trichomoniasis-->
<div class="text-left border border-info rounded" id="Trichomoniasis">
<h2 class="text-center" id="PCTrichomoniasis">Trichomoniasis</h2>
As this is a sexually transmitted infection treatment of the partner is important. Other sexually transmitted infections may be present as well as Trichomonas. Refer to GUM clinic for confirmation of diagnosis, treatment and partner notification. There is emerging evidence that pregnant women with Trichomoniasis should be treated, but there is no alternative to Metronidazole. Wait until the second trimester before treating with 400mg twice daily for 7 days. <!--Start accordian-->

<div id="PCaccordionTrichomoniasis">
<div class="card">
<div class="card-header" id="PCTrichomoniasisTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseTrichomoniasis" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseTrichomoniasis" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCTrichomoniasis" class="collapse" data-parent="#PCaccordionTrichomoniasis" id="PCcollapseTrichomoniasis">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Metronidazole 400mg BD</strong></span> for 7 days</p>

<p><strong>or</strong></p>

<p><span style="color:#800080"><strong>Metronidazole 2g stat</strong></span></p>

<p>Consider clotrimazole for symptom relief (not cure) if metronidazole declined. During pregnancy avoid high dose regimens of metronidazole (2g stat dose)</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCGTI"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- LRTI-->

<div aria-hidden="true" aria-labelledby="LRTILabel" class="portfolio-modal modal fade " id="PCLRT" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="LRTILabel">Lower Respiratory Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<div>
<p>Many infections are viral but the principal bacterial pathogens in acute lower respiratory tract infections are Streptococcus pneumoniae (which is the most common cause of community-acquired pneumonia), Haemophilus influenzae and atypical organisms such as Legionella and Mycoplasma. Staphylococcus aureus lower respiratory infections can occur as a complication following influenza. Pseudomonas may be isolated from sputum cultures but, in the community, this would usually reflect colonisation and should not be treated; it may be helpful to discuss with a microbiologist if in doubt. Avoid use of low dose amoxicillin which may encourage bacterial resistance. Note that excessive use of quinolones (e.g. ciprofloxacin) and co-amoxiclav is implicated in development of MRSA and Clostridium difficile infections.</p>
</div>

<h4 id="PCLRTISection"><a href="#PCAcuteBronchitis">Acute Bronchitis</a></h4>

<h4><a href="#PCAcuteExacBronch">Acute Exacerbation of Bronchiectasis</a></h4>

<h4><a href="#PCAcuteCOPD">Acute Exacerbation of COPD</a></h4>

<h4><a href="#PCCAP">Community-Acquired Pneumonia</a></h4>
<br />
<!--Acute Bronch-->
<div class="text-left border border-info rounded" id="AcuteBronchitis">
<h2 class="text-center" id="PCAcuteBronchitis">Acute Bronchitis</h2>

<p>Systematic reviews indicate antibiotics have marginal benefits in otherwise healthy adults. Explain to patients why they have not been prescribed antibiotics. Consider prescribing antibiotics for people who have a pre-existing co-morbid condition that impairs their ability to deal with infection or is likely to deteriorate with acute bronchitis. Consider immediate antibiotics in patients over 80 years old and ONE of: hospitalisation in past year, oral steroids, diabetic, congestive heart failure OR over 65 years with 2 of the above.</p>
<!--Start accordian-->

<div id="PCaccordionacuteBronch">
<div class="card">
<div class="card-header" id="PCAcuteBronchTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseAcuteBronch" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseAcuteBronch" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCAcuteBronchTreatment" class="collapse" data-parent="#PCaccordionacuteBronch" id="PCcollapseAcuteBronch">
<div class="card-body text-left">
<p><span style="color:rgb(0, 0, 255)"><strong>Amoxicillin 1g TDS</strong></span> for 3 days (or <span style="color:rgb(0, 0, 255)"><strong>amoxicillin 500mg TDS</strong></span> for 5 days)</p>

<p><span style="color:rgb(0, 0, 0)"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:rgb(128, 0, 128)"><strong>Doxycycline 200 mg STAT then 100 mg OD</strong></span> for 5 days (or <span style="color:rgb(128, 0, 128)"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span> for 3 days)</p>

<p>Doxycycline must NOT be prescribed for children under 12 years, or for pregnant or breast-feeding women.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Acute Exacerbation of Bronchiectasis-->
<div class="text-left border border-info rounded" id="acuteExacBronch">
<h2 class="text-center" id="PCAcuteExacBronch">Acute Exacerbation of Bronchiectasis</h2>

<p>An acute exacerbation of bronchiectasis is sustained worsening of symptoms from a person&rsquo;s stable state.</p>

<p>When choosing antibiotics, take account of:</p>

<ul>
    <li>the severity of symptoms</li>
    <li>previous exacerbations, hospitalisations and risk of complications</li>
    <li>previous sputum culture and susceptibility results.</li>
</ul>

<p>NICE (2019) recommends to send a sputum sample for culture and susceptibility testing and then offer an antibiotic.&nbsp; Also, when results of sputum culture are available:</p>

<ul>
    <li>review choice of antibiotic</li>
    <li>only change antibiotic according to susceptibility results if bacteria are resistant and symptoms are not already improving, <strong>using narrow spectrum antibiotics when possible.</strong></li>
</ul>

<p>Refer to hospital if the person has any symptoms or signs suggesting a more serious illness or condition (for example, cardiorespiratory failure or sepsis).</p>

<p>Seek specialist advice if:</p>

<ul>
    <li>symptoms do not improve with repeated courses of antibiotics</li>
    <li>bacteria are resistant to oral antibiotics</li>
    <li>the person cannot take oral medicines (to explore giving intravenous antibiotics at home or in the community if appropriate)</li>
</ul>
<!--Start accordian-->

<div id="PCaccordionAcuteExacBronch">
<div class="card">
<div class="card-header" id="PCAcuteExacBronchTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseAcuteExacBronch" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseAcuteExacBronch" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCAcuteExacBronch" class="collapse" data-parent="#PCaccordionAcuteExacBronch" id="PCcollapseAcuteExacBronch">
<div class="card-body text-left">
<p>Please ensure response to treatment is reviewed after 7 days at the very most.&nbsp; DO NOT routinely offer two weeks of antibiotics without adequate review.&nbsp; NICE (2019) guidance gives the duration of 7-14 as a guide and up to weeks may be required for some patients.&nbsp; However, adequate review is crucial when treating exacerbation of bronchiectesis to ensure the patient is responding and not deteriorating.</p>

<p>1.<span style="color:#0000ff"><strong> Amoxicillin 1g TDS</strong></span> &nbsp;(or <span style="color:#0000ff"><strong>amoxicillin 500mg TDS</strong></span>&nbsp;if less than 50kg) for 7-14&nbsp;days</p>

<p>or</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong>&nbsp;(or alternative regime if amoxicillin not suitable)</span></p>

<p>2.<span style="color:#800080"><strong> Doxycycline 200 mg STAT then 100 mg OD</strong></span> for 7-14&nbsp;days (or <span style="color:#800080"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span>)</p>

<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td>
            <p>If Legionella is suspected:</p>

            <p>Add <span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span><span style="color:#0000ff"><strong> </strong></span>for 7-14&nbsp;days to amoxicillin</p>
            </td>
        </tr>
    </tbody>
</table>

<p>If there is inadequate&nbsp;clinical response to amoxicillin and/or doxycyline, co-amoxiclav 625 mg TDS for 7-14 days can be tried as an alternative antibiotic.&nbsp;</p>

<p>It is recommended that only hospital consultants should commence long-term antibiotic prophylaxis for bronchiectesis&nbsp;patients and that those patients who would benefit are carefully selected and closely monitored with regular follow ups.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--AcuteCOPD-->
<div class="text-left border border-info rounded" id="AcuteCOPD">
<h2 class="text-center" id="PCAcuteCOPD">Acute exacerbation of COPD</h2>

<p>About up to 50% of cases are viral, 30-50% are bacterial and the rest are undetermined. Antibiotics are not indicated in the absence of purulent/mucopurulent sputum especially if not associated with increased dyspnoea or clinical toxicity.</p>

<p>Treat exacerbations promptly with antibiotics if purulent sputum <strong>and</strong> increased shortness of breath <strong>and/or</strong> increased sputum volume.</p>

<p>Risk factors for antibiotic resistant organisms include co-morbid disease, severe COPD, frequent exacerbations, antibiotics in last 3 months.</p>
<!--Start accordian-->

<div id="PCaccordionAcuteCOPD">
<div class="card">
<div class="card-header" id="PCAcuteCOPDRescue">
<h5 class="mb-0"><button aria-controls="PCcollapseAcuteCOPD" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseAcuteCOPD" data-toggle="collapse" type="button">Rescue Packs</button></h5>
</div>

<div aria-labelledby="PCAcuteCOPD" class="collapse" data-parent="#PCaccordionAcuteCOPD" id="PCcollapseAcuteCOPD">
<div class="card-body text-left">

<p>There has been some recent information circulated on this from the medicines management team.&nbsp; All patients issued with a rescue pack should <strong>ONLY</strong> be done so after a proper clinical assessment and the patient should be issued with an <strong><u>individualised and detailed care plan</u></strong> &ndash; so they are aware of what actions need to be taken.</p>

<p>Please refrain from conducting practice-wide searches and sending out rescue pack prescriptions to all on the COPD or asthma registers.&nbsp; This is inappropriate and the medicines supply chain will be unable to cope with such increased demand, meaning those actually requiring rescue medication will not be able to source it.</p>

<p>COVID19 is a viral infection and so the advice stands as for all other respiratory viral pathogens.&nbsp; If patients are unwell then they are advised to seek medication attention.</p>
</div>
</div>

<div class="card-header" id="PCAcuteCOPDTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseAcuteCOPDTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseAcuteCOPDTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCAcuteCOPDTreatment" class="collapse" data-parent="#PCaccordionAcuteCOPD" id="PCcollapseAcuteCOPDTreatment">
<div class="card-body text-left">
<p>1.<span style="color:#0000ff"><strong> Amoxicillin 1g TDS</strong></span> for 3 days (or <span style="color:#0000ff"><strong>amoxicillin 500mg TDS</strong></span>&nbsp;if less than 50kg for 5 days)</p>

<p>or</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong>&nbsp;(or alternative regime if amoxicillin not suitable)</span></p>

<p>2.<span style="color:#800080"><strong> Doxycycline 200 mg STAT then 100 mg OD</strong></span> for 5 days (or <span style="color:#800080"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span> for 3 days)</p>

<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td>
            <p>If Legionella is suspected:</p>

            <p>Add <span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span><span style="color:#0000ff"><strong> </strong></span>for 5 days to amoxicillin</p>
            </td>
        </tr>
    </tbody>
</table>

<p>If there is inadequate&nbsp;clinical response to amoxicillin and/or doxycyline, co-amoxiclav 625 mg TDS for 5 days can be tried as an alternative antibiotic.&nbsp;However, the diagnosis should also be reviewed to ensure that exacerbation is indeed bacterial in nature, as up to 50% of acute exacerbation of COPD are&nbsp;due to a viral cause.</p>

<p>It is recommended that only hospital consultants should commence long-term antibiotic prophylaxis for COPD patients and that those patients who would benefit are carefully selected and closely monitored with regular follow ups.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--CAP-->
<div class="text-left border border-info rounded" id="cap">
<h2 class="text-center" id="PCCAP">Community-acquired Pneumonia</h2>

<p>The intensity of pneumonia in the community can be assessed using the CRB65 score;<strong> each factor scores one point:</strong></p>

<ul>
    <li>confusion (abbreviated Mental Test score 8 or less, or new disorientation in person, place, or time);</li>
    <li>a raised respiratory rate (30 breaths per minute or more);</li>
    <li>a low blood pressure (diastolic 60 mmHg or less, or systolic less than 90 mmHg);</li>
    <li>age 65 years or over.</li>
</ul>

<p><strong>Score 1 or 2: intermediate risk (1-10% mortality risk). </strong></p>

<p><strong>Score 3 or 4: high risk (more than 10% mortality risk)</strong></p>

<p>For life-threatening illness or where hospital admission is likely to be delayed, give intravenous <span style="color:#0000ff"><strong>Benzylpenicillin 1.2g</strong></span> (give intramuscular if a vein cannot be found) or <strong><span style="color:#0000ff">oral Amoxicillin 1g</span></strong> <strong>immediately</strong>.</p>

<p>If it is felt that&nbsp;blood cultures are required, due to severity of illness, then the patient should be referred to secondary care.&nbsp; It is vital that blood cultures are taken by someone who is appropriately trained to do so, reducing the chances of contamination.&nbsp;&nbsp;&nbsp;</p>

<p>NB: it is recognised that due to increased remote consultations it may not always be possible to obtain a BP reading.&nbsp; Some patients may have suitable equipment at home, assisting the clinician in making an assesment.&nbsp; The antibiotic choices have been amended to help with this in this current climate.</p>
<!--Start accordian-->

<div id="PCaccordionCap">
<div class="card">
<div class="card-header" id="PCCapTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseCap" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseCap" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCCap" class="collapse" data-parent="#PCaccordionCap" id="PCcollapseCap">
<div class="card-body text-left">
<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td><span style="color:#c0392b"><strong>CRB score</strong></span></td>
            <td><span style="color:#c0392b"><strong>Antibiotic choice (5 day treatment)</strong></span></td>
        </tr>
        <tr>
            <td>CRB = 0</td>
            <td>
            <p><span style="color:#0000ff"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span><span style="color:#800080"><strong> </strong></span>(suitable for penicillin allergy)</p>

            <p>OR</p>

            <p><span style="color:#990066"><strong>Amoxicillin 1 g TDS</strong></span></p>
            </td>
        </tr>
        <tr>
            <td>CRB = 1-2</td>
            <td>
            <p><span style="color:#0000ff"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span><span style="color:#800080"><strong> </strong></span>(suitable for penicillin allergy)</p>

            <p>OR</p>

            <p><span style="color:#990066"><strong>Amoxicillin 1 g TDS&nbsp;</strong></span>PLUS&nbsp;<span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span></p>
            </td>
        </tr>
        <tr>
            <td>CRB = 3-4</td>
            <td>
            <p><strong><span style="color:#66cc33">Co-amoxiclav 625mg TDS&nbsp;</span></strong>PLUS&nbsp;<span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span></p>

            <p><strong><span style="color:#9900cc">Levofloxacin 500mg BD</span><span style="color:#cc0099">&nbsp;</span></strong>if penicillin allergic</p>
            </td>
        </tr>
    </tbody>
</table>

<p>Post influenzal pneumonia can be due to S. aureus which usually requires hospital admission because of the clinical severity of staphylococcal pneumonia.&nbsp; Following recovery consider pneumococcal vaccination.</p>
</div>
</div>

<div class="card-header" id="PCCap19Treatment">
<h5 class="mb-0"><button aria-controls="PCcollapseCap19" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseCap19" data-toggle="collapse" type="button">COVID19 plus CAP</button></h5>
</div>

<div aria-labelledby="PCCap19Treatment" class="collapse" data-parent="#PCaccordionCap" id="PCcollapseCap19">
<div class="card-body text-left">
<p>The current COVID19 pandemic has highlighted the risk faced by older adults who are more susceptible to complications as a result of pneumonia.</p>

<p>Comorbidities, impaired immunity and frailty, including a reduced ability to cough and to clear secretions from the lungs, can all contribute to this complication.</p>

<p>Viruses are thought to cause around 50% of cases of pneumonia.&nbsp; Viral pneumonia is generally less severe than bacterial pneumonia but can act as a precursor to it.&nbsp; Preventing any pneumonia in older adults is preferable to treating it.</p>

<p>Where physical examination and other ways of making an objective diagnosis are not possible, the clinical diagnosis of CAP of any cause in an adult can be informed by other clinical signs or symptoms such as:</p>

<ul>
    <li>temperature above 38 <sup>o</sup>C</li>
    <li>respiratory rate above 20 breaths per minute</li>
    <li>heart rate above 100 beats per minute</li>
    <li>new confusion</li>
</ul>

<p>Use of NEWS2 score in the community for predicting the risk of clinical deterioration may be useful.</p>
</div>
</div>



</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCLRTISection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- HCA Infections-->

<div aria-hidden="true" aria-labelledby="HCAILabel" class="portfolio-modal modal fade " id="PCHCAI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAILabel">HealthCare Associated Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="PCHCA"><a href="#PCHCAIntro">Introduction</a></h4>

<h4><a href="#PCHCARec">Key DoH Recommendations</a></h4>

<h4><a href="#PCPreventionHCAI">Prevention &amp; Treatment of HCAIs</a></h4>
<br />
<!--Introduction-->
<div class="text-left border border-info rounded px-1" id="HCAIntro">
<h2 class="text-center" id="PCHCAIntro">Introduction</h2>

<p>In December 2003 The Department of health published a National Plan that set out the actions to control the transmission of Healthcare Associated Infections, Winning Ways: Working Together to reduce Healthcare Associated Infections in England. &lsquo;Action area Five&rsquo; of the plan refers to the &lsquo;Prudent use of Antibiotics&rsquo;. The key issue states that: &lsquo;Indiscriminate and inappropriate use of antibiotics to treat infection within a clinical service promotes the emergence of antibiotic resistant organisms and &lsquo;super bug&rsquo; strains.</p>
</div>
<br />
<!--DoH recommendations-->
<div class="text-left border border-info rounded" id="dohrecs">
<h2 class="text-center" id="PCHCARec">Key DoH Recommendations</h2>

<ul>
    <li>Antibiotics normally to be used only after a treatable infection has been recognised or there is a high degree of suspicion of infection.</li>
    <li>Choice of antibiotic normally to be governed by local information about trends in antibiotic resistance or a known sensitivity of the organism.</li>
    <li>Antibiotics only to be taken by patients over the prescribed period at the correct dose.</li>
    <li>Prescription of the antibiotics for children to be carefully considered; they are often unnecessarily prescribed for common viral infections and the child is subsequently more likely to develop antibiotic resistance.</li>
    <li>Support for prudent antibiotic prescribing to be provided by clinical pharmacists, medical microbiologists and infectious disease physicians.</li>
    <li>Antibiotics to be used for prevention of infection only where benefit has been proven.</li>
    <li>Narrow-spectrum antibiotics to be preferred to the broad-spectrum groups.</li>
</ul>
</div>
<br />
<!--Prevention of HCAIs-->
<div class="text-left border border-info rounded" id="preventionHCAI">
<h2 class="text-center" id="PCPreventionHCAI">Prevention of HCAIs</h2>
<!--Start accordian-->

<div id="PCaccordionPrevention">
<div class="card">
<div class="card-header" id="PCPreventionCDIFF">
<h5 class="mb-0"><button aria-controls="PCcollapsePreventionCDIFF" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePreventionCDIFF" data-toggle="collapse" type="button">Clostridium Difficile Infection</button></h5>
</div>

<div aria-labelledby="PCPreventionCDIFF" class="collapse" data-parent="#PCaccordionPrevention" id="PCcollapsePreventionCDIFF">
<div class="card-body text-left">
<p>Prevention of CDI relies on ensuring that patients do not become susceptible through disruption of their normal gut flora and on preventing as far as possible their exposure to the organism. These approaches are implemented through careful measures to control antibiotic usage and through routine infection control procedures.</p>
<!--Start inner accordian-->

<div id="PCaccordionCDIFF">
<div class="card">
<div class="card-header" id="PCPreventionCDIFFrecs">
<h5 class="mb-0"><button aria-controls="PCcollapsePreventionCDIFFrecs" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePreventionCDIFFrecs" data-toggle="collapse" type="button">Key Recommendations</button></h5>
</div>

<div aria-labelledby="PCPreventionCDIFFrecs" class="collapse" data-parent="#PCaccordionCDIFF" id="PCcollapsePreventionCDIFFrecs">
<div class="card-body text-left">
<p>For the purpose of preventing CDI, the main component of an antibiotic policy should be:</p>

<ul>
    <li>The avoidance of unnecessary antibiotic use.</li>
    <li>The use of narrow spectrum antibiotics whenever the causative pathogen is known.</li>
    <li>Review of &ldquo;blind&rdquo; empiric antibiotic therapy as soon as the causative pathogen has been identified.</li>
    <li>Avoidance, wherever possible, of the use of antibiotic &lsquo;cocktails.&rsquo;</li>
    <li>Regular (daily if possible) prescription review to ensure that antibiotics are discontinued as soon as possible.</li>
</ul>
</div>
</div>

<div class="card-header" id="PCPreventionCDIFFIVABT">
<h5 class="mb-0"><button aria-controls="PCcollapsePreventionCDIFFIVABT" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePreventionCDIFFIVABT" data-toggle="collapse" type="button">Intravenous Antibiotic Therapy</button></h5>
</div>

<div aria-labelledby="PCPreventionCDIFFIVABT" class="collapse" data-parent="#PCaccordionCDIFF" id="PCcollapsePreventionCDIFFIVABT">
<div class="card-body text-left">
<p>If a patient is deemed suitable for intravenous antibiotic therapy they may be treated at home with intravenous antibiotics in accordance with the OPAT pathways.&nbsp; If CDI is known to be a problem;</p>

<ul>
    <li>It should be noted that parenteral aminoglycosides (e.g. gentamicin), when given alone, have seldom been associated with CDI, although their potential serious toxicity must be recognised.</li>
    <li>Consideration should be given to whether the intramuscular or intravenous route should be used, since parenteral antimicrobials can be less likely than oral preparations to predispose to CDI.&nbsp;</li>
</ul>

<p>For further information on the prevention and control of CDI, please refer to the Infection Prevention Team on 0161 922 6194, C.difficile Policy or contact the Microbiologist, for advice on individual cases if required.</p>
</div>
</div>

<div class="card-header" id="PCPreventionCDIFFTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapsePreventionCDIFFTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePreventionCDIFFTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCPreventionCDIFFTreatment" class="collapse" data-parent="#PCaccordionCDIFF" id="PCcollapsePreventionCDIFFTreatment">
<div class="card-body text-left">
<p>It is important to exclude non-infectious causes of diarrhoea, such as laxatives, high-energy feeds or inflammatory bowel disease. Usual diarrhoeal pathogens, notably Salmonella, Shigella, Campylobacter, E coli 0157 should be tested for.</p>

<p>Consideration should be given to the possibility of norovirus (depending on the time of year).</p>

<p>Treatment should be initiated after receiving a positive result from a stool sample if the diarrhoea is not settling within about 72 hours and the decision to treat should be based on the clinical condition of the patient, i.e. either acutely ill or otherwise well despite their diarrhoea. It is important to <strong>palpate the abdomen </strong>which in the acutely ill patient would be tender with distension versus soft, non-tender, not distended in the patient who is well. Withdraw antibiotics if possible. Mild cases will often resolve without treatment if antibiotics are stopped. Consider stopping PPIs if possible.</p>

<p><span style="color:#0000FF"><strong>Metronidazole 400 mg TDS</strong></span> for <strong>3 to 10 days</strong> depending on clinical response.</p>

<p>Consider also a probiotic yoghurt drink (Actimel) 100ml twice a day for 7 days.</p>

<p>Refractory disease:</p>

<p><span style="color:#800080"><strong>Vancomycin 125 mg QDS</strong></span> for <strong>3 to 10 days</strong> depending on clinical response.</p>

<p>Antibiotics can be stopped for CDI as soon as the diarrhoea settles and the patient is not acutely ill or debilitated and there is no abdominal pain or tenderness.&nbsp; Good hygiene is important to prevent re-infection; patients should wash their hands after using the toilet and before eating with soap and water.&nbsp; Patients who do not respond to the above treatment can be discussed with the hospital microbiologists.</p>
</div>
</div>

<div class="card-header" id="PCPreventionCDIFFretest">
<h5 class="mb-0"><button aria-controls="PCcollapsePreventionCDIFFretest" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePreventionCDIFFretest" data-toggle="collapse" type="button">Retesting Criteria</button></h5>
</div>

<div aria-labelledby="PCPreventionCDIFFretest" class="collapse" data-parent="#PCaccordionCDIFF" id="PCcollapsePreventionCDIFFretest">
<div class="card-body text-left">
<p>As the lab is now located at MRI for Tameside they will automatically test for clostridium difficile toxin if the stool fits a certain criteria. &nbsp;Another positive toxin test will count as another case for Tameside and Glossop CCG.</p>

<p>If a patient has previously been tested positive for CDI and symptoms have now recurred please contact the&nbsp;<u><span style="color:#008000"><strong>Infection Prevention Team</strong></span></u> on&nbsp;<strong>0161 922 6194</strong>&nbsp;</p>

<p>Or</p>

<p><span style="color:#800080"><strong>Consultant Microbiologist</strong></span> on&nbsp;<strong>0161 922 4086 (Dr Sacho)</strong>&nbsp;/<strong>&nbsp;0161 922 6500 (Dr Unsworth)</strong></p>

<p><strong><u>BEFORE</u>&nbsp;</strong>sending another sample for advice. &nbsp;</p>

<p>This is to ensure whether a&nbsp;repeat sample is required.</p>
</div>
</div>
</div>
</div>
</div>
</div>

<div class="card-header" id="PCCRE">
<h5 class="mb-0"><button aria-controls="PCcollapsePreventionCRE" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePreventionCRE" data-toggle="collapse" type="button">CRE</button></h5>
</div>

<div aria-labelledby="PCCRE" class="collapse" data-parent="#PCaccordionPrevention" id="PCcollapsePreventionCRE">
<div class="card-body text-left">
<p>Enterobacteriaceae are a large family of bacteria that usually live harmlessly in the gut of all humans and animals. However, these organisms are also some of the most common causes of urinary tract infections, intra-abdominal and bloodstream infections. They include species such as E coli, Klebsiella and Enterobacter.</p>

<p>Carbapenems are a group of penicillin-like antibiotics. Until now, they have been the antibiotics that we could always rely upon to treat infections caused by Enterobacteriaceae. Carbapenemases are enzymes that destroy carbapenem antibiotics, conferring resistance to the bacteria. Carbapenemases are made by a small but growing number of Enterobacteriaceae, with resistance able to transfer between bacterial species.</p>

<p>In the last 5 years England has seen a rapid increase in the incidence of infection and colonisation by multi-drug resistant carbapenemase-producing organisms. This reflects similar problems worldwide and indicates the urgent need for guidance, particularly on infection prevention and control management.</p>

<p>Useful resources:</p>

<p><a href="https://www.gov.uk/government/news/phe-carbapenemase-producing-enterobacteriaceae-toolkit-published" target="_blank">https://www.gov.uk/government/news/phe-carbapenemase-producing-enterobacteriaceae-toolkit-published</a></p>

<p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/329232/CPE_Acute_Trust_Toolkit_Relevant_Literature_and_Resources.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/329232/CPE_Acute_Trust_Toolkit_Relevant_Literature_and_Resources.pdf</a></p>

<p><a href="https://www.gov.uk/government/publications/carbapenemase-producing-enterobacteriaceae-early-detection-management-and-control-toolkit-for-acute-trusts" target="_blank">https://www.gov.uk/government/publications/carbapenemase-producing-enterobacteriaceae-early-detection-management-and-control-toolkit-for-acute-trusts</a></p>
</div>
</div>

<div class="card-header" id="PCESBL">
<h5 class="mb-0"><button aria-controls="PCcollapsePreventionESBL" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapsePreventionESBL" data-toggle="collapse" type="button">ESBL&#39;s</button></h5>
</div>

<div aria-labelledby="PCESBLrecs" class="collapse" data-parent="#PCaccordionPrevention" id="PCcollapsePreventionESBL">
<div class="card-body text-left">
<ul>
    <li>Avoid inappropriate or excessive antibiotic therapy and prophylaxis.</li>
    <li>Ensure antibiotics are given at the correct dosage and for an appropriate duration.</li>
    <li>Limit the use of glycopeptide antibiotics (vancomycin and teicoplanin) to situations where their use has been shown to be appropriate. If possible, prolonged courses of glycopeptide therapy should be avoided.</li>
    <li>Reduce the use of broad-spectrum antibiotics, particularly third-generation cephalosporins and fluoroquinolones, to what is clinically appropriate.</li>
    <li>Instituting antibiotic stewardship programmes in healthcare facilities, key components of which include the identification of key personnel who are responsible for this, surveillance of antibiotic resistance and antibiotic consumption, and prescriber education. To combat resistance, the CCG Clinical Lead for Infection prevention recommends that:</li>
    <li>For community patients, repeated topical therapies should not be prescribed.</li>
    <li>Community patients need not be re-screened, unless they are pre-operative and there is direction to the GP in the form of a &lsquo;treatment and screening protocol&rsquo; from the hospital that is planning the surgery.</li>
    <li>Community patient&rsquo;s wounds need not be swabbed unless there are clinical signs of infection, (Consultation can be sought from the CCG Tissue Viability Nurse Specialist).</li>
    <li>Advice on good personal and home hygiene must be given to promote a reduction in MRSA colonisation.</li>
</ul>

<div id="PCaccordionESBLrecs">
<div class="card">
<div class="card-header" id="PCPreventionESBLrecs">
<h5 class="mb-0"><button aria-controls="PCcollapseESBLrecs" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseESBL" data-toggle="collapse" type="button">Key Recommendations</button></h5>
</div>

<div aria-labelledby="PCPreventionESBLrecs" class="collapse" data-parent="#PCaccordionCDIFF" id="PCcollapseESBLrecs">
<div class="card-body text-left">
<ul>
    <li>Effective control measures are less well understood than for other types of antibiotic resistant bacteria for example C. difficile.&nbsp; Until we know more about how to control these bacteria it is suggested that;</li>
    <li>All care establishments should ensure that hand washing and other infection control procedures are rigorously enforced. Visitors and patients should also practice good hand hygiene</li>
    <li>In some circumstances patients with ESBL producing bacteria will be isolated whilst in hospital to prevent spread to others</li>
    <li>Individuals known to be colonised should not share a room with someone with a urinary catheter or IV line.</li>
    <li>Minimising the use of antibiotics is crucial in helping reduce spread.</li>
    <li>Thorough cleaning should also be undertaken to maintain a clean and safe environment</li>
    <li>For further information on the prevention and control of ESBL infections, please refer to the CCG Infection Prevention Service.</li>
</ul>
</div>
</div>
</div>
</div>
</div>
</div>

<div class="card-header" id="PCMRSA">
<h5 class="mb-0"><button aria-controls="PCcollapseMRSA" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseMRSA" data-toggle="collapse" type="button">MRSA</button></h5>
</div>

<div aria-labelledby="PCMRSA" class="collapse" data-parent="#PCaccordionPrevention" id="PCcollapseMRSA">
<div class="card-body text-left">
<p>Prevention of CDI relies on ensuring that patients do not become susceptible through disruption of their normal gut flora and on preventing as far as possible their exposure to the organism. These approaches are implemented through careful measures to control antibiotic usage and through routine infection control procedures.</p>
<!--Start inner accordian-->

<div id="PCaccordionMRSA">
<div class="card">
<div class="card-header" id="PCPreventionMRSArecs">
<h5 class="mb-0"><button aria-controls="PCcollapseMRSArecs" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseMRSArecs" data-toggle="collapse" type="button">Key Recommendations</button></h5>
</div>

<div aria-labelledby="PCMRSArecs" class="collapse" data-parent="#PCaccordionMRSA" id="PCcollapseMRSArecs">
<div class="card-body text-left">
<ul>
    <li>Avoid inappropriate or excessive antibiotic therapy and prophylaxis.</li>
    <li>Ensure antibiotics are given at the correct dosage and for an appropriate duration.</li>
    <li>Limit the use of glycopeptide antibiotics (vancomycin and teicoplanin) to situations where their use has been shown to be appropriate. If possible, prolonged courses of glycopeptide therapy should be avoided.</li>
    <li>Reduce the use of broad-spectrum antibiotics, particularly third-generation cephalosporins and fluoroquinolones, to what is clinically appropriate.</li>
    <li>Instituting antibiotic stewardship programmes in healthcare facilities, key components of which include the identification of key personnel who are responsible for this, surveillance of antibiotic resistance and antibiotic consumption, and prescriber education. To combat resistance, the CCG Clinical Lead for Infection prevention recommends that:</li>
    <li>For community patients, repeated topical therapies should not be prescribed.</li>
    <li>Community patients need not be re-screened, unless they are pre-operative and there is direction to the GP in the form of a &lsquo;treatment and screening protocol&rsquo; from the hospital that is planning the surgery.</li>
    <li>Community patient&rsquo;s wounds need not be swabbed unless there are clinical signs of infection, (Consultation can be sought from the CCG Tissue Viability Nurse Specialist).</li>
    <li>Advice on good personal and home hygiene must be given to promote a reduction in MRSA colonisation.</li>
</ul>
</div>
</div>

<div class="card-header" id="PCPreventionMRSAtopical">
<h5 class="mb-0"><button aria-controls="PCcollapseMRSAtopical" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseMRSAtopical" data-toggle="collapse" type="button">Topical Decolonisation</button></h5>
</div>

<div aria-labelledby="PCMRSAtopical" class="collapse" data-parent="#PCaccordionMRSA" id="PCcollapseMRSAtopical">
<div class="card-body text-left">
<p>For further information on the prevention and control of MRSA colonisation / infections, please refer to the CCG Infection Prevention Service MRSA Policy or contact the Microbiologist, or the CCG Infection Prevention Service staff, for advice on individual cases, if required.</p>
</div>
</div>

<div class="card-header" id="PCPreventionMRSASysAbx">
<h5 class="mb-0"><button aria-controls="PCcollapseMRSASysAbx" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseMRSASysAbx" data-toggle="collapse" type="button">Systemic Antibiotic Therapy</button></h5>
</div>

<div aria-labelledby="PCMRSASysAbx" class="collapse" data-parent="#PCaccordionMRSA" id="PCcollapseMRSASysAbx">
<div class="card-body text-left">
<p>The need for systemic antibiotic therapy should be considered in immunocompromised patients or those with severe disease, based on clinical judgement and local susceptibilities of strains. It is important to ensure empiric treatment also provides cover against Streptococcus pyogenes. Contact the Microbiologist for advice, if required.</p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCHCA"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Primary Care Parasite section-->

<div aria-hidden="true" aria-labelledby="ParasiteLabel" class="portfolio-modal modal fade " id="PCParasite" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ParasiteLabel">Parasites</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="PCParasites"><a href="#PCHeadlice">Headlice</a></h4>

<h4><a href="#PCScabies">Scabies</a></h4>

<h4><a href="#PCThreadworm">Threadworm (Enterobius Vermicularis)</a></h4>
<br />
<!--Headlice-->
<div class="text-left border border-info rounded" id="PCHeadliceSection">
<h2 class="text-center" id="PCHeadlice">Headlice</h2>

<p>Advise the individual or parent to use detection combing on wet or dry hair to confirm head lice infestation. All close contacts and household members should be checked. Only the presence of live lice confirms infestation and then treatment is necessary. There are 3 treatment options, none of which are 100 % effective, which can be discussed with the patient or parent.</p>

<p><strong>1. Insecticide</strong></p>

<p><strong>2. Dimeticone</strong></p>

<p><strong>3. Wet combing</strong></p>

<p>The latter 2 options are suitable in pregnancy and breastfeeding.</p>
<!--Start accordian headlice-->

<div id="PCaccordionParasites">
<div class="card">
<div class="card-header" id="PCPreventionParaInsecticide">
<h5 class="mb-0"><button aria-controls="PCcollapseParaInsecticide" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseParaInsecticide" data-toggle="collapse" type="button">Insecticide</button></h5>
</div>

<div aria-labelledby="PCParaInsecticide" class="collapse" data-parent="#PCaccordionParasites" id="PCcollapseParaInsecticide">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Malathion 0.5 % aqueous solution</strong></span></p>

<p>Apply to dry hair and scalp, wash off after 12 hours and repeat in 7 days. 200 ml should be sufficient for an adult to have 2 treatments.</p>

<p>Treatment failure maybe due to resistance, reinfection from another household member or poor treatment technique.</p>
</div>
</div>

<div class="card-header" id="PCPreventionParaDimet">
<h5 class="mb-0"><button aria-controls="PCcollapseParaDimet" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseParaDimet" data-toggle="collapse" type="button">Dimeticone</button></h5>
</div>

<div aria-labelledby="PCParaDimet" class="collapse" data-parent="#PCaccordionParasites" id="PCcollapseParaDimet">
<div class="card-body text-left">
<p>Rub into dry hair and scalp, allow to dry naturally, shampoo off after 8 hours (or overnight); repeat after 7 days.</p>
</div>
</div>

<div class="card-header" id="PCPreventionParaComb">
<h5 class="mb-0"><button aria-controls="PCcollapseParaComb" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseParaComb" data-toggle="collapse" type="button">Wet Combing</button></h5>
</div>

<div aria-labelledby="PCParaComb" class="collapse" data-parent="#PCaccordionParasites" id="PCcollapseParaComb">
<div class="card-body text-left">
<p>Wash the hair with ordinary shampoo and apply plenty of conditioner. Untangle the hair with an ordinary comb and then work through the hair in sections with a louse detection comb drawing downwards from root to tip ensuring the whole head of hair is worked through.</p>

<p>Remove lice and eggs from the comb by wiping or washing the comb. Four sessions at 4 day intervals are needed over 2 weeks. The process should continue until no live lice are found on 3 consecutive sessions.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Scabies-->
<div class="text-left border border-info rounded" id="PCScabiesSection">
<h2 class="text-center" id="PCScabies">Scabies</h2>

<p>Treat the patient and all members of the household, close contacts and sexual contacts with a topical insecticide within 24 hours.</p>

<p><span style="color:#0000CD"><strong>Permethrin 5 % dermal cream</strong></span></p>

<p><strong>should be used as first line treatment. Most adults should only need one tube of cream. The cream should be washed off after 8&ndash;12 hours.</strong></p>

<p><span style="color:#800080"><strong>Malathion 0.5 % aqueous solution</strong></span></p>

<p><strong>can be used second line if permethrin is unsuitable (e.g. if the patient is allergic to chrysanthemums) and washed off after 24 hours</strong>.</p>

<p>If any treated areas are washed during the application time, the cream/lotion must be reapplied. The insecticide should be applied twice with applications one week apart. Treat the whole body including scalp, face, neck, ears and under the nails. Treating the face and scalp is important in the immunocompromised, very young and elderley. Refer if there is crusted scabies or if there have been multiple treatment failures.</p>
</div>
<br />
<!--Threadworm-->
<div class="text-left border border-info rounded" id="PCThreadwormSection">
<h2 class="text-center" id="PCThreadwormLabel">Threadworm (Enterobius Vermicularis)</h2>

<p>Treat both the patient and all household members unless contraindicated. Good hygiene is very important in breaking the lifecycle of the worms:</p>

<ul>
    <li>Hands should be washed after using the toilet and nails should be kept short.</li>
    <li>Showering or bathing in the morning, washing around the anus, is recommended.</li>
    <li>Underpants should be worn at night in bed and changed every morning</li>
    <li>Sleepwear and bedding should be washed</li>
    <li>Dusting and vacuuming of the surroundings (especially bedrooms) should be done and damp-dusting of the bathroom.</li>
</ul>

<p>Hygiene methods should be used for 2 weeks if drug treated; in those who do not receive drug treatment ,e.g. under 3 months, pregnant or breastfeeding women, they should be continued for 6 weeks.</p>
<!--Start accordian threadworm-->

<div id="PCaccordionThreadworm">
<div class="card">
<div class="card-header" id="PCThreadworm">
<h5 class="mb-0"><button aria-controls="PCcollapseThreadworm" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseThreadworm" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCParaThreadworm" class="collapse" data-parent="#PCaccordionThreadworm" id="PCcollapseThreadworm">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Mebendazole </strong></span>(over 2 years) <span style="color:#0000FF"><strong>100 mg as a single</strong></span> dose r<u>epeat in 2 weeks</u></p>

<p>if infection persists or if <u>under 2 years</u></p>

<p><span style="color:#800080"><strong>Piperazine and sennosides sachet</strong></span>: <u>3 - 12 months</u> <span style="color:#800080"><strong>2.5 ml spoon</strong></span> (from sachet in water), <u>1 - 6 years</u> <span style="color:#800080"><strong>5ml spoon</strong></span> repeat in 2 weeks.</p>

<p>There is information in the cBNF on mebendazole dosing from 6 months of age. However this is unlicensed so the patient information leaflet may cause alarm to the parent.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#PCParasites"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Primary Care Gastro section-->

<div aria-hidden="true" aria-labelledby="GastroLabel" class="portfolio-modal modal fade " id="PCGastro" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="GastroLabel">Gastrointestinal</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="PCGastroSection"><a href="#PCClostDiff">Clostridium Difficile Infection</a></h4>

<h4><a href="#PCDiverticulitis">Diverticulitis</a></h4>

<h4><a href="#PCHpylori">Eradication of Helicobacter Pylori</a></h4>

<h4><a href="#PCGastroenteritis">Gastroenteritis</a></h4>

<h4><a href="#PCThrush">Oral Candidiasis (Oral Thrush)</a></h4>

<h4><a href="#PCThreadwormGastro">Threadworm</a></h4>

<h4><a href="#PCTravDiar">Travellers Diarrhoea</a></h4>
<br />
<!--ClostDif-->
<div class="text-left border border-info rounded" id="PCGastroClostSection">
<h2 class="text-center" id="PCClostDiff">Clostridium Difficile</h2>

<p><span style="color:#0000ff"><strong>Metronidazole 400 mg TDS</strong></span> for <strong>3 to 10 days</strong> depending on clinical response.</p>

<p>Consider also a probiotic yoghurt drink (Actimel) 100ml twice a day for 7 days.</p>

<p>Refractory disease:</p>

<p><span style="color:#800080"><strong>Vancomycin 125 mg QDS</strong></span> for <strong>3 to 10 days</strong> depending on clinical response.</p>
</div>
<br />
<!--Diverticulitis-->
<div class="text-left border border-info rounded" id="PCDiverticulitis">
<h2 class="text-center" id="PCDivertic">Diverticulitis</h2>
<!--Start accordian diverticulitis-->

<div id="PCaccordionDivertic">
<div class="card">
<div class="card-header" id="PCDiverticulit">
<h5 class="mb-0"><button aria-controls="PCcollapseDivertic" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseDivertic" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCParaDivertic" class="collapse" data-parent="#PCaccordionDivertic" id="PCcollapseDivertic">
<div class="card-body text-left">
<p><span style="color:#3300cc"><strong>Cefalexin 1g TDS </strong></span><span style="color:#000000">for 5 days.</span></p>

<p><strong><span style="color:#000000"><u>Penicillin allergy (anaphylaxis)</u>:</span></strong></p>

<p><strong><span style="color:#c0392b">Co-trimoxazole 960mg BD</span><span style="color:#b22222">&nbsp;</span><span style="color:#000000">plus</span><span style="color:#b22222"><strong> </strong></span><span style="color:#c0392b">Metronidazole 400mg TDS<strong><strong> </strong></strong></span></strong><span style="color:#000000">for 5 days.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Hpylori-->
<div class="text-left border border-info rounded" id="PCHpyloriSection">
<h2 class="text-center" id="PCHpylori">Helicobacter Pylori</h2>

<p>Eradication is beneficial in duodenal ulcers, gastric ulcers and low grade MALT lymphoma but not in GORD.</p>

<p>In non ulcer dyspepsia only 8 % of patients benefit.</p>

<p>13Ca urea breath test or stool antigen test are the favoured diagnostic tests. The tests require a 4 week washout period for antibiotics and a 2 week washout period for PPIs.</p>

<p>PHE guidance recommends that&nbsp;<span style="color:rgb(0, 128, 128)"><strong>clarithromycin,&nbsp;metronidazole or quinolone</strong></span>&nbsp;<u>should not be used</u>&nbsp;if the patient has received these antibiotics&nbsp;<u>in the past year for <strong>any infection</strong></u>.</p>

<p>Treatment duration:</p>

<p>7 days in total, but&nbsp;14 days&nbsp;in&nbsp;MALToma&nbsp;</p>
<!--Start accordian diverticulitis-->

<div id="PCaccordionHpylori">
<div class="card">
<div class="card-header" id="PCHpyloriTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseHpyloriTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseHpyloriTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="PCParaHpyloriTreatment" class="collapse" data-parent="#PCaccordionHpylori" id="PCcollapseHpyloriTreatment">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Full dose PPI</strong> </span>(proton pump inhibitor) <span style="color:#0000ff"><strong>BD</strong></span></p>

<p><strong>plus </strong></p>

<p><span style="color:#0000ff"><strong>Amoxicillin 1g</strong> </span><strong>and</strong> <span style="color:#0000ff"><strong>Clarithromycin 500mg BD / Metronidazole 400mg BD</strong></span></p>

<p><u><strong>Penicillin allergy and no prior treatment</strong></u></p>

<p><span style="color:#990066"><strong>Full dose PPI BD</strong></span></p>

<p><strong>plus</strong></p>

<p><span style="color:#990066"><strong>Clarithromycin 500mg BD</strong></span><span style="color:#000000"><strong> and </strong></span><span style="color:#990066"><strong>Metronidazole 400mg BD</strong></span></p>

<p><u><span style="color:#000000"><strong>Penicillin allergy &amp; previous treatment/exposure to&nbsp;clarithromycin or levofloxacin</strong></span></u></p>

<p><span style="color:#00ff00"><strong>Full dose PPI</strong>&nbsp;<strong>BD</strong></span></p>

<p><strong>plus </strong></p>

<p><span style="color:#00ff00"><strong>Bismuth subsalicylate 525mg QDS</strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#000000">(this is pepto-bismol and is blacklisted in the drug tariff. &nbsp;If treatment is required with this regimen then patient will have to buy this over-the-counter.&nbsp;Please inform the patient of this)</span></p>

<p><strong>plus</strong></p>

<p><strong><span style="color:#00ff00">Metronidazole 400mg BD</span><span style="color:#800080">&nbsp;</span>and <span style="color:#00ff00">Tetracycline 500mg QDS</span></strong></p>

<p><strong><u>Please note</u></strong></p>

<p><strong>Full dose PPI BD refers to:</strong></p>

<p><span style="color:#ff0000"><strong>Omeprazole 20mg BD</strong></span>&nbsp;or&nbsp;<span style="color:#ff0000"><strong>Lansoprazole 30mg BD</strong></span></p>
</div>
</div>

<div class="card-header" id="PCHpyloriInfo">
<h5 class="mb-0"><button aria-controls="PCcollapseHpyloriInfo" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseHpyloriInfo" data-toggle="collapse" type="button">Further Treatment Information</button></h5>
</div>

<div aria-labelledby="PCParaHpyloriInfo" class="collapse" data-parent="#PCaccordionHpylori" id="PCcollapseHpyloriInfo">
<div class="card-body text-left">
<p><span style="color:rgb(0, 0, 0)"><u><strong>Relapse &amp; previous treatment with metronidazole and clarithromycin</strong></u></span></p>

<p><span style="color:#008000"><strong>Full dose PPI</strong></span>&nbsp;(proton pump inhibitor)&nbsp;<span style="color:#008000"><strong>BD</strong></span></p>

<p><strong>plus</strong></p>

<p><span style="color:#008000"><strong>Amoxicillin 1g BD</strong></span></p>

<p><strong>plus</strong></p>

<p><strong><span style="color:#008000">Tetracycline 500mg QDS</span> or <span style="color:#008000">Levofloxacin 250mg BD</span></strong></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Gastroenteritis-->
<div class="text-left border border-info rounded" id="PCGastroentSection">
<h2 class="text-center" id="PCGastroenteritis">Gastroenteritis</h2>

<p><strong>Check the patient&rsquo;s travel, food, hospitalisation and antibiotic history (CDI).</strong></p>

<p><span style="color:#FF0000"><strong>Fluid replacement is the mainstay of treatment</strong></span>. Antibiotic therapy is <strong><u>not</u></strong> usually indicated because food -borne associated gastroenteritis is usually a self-limiting condition, and treatment only reduces diarrhoea by 1&ndash;2 days and can cause antibiotic resistance.</p>

<p>Initiate antibiotics, on the advice of the microbiologist, if the patient is systemically unwell (ongoing pyrexia, diarrhoea, dehydration, and clinical toxicity). If the patient has suspected food poisoning or CDI, send a stool specimen to the lab. These conditions can then be treated according to the results.</p>

<p>7 days in total, but&nbsp;14 days&nbsp;in&nbsp;MALToma&nbsp;</p>
</div>
<br />
<!--Thrush-->
<div class="text-left border border-info rounded" id="PCThrushSection">
<h2 class="text-center" id="PCThrush">Oral Candidiasis (Oral Thrush)</h2>

<p>Oral candidiasis tends to occur most commonly in babies, people who wear dentures or use inhaled corticosteroids and in immunocompromised patients. Antibiotic use can also predispose to the development of oral candidiasis.</p>

<p>If a patient has oral thrush and is otherwise healthy treatment should be given.</p>
<!--Start accordian diverticulitis-->

<div id="PCaccordionThrush">
<div class="card">
<div class="card-header" id="PCThrushTreatment">
<h5 class="mb-0"><button aria-controls="PCcollapseThrushTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseThrushTreatment" data-toggle="collapse" type="button">Topical Treatment</button></h5>
</div>

<div aria-labelledby="PCParaThrushTreatment" class="collapse" data-parent="#PCaccordionThrush" id="PCcollapseThrushTreatment">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Miconazole oral gel 2.5ml QDS</strong></span>. Treatment should continue for at least 7 days after lesions have healed.</p>

<p>If not suitable or failure to respond,</p>

<p><span style="color:#800080"><strong>Nystatin suspension 1ml QDS</strong></span> usually for 7 days (continued for at least 48 hours after lesions have healed).</p>

<p>If the patient is using an inhaled corticosteroid assess inhaler technique. Advise the patient to brush teeth or rinse mouth with water (do not swallow) after using the inhaled corticosteroid. Use of a spacer can reduce the deposition of the drug on oromucosal surfaces and use of the lowest maintenance dose also reduces likelihood of oral candidiasis. If the patient wears dentures give advice on oral hygiene measures to prevent recurrence.</p>
</div>
</div>

<div class="card-header" id="PCHpyloriThrushSys">
<h5 class="mb-0"><button aria-controls="PCcollapseThrushSys" aria-expanded="false" class="btn btn-link collapsed" data-target="#PCcollapseThrushSys" data-toggle="collapse" type="button">Systemic Treatment</button></h5>
</div>

<div aria-labelledby="PCParaThrushSys" class="collapse" data-parent="#PCaccordionThrush" id="PCcollapseThrushSys">
<div class="card-body text-left">
<p>Systemic treatment should be offered if the patient does not respond to topical treatment, the infection is extensive or severe, or if the patient is immunocompromised.</p>

<p><span style="color:#B22222"><strong>Fluconazole 50mg OD </strong></span>for 7 - 14 days maximum.</p>

<p>Unusually difficult infections may need up to 100mg OD and immunocompromised patients may need treatment for longer than 14 days</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Threadworm-->
<div class="text-left border border-info rounded" id="PCGastroThreadwormSection">
<h2 class="text-center" id="PCThreadwormGastro">Threadworm</h2>

<p>See <a data-dismiss="modal" data-target="#PCParasite" data-toggle="modal" href="#PCParasite"> Threadworm </a>section on the Parasites page</p>
</div>
<br />
<!--Diarrhoea-->
<div class="text-left border border-info rounded" id="PCTravDiarrSection">
<h2 class="text-center" id="PCTravDiar">Traveller&#39;s Diarrhoea</h2>

<p><strong>Pre-travel</strong>: provide advice on prevention and consider vaccination if appropriate. A &lsquo;just in case&rsquo; course of antibiotics may be carried by people travelling to remote areas and for people in whom an episode of infective diarrhoea could be dangerous. If used in this way<strong><span style="color:#0000ff"> Azithromycin 500mg OD for 3 days</span></strong> should be prescribed.</p>

<p>This should be prescribed as a <u>private prescription</u> and not on an NHS FP10 prescription. If quinolone resistance is high e.g. South Asia consider bismuth subsalicylate (Pepto Bismol) 2 tablets QDS as prophylaxis for 2 days.</p>

<p>There is also a drug called <span style="color:#800080"><strong>Rifaximin</strong></span> available which is indicated for the treatment of travellers&#39; diarrhoea that is not associated with any of:</p>

<ul>
    <li>Fever</li>
    <li>Bloody diarrhoea</li>
    <li>Eight or more unformed stools in the previous 24 h</li>
    <li>Occult blood or leucocytes in the stool.</li>
</ul>

<p>Dose&nbsp;of <span style="color:#800080"><strong>Rifaximin&nbsp;is&nbsp;200mg TDS for 3 days</strong></span>. This can also be used as an alternative especially in areas of high quinolone resistance.</p>

<p><strong>Post-travel</strong>: send a stool sample to the lab for culture if the patient is systemically unwell or symptoms persist, obtain advice from microbiologist before initiating empiric treatment. If the patient is very ill admit to hospital.</p>
</div>
<br />
<!--floating icon--><a class="float" href="#PCGastroSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!--Intermediate Care Modals--> <!-- Bone and Joint section-->

<div aria-hidden="true" aria-labelledby="BoneAndJointLabel" class="portfolio-modal modal fade " id="ICBone" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICBoneAndJointLabel">Bone and Joint</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>
<!--Osteomyelitis-->

<div class="text-left border border-info rounded">
<h2 class="text-center" id="ICosteomyelitis">Osteomyelitis Suspected</h2>

<p>Osteomyelitis could be suspected if the following are seen:</p>

<ul>
    <li>Wound probing to bone</li>
    <li>sequestrated bone removed from wound</li>
    <li>static ulceration not responding to treatment (first address soft tissue infection, mechanical causes, ischaemia, co-morbidities)</li>
    <li>history of soft tissue infection increases suspicion</li>
    <li>&ldquo;Sausage toe&rdquo;</li>
</ul>
<!--Accordion-->

<div id="ICaccordion1">
<div class="card">
<div class="card-header" id="ICosteoManagement">
<h5 class="mb-0"><button aria-controls="collapseTwo" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseOsteoManagement" data-toggle="collapse" type="button">Management</button></h5>
</div>

<div aria-labelledby="osteoManagement" class="collapse" data-parent="#ICaccordion1" id="ICcollapseOsteoManagement">
<div class="card-body text-left">
<ul>
    <li>Arrange x-ray to rule out osteomyelitis</li>
    <li>Collect and sent any bone fragments to microbiology for culture and sensitivity</li>
    <li>Whilst results of x-ray awaited, treat any signs or symptoms of soft tissue infection using the CCG guidelines.&nbsp; If the infection does not respond to treatment liaise with microbiology.</li>
    <li>Refer patient to High Risk Foot Team for assessment and treatment plan advice (email:&nbsp; <a href="mailto:tga-tr.cids@nhs.net" target="_blank">tga-tr.cids@nhs.net</a>)</li>
</ul>

<p><strong>If radiology report diagnoses osteomyelitis:&nbsp; </strong></p>

<p>Liaise with microbiology around individualised treatment plan for patient.</p>

<p><strong>Dr H Sacho </strong>0161 922 4086 or contact via hospital switchboard (0161 922 6000)</p>

<p><strong>Dr P F Unsworth </strong>0161 922 6500 or contact via hospital switchboard</p>

<p>Monitor patient&rsquo;s wound at least weekly until healing achieved/ conservative plan set</p>

<p><strong>Please Note:</strong></p>

<p>Patient may need MRI to affected area if complex case/lack of clarity</p>
</div>
</div>
</div>
<!--Treatment-->

<div class="card">
<div class="card-header" id="ICosteoTreatment">
<h5 class="mb-0"><button aria-controls="collapseTwo" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseOsteoTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICosteoTreatment" class="collapse" data-parent="#ICaccordion1" id="ICcollapseOsteoTreatment">
<div class="card-body text-left">
<p><strong><span style="color:#0000FF">Flucloxacillin 1g QDS</span></strong></p>

<p><u><strong><span style="color:#000000">Penicillin allergy</span></strong></u></p>

<p><strong><font color="#800080">Clindamycin 450mg QDS</font></strong></p>

<p>Typical treatment duration:</p>

<p><span style="color:#FF0000">4 weeks for septic arthritis and 6 weeks for osteomyelitis</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#ICBone"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Intermediate care Upper Respiratory infections-->

<div aria-hidden="true" class="portfolio-modal modal fade " id="ICURTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICURT">Upper Respiratory Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>
<!-- Portfolio Modal - Acute Cough-->

<h4><a href="#ICacuteCough" id="ICURTSection">Acute Cough</a></h4>

<h4><a href="#ICacuteRhin">Acute Rhinosinusitis</a></h4>

<h4><a href="#ICflu">Influenza</a></h4>

<h4><a href="#ICotExt">Otitis Externa</a></h4>

<h4><a href="#ICotMedia">Otitis Media</a></h4>

<h4><a href="#ICpharyngitis">Pharyngitis</a></h4>

<hr class="mt-2 mb-3" />
<div class="text-left border border-info rounded" id="ICacuteCough">
<h4>Acute Cough</h4>

<h5 class="text-left">Be aware that an acute cough:</h5>

<ul class="text-left">
    <li>is usually self-limiting and gets better within 3 to 4 weeks without antibiotics</li>
    <li>is most commonly caused by a viral upper respiratory tract infection, such as a cold or flu</li>
    <li>can also be caused by acute bronchitis, a lower respiratory tract infection, which is usually a viral infection but can be bacterial</li>
    <li>can also have other infective or non-infective causes.</li>
</ul>

<hr class="mt-2 mb-3" /><!--Accordian-->
<div id="ICaccordionAc">
<div class="card">
<div class="card-header" id="ICacManagement">
<h5 class="mb-0"><button aria-controls="ICcollapseICacManagement" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseICacManagement" data-toggle="collapse" type="button">Management</button></h5>
</div>

<div aria-labelledby="ICacManagement" class="collapse" data-parent="#ICaccordionAc" id="iCcollapseICacManagement">
<div class="card-body text-left">
<p>Be aware that some people may wish to try the following self-care treatments, which have limited evidence of some benefit for the relief of cough symptoms:</p>

<ul>
    <li>honey (in people aged over 1 year)</li>
    <li>pelargonium (a herbal medicine; in people aged 12 and over)</li>
    <li>over-the-counter cough medicines containing the expectorant guaifenesin (in people aged 12 and over)</li>
    <li>over-the-counter cough medicines containing cough suppressants, except codeine, (in people aged 12 and over who do not have a persistent cough, such as in asthma, or excessive secretions).</li>
</ul>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="ICacTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseAcuteCoughTx" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseAcuteCoughTx" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICacTreatment" class="collapse" data-parent="#ICaccordionAc" id="ICcollapseAcuteCoughTx">
<div class="card-body text-left">
<p>For people with an acute cough who are identified at a face-to-face clinical examination as systemically very unwell, offer an immediate antibiotic prescription&nbsp;</p>

<p>Be aware that people with an acute cough may be at higher risk of complications if they:</p>

<ul>
    <li>have a pre-existing comorbidity, such as significant heart, lung, renal, liver or neuromuscular disease, immunosuppression or cystic fibrosis</li>
    <li>are young children who were born prematurely</li>
    <li>are older than 65 years with 2 or more of the following criteria, or older than 80 years with 1 or more of the following criteria:  hospitalisation in previous year  type 1 or type 2 diabetes  history of congestive heart failure  current use of oral corticosteroids.</li>
</ul>

<p><span style="color:#c0392b"><u><strong>Reassess</strong></u></span> people with an acute cough if their symptoms worsen rapidly or significantly, taking account of:</p>

<ul>
    <li>alternative diagnoses, such as pneumonia</li>
    <li>any symptoms or signs suggesting a more serious illness or condition, such as cardiorespiratory failure or sepsis</li>
    <li>previous antibiotic use, which may have led to resistant bacteria.</li>
</ul>

<p><span style="color:#0000ff"><strong>Doxycycline 200 mg on first day, then 100 mg once a day</strong></span>&nbsp;</p>

<p><strong><span style="color:#660099">Amoxicillin 500mg - 1g three times a day</span></strong>&nbsp;</p>

<p><span style="color:#66cc00"><strong>Clarithromycin 500 mg twice a day</strong>&nbsp;</span></p>

<p>Review at day 3 and do not exceed total duration of treatment by 5 days in total</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Influenza-->
<div class="text-left border border-info rounded" id="ICinfluenzaSection">
<hr class="mt-2 mb-3" />
<h4 id="ICflu">Influenza</h4>

<hr class="mt-2 mb-3" />
<div class="text-left">
<p>For further information on management of seasonal influenza please see <a href="https://cks.nice.org.uk/influenza-seasonal#!scenarioclarification" target="_blank">NICE guidance</a></p>

<p>Please note this service is provided by Public Health Laboratory Manchester</p>

<p><strong><strong>Influenza diagnostic service for General Practice </strong></strong></p>

<p><strong><strong>INTRODUCTION</strong></strong></p>

<ul>
    <li>Public Health Laboratory Manchester provides a testing service for respiratory viral infections, including Influenza.</li>
    <li>Primary Care leads will be notified by email once the enhanced service is operational. This will be when Influenza is circulating, either nationally (by CMO notification) or locally, whichever is sooner.</li>
</ul>

<p><strong><strong>SAMPLES</strong></strong></p>

<ul>
    <li>If patients are producing sputum, please collect a sample in sputum pot.</li>
    <li>For patients who are not producing sputum: Please send nose and throat swabs, combined in a single vial of virus transport medium (VTM). Please use one flocked swab to swab the nose and another one to swab the throat and then place both in a single vial of VTM.</li>
    <li>If virus transport medium is not available, specimens can be taken using dry cotton or Dacron-tipped swabs but they should <strong><strong>not </strong></strong>be sent in charcoal transport medium.</li>
</ul>

<p><strong><strong>REQUESTS</strong></strong></p>

<ul>
    <li>Respiratory virus testing, including Influenza can be requested on GP ICE.</li>
</ul>

<p><strong><strong>RESULTS </strong></strong></p>

<ul>
    <li>Between Monday and Friday routine respiratory virus results will generally be available within 24 hours of receipt in the laboratory. Results for samples received after 09.00 on Saturday or during Sunday will be available on the following Monday.</li>
    <li>Positive results will be telephoned to the requesting location during the following hours: 08.30-17.00 Monday to Friday and 08.30 to 12.30 on Saturday.</li>
    <li>A dedicated mobile phone number (07973 870099) will be available (08:30 to 17:00 seven days a week) for chasing urgent results.</li>
</ul>

<p><strong><strong>ADDITIONAL CONTACT DETAILS</strong></strong></p>

<ul>
    <li>For further information during normal working hours (Mon-Fri 9am-5pm and Saturday 09.00-12.30) please contact the laboratory (0161 2768854 Option 1).</li>
    <li>Outside of normal working hours the duty consultant virologist can be contacted for urgent clinical and operational advice via the hospital switchboard (01612761234).</li>
</ul>
</div>
<!--Accordion-->

<div id="ICaccordionFlu">
<div class="card-header" id="ICfluPrevention">
<h5 class="mb-0"><button aria-controls="ICcollapseFluPrevention" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseFluPrevention" data-toggle="collapse" type="button">Prevention</button></h5>
</div>

<div aria-labelledby="ICfluPrevention" class="collapse" data-parent="#ICaccordionFlu" id="ICcollapseFluPrevention">
<div class="card-body text-left">
<p>The current Department of Health advice should be followed.</p>

<p>Annual vaccination is essential for all those at risk of influenza.</p>
</div>
</div>

<div class="card-header" id="ICfluTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseFluTx" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseFluTx" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICfluTreatment" class="collapse" data-parent="#ICaccordionFlu" id="ICcollapseFluTx">
<div class="card-body text-left">
<p>Treatment is recommended when all of the following apply:</p>

<ul>
    <li>Influenza is known to be circulating in the community (indicated by national surveillance schemes).</li>
    <li>The patient is in an &lsquo;at-risk&rsquo; group.</li>
    <li>The patient presents with influenza-like illness and can begin treatment within 48 hours of the onset of symptoms.</li>
</ul>

<p><span style="color:#0000FF"><strong>Oseltamivir 75mg BD for 5 days</strong></span></p>

<p><strong>or</strong></p>

<p><strong><span style="color:#800080">Zanamivir 10 mg (2 inhalations via diskhaler) BD for 5 days </span></strong>(caution in asthma and COPD; there is a risk of bronchospasm so a short- acting bronchodilator should be available).</p>
</div>
</div>

<div class="card-header" id="ICfluProphylaxis">
<h5 class="mb-0"><button aria-controls="ICcollapseFluProphylaxis" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseFluProphylaxis" data-toggle="collapse" type="button">Prophylaxis</button></h5>
</div>

<div aria-labelledby="fluProphylaxis" class="collapse" data-parent="#ICaccordionFlu" id="ICcollapseFluProphylaxis">
<div class="card-body text-left">
<ul>
    <li><span style="color:#000000">Prophylaxis is normally not considered in at-risk groups who have been vaccinated against seasonal influenza at least 14 days before exposure.&nbsp;</span></li>
    <li><span style="color:#000000">Prescribe an antiviral drug for post-exposure prophylaxis if all of the following circumstances apply:&nbsp;</span>
    <ul>
        <li><span style="color:#000000">The national surveillance scheme indicates that influenza is circulating.</span></li>
        <li><span style="color:#000000">The person has been exposed to a person (in the same household or residential setting) with&nbsp;an influenza-like illness.</span></li>
        <li><span style="color:#000000">The person is in an &#39;at risk&#39; group&nbsp;</span> <span style="color:#000000">(see below for more information)&nbsp;and has not been&nbsp;adequately protected by vaccination, that is:</span>
        <ul>
            <li><span style="color:#000000">They have not been vaccinated since the previous influenza season.</span></li>
            <li><span style="color:#000000">The vaccination is not well matched to the circulating strain.</span></li>
            <li><span style="color:#000000">There has been less than 14 days between vaccination and date of contact with influenza.</span></li>
        </ul>
        </li>
        <li><span style="color:#000000">The person is able to start treatment within 48&nbsp;hours of this contact (for oseltamivir) or 36&nbsp;hours of this contact (for zanamivir).</span>
        <ul>
            <li><span style="color:#000000">Treatment after 48&nbsp;hours of this contact (for oseltamivir) or 36&nbsp;hours of this contact (for zanamivir) is an off-label use and should be done on specialist advice only.</span></li>
        </ul>
        </li>
    </ul>
    </li>
</ul>

<p><span style="color:#000000">Prophylaxis is also recommended for residents in chronic care establishments (regardless of influenza vaccination) using oseltamivir within 48 hours of influenza-like illness being present in the establishment.</span></p>

<p><span style="color:#0000ff"><strong>Oseltamivir 75mg OD for 10 days</strong></span><span style="color:#000000"> (within 48 hours of contact)</span></p>

<p><span style="color:#000000"><strong>or</strong></span></p>

<p><span style="color:#990099"><strong>Zanamivir 10mg (via diskhaler) OD for 10 days</strong></span><span style="color:#000000"> (within 36 hours of contact)</span></p>
</div>
</div>

<div class="card-header" id="ICfluRisk">
<h5 class="mb-0"><button aria-controls="ICcollapseFluRisk" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseFluRisk" data-toggle="collapse" type="button">At Risk Groups</button></h5>
</div>

<div aria-labelledby="ICfluRisk" class="collapse" data-parent="#ICaccordionFlu" id="ICcollapseFluRisk">
<div class="card-body text-left">
<ul>
    <li><strong>Chronic respiratory disease</strong>, including:

    <ul>
        <li>Chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis, and bronchopulmonary dysplasia.</li>
        <li>Asthma that requires continuous or repeated use of inhaled corticosteroids or with previous exacerbations requiring hospital admission.</li>
        <li>Children who have previously been admitted to hospital for lower respiratory tract disease.</li>
    </ul>
    </li>
    <li><strong>Chronic heart disease</strong>, including congenital heart disease, hypertension with cardiac complications, chronic heart failure, and individuals requiring regular medication or follow up for ischaemic heart disease.</li>
    <li><strong>Chronic kidney disease</strong>, including nephrotic syndrome, chronic renal failure, and renal transplantation.</li>
    <li><strong>Chronic liver disease</strong>, including cirrhosis, biliary atresia, and chronic hepatitis.</li>
    <li><strong>Chronic neurological disease</strong>, including stroke and transient ischaemic attack.</li>
    <li><strong>Diabetes</strong>, including type&nbsp;1 diabetes and type&nbsp;2 diabetes (requiring oral hypoglycaemic drugs or a controlled diet).</li>
    <li><strong>Immunosuppression</strong>&nbsp;due to disease or treatment, including:
    <ul>
        <li>People undergoing chemotherapy (or radiotherapy) leading to immunosuppression.</li>
        <li>People with asplenia or splenic dysfunction.</li>
        <li>HIV infection (all stages).</li>
        <li>Individuals treated with, or likely to be treated with, systemic steroids for more than 1&nbsp;month at dosages equivalent to 20&nbsp;mg prednisolone daily (at any age) or, for children weighing less than 20&nbsp;kg, a dose of 1&nbsp;mg or more per kg body weight per day.</li>
    </ul>
    </li>
    <li><strong>Morbid obesity (body mass index of 40 or more).</strong></li>
</ul>

<p><strong>Consideration should also be given to:</strong></p>

<ul>
    <li>People living in long-stay residential or nursing homes.</li>
    <li>People who receive a carer&rsquo;s allowance or care for disabled or elderley people, whose welfare may be at risk if the carer falls ill.</li>
</ul>
</div>
</div>
</div>
</div>
<br />
<!--Pharyngitis-->
<div class="text-left border border-info rounded" id="ICpharyngitisSection">
<hr class="mt-2 mb-3" />
<h4 id="ICpharyngitis">Pharyngitis / Sore Throat / Tonsillitis</h4>

<hr class="mt-2 mb-3" />
<div class="text-left">
<p><strong>Avoid antibiotics </strong>as 90% resolve in 7 days&nbsp;without, and pain only reduced by 16 hours.</p>

<p>Use<strong> <a href="https://ctu1.phc.ox.ac.uk/feverpain/index.php" target="_blank">FeverPAIN</a> Score: </strong></p>

<p>Fever in last 24h, Purulence, Attend rapidly under 3d, severely Inflamed tonsils, No cough or coryza</p>

<p><strong>Score 0-1</strong>: 13-18% streptococci, use NO antibiotic strategy;</p>

<p><strong>2-3: </strong>34-40% streptococci, use 3 day back-up antibiotic;</p>

<p><strong>&gt;4:</strong> 62-65% streptococci, use immediate antibiotic if severe, &nbsp;or 48hr short back-up prescription</p>

<p>A positive throat swab culture growing Streptococcus Group A, together with clinical features of acute pharyngotonsillitis almost certainly indicates infection.&nbsp;</p>

<p>If you have taken a throat swab before prescribing antibiotics and it is reported negative for Streptococcus&nbsp;Group A&nbsp;do not prescribe antibiotics, and if antibiotics have already been commenced, discontinue them.</p>

<p>Streptococcus A throat swab POC testing can be a&nbsp;rapid way to determine bacterial vs viral sore throat and consideration should be given to this method of testing especially in the urgent care or walk-in setting.</p>
</div>
<!--Treatment-->

<div id="ICaccordionPharyngitis">
<div class="card">
<div class="card-header" id="ICpharyngitisTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapsePharyngitisTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapsePharyngitisTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICpharyngitisTreatment" class="collapse" data-parent="#ICaccordionPharyngitis" id="ICcollapsePharyngitisTreatment">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Phenoxymethylpenicillin 500mg QDS</strong></span> or <span style="color:#0000ff"><strong>1g BD (QDS) when severe</strong></span>&nbsp;for 5 days.&nbsp; (10 days for scarlet fever).</p>

<p><u><span style="color:#000000"><strong>Penicillin allergy</strong></span></u></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg BD</strong></span> for 5&nbsp;days. (10 days for scarlet fever).</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Otitis Media-->
<div class="text-left border border-info rounded" id="ICOtMediaSection">
<hr class="mt-2 mb-3" />
<h4 id="ICotMedia">Otitis Media</h4>

<hr class="mt-2 mb-3" />
<div class="text-left">
<p><strong>Many cases are viral and otitis media resolves in 60% of cases without antibiotics within 24 hours</strong>. You need to treat 15 children aged over 2 years to get pain relief in one child, at 2 days. A poor outcome is unlikely if there is no vomiting and the temperature is below 38.5C. Recent evidence suggests that antibiotics seem to be most beneficial in children younger than 2 years of age with bilateral acute otitis media, and in children with both acute otitis media and otorrhoea.</p>

<p>The best option is to use pain relief for 24 hours (ibuprofen or paracetamol) before deciding if antibiotics&nbsp; are needed.&nbsp; Consider a delayed prescription to use if symptoms dont improve in 24 hours.</p>

<p>2-3 days treatment may be sufficient so parents can stop the antibiotics before the end of the course if the patient&nbsp;has recovered.</p>

</div>

<div id="ICaccordionOtMedia">
<div class="card">
<div class="card-header" id="ICOtMediaTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseOtMediaTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseOtMediaTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICOtMediaTreatment" class="collapse" data-parent="#ICaccordionOtMedia" id="ICcollapseOtMediaTreatment">
<div class="card-body text-left">

                                        <p><span style="color:#0000ff"><strong>Amoxicillin 500mg TDS</strong></span>&nbsp;or <span style="color:#0000ff"><strong>1g TDS</strong></span> review after 72 hours</p>

<p><strong><u>Penicillin allergy</u></strong></p>

<p><span style="color:#990066"><strong>Clarithromycin 500mg BD</strong></span> review after 72 hours</p>

<p>treatment should exceed 5 days</p>

                                   
</div>
</div>
</div>
</div>
</div>
<br />
<!--Otitis Externa-->
<div class="text-left border border-info rounded" id="ICOtExternaSection">
<hr class="mt-2 mb-3" />
<h4 id="ICotExt">Otitis Externa</h4>

<hr class="mt-2 mb-3" />
<div class="text-left">
<p>First use aural toilet and analgesics.</p>

<p>Cure rates are similar at 7 days for topical acetic acid or antibiotic +/- steroid.</p>

<p>First line:<span style="color:rgb(0, 0, 255)"> <strong>Acetic acid 2%</strong> </span>(e.g. Earcalm available over the counter)<span style="color:rgb(0, 0, 255)"> <strong>1 spray TDS</strong></span> 7 days</p>

<p>Second line: <span style="color:rgb(0, 0, 255)"><strong>Neomycin sulphate with corticosteroid </strong>(e.g. Otomize ear spray, 1 puff TDS or Betnesol N ear drops 3 drops TDS) 7 days min to 14 days max.</span></p>

<p>Advise patient to apply tragal pressure to help remove&nbsp;the debris.</p>

<p><span style="color:#FF0000"><strong>AVOID IF PERFORATED TYMPANIC MEMBRANE. </strong></span></p>

<p>If cellulitis or disease extending outside the ear canal, start oral antibiotics and refer.</p>
</div>
</div>
<br />
<!--Acute Rhinosinusitis-->
<div class="text-left border border-info rounded" id="ICacuteRhinosSection">
<hr class="mt-2 mb-3" />
<h4 id="ICacuteRhin">Acute Rhinosinusitis</h4>

<hr class="mt-2 mb-3" />
<div class="text-left">
<p><strong>Avoid antibiotics as 80% resolve in 14 days without, and they only offer marginal benefit after 7 days. </strong></p>

<p>Reserve antibiotics for those with severe or persistent (10 days plus) symptoms. Steam inhalations will encourage drainage and can give relief. Use adequate analgesia. Consider delayed or immediate antibiotic when purulent nasal discharge.</p>
</div>

<div id="ICaccordionRhinosinusitis">
<div class="card">
<div class="card-header" id="ICRhinoTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseRhinoTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseRhinoTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICRhinoTreatment" class="collapse" data-parent="#ICaccordionRhinosinusitis" id="ICcollapseRhinoTreatment">
<div class="card-body text-left">

                                        <p><span style="color:#0000ff"><strong>Amoxicillin 1g TDS</strong></span>&nbsp;review after 72 hours&nbsp;&nbsp;</p>

<p><u><strong>Penicillin allergy</strong></u></p>

<p><span style="color:#990066"><strong>Doxycycline 200 mg STAT then 100 mg OD&nbsp;</strong></span></p>

<p>Doxycycline must <strong>NOT </strong>be prescribed for children under 12 years, or for pregnant or breast-feeding women.</p>

<p><u><strong>Penicillin allergy</strong></u></p>

<p><span style="color:#27ae60"><strong>Clarithromycin 500 mg BD</strong></span><span style="color:#27ae60"> </span>for 7 days</p>

<p><strong>Treatment should not exceed 5 days in total</strong></p>

</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#ICURTSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Intermediate Care Gastro section-->

<div aria-hidden="true" aria-labelledby="GastroLabel" class="portfolio-modal modal fade " id="ICGastro" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICGastroLabel">Gastrointestinal</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="ICGastroTop"><a href="#ICClostDiff">Clostridium Difficile Infection</a></h4>

<h4><a href="#ICDiverticulitis">Diverticulitis</a></h4>

<h4><a href="#ICGastroenteritis">Gastroenteritis</a></h4>

<h4><a href="#ICThrush">Oral Candidiasis (Oral Thrush)</a></h4>

<h4><a href="#ICThreadwormGastro">Threadworm</a></h4>
<br />
<!--ClostDif-->
<div class="text-left border border-info rounded" id="ICGastroClostSection">
<h2 class="text-center" id="ICClostDiff">Clostridium Difficile</h2>

<p><span style="color:#0000ff"><strong>Metronidazole 400 mg TDS</strong></span> for <strong>3 to 10 days</strong> depending on clinical response.</p>

<p>Consider also a probiotic yoghurt drink (Actimel) 100ml twice a day for 7 days.</p>

<p>Refractory disease:</p>

<p><span style="color:#800080"><strong>Vancomycin 125 mg QDS</strong></span> for <strong>3 to 10 days</strong> depending on clinical response.</p>
</div>
<br />
<!--Diverticulitis-->
<div class="text-left border border-info rounded" id="ICDiverticulitis">
<h2 class="text-center" id="ICDivertic">Diverticulitis</h2>
<!--Start accordian diverticulitis-->

<div id="ICaccordionDivertic">
<div class="card">
<div class="card-header" id="ICDiverticulit">
<h5 class="mb-0"><button aria-controls="ICcollapseDivertic" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseDivertic" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICParaDivertic" class="collapse" data-parent="#ICaccordionDivertic" id="ICcollapseDivertic">
<div class="card-body text-left">
<p><span style="color:#3300cc"><strong>Cefalexin 1g TDS </strong></span><span style="color:#000000">for 5 days.</span></p>

<p><strong><span style="color:#000000"><u>Penicillin allergy (anaphylaxis)</u>:</span></strong></p>

<p><strong><span style="color:#c0392b">Co-trimoxazole 960mg BD</span><span style="color:#b22222">&nbsp;</span><span style="color:#000000">plus</span><span style="color:#b22222"><strong> </strong></span><span style="color:#c0392b">Metronidazole 400mg TDS<strong><strong> </strong></strong></span></strong><span style="color:#000000">for 5 days.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Gastroenteritis-->
<div class="text-left border border-info rounded" id="ICGastroentSection">
<h2 class="text-center" id="ICGastroenteritis">Gastroenteritis</h2>

<p><strong>Check the patient&rsquo;s travel, food, hospitalisation and antibiotic history (CDI).</strong></p>

<p><span style="color:#FF0000"><strong>Fluid replacement is the mainstay of treatment</strong></span>. Antibiotic therapy is <strong><u>not</u></strong> usually indicated because food -borne associated gastroenteritis is usually a self-limiting condition, and treatment only reduces diarrhoea by 1&ndash;2 days and can cause antibiotic resistance.</p>

<p>Initiate antibiotics, on the advice of the microbiologist, if the patient is systemically unwell (ongoing pyrexia, diarrhoea, dehydration, and clinical toxicity). If the patient has suspected food poisoning or CDI, send a stool specimen to the lab. These conditions can then be treated according to the results.</p>

<p>7 days in total, but&nbsp;14 days&nbsp;in&nbsp;MALToma&nbsp;</p>
</div>
<br />
<!--Thrush-->
<div class="text-left border border-info rounded" id="ICThrushSection">
<h2 class="text-center" id="ICThrush">Oral Candidiasis (Oral Thrush)</h2>

<p>Oral candidiasis tends to occur most commonly in babies, people who wear dentures or use inhaled corticosteroids and in immunocompromised patients. Antibiotic use can also predispose to the development of oral candidiasis.</p>

<p>If a patient has oral thrush and is otherwise healthy treatment should be given.</p>
<!--Start accordian diverticulitis-->

<div id="ICaccordionThrush">
<div class="card">
<div class="card-header" id="ICThrushTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseThrushTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseThrushTreatment" data-toggle="collapse" type="button">Topical Treatment</button></h5>
</div>

<div aria-labelledby="ICParaThrushTreatment" class="collapse" data-parent="#ICaccordionThrush" id="ICcollapseThrushTreatment">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Miconazole oral gel 2.5ml QDS</strong></span>. Treatment should continue for at least 7 days after lesions have healed.</p>

<p>If not suitable or failure to respond,</p>

<p><span style="color:#800080"><strong>Nystatin suspension 1ml QDS</strong></span> usually for 7 days (continued for at least 48 hours after lesions have healed).</p>

<p>If the patient is using an inhaled corticosteroid assess inhaler technique. Advise the patient to brush teeth or rinse mouth with water (do not swallow) after using the inhaled corticosteroid. Use of a spacer can reduce the deposition of the drug on oromucosal surfaces and use of the lowest maintenance dose also reduces likelihood of oral candidiasis. If the patient wears dentures give advice on oral hygiene measures to prevent recurrence.</p>
</div>
</div>

<div class="card-header" id="ICHpyloriThrushSys">
<h5 class="mb-0"><button aria-controls="ICcollapseThrushSys" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseThrushSys" data-toggle="collapse" type="button">Systemic Treatment</button></h5>
</div>

<div aria-labelledby="ICParaThrushSys" class="collapse" data-parent="#ICaccordionThrush" id="ICcollapseThrushSys">
<div class="card-body text-left">
<p>Systemic treatment should be offered if the patient does not respond to topical treatment, the infection is extensive or severe, or if the patient is immunocompromised.</p>

<p><span style="color:#B22222"><strong>Fluconazole 50mg OD </strong></span>for 7 - 14 days maximum.</p>

<p>Unusually difficult infections may need up to 100mg OD and immunocompromised patients may need treatment for longer than 14 days</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Threadworm-->
<div class="text-left border border-info rounded" id="ICGastroThreadwormSection">
<h2 class="text-center" id="ICThreadwormGastro">Threadworm</h2>

<p>Treat both the patient and all household members unless contraindicated. Good hygiene is very important in breaking the lifecycle of the worms:</p>

<ul>
    <li>Hands should be washed after using the toilet and nails should be kept short.</li>
    <li>Showering or bathing in the morning, washing around the anus, is recommended.</li>
    <li>Underpants should be worn at night in bed and changed every morning</li>
    <li>Sleepwear and bedding should be washed</li>
    <li>Dusting and vacuuming of the surroundings (especially bedrooms) should be done and damp-dusting of the bathroom.</li>
</ul>

<p>Hygiene methods should be used for 2 weeks if drug treated; in those who do not receive drug treatment ,e.g. under 3 months, pregnant or breastfeeding women, they should be continued for 6 weeks.</p>
</div>
<br />
<a class="float" href="#ICGastroTop"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Intermediate care UTI section-->

<div aria-hidden="true" aria-labelledby="UrinaryTractLabel" class="portfolio-modal modal fade " id="ICUTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICUrinaryTractLabel">Urinary Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="ICUrine"><a href="#ICacutePyelonephritis">Acute Pyelonephritis</a></h4>

<h4><a href="#ICbacterialProstatitis">Bacterial Prostatitis</a></h4>

<h4><a href="#ICcatheterUTI">Catheter-associated UTI</a></h4>

<h4><a href="#ICrecurrentUTI">Recurrent UTI</a></h4>

<h4><a href="#ICuncomplicatedFemales">Uncomplicated UTI in Females</a></h4>

<h4><a href="#ICmaleUTI">UTI in Males</a></h4>
<br />
<!--Acute pyelonephritis-->
<div class="text-left border border-info rounded" id="ICpyelonephritisSection">
<h2 class="text-center" id="ICacutePyelonephritis">Acute Pyelonephritis</h2>

<p>Pyelonephritis is inflammation of the kidney which usually results from bacterial infection. It is important to differentiate pyelonephritis (upper urinary tract infection) from cystitis (lower urinary tract infection) in order to treat the patient appropriately. Pyelonephritis triggers a systemic response and symptoms include: fever, rigors, flank pain, nausea, vomiting and costovertebral angle tenderness, whereas symptoms of cystitis are more localised to the area of infection i.e. the bladder and include dysuria, urinary bladder frequency and urgency,and suprapubic pain.</p>
<!--Start accordian-->

<div id="ICaccordionAcutePye">
<div class="card">
<div class="card-header" id="ICacutePyeTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseAcutePyeTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseAcutePyeTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICacutePyeTreatment" class="collapse" data-parent="#ICaccordionAcutePye" id="ICcollapseAcutePyeTreatment">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Cefalexin 1g&nbsp;TDS</strong></span> for 7-10 days.</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

<p><strong><span style="color:#800080">Ciprofloxacin 500mg BD</span></strong> for 7 days.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Bacterial Prostatitis-->
<div class="text-left border border-info rounded" id="ICprostatitisSection">
<h2 class="text-center" id="ICbacterialProstatitis">Bacterial Prostatitis</h2>

<p>Send MSU for culture and prescribe empiric antibiotics.&nbsp; Ensure that antibiotic therapy is reviewed whilst the patient remains in the intermediate care setting and if not improvement then a different diagnosis is sought.</p>

<p>Ensure antibiotics are reviewed when results are available and alter/stop therapy accordingly.</p>

<p>Refer to Urology&nbsp;if needed</p>
<!--Start accordian-->

<div id="ICaccordionProstatitis">
<div class="card">
<div class="card-header" id="ICprostatitisTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseProstatitisTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseProstatitisTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICprostatitisTreatment" class="collapse" data-parent="#ICaccordionProstatitis" id="ICcollapseProstatitisTreatment">
<div class="card-body text-left">
<p><span style="color:#000000"><strong>1st line:</strong></span><span style="color:#800080"><strong> </strong></span><strong><span style="color:#0000ff">Co-trimoxazole 960mg BD</span></strong><span style="color:#3333cc"> </span>for 14&nbsp;days.</p>

<p><span style="color:#000000"><strong>2nd line:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#8e44ad"><strong>Ciprofloxacin 500mg BD</strong> </span>for 14&nbsp;days.</p>

<p><span style="color:#000000"><strong>3rd line:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#e74c3c"><strong>Doxycycline 100mg&nbsp;BD</strong> </span>for 14&nbsp;days.</p>

<p>In sexually active young men consider a diagnosis of Chlamydia trachomatis or gonorrhoea. Refer all men for investigation by a specialist after recovery to exclude a structural cause.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Catheter-associated UTI-->
<div class="text-left border border-info rounded" id="ICcathUTISection">
<h2 class="text-center" id="ICcatheterUTI">Catheter-associated UTI</h2>

<ul>
    <li>Catheter-associated UTI occurs when bacteria in a catheter bypass the body&#39;s defence mechanisms and enter the bladder.</li>
    <li>The longer a catheter has been in place the more likely bacteria will be found in the urine</li>
    <li>Treatment is only needed for <u><strong>symptomatic</strong></u>&nbsp;catheter-associated UTI (apart from in pregnancy)</li>
    <li>Removing or changing the catheter (especially if it has been in place for longer than 7 days) should be strongly considered.</li>
    <li>Catheters should be&nbsp;reviewed and&nbsp;removed rather than changed if possible</li>
</ul>
<!--Start accordian-->

<div id="ICaccordionCatheterUTI">
<div class="card">
<div class="card-header" id="ICcatheterUTITreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseCatheterUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseCatheterUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICcatheterUTITreatment" class="collapse" data-parent="#ICaccordionCatheterUTI" id="ICcollapseCatheterUTITreatment">
<div class="card-body text-left">
<p><span style="background-color:white"><strong>This is not routinely required for every patient</strong>.&nbsp; However, for those patients that are truly symptomatic of a UTI and require a catheter change (rather than just removal)&nbsp;<strong>and</strong>&nbsp;there is concern regarding&nbsp;introduction of bacteria during the change (due to previous medical history or traumatic catheter change),&nbsp;then antibiotics can be given to reduce the incidence of bacteraemia.</span></p>

<p><span style="background-color:white">Any antibiotic therapy for these patients should be based on previous known urine sensitivities and ideally a specimen&nbsp;be sent for urinalysis&nbsp;<strong><u>BEFORE</u></strong>&nbsp;any antibiotic therapy is started for resolution of the UTI.</span></p>

<p><span style="background-color:white">Urine specimens should&nbsp;<strong><u>ALWAYS</u></strong>&nbsp;be taken from the sampling port and&nbsp;<u>NOT</u>&nbsp;the catheter bag.&nbsp;Refer to the <u>Trust Urinary catheterisation and catheter care management adults policy</u> for guidance on best practice.</span></p>

<p><span style="background-color:white"><a data-dismiss="modal" data-target="#HCProphSurg" data-toggle="modal" href="#HCSurgUrinCatheter"> Urinary catheterisation prophylaxis  </a>&nbsp;&nbsp;for those patients with urethritis, where Staph aureus has been isolated, and require a catheter change.</span></p>

<p><span style="background-color:white">For further advice on individual patients contact Urology Specialist Nurses 0161 922 6696, Infection Prevention Nurses on 0161 922 6194 or the Consultant Microbiologist on 0161 922 4086 / 6500.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Recurrent UTI-->
<div class="text-left border border-info rounded" id="ICrecurrentUTISection">
<h2 class="text-center" id="ICrecurrentUTI">Recurrent UTI</h2>

<p>Recurrent urinary tract infection (UTI) in adults is defined as repeated UTI with frequency of 2 or more UTIs in the last 6 months or 3 or more UTIs in the last 12 months.</p>

<p>Comprehensively assess the problem and refer to a specialist urologist or gynaecologist (for female patients).</p>

<p><strong>Behavioural and personal hygiene measures:</strong></p>

<p>Patients <span style="color:#282828"><span style="color:#282828"><span style="color:#282828"><span style="color:#282828">should be given advice about behavioural and personal <span style="color:#282828"><span style="color:#282828">hygiene measures to reduce the risk of UTI, such as:</span></span></span></span></span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- drinking enough fluids to avoid dehydration</span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- </span></span><span style="color:#282828"><span style="color:#282828">not delaying habitual and post-coital urination</span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- wiping from front to back after defaecation</span></span></p>

<p><span style="color:#282828"><span style="color:#282828">- not douching or wearing occlusive underwear.</span></span></p>

<p><strong><span style="color:#000000">Cranberry products and D-mannose:</span></strong></p>

<p><span style="color:#58595b">Some women find these effective, but there is currently poor evidence to support this and patients should be warned about the sugar content of these products if relevant.&nbsp; Cranberry products should be avoided by patients on warfarin.</span></p>
<!--Start accordian-->

<div id="ICaccordionRecurrentUTI">
<div class="card">
<div class="card-header" id="ICrecurrentUTITreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseRecurrentUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseRecurrentUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICcatheterUTITreatment" class="collapse" data-parent="#ICaccordionRecurrentUTI" id="ICcollapseRecurrentUTITreatment">
<div class="card-body text-left">
<p><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></p>

<p>If behavioural and personal hygiene measures do not reduce incidence of UTI, antibiotic treatment may be considered from one of the following recommendations below:</p>

<ul>
    <li>Each episode of UTI may be treated by a healthcare professional as it occurs.</li>
    <li>Patient/carer initiated antibiotic treatment is a cost-effective and safer alternative (in terms of avoiding the development of CDI and antibiotic resistance) compared to continuous antibiotic prophylaxis.&nbsp; This&nbsp;entails self-administration of single high-dose antibiotic treatment; however, if symptoms persist, treatment could continue for up to 3 days, but often 1 or 2 days are sufficient.&nbsp; This should be considered in patients who are compos mentis and are capable of recognising the symptoms of UTI. The patient should be counselled on how and when to self-treat.&nbsp; Antibiotics should be reviewed every 6 months.</li>
    <li>Antibiotic prophylaxis with either trimethoprim 100mg or nitrofurantoin 50mg nocte (provided there is sensitivity to these antibiotics) may be considered where it may be impractical for patients or carers to initiate antibiotics appropriately however antibiotics must be reviewed at least every 6 months.&nbsp; The patient should be counselled on adverse effects&nbsp;and&nbsp;the risk of antibiotic resistance developing.</li>
    <li>If related to sexual intercourse consider a single dose of antibiotic post coital (off-label use).&nbsp; Trimethoprim 200mg or nitrofurantoin 100mg stat&nbsp;may be given&nbsp;after taking into account sensitivity results.&nbsp; Antibiotics should be reviewed every 6 months.</li>
</ul>

<p>For patients who develop and continue to have symptoms of UTI whilst taking antibiotic prophylaxis or treating a UTI, they should be advised to seek medical help.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Uncomplicated Female UTI-->
<div class="text-left border border-info rounded" id="ICuncomplicatedFemales">
<h2 class="text-center" id="ICfemaleUTI">Uncomplicated UTI in Females</h2>

<p>If there is fever, flank or back pain then it is likely to be an upper UTI and antibiotic treatment for 7 - 14 days is needed, (see pyelonephritis section).</p>

<p>If symptoms are mild the woman may wish to consider not taking antibiotics and simply increase her fluid intake as UTIs often resolve spontaneously in a few days.</p>

<p><strong>If the woman has more than 3 typical symptoms of a UTI, and no vaginal discharge, then treat empirically with antibiotics as below.</strong></p>

<p><strong>If the woman has 2 or less, or mild symptoms, obtain a urine sample. If the urine is NOT cloudy this gives a 97% negative predictive value, so do not treat unless other risk factors of infection are present.</strong></p>

<p>If urine is cloudy then perform a urine dipstick test (if under 65 years of age) containing nitrite and leucocyte esterase impregnated reagent. If the results are negative for leucocytes and nitrites then there is a 95% negative predictive value. If both are positive, or nitrite or leucocyte esterase are positive, then treat.&nbsp; However, if only leucocytes are positive only treat if symptoms are severe and send urine for culture.</p>

<p><span style="color:#c0392b"><strong>Do not use dipstick testing in patients over the age of 65.&nbsp; If symptomatic of a UTI then send a urine specimen for testing and base any antibiotic treatment on this result.&nbsp; If empiric treatment is required because patient is symptomatic REVIEW this once MSU results available.</strong></span></p>

<!--Start accordian-->

<div id="ICaccordionFemaleUTI">
<div class="card">
<div class="card-header" id="ICfemaleUTITreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseFemaleUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseFemaleUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICfemaleUTITreatment" class="collapse" data-parent="#ICaccordionFemaleUTI" id="ICcollapseFemaleUTITreatment">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Nitrofurantoin 100mg MR BD</span></strong>&nbsp;for 3 days (nitrofurantoin 50mg QDS may be an alternative if supply issues with MR preparations).</p>

<p>Nitrofurantoin is contraindicated in patients with an eGFR of &le;45ml/min; however it maybe used with caution in patients with eGFR 30-44ml/min provided the duration of treatment does not exceed 7 days</p>

<p>OR</p>

<p><span style="color:#800080"><strong>Pivmecillinam 400mg STAT then 200mg TDS</strong></span> for 3 days <strong>(this is a penicillin)</strong></p>

<p>If the above two options are not suitable for patients then please use MSU results to guide treatment or discuss with Microbiologist on 0161 922 4086/6500 or mobile via switch 0161 922 6000</p>

<p>If a patient is penicillin allergic (anaphylaxis) and has poor renal function whereby other antibiotic options can&#39;t be used then<span style="color:#00ff00"><strong>&nbsp;</strong></span><span style="color:#008000"><strong>Fosfomycin (prescribe as <em>Monuril</em>) 3g STAT once only</strong></span> can be given.</p>
</div>
</div>

<div class="card-header" id="ICfemaleUTIResistence">
<h5 class="mb-0"><button aria-controls="ICcollapseFemaleUTIResistence" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseFemaleUTIResistence" data-toggle="collapse" type="button">Resistance within our population</button></h5>
</div>

<div aria-labelledby="ICfemaleUTIResistence" class="collapse" data-parent="#ICaccordionFemaleUTI" id="ICcollapseFemaleUTIResistence">
<div class="card-body text-left">
<p>We have high levels of resistance (50%) to co-amoxiclav of E coli. &nbsp;Pivecillinam has shown to be effective against E coli and is also a recommended choice in the PHE guidelines. The resistance to this drug is low in our local population at 16%. Cephalosporins have high sensitivity rates in Tameside.</p>

<p>Extended - spectrum Beta-lactamase enzymes (ESBLs) in gram-negative bacilli such as E. coli are increasing, and these ESBL-producing E. coli are multi-resistant but remain sensitive to nitrofurantoin. Consider a diagnosis of Chlamydia trachomatis in sexually active young women (in which case urine or endocervical specimens should be submitted for Chlamydia PCR assay).</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--UTI Males-->
<div class="text-left border border-info rounded" id="ICmaleUTISection">
<h2 class="text-center" id="ICmaleUTI">UTI in Males</h2>

<p>Always send a MSU off to the lab for culture. Consider a diagnosis of prostatitis and refer if necessary. In sexually active young men with urinary symptoms consider Chlamydia trachomatis and other sexually transmitted infections.</p>
<!--Start accordian-->

<div id="ICaccordionMaleUTI">
<div class="card">
<div class="card-header" id="ICmaleUTITreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseMaleUTITreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseMaleUTITreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICmaleUTITreatment" class="collapse" data-parent="#ICaccordionMaleUTI" id="ICcollapseMaleUTITreatment">
<div class="card-body text-left">
<p>1st choice:<strong> <span style="color:#3300ff">Pivmecillinam 400mg STAT</span>&nbsp;</strong>for the first dose followed by<strong><span style="color:#3300ff"> 200mg TDS</span>&nbsp;</strong>thereafter&nbsp;for&nbsp;7 days<strong>.</strong></p>

<p>2nd choice:<span style="color:#8e44ad"><strong> Nitrofurantoin 100mg MR BD</strong></span>&nbsp;for&nbsp;7 days (nitrofurantoin 50mg QDS may be an alternative if supply issues with MR preparations)</p>

<p>Nitrofurantoin is contraindicated in patients with an eGFR of &le;45ml/min however it may be used with caution in patients with eGFR 30-44ml/min provided the duration of treatment does not exceed 7 days.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#ICUrine"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Intermediate Care Genital tract section-->

<div aria-hidden="true" aria-labelledby="ICGenitalTractLabel" class="portfolio-modal modal fade " id="ICGTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICGenitalTractLabel">Genital Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<div>
<p>Consider a diagnosis of Chlamydia infection in anyone who is (or has been) sexually active who presents with a genital infection.</p>

<p>To identify Chlamydia infection first catch urine sample after holding urine in bladder for at least 1 hour, can be sent to the laboratory at Tameside General Hospital. A test for Chlamydia on first catch urine is very reliable and the specimen is also tested for gonorrhoea. Gonorrhoea positive cases should be referred for management by a GUM clinic where swabs for culture and sensitivity will betaken and contact tracing will be carried out.</p>

<p><strong><u>Ashton Primary Care Sexual Health Clinic</u></strong></p>

<p><strong>Ashton Primary Care Centre, 193 Old Street, Ashton-under-Lyne, OL6 7SR</strong></p>

<p><strong>0161 342 7101</strong></p>
</div>

<h4 id="ICGT"><a href="#ICBV">Bacterial Vaginosis</a></h4>

<h4><a href="#ICcandidae">Candidiasis</a></h4>

<h4><a href="#ICEpididymo">Epididymo - Orchitis</a></h4>

<h4><a href="#ICInfectBarthCyst">Infected Bartholin&#39;s Cyst/Abcess</a></h4>
<br />
<!--Bacterial Vaginosis-->
<div class="text-left border border-info rounded" id="ICBV">
<h2 class="text-center" id="ICBVLabel">Bacterial Vaginosis</h2>

<p>A seven day course of metronidazole is slightly more effective than 2g stat.</p>

<p>Clindamycin gel is expensive but is a useful alternative if metronidazole cannot be tolerated</p>
<!--Start accordian-->

<div id="ICaccordionBV">
<div class="card">
<div class="card-header" id="ICBVTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseBV" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseBV" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICBVLabel" class="collapse" data-parent="#ICaccordionBV" id="ICcollapseBV">
<div class="card-body text-left">
<p><span style="color:#0000FF"><strong>Metronidazole 400mg BD</strong></span> for 7 days</p>

<p>or</p>

<p><span style="color:#008000"><strong>Metronidazole 2g STAT</strong></span></p>

<p>or</p>

<p><span style="color:#800080"><strong>Metronidazole vaginal gel 0.75% 5g</strong></span> nightly for 5 nights</p>

<p>or</p>

<p><span style="color:#B22222"><strong>Clindamycin 2 % vaginal cream 5g </strong></span>nightly for 7 nights (expensive)</p>

<p>During pregnancy /breastfeeding avoid high dose regimens of metronidazole (2g stat dose). During lactation metronidazole enters breast milk and can alter the taste of breast milk, therefore avoid oral treatment in lactating women and use topical treatment instead.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Candidiasis-->
<div class="text-left border border-info rounded" id="ICcandidae">
<h2 class="text-center" id="ICCandidae">Candidiasis</h2>

<p>Many products are available over the counter, so check whether the patient has already self-treated. Systemic treatments are best reserved for failures of topical treatment and for patients who prefer oral treatment to topical.</p>
<!--Start accordian-->

<div id="ICaccordionCandidae">
<div class="card">
<div class="card-header" id="ICCandidaeTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseCandidae" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseCandidae" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICCandidae" class="collapse" data-parent="#ICaccordionCandidae" id="ICcollapseCandidae">
<div class="card-body text-left">
<p><strong><span style="color:#0000FF">Clotrimazole 10% vaginal cream 5g single dose</span></strong></p>

<p>or</p>

<p><span style="color:#800080"><strong>Clotrimazole pessary 500mg as a single dose</strong></span></p>

<p>If <u>topical treatment fails</u> or the <u>patient prefers oral preparation</u>:</p>

<p><strong><span style="color:#008080">Fluconazole 150mg orally STAT</span></strong></p>

<p><strong>In pregnancy avoid oral azole and use intravaginal treatment for 7 days</strong>:</p>

<p><span style="color:#B22222"><strong>Clotrimazole pessary 100mg </strong></span>at night for 6 nights</p>

<p>(This slightly shorter treatment duration is considered acceptable by PHE as that is the number of pessaries in one original pack of clotrimazole 100mg pessaries).</p>

<p>or</p>

<p><span style="color:#008000"><strong>Miconazole 2% cream 5g BD</strong></span> as intravaginal application for 7 days</p>

<p>In pregnancy the use of an <u>applicator</u> to insert pessaries should be <u>avoided</u> and insertion by hand is preferable.</p>

<p>The patient should be instructed to wash hands before insertion. For intravaginal creams where use of an applicator cannot be avoided, care must be taken to avoid injuring the cervix.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Epididymo-orchitis-->
<div class="text-left border border-info rounded" id="ICepydidymo">
<h2 class="text-center" id="ICEpididymo">Epididymo-Orchitis</h2>
<!--Start accordian-->

<div id="ICaccordionEpididymo">
<div class="card">
<div class="card-header" id="ICEpididymoTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseEpididymo" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseEpididymo" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICEpididymo" class="collapse" data-parent="#ICaccordionEpididymo" id="ICcollapseEpididymo">
<div class="card-body text-left">
<p><span style="color:#000000"><u>Due to chlamydial infection</u>:</span></p>

<p><span style="color:#0000ff"><strong>Ceftriaxone 500mg IM stat</strong></span><span style="color:#000000"> then </span><span style="color:#0000ff"><strong>Doxycycline 100mg po bd</strong></span><span style="color:#000000"> for <u>14 days.</u></span></p>

<p><span style="color:#000000">Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</span></p>

<p><u>Due to Gram negative&nbsp;enteric organisms (urinary pathogens):</u></p>

<p><u><span style="color:#000000"><strong>1st line:</strong></span></u><span style="color:#0000ff"><strong> Co-trimoxazole 960mg po bd </strong></span><span style="color:#000000">for 10 days.</span></p>

<p><span style="color:#000000"><u><strong>2nd line:</strong></u></span> <span style="color:#8e44ad"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000">for 10 days</span></p>

<p><strong>or</strong></p>

<p><span style="color:#8e44ad"><strong>ofloxacin 200mg po bd</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#000000">for&nbsp;<u>14 days.</u></span></p>

<p><u><strong><span style="color:black">3rd line:</span></strong></u><strong> </strong><strong><span style="color:#e74c3c">Doxycycline 100mg BD</span></strong> <span style="color:#333333">for&nbsp;10 days.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--InfectbarthCyst-->
<div class="text-left border border-info rounded" id="ICInfectBarthCyst">
<h2 class="text-center" id="ICInfectbarthCystLabel">Infected Bartholin&#39;s cyst/abscess</h2>
<!--Start accordian-->

<div id="ICaccordionInfectbarthCyst">
<div class="card">
<div class="card-header" id="ICInfectbarthCystTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseInfectbarthCyst" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseInfectbarthCyst" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICInfectbarthCystLabel" class="collapse" data-parent="#ICaccordionInfectbarthCyst" id="ICcollapseInfectbarthCyst">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Cefalexin 1g TDS&nbsp;</span></strong><span style="color:#000000">plus</span><strong><span style="color:#0000ff"> clindamycin 450mg TDS&nbsp;</span></strong><span style="color:#000000">for 5 days.</span></p>

<p><span style="color:#000000"><strong>Note:</strong> cephalosporins can be given in penicillin allergy with a rash.</span></p>

<p><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis):</u></strong></span></p>

<p><span style="color:#990066"><strong>Co-trimoxazole 960mg BD</strong></span><span style="color:#c0392b"><strong>&nbsp;</strong></span><span style="color:#000000">plus</span><span style="color:#800080"><strong> </strong></span><span style="color:#990066"><strong>clindamycin 450mg BD</strong></span><span style="color:#000000"><strong> </strong>for 5 days.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#ICGT"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Intermediate Care LRTI-->

<div aria-hidden="true" aria-labelledby="ICLRTILabel" class="portfolio-modal modal fade " id="ICLRTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICLRTILabel">Lower Respiratory Tract Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<div>
<p>Many infections are viral but the principal bacterial pathogens in acute lower respiratory tract infections are Streptococcus pneumoniae (which is the most common cause of community-acquired pneumonia), Haemophilus influenzae and atypical organisms such as Legionella and Mycoplasma. Staphylococcus aureus lower respiratory infections can occur as a complication following influenza. Pseudomonas may be isolated from sputum cultures but, in the community, this would usually reflect colonisation and should not be treated; it may be helpful to discuss with a microbiologist if in doubt. Avoid use of low dose amoxicillin which may encourage bacterial resistance. Note that excessive use of quinolones (e.g. ciprofloxacin) and co-amoxiclav is implicated in development of MRSA and Clostridium difficile infections.</p>
</div>

<h4 id="ICLRT"><a href="#ICAcuteBronchitis">Acute Bronchitis</a></h4>

<h4><a href="#ICAcuteExacBronch">Acute Exacerbation of Bronchiectasis</a></h4>

<h4><a href="#ICAcuteCOPD">Acute Exacerbation of COPD</a></h4>

<h4><a href="#ICCap">Community-Acquired Pneumonia</a></h4>

<h4><a href="#ICHap">Hospital-Acquired Pneumonia</a></h4>
<br />
<!--Acute Bronch-->
<div class="text-left border border-info rounded" id="ICAcuteBronchitis">
<h2 class="text-center" id="ICAcuteBronchitisLabel">Acute Bronchitis</h2>

<p>Systematic reviews indicate antibiotics have marginal benefits in otherwise healthy adults. Explain to patients why they have not been prescribed antibiotics. Consider prescribing antibiotics for people who have a pre-existing co-morbid condition that impairs their ability to deal with infection or is likely to deteriorate with acute bronchitis. Consider immediate antibiotics in patients over 80 years old and ONE of: hospitalisation in past year, oral steroids, diabetic, congestive heart failure OR over 65 years with 2 of the above.</p>
<!--Start accordian-->

<div id="ICaccordionacuteBronch">
<div class="card">
<div class="card-header" id="ICAcuteBronchTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseAcuteBronch" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseAcuteBronch" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICAcuteBronchitisLabel" class="collapse" data-parent="#ICaccordionacuteBronch" id="ICcollapseAcuteBronch">
<div class="card-body text-left">

                                        <p><span style="color:#0000ff"><strong>Amoxicillin 1g TDS</strong></span> for 3 days (or&nbsp;<span style="color:#0000ff"><strong>amoxicillin 500mg TDS</strong></span> only if body weight less than 50kg)</p>

<p><u><strong>Penicillin allergy</strong></u></p>

<p><span style="color:#990066"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span> for 3 days</p>

<p>Doxycycline must NOT be prescribed for children under 12 years, or for pregnant or breast-feeding women.</p>

</div>
</div>
</div>
</div>
</div>
<br />
<!--Acute Exacerbation of Bronchiectasis-->
<div class="text-left border border-info rounded" id="ICacuteExacBronch">
<h2 class="text-center" id="ICAcuteExacBronch">Acute Exacerbation of Bronchiectasis</h2>

<p>An acute exacerbation of bronchiectasis is sustained worsening of symptoms from a person&#39;s stable state..</p>

<p>When choosing antibiotics, take account of:</p>

<ul>
    <li>the severity of symptoms</li>
    <li>previous exacerbations, hospitalisations and risk of complications</li>
    <li>previous sputum culture and susceptibility results.</li>
</ul>

<p>NICE (2019) recommends to send a sputum sample for culture and susceptibility testing and then offer an antibiotic.&nbsp; Also, when results of sputum culture are available:</p>

<ul>
    <li>review choice of antibiotic</li>
    <li>only change antibiotic according to susceptibility results if bacteria are resistant and symptoms are not already improving, <strong>using narrow spectrum antibiotics when possible.</strong></li>
</ul>

<p>Refer to hospital if the person has any symptoms or signs suggesting a more serious illness or condition (for example, cardiorespiratory failure or sepsis).</p>

<p>Seek specialist advice if:</p>

<ul>
    <li>symptoms do not improve with repeated courses of antibiotics</li>
    <li>bacteria are resistant to oral antibiotics</li>
    <li>the person cannot take oral medicines (to explore giving intravenous antibiotics at home or in the community if appropriate)</li>
</ul>
<!--Start accordian-->

<div id="ICaccordionAcuteExacBronch">
<div class="card">
<div class="card-header" id="ICAcuteExacBronchTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseAcuteExacBronch" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseAcuteExacBronch" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICAcuteExacBronch" class="collapse" data-parent="#ICaccordionAcuteExacBronch" id="ICcollapseAcuteExacBronch">
<div class="card-body text-left">
<p>Please ensure response to treatment is reviewed after 7 days at the very most.&nbsp; DO NOT routinely offer two weeks of antibiotics without adequate review.&nbsp; NICE (2019) guidance gives the duration of 7-14 as a guide and up to weeks may be required for some patients.&nbsp; However, adequate review is crucial when treating exacerbation of bronchiectesis to ensure the patient is responding and not deteriorating.</p>

<p>1.<span style="color:#0000ff"><strong> Amoxicillin 1g TDS</strong></span> &nbsp;(or <span style="color:#0000ff"><strong>amoxicillin 500mg TDS</strong></span>&nbsp;if less than 50kg) for 7-14&nbsp;days</p>

<p>or</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong>&nbsp;(or alternative regime if amoxicillin not suitable)</span></p>

<p>2.<span style="color:#800080"><strong> Doxycycline 200 mg STAT then 100 mg OD</strong></span> for 7-14&nbsp;days (or <span style="color:#800080"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span>)</p>

<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td>
            <p>If Legionella is suspected:</p>

            <p>Add <span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span><span style="color:#0000ff"><strong> </strong></span>for 7-14&nbsp;days to amoxicillin</p>
            </td>
        </tr>
    </tbody>
</table>

<p>If there is inadequate&nbsp;clinical response to amoxicillin and/or doxycyline, co-amoxiclav 625 mg TDS for 7-14 days can be tried as an alternative antibiotic.&nbsp;</p>

<p>It is recommended that only hospital consultants should commence long-term antibiotic prophylaxis for bronchiectesis&nbsp;patients and that those patients who would benefit are carefully selected and closely monitored with regular follow ups.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--AcuteCOPD-->
<div class="text-left border border-info rounded" id="ICAcuteCOPD">
<h2 class="text-center" id="ICAcuteCOPDLabel">Acute Exacerbation of COPD</h2>

<p>About up to 50% of cases are viral, 30-50% are bacterial and the rest are undetermined. Antibiotics are not indicated in the absence of purulent/mucopurulent sputum especially if not associated with increased dyspnoea or clinical toxicity.</p>

<p>Treat exacerbations promptly with antibiotics if purulent sputum <strong>and</strong> increased shortness of breath <strong>and/or</strong> increased sputum volume.</p>

<p>Risk factors for antibiotic resistant organisms include co-morbid disease, severe COPD, frequent exacerbations, antibiotics in last 3 months.</p>
<!--Start accordian-->

<div id="ICaccordionAcuteCOPD">
<div class="card">
<div class="card-header" id="ICAcuteCOPDRescue">
<h5 class="mb-0"><button aria-controls="ICcollapseAcuteCOPD" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseAcuteCOPD" data-toggle="collapse" type="button">Rescue Packs</button></h5>
</div>

<div aria-labelledby="ICAcuteCOPDLabel" class="collapse" data-parent="#ICaccordionAcuteCOPD" id="ICcollapseAcuteCOPD">
<div class="card-body text-left">
<p>We have become aware of some posts on social media &ldquo;advising&rdquo; patients to contact their GP if they have asthma or COPD for a rescue pack.</p>

<p>There has been some recent information circulated on this from the medicines management team.&nbsp; All patients issued with a rescue pack should <strong>ONLY</strong> be done so after a proper clinical assessment and the patient should be issued with an <strong><u>individualised and detailed care plan</u></strong> &ndash; so they are aware of what actions need to be taken.</p>

<p>Please refrain from conducting practice-wide searches and sending out rescue pack prescriptions to all on the COPD or asthma registers.&nbsp; This is inappropriate and the medicines supply chain will be unable to cope with such increased demand, meaning those actually requiring rescue medication will not be able to source it.</p>

<p>COVID19 is a viral infection and so the advice stands as for all other respiratory viral pathogens.&nbsp; If patients are unwell then they are advised to seek medication attention.</p>
</div>
</div>

<div class="card-header" id="ICAcuteCOPDTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseAcuteCOPDTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseAcuteCOPDTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICAcuteCOPDTreatment" class="collapse" data-parent="#ICaccordionAcuteCOPD" id="ICcollapseAcuteCOPDTreatment">
<div class="card-body text-left">
<p>1.<span style="color:#0000ff"><strong> Amoxicillin 1g TDS</strong></span> for 3 days (or <span style="color:#0000ff"><strong>amoxicillin 500mg TDS</strong></span>&nbsp;if less than 50kg for 5 days)</p>

<p>or</p>

<p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong>&nbsp;(or alternative regime if amoxicillin not suitable)</span></p>

<p>2.<span style="color:#800080"><strong> Doxycycline 200 mg STAT then 100 mg OD</strong></span> for 5 days (or <span style="color:#800080"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span> for 3 days)</p>

<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td>
            <p>If Legionella is suspected:</p>

            <p>Add <span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span><span style="color:#0000ff"><strong> </strong></span>for 5 days to amoxicillin</p>
            </td>
        </tr>
    </tbody>
</table>

<p>If there is inadequate&nbsp;clinical response to amoxicillin and/or doxycyline, co-amoxiclav 625 mg TDS for 5 days can be tried as an alternative antibiotic.&nbsp;However, the diagnosis should also be reviewed to ensure that exacerbation is indeed bacterial in nature, as up to 50% of acute exacerbation of COPD are&nbsp;due to a viral cause.</p>

<p>It is recommended that only hospital consultants should commence long-term antibiotic prophylaxis for COPD patients and that those patients who would benefit are carefully selected and closely monitored with regular follow ups.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--CAP-->
<div class="text-left border border-info rounded" id="ICCap">
<h2 class="text-center" id="ICCapLabel">Community-acquired Pneumonia</h2>

<p>The intensity of pneumonia in the community can be assessed using the CRB65 score;<strong> each factor scores one point:</strong></p>

<ul>
    <li>confusion (abbreviated Mental Test score 8 or less, or new disorientation in person, place, or time);</li>
    <li>a raised respiratory rate (30 breaths per minute or more);</li>
    <li>a low blood pressure (diastolic 60 mmHg or less, or systolic less than 90 mmHg);</li>
    <li>age 65 years or over.</li>
</ul>

<p><strong>Score 1 or 2: intermediate risk (1-10% mortality risk). </strong></p>

<p><strong>Score 3 or 4: high risk (more than 10% mortality risk)</strong></p>

<p>For life-threatening illness or where hospital admission is likely to be delayed, give intravenous <span style="color:#0000ff"><strong>Benzylpenicillin 1.2g</strong></span> (give intramuscular if a vein cannot be found) or <strong><span style="color:#0000ff">oral Amoxicillin 1g</span></strong> <strong>immediately</strong>.</p>

<p>If it is felt that&nbsp;blood cultures are required, due to severity of illness, then the patient should be referred to secondary care.&nbsp; It is vital that blood cultures are taken by someone who is appropriately trained to do so, reducing the chances of contamination.&nbsp;&nbsp;&nbsp;</p>

<p>NB: it is recognised that due to increased remote consultations it may not always be possible to obtain a BP reading.&nbsp; Some patients may have suitable equipment at home, assisting the clinician in making an assesment.&nbsp; The antibiotic choices have been amended to help with this in this current climate.</p>
<!--Start accordian-->

<div id="ICaccordionCap">
<div class="card">
<div class="card-header" id="ICCapTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseCap" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseCap" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICCapLabel" class="collapse" data-parent="#ICaccordionCap" id="ICcollapseCap">
<div class="card-body text-left">
<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td><span style="color:#c0392b"><strong>CRB score</strong></span></td>
            <td><span style="color:#c0392b"><strong>Antibiotic choice (5 day treatment)</strong></span></td>
        </tr>
        <tr>
            <td>CRB = 0</td>
            <td>
            <p><span style="color:#0000ff"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span><span style="color:#800080"><strong> </strong></span>(suitable for penicillin allergy)</p>

            <p>OR</p>

            <p><span style="color:#990066"><strong>Amoxicillin 1 g TDS</strong></span></p>
            </td>
        </tr>
        <tr>
            <td>CRB = 1-2</td>
            <td>
            <p><span style="color:#0000ff"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span><span style="color:#800080"><strong> </strong></span>(suitable for penicillin allergy)</p>

            <p>OR</p>

            <p><span style="color:#990066"><strong>Amoxicillin 1 g TDS&nbsp;</strong></span>PLUS&nbsp;<span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span></p>
            </td>
        </tr>
        <tr>
            <td>CRB = 3-4</td>
            <td>
            <p><strong><span style="color:#66cc33">Co-amoxiclav 625mg TDS&nbsp;</span></strong>PLUS&nbsp;<span style="color:#b22222"><strong>Clarithromycin 500mg BD</strong></span></p>

            <p><strong><span style="color:#9900cc">Levofloxacin 500mg BD</span><span style="color:#cc0099">&nbsp;</span></strong>if penicillin allergic</p>
            </td>
        </tr>
    </tbody>
</table>

<p>Post influenzal pneumonia can be due to S. aureus which usually requires hospital admission because of the clinical severity of staphylococcal pneumonia.&nbsp; Following recovery consider pneumococcal vaccination.</p>
</div>
</div>

<div class="card-header" id="ICCap19Treatment">
<h5 class="mb-0"><button aria-controls="ICcollapseCap19" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseCap19" data-toggle="collapse" type="button">COVID19 plus CAP</button></h5>
</div>

<div aria-labelledby="ICCap19" class="collapse" data-parent="#ICaccordionCap" id="ICcollapseCap19">
<div class="card-body text-left">
<p>The current COVID19 pandemic has highlighted the risk faced by older adults who are more susceptible to complications as a result of pneumonia.</p>

<p>Comorbidities, impaired immunity and frailty, including a reduced ability to couggh and to clear secretions from the lungs, can all contribute to this complication.</p>

<p>Viruses are thought to cause around 50% of cases of pneumonia.&nbsp; Viral pneumonia is generally less severe than bacterial pneumonia but can act as a precursor to it.&nbsp; Preventing any pneumonia in older adults is preferable to treating it.</p>

<p>Where physical examination and other ways of making an objective diagnosis are not possible, the clinical diagnosis of CAP of any cause in an adult can be informed by other clinical signs or symptoms such as:</p>

<ul>
    <li>temperature above 38 <sup>o</sup>C</li>
    <li>respiratory rate above 20 breaths per minute</li>
    <li>heart rate above 100 beats per minute</li>
    <li>new confusion</li>
</ul>

<p>Use of NEWS2 score in the community for predicting the risk of clinical deterioration may be useful.</p>
</div>
</div>




</div>
</div>
</div>
<br />
<!--HAP-->
<div class="text-left border border-info rounded" id="ICHap">
<h2 class="text-center" id="ICHapLabel">Hospital-acquired Pneumonia</h2>

<p>Hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs <strong><u>48 hours or more after hospital admission</u></strong> and is not incubating at hospital admission.</p>

<p>Early-onset (occurring within 4 days of admission) HAP is usually caused by the same bacteria and viruses as CAP and has a good prognosis.</p>

<p>Late-onset (starting 5 days or more after admission) HAP has a worse prognosis and is usually caused by microorganisms that are acquired from the hospital environment. Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA) and other nonpseudomonal Gram-negative bacteria are the most common causes.</p>
<!--Start accordian-->

<div id="ICaccordionHap">
<div class="card">
<div class="card-header" id="ICHapTreatment">
<h5 class="mb-0"><button aria-controls="ICcollapseHap" aria-expanded="false" class="btn btn-link collapsed" data-target="#ICcollapseHap" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="ICHapLabel" class="collapse" data-parent="#ICaccordionHap" id="ICcollapseHap">
<div class="card-body text-left">
<p><span style="color:#990066"><strong>Doxycycline 200 mg STAT then 100 mg BD</strong></span> for&nbsp; 72 hours and review</p>

<p>Doxycycline must NOT be prescribed for children under 12 years, or for pregnant or breast-feeding women</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#ICLRT"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Intermediate Care Sepsis section-->

<div aria-hidden="true" aria-labelledby="SepsisLabel" class="portfolio-modal modal fade " id="ICSepsis" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICSepsisLabel">Sepsis Syndrome</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>
<!--Sepsis-->

<div class="text-left border border-info rounded" id="sepsisSection">
<h2 class="text-center" id="sepsis">Sepsis</h2>

<p>Diagnosis of possible sepsis relies on clinical judgment. Healthcare professionals assessing people with clinical deterioration due to likely infection, or in those who are acutely unwell with no clear cause should consider the possibility of sepsis.</p>

<p>They should:</p>

<p>a. take into account the patient&#39;s history and risk factors alongside clinical assessment</p>

<p>b. Make a clinical assessment that includes measurement of physiological variables (temperature, heart rate, respiratory rate, level of consciousness, oxygen saturation) that can be used to stratify the severity of illness.&nbsp;</p>

<p>NEWS (the National Early Warning Score) provides an appropriate framework for risk stratification in adults in acute care. The National Quality Board strongly endorses the use of NEWS in adult patients as the standardised system for assessment of the severity of acute illness and communication of this between healthcare practitioners. NEWS is recommended for use in hospitals including mental health hospitals and in ambulance services and in prison healthcare.</p>

<p>NEWS has not yet received NICE support for use in primary care, pending further evidence of its value in this setting. The National Quality Board and NICE have recommended further evaluation of the use of NEWS in primary care and recognises the value of a &quot;common language&quot; across the NHS in England to communicate the severity of a patient&#39;s acute illness.</p>

<p>A diagnosis of sepsis should be considered in patient with a NEWS2 score of 5 or more.&nbsp; Patients with a NEWS2 score of less than 5 might also have or develop sepsis.</p>

<p>Clinicians assessing patients with a NEWS2 score of less than 5 should still be aware of the risk of sepsis and should specifically look for: a single NEWS parameter of 3; non-blanching rash/mottled/ashen/cyanotic skin; responds only to voice or pain, or unresponsive; not passed urine in last 18 hours/urine output&lt;0.5 ml/kg/hr; lactate 2+ as any of these indicators suggest the possibility of underlying infection and sepsis.</p>
</div>
<br />
<!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Intermediate Care Skin section-->

<div aria-hidden="true" aria-labelledby="SkinLabel" class="portfolio-modal modal fade " id="ICSkin" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ICSkinLabel">Skin and Soft Tissue Infections</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="ICSkinTissue"><a href="#bites">Human and Animal Bites</a></h4>

<h4><a href="#cellulitis">Cellulitis</a></h4>

<h4><a href="#derma">Dermatophyte Infection of the Skin</a></h4>

<h4><a href="#diabeticFoot">Diabetic Foot Infection</a></h4>

<h4><a href="#legUlcers">Leg Ulcers / Pressure Sores</a></h4>

<h4><a href="#shingles">shingles</a></h4>

<h4><a href="#strepA">Strep Group A</a></h4>
<br />
<!--Bites-->
<div class="text-left border border-info rounded" id="bitesSection">
<h2 class="text-center" id="bites">Human and Animal Bites</h2>

<p><strong><u><span style="color:black">Note:</span></u></strong><strong><u><span style="color:#e74c3c"> see also section below under the heading animal and human bites to the hand including clenched fist injuries.</span></u></strong></p>

<p>Antibiotic prophylaxis is recommended for all wounds under 72 hours old even if there is no sign of infection.&nbsp; Consider if tetanus prophylaxis is needed. Assess the HIV, hepatitis B and C and syphillis risk and if necessary discuss with a Consultant in Communicable Disease Control.</p>

<p>If the skin is not broken just clean it, but if the skin is broken irrigate it with warm, running water. Send the patient to ED&nbsp;if severe.</p>

<p><strong>Check tetanus status</strong>&nbsp;and immunise if necessary.&nbsp; Prophylaxis is advised for puncture wounds, any bite involving the hand, face, foot, joint tendon or ligament, and in immunocompromised, diabetic, asplenic or elderley patients.</p>

<p>If treating an<strong>&nbsp;insect bite</strong>&nbsp;then treat as&nbsp;<u><strong>cellulitis</strong></u>. &nbsp;True cellulitis is a systemic infection and you would expect some systemic signs and symptoms, please ensure an infection is confirmed as all insect bites do not need to be treated with antibiotics.</p>
<!--Start accordian-->

<div id="accordionBites">
<div class="card">
<div class="card-header" id="bitesTreatment">
<h5 class="mb-0"><button aria-controls="collapseBitesTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseBitesTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="bitesTreatment" class="collapse" data-parent="#accordionBites" id="collapseBitesTreatment">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Co-amoxiclav 625 mg TDS</strong></span>&nbsp;- review every 72 hours and treatment duration should not exeed 5 days.&nbsp;</p>

<p><strong><u>Penicillin allergy</u></strong></p>

<p><span style="color:#8e44ad"><strong>Doxycycline 200mg po for the first dose then 100mg po bd</strong></span>&nbsp;- review every 72 hours and treatment duration should not exceed 5 days.&nbsp;&nbsp;</p>
</div>
</div>

<div class="card-header" id="pregnancyUTIHand">
<h5 class="mb-0"><button aria-controls="collapsePregnancyUTIHand" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsePregnancyUTIHand" data-toggle="collapse" type="button">Animal and Human Bites to the Hand</button></h5>
</div>

<div aria-labelledby="pregnancyUTIHand" class="collapse" data-parent="#accordionPregnancyUTI" id="collapsePregnancyUTIHand">
<div class="card-body text-left">
<p><span style="color:#333333">Animal and human bites to the hand including clenched fist injuries (&#39;fight-bite&#39;) are at <u>greater risk for development of complications</u> associated with infection particularly septic arthritis, osteomyelitis and tendon sheath infection.</span></p>

<p><span style="color:#333333">These patients would require <u>hospital admission</u> for intravenous antibiotic treatment as well as <u>orthopaedic review</u> with assessment of surgical intervention including joint washout and tissue debridement.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Cellulitis-->
<div class="text-left border border-info rounded" id="cellulitisSection">
<h2 class="text-center" id="cellulitis">Cellulitis</h2>

<p>True cellulitis is a systemic infection and you would expect some systemic signs and symptoms.</p>

<p>This treatment also applies if there is&nbsp;<strong><u>spreading cellulitis</u></strong>&nbsp;resulting from an insect bite (please ensure an infection is confirmed as all insect bites&nbsp;<u>do not</u>&nbsp;need to be treated with antibiotics).&nbsp;</p>

<p>If there is history of exposure to fresh water, i.e. rivers or streams (Aeromonas hydrophilia) at the site add&nbsp;<strong>ciprofloxacin</strong>&nbsp;(750 mg twice daily 7 days) and if there is history of exposure to salt water (Vibrio vulnificus) add&nbsp;<strong>doxycycline</strong>&nbsp;(200mg stat then 100mg daily 7 days total).</p>

<p>Doxycycline must NOT be prescribed for children under 12 years, or for pregnant or breast-feeding women.</p>

<p>Please refer to the full guidance distributed for the community IV cellulitis pathway</p>
<!--Start accordian-->

<div id="accordionCellulitis">
<div class="card">
<div class="card-header" id="cellulitisTreatment">
<h5 class="mb-0"><button aria-controls="collapseCellulitisTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseCellulitisTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="cellulitisTreatment" class="collapse" data-parent="#accordionCellulitis" id="collapseCellulitisTreatment">
<div class="card-body text-left">
<p><span style="color:#0000cc"><strong>Flucloxacillin 1g QDS</strong></span>&nbsp;and review every 72 hours</p>

<p><strong><u>Penicillin allergy</u></strong></p>

<p><span style="color:#990066"><strong>Clindamycin 450mg QDS&nbsp;</strong></span>and review every 72 hours</p>

<p><strong>DO NOT PRESCRIBE FOR LONGER THAN 72 HOURS AT A TIME</strong></p>
</div>
</div>

<div class="card-header" id="cellulitisFacial">
<h5 class="mb-0"><button aria-controls="collapseCellulitisFacial" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseCellulitisFacial" data-toggle="collapse" type="button">Facial Cellulitis</button></h5>
</div>

<div aria-labelledby="cellulitisFacial" class="collapse" data-parent="#accordionCellulitis" id="collapseCellulitisFacial">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Co-amoxiclav 625 mg TDS</strong></span>&nbsp;<u><strong>plus</strong></u> <strong><span style="color:#0000ff">clindamycin 450mg QDS</span></strong>&nbsp;<strong>for&nbsp;10 days (ensure review every 72 hours)</strong></p>

<p><u><strong>Penicillin allergy</strong></u></p>

<p>If rash -<strong><span style="color:#990066"> Cefalexin 1g TDS </span><u>plus</u><span style="color:#990066"> clindamycin 450mg QDS</span> for 10 days&nbsp;(ensure review every 72 hours)</strong></p>

<p>If anaphylaxis - <strong><span style="color:#2ecc71">Levofloxacin 500mg BD</span> plus <span style="color:#2ecc71">clindamycin&nbsp;450mg QDS</span> for 10 days</strong></p>

<p><strong>A total of 10 days of antibiotic treatment to cover both Group A Strep and Staph aureus would be required in order to prevent recurrence</strong></p>

<p><u>If the patient is febrile and acutely ill, refer to hospital for IV treatment.</u></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Dermatophyte-->
<div class="text-left border border-info rounded" id="dermatoPhyteSection">
<h2 class="text-center" id="derma">Dermatophyte Infection of the Skin</h2>

<p>Take skin scrapings for culture. Topical azoles,<span style="color:#0000ff">&nbsp;<strong>clotrimazole 1 % or miconazole 2 %</strong></span>, are useful if you are not sure if there is Candida or dermatophyte infection.&nbsp; The azoles can take 4&ndash;6 weeks to work. Topical terbinafine 1% although more expensive can work with in a week. Consider oral treatment only if disease is extensive or severe (however, consider referral) or if topical treatment has failed. Discuss scalp infections with a specialist</p>
</div>
<br />
<!--Diabetic foot-->
<div class="text-left border border-info rounded" id="diabeticFootSection">
<h2 class="text-center" id="diabeticFoot">Diabetic Foot Infection</h2>

<p>The recommendations&nbsp;for treatment of DFI&nbsp;have been made following discussion with Abigail Hall (High Risk Foot Team Podiatrist) and Dr Haris Rathur (Consultant for Adult Medicine).</p>

<p>Refer to Diabetes Service</p>

<p>email:&nbsp;<a href="mailto:tga-tr.cids@nhs.net" target="_blank">tga-tr.cids@nhs.net</a>&nbsp;(Contact High Risk Foot Podiatry on <a href="tel:01613662335">0161 366 2335</a>)</p>

<p><span style="color:#e74c3c"><strong>All patients with Diabetic Foot Ulcers MUST be under the care of a Podiatrist</strong></span></p>
<!--Start accordian-->

<div id="accordionDiabeticFoot">
<div class="card">
<div class="card-header" id="diabeticFootMild">
<h5 class="mb-0"><button aria-controls="collapseDiabeticFootMild" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseDiabeticFootMild" data-toggle="collapse" type="button">Mild Infection</button></h5>
</div>

<div aria-labelledby="diabeticFootMild" class="collapse" data-parent="#accordionCellulitis" id="collapseDiabeticFootMild">
<div class="card-body text-left">
<p>Presence of at least 2 of the following:</p>

<p>local swelling, erythema, local tenderness or pain, local warmth, purulent discharge.</p>

<p>Local infection involving only skin and subcutaneous tissue.&nbsp; If erythema, must be &lt;2cm around ulcer</p>

<p><span style="color:#0000ff"><strong>Flucloxacillin 1g QDS for a maximum of 5 days </strong></span>(review every 72 hours)</p>

<p><u>Penicillin allergy</u></p>

<p><span style="color:#990066"><strong>Clarithromycin 500mg BD for a maximum of&nbsp;5 days </strong></span>(review every&nbsp;72 hours)</p>
</div>
</div>

<div class="card-header" id="diabeticFootMod">
<h5 class="mb-0"><button aria-controls="collapseDiabeticFootMod" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseDiabeticFootMod" data-toggle="collapse" type="button">Moderate Infection</button></h5>
</div>

<div aria-labelledby="diabeticFootMod" class="collapse" data-parent="#accordionCellulitis" id="collapseDiabeticFootMod">
<div class="card-body text-left">
<p>as above <strong>plus</strong> erythema &gt; 2cm but &lt;5cm, or involving structures deeper than skin and subcutaneous tissues.</p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav 625mg TDS for a maximum of 5 days</strong></span> (review every 72 hours)</p>
</div>
</div>

<div class="card-header" id="diabeticFootSev">
<h5 class="mb-0"><button aria-controls="collapseDiabeticFootSev" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseDiabeticFootSev" data-toggle="collapse" type="button">Severe Infection</button></h5>
</div>

<div aria-labelledby="diabeticFootMod" class="collapse" data-parent="#accordionCellulitis" id="collapseDiabeticFootSev">
<div class="card-body text-left">
<p>Spreading cellulitis (&gt; 5cm from the wound), ascending lymphangitis, deep tissue abscess formation with or without&nbsp;systemic inflammatory response syndrome</p>

<p><strong>arrange admittance into hospital for IV antibiotics</strong></p>

<p>Note: Systemic infection may sometimes manifest with sepsis syndrome including&nbsp;fever, vomiting, hypotension, deranged blood glucose levels and confusion.&nbsp; It is important to note that patients with ischaemia and neuropathy may not mount an appropriate inflammatory response, but nevertheless be extremely ill.</p>
</div>
</div>

<div class="card-header" id="diabeticFootRef">
<h5 class="mb-0"><button aria-controls="collapseDiabeticFootRef" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseDiabeticFootRef" data-toggle="collapse" type="button">References</button></h5>
</div>

<div aria-labelledby="diabeticFootRef" class="collapse" data-parent="#accordionCellulitis" id="collapseDiabeticFootRef">
<div class="card-body text-left">
<p>National Institute of Health and Care Excellence (NICE), (2015).&nbsp; <em>Diabetic foot problems: prevention and management, NICE guideline 19.</em>&nbsp; <a href="http://www.nice.org.uk/guidance/ng19/chapter/1-Recommendations#diabetic-foot-infection-2" target="_blank">http://www.nice.org.uk/guidance/ng19/chapter/1-Recommendations#diabetic-foot-infection-2</a></p>

<p>Lipsky, B.A., Berendt, A.R., Cornia, P.B., Pile, J.C., Peters, E.J.G., Armstrong, D.G.&hellip; Senneville, E. (2012) 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections.&nbsp; <em>CID 2012</em>, 54:132-164</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Leg Ulcers-->
<div class="text-left border border-info rounded" id="legUlcerSection">
<h2 class="text-center" id="legUlcers">Leg Ulcers / Pressure Sores</h2>

<p>Bacteria will always be present and therefore culture swabs of deeper tissues should be taken and not slough or necrotic tissue.&nbsp; Systemic antibiotics are only indicated if there is evidence of clinical infection (e.g. increasing pain, pyrexia, spreading cellulitis, tissue induration, enlarging ulcer).</p>

<p>In the absence of systemic features of infection, only topical treatment&nbsp;<strong><u>without</u></strong>&nbsp;the addition of systemic&nbsp;antibiotic is indicated for these patients</p>
<!--Start accordian-->

<div id="accordionLegUlcer">
<div class="card">
<div class="card-header" id="legUlcersTop">
<h5 class="mb-0"><button aria-controls="collapseLegUlcer" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseLegUlcer" data-toggle="collapse" type="button">Topical Treatment</button></h5>
</div>

<div aria-labelledby="legUlcers" class="collapse" data-parent="#accordionLegUlcer" id="collapseLegUlcer">
<div class="card-body text-left">
<p>In consultation with the community tissue viability team, either:</p>

<p><span style="color:#0000ff"><strong>Flamazine (silver sulphadiazine) cream</strong></span><strong> </strong>for <u>non</u>-exudative wounds</p>

<p>Apply at every dressing change</p>

<p>OR</p>

<p><span style="color:#2ecc71"><strong>Medicinal honey (Mesitran soft ointment dressing)</strong></span> for wounds with an exudate</p>

<p>Apply at every dressing change</p>
</div>
</div>

<div class="card-header" id="legUlcerSys">
<h5 class="mb-0"><button aria-controls="collapseLegUlcerSys" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseLegUlcerSys" data-toggle="collapse" type="button">Systemic Treatment</button></h5>
</div>

<div aria-labelledby="legUlcerSys" class="collapse" data-parent="#accordionLegUlcer" id="collapseLegUlcerSys">
<div class="card-body text-left">
<p>If these ulcers are complicated&nbsp;by systemic features of infection (as above), give:</p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav 625mg TDS</strong></span> for 72 hours&nbsp;and <strong><u>then review</u></strong> - if the systemic symptoms of infection have resolved, stop antibiotics and continue topical treatment.&nbsp; If not fully reolved then prescription can continue but review, at least every 72, hours is a must.&nbsp; Treatment should not generall continue for longer than 6 days.&nbsp; If unresolving after 6 days please contact the Consultant Microbiologist as below.</p>

<p>For penicillin allergy options please contact Consultant Microbiology on 0161 922 4086 or 6500 (or mobile via switchboard 0161 922 6000)</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Shingles-->
<div class="text-left border border-info rounded" id="shinglesSection">
<h2 class="text-center" id="shingles">Shingles (Herpes Zoster)</h2>

<p>Antivirals should be started within 72 hours of onset of the rash.</p>

<p>They should be used in adults over 50 years, in the immunocompromised, in anyone with ophthalmic involvement, in anyone in severe, acute pain or with an extensive rash; they can also be used in people who are likely to come in close contact with &ldquo;at risk&rdquo; groups (e.g. immunocompromised, pregnancy).</p>

<p>Specialist advice should be sought for immunocompromised patients.</p>
<!--Start accordian-->

<div id="accordionShingles">
<div class="card">
<div class="card-header" id="shinglesTreatment">
<h5 class="mb-0"><button aria-controls="collapseShinglesTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseShinglesTreatment" data-toggle="collapse" type="button">Treatment</button></h5>
</div>

<div aria-labelledby="shinglesTreatment" class="collapse" data-parent="#accordionShingles" id="collapseShinglesTreatment">
<div class="card-body text-left">

                                        <p><span style="color:#0000ff">&nbsp;<strong>Aciclovir 800 mg orally five times a day</strong></span> for 7 days</p>

<p><u><strong>Infection Control Measures</strong></u></p>

<p><strong>Only a person who has <u>not</u>&nbsp;had chickenpox or varicella vaccine is susceptible to chickenpox infection from a person active shingles; however spead is via direct skin contact with the lesions and <u>not</u>&nbsp;via the respiratory route as is the case with chickenpox.&nbsp; Infection prevention measures are therefore primarily aimed at skin contact precautions.</strong></p>

<p><strong>The person with shingles is infectious until lesions have crusted over; howver if the rash is covered then the risk of transmission is very low.</strong></p>

                                    
</div>
</div>
</div>
</div>
</div>
<br />
<!--Strep A-->
<div class="text-left border border-info rounded" id="strepSection">
<h2 class="text-center" id="strepA">Strep A Group Infection</h2>

<p>Strep Group A infections can be clinically classified into 2 main groups:</p>

<ul>
    <li>Non-invasive and treatable with oral antibiotics in the GP/outpatient setting and includes:
    <ul>
        <li>Pharyngotonsillitis</li>
        <li>Cellulitis</li>
        <li>Skin and wound infections (such as impetigo and chronic leg ulcers)</li>
        <li>Scarlet fever (toxin mediated infection).</li>
    </ul>
    </li>
    <li>Invasive and potentially life-threatening including:
    <ul>
        <li>Necrotizing fasciitis</li>
        <li>Bacteraemia (including bacteraemic pneumonia)</li>
        <li>Facial erysipelas</li>
        <li>Streptococcal toxic shock syndrome.</li>
    </ul>
    </li>
</ul>

<p>Differentiation between non-invasive and invasive Strep Group A infection is important for appropriate clinical management. Because of the potential for non-invasive Strep Group A infections to be become invasive all clinical laboratory&nbsp;<u>culture proven</u>&nbsp;Strep Group A infections must be treated with antibiotics as follows:</p>

<p><strong>Amoxicillin 1g po tds&nbsp;</strong>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a data-dismiss="modal" data-target="#ICURTI" data-toggle="modal" href="#ICURTI"> Pharyngitis / Tonsillitis</a> section in intermediate care guidelines.</p>

<p>&nbsp;</p>

<p><u><strong>Penicillin allergy</strong></u></p>

<p><strong>Clarithromycin 500mg BD</strong>&nbsp;for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a data-dismiss="modal" data-target="#ICURTI" data-toggle="modal" href="#ICURTI"> Pharyngitis / Tonsillitis</a> section in intermediate care guidelines.</p>

<p>&nbsp;</p>
</div>
<br />
<!--floating icon--><a class="float" href="#ICSkinTissue"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!--Hospital Guidelines--> <!-- Hospital Care A&E Adults section-->

<div aria-hidden="true" aria-labelledby="AEAdultsLabel" class="portfolio-modal modal fade " id="HCAdults" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCSkinLabel">A&amp;E - Adults</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="HCAdultsSection"><a href="#HCdentalAbscess">Dental Abscess</a></h4>

<h4><a href="#HCentSection">Ear, Nose and Throat Infections</a></h4>

<h4><a href="#HCGTI">Genital Tract</a></h4>

<h4><a href="#HCLRTI">Lower Respiratory Tract Infections</a></h4>

<h4><a href="#HCSkin">Skin and Soft Tissue</a></h4>

<h4><a href="#HCUTI">Urinary Tract Infection</a></h4>
<br />
<!--Dental-->
<div class="text-left border border-info rounded" id="HCdentalAbscess">
<h2 class="text-center" id="dentalAbscess">Dental Abscess</h2>

<p><strong><span style="color:#0000ff">Amoxicillin 1g po tds for 3 days.</span></strong></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Clindamycin 450mg po qds&nbsp;for 3 days.</strong></span></p>
</div>
<br />
<!--ENT-->
<div class="text-left border border-info rounded" id="HCentSection">
<h2 class="text-center" id="HCentLabel">Ear, Nose and Throat Infections</h2>
<!--Start accordian-->

<div id="accordionEnt">
<div class="card">
<div class="card-header" id="HCOtitMedia">
<h5 class="mb-0"><button aria-controls="collapseHCENT" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCENT" data-toggle="collapse" type="button">Otitis Media</button></h5>
</div>

<div aria-labelledby="HCEntLabel" class="collapse" data-parent="#accordionEnt" id="collapseHCENT">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Amoxicillin 1g po tds for 3 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg po bd&nbsp;for 3 days</strong><strong>.</strong></span></p>

<p>Most infections are&nbsp;caused by viruses; most uncomplicated cases resolve without antibiotic treatment.</p>
</div>
</div>

<div class="card-header" id="HCSinusitis">
<h5 class="mb-0"><button aria-controls="collapseHCSinusitis" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCSinusitis" data-toggle="collapse" type="button">Sinusitis</button></h5>
</div>

<div aria-labelledby="HCSinusitis" class="collapse" data-parent="#accordionEnt" id="collapseHCSinusitis">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Amoxicillin 1g po tds for 3 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Doxycycline 200mg po </strong><strong>stat on day 1,&nbsp;then 100mg po od days 2 and 3.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCSoreThroat">
<h5 class="mb-0"><button aria-controls="collapseHCSoreThroat" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCSoreThroat" data-toggle="collapse" type="button">Sore Throat</button></h5>
</div>

<div aria-labelledby="HCSoreThroat" class="collapse" data-parent="#accordionEnt" id="collapseHCSoreThroat">
<div class="card-body text-left">
<p><strong>(not due to group A Streptococci)</strong></p>

<p><strong><span style="color:#ff0000">No Antibiotics required</span></strong></p>

<p><strong>Avoid antibiotics&nbsp;</strong>as 90% resolve in 7 days&nbsp;without, and pain only reduced by 16 hours.</p>

<p>Use<strong>&nbsp;<a href="https://ctu1.phc.ox.ac.uk/feverpain/index.php" target="_blank">FeverPAIN</a>&nbsp;Score:</strong></p>

<p>Fever in last 24h, purulence, attend rapidly under 3d, severely inflamed tonsils, no cough or coryza</p>

<p><strong>Score 0-1</strong>: 13-18% streptococci, use NO antibiotic strategy;</p>

<p><strong>2-3:&nbsp;</strong>34-40% streptococci, use 3 day back-up antibiotic;</p>

<p><strong>&gt;4:</strong>&nbsp;62-65% streptococci, use immediate antibiotic if severe, &nbsp;or 48hr short back-up prescription</p>

<p>A positive throat swab culture growing Streptococcus Group A, together with clinical features of acute pharyngotonsillitis almost certainly indicates infection.&nbsp;</p>

<p>If you have taken a throat swab before prescribing antibiotics and it is reported negative for Streptococcus&nbsp;Group A&nbsp;do not prescribe antibiotics, and if antibiotics have already been commenced, discontinue them.</p>

<p>Streptococcus A throat swab POC testing can be a&nbsp;rapid way to determine bacterial vs viral sore throat and consideration should be given to this method of testing especially in the urgent care or walk-in setting.</p>
<!--Inner accordion-->

<div id="accordionHCStrepA">
<div class="card">
<div class="card-header" id="HCStrepA">
<h5 class="mb-0"><button aria-controls="collapseHCStrepA" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCStrepA" data-toggle="collapse" type="button">Strep Group A Pharyngo-tonsillitis</button></h5>
</div>

<div aria-labelledby="HCStrepA" class="collapse" data-parent="#accordionHCStrepA" id="collapseHCStrepA">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Penicillin V 1g po qds for 5 days.&nbsp;</strong></span>Treatment duration will be longer in more complicated infections such as Scarlet fever (at least 10 days).</p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></p>

<p><span style="color:#800080"><strong>Cefalexin 1g po tds for 5&nbsp;days.&nbsp;</strong></span>Treatment duration will be longer in more complicated infections such as Scarlet fever (at least 10 days).</p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></p>

<p><span style="color:#b22222"><strong>Clarithromycin 500mg po bd for 5&nbsp;days.&nbsp;</strong></span>Treatment duration will be longer in more complicated infections such as Scarlet fever (at least 10 days).</p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Genital Tract-->
<div class="text-left border border-info rounded" id="HCGTI">
<h2 class="text-center" id="HCGTSection">Genital Tract Infections</h2>
<!--Inner accordian-->

<div id="accordionGenitalTract">
<div class="card">
<div class="card-header" id="HCPID">
<h5 class="mb-0"><button aria-controls="collapseHCPID" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPID" data-toggle="collapse" type="button">Pelvic Inflammatory Disease</button></h5>
</div>

<div aria-labelledby="HCPID" class="collapse" data-parent="#accordionGenitalTract" id="collapseHCPID">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Ceftriaxone 500mg IM stat </span>(administer in A&amp;E) - do not give if allergic to penicillin (anaphylaxis)</strong></p>

<p><strong><u>plus</u> </strong></p>

<p><span style="color:#0000ff"><strong>Doxycycline 100mg po bd for 14 days</strong></span></p>

<p><u><strong>plus</strong></u></p>

<p><span style="color:#0000ff"><strong>Metronidazole 400mg po bd for 14 days.</strong></span></p>

<p><span style="color:#ff0000"><strong>Avoid tetracyclines in pregnancy.</strong></span></p>

<p>Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</p>
</div>
</div>

<div class="card-header" id="HCInfBarthCyst">
<h5 class="mb-0"><button aria-controls="collapseHCInfBarthCyst" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCInfBarthCyst" data-toggle="collapse" type="button">Infected Bartholin&#39;s Cyst/Abscess</button></h5>
</div>

<div aria-labelledby="HCInfBarthCyst" class="collapse" data-parent="#accordionGenitalTract" id="collapseHCInfBarthCyst">
<div class="card-body text-left">
<p><u><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></u></p>

<p><strong><span style="color:#0000ff">Cefalexin 1g po tds </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> clindamycin 450mg po qds </span><span style="color:#000000">for 5 days</span></strong></p>

<p><span style="color:#000000"><strong>Note:</strong> cephalosporins can be given in penicillin allergy with a rash.</span></p>

<p><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis):</u></strong></span></p>

<p><span style="color:#c0392b"><strong>Co-trimoxazole 960mg&nbsp;po&nbsp;bd </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#c0392b"><strong>clindamycin 450mg po qds </strong></span><span style="color:#000000"><strong>for 5 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCEpido">
<h5 class="mb-0"><button aria-controls="collapseHCEpido" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCEpido" data-toggle="collapse" type="button">Epididymo-orchitis</button></h5>
</div>

<div aria-labelledby="HCEpido" class="collapse" data-parent="#accordionGenitalTract" id="collapseHCEpido">
<div class="card-body text-left">
<p><u><span style="color:black">Due to chlamydial infection</span></u><span style="color:black">:</span></p>

<p><strong><span style="color:blue">Ceftriaxone 500mg IM stat</span></strong><span style="color:black"> then </span><strong><span style="color:blue">Doxycycline 100mg po bd</span></strong><span style="color:black"> for <u>14 days.</u></span></p>

<p><span style="color:black">Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</span></p>

<p><span style="color:#000000"><u>Due to Gram negative enteric organisms (urinary pathogens):</u></span></p>

<p><strong><u><span style="color:black">1st line:</span></u></strong><strong><span style="color:blue"> Co-trimoxazole 960mg po bd </span></strong><span style="color:black">for 10 days.</span></p>

<p><strong><u><span style="color:black">2nd line:</span></u></strong> <strong><span style="color:#8e44ad">Ciprofloxacin 500mg po bd </span></strong><span style="color:black">for 10 days</span></p>

<p><strong><span style="color:#333333">or</span></strong></p>

<p><strong><span style="color:#8e44ad">ofloxacin 200mg po bd</span></strong><strong> </strong><span style="color:black">for <u>14 days.</u></span></p>

<p><strong><u><span style="color:black">3rd line:</span></u></strong><strong> </strong><strong><span style="color:#e74c3c">Doxycycline 100mg BD</span></strong><span style="color:#333333"> for 10 days.</span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--LRTI-->
<div class="text-left border border-info rounded" id="HCLRTI">
<h2 class="text-center" id="HCLRT">Lower Respiratory Tract Infections</h2>
<!--Inner accordian-->

<div id="accordionHCLRTI">
<div class="card">
<div class="card-header" id="HCLoRTI">
<h5 class="mb-0"><button aria-controls="collapseHCABr" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCABr" data-toggle="collapse" type="button">Acute Bronchitis</button></h5>
</div>

<div aria-labelledby="HCABr" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCABr">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Amoxicillin 1g po tds for 3 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Doxycycline 200mg po </strong><strong>stat on day 1,&nbsp;then 100mg po od days 2 and 3.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCACOPD">
<h5 class="mb-0"><button aria-controls="collapseHCACOPD" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCACOPD" data-toggle="collapse" type="button">Acute Exacerbation of COPD</button></h5>
</div>

<div aria-labelledby="HCACOPD" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCACOPD">
<div class="card-body text-left">
<p><span style="color:#000000">Only if associated with systemic symptoms/constitutional involvement.</span></p>

<p><span style="color:#0000ff"><strong>Amoxicillin 1g po tds for 3 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Doxycycline 200mg po </strong><strong>stat on day 1,&nbsp;then 100mg po od days 2 and 3.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCCAP">
<h5 class="mb-0"><button aria-controls="collapseHCCAP" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCCAP" data-toggle="collapse" type="button">Community-acquired Pneumonia</button></h5>
</div>

<div aria-labelledby="HCCAP" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCCAP">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Amoxicillin 1g po tds for 3 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg po bd for 3 days.</strong></span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Skin & soft tissue-->
<div class="text-left border border-info rounded" id="HCSkin">
<h2 class="text-center" id="HCSkinLabel">Skin &amp; Soft Tissue</h2>
<!--Inner accordian-->

<div id="accordionHCSkin">
<div class="card">
<div class="card-header" id="HCCellulitisHeader">
<h5 class="mb-0"><button aria-controls="collapseHCCellulitis" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCCellulitis" data-toggle="collapse" type="button">Cellulitis</button></h5>
</div>

<div aria-labelledby="HCCellulitis" class="collapse" data-parent="#accordionHCSkin" id="collapseHCCellulitis">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Flucloxacillin 1g po qds for 3 days.</strong></span></p>

<p><u><span style="color:#000000"><strong>Penicillin allergy</strong></span></u></p>

<p><span style="color:#800080"><strong>Clarithromycin 500mg po bd for 3 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCFacial">
<h5 class="mb-0"><button aria-controls="collapseHCFacial" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCFacial" data-toggle="collapse" type="button">Facial Cellulitis / Orbital Cellulitis</button></h5>
</div>

<div aria-labelledby="HCFacial" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCFacial">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Co-amoxiclav 625mg po tds for&nbsp;10 days.</span></strong></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><strong><span style="color:#800080">Clindamycin 450mg po qds for&nbsp;10 days.</span></strong></p>

<p><strong>&nbsp;</strong><span style="color:#000000">Duration must be 10 days in order to include adequate duration of treatment of Strep&nbsp;group A</span></p>
</div>
</div>

<div class="card-header" id="HCBites">
<h5 class="mb-0"><button aria-controls="collapseHCBites" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCBites" data-toggle="collapse" type="button">Animal / Human Bites</button></h5>
</div>

<div aria-labelledby="HCBites" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCBites">
<div class="card-body text-left">
<p><strong><u><span style="color:black">Note:</span></u></strong><strong><u><span style="color:#e74c3c"> see also section below under the heading animal and human bites to the hand including clenched fist injuries.</span></u></strong></p>

<p><span style="color:#000000"><strong><u>Tetanus Prophylaxis</u></strong></span></p>

<p><span style="color:#000000">See tetanus prophylaxis in the<strong> &#39;Medical Prophylaxis Guideline&#39; </strong>section.</span></p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav 625mg po tds for 5 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><strong><span style="color:#800080">Doxycycline 200mg po for the first dose then 100mg po bd f</span><span style="color:#800080">or 5 days.</span></strong></p>
</div>
</div>

<div class="card-header" id="HCHandBite">
<h5 class="mb-0"><button aria-controls="collapseHCHandBite" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCHandBite" data-toggle="collapse" type="button">Animal / Human Bites to the Hand</button></h5>
</div>

<div aria-labelledby="HCHandBite" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCHandBite">
<div class="card-body text-left">
<p><span style="color:#333333">Animal and human bites to the hand including clenched fist injuries (&#39;fight-bite&#39;) are at <u>greater risk for development of complications</u> associated with infection particularly septic arthritis, osteomyelitis and tendon sheath infection.</span></p>

<p><span style="color:#333333">These patients would require <u>hospital admission</u> for intravenous antibiotic treatment as well as <u>orthopaedic review</u> with assessment of surgical intervention including joint washout and tissue debridement.</span></p>

<p>See <a data-dismiss="modal" data-target="#HCAdSkin" data-toggle="modal" href="#HCAdSkin"> Animal and Human bites </a>section under bite wounds for treatment recommendations.</p>

<p><span style="color:#000000"><strong><u>Tetanus Prophylaxis</u></strong></span></p>

<p>See <a data-dismiss="modal" data-target="#HCMedProph" data-toggle="modal" href="#HCMedProph"> tetanus </a> In the medical prophylaxis section.</p>
</div>
</div>

<div class="card-header" id="HCLaceration">
<h5 class="mb-0"><button aria-controls="collapseHCLaceration" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCLaceration" data-toggle="collapse" type="button">Laceration</button></h5>
</div>

<div aria-labelledby="HCLaceration" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCLaceration">
<div class="card-body text-left">
<p><u><strong>Clean/non-contaminated laceration</strong></u></p>

<p>A laceration&nbsp;caused by a clean object e.g. a knife, does <strong><u>not</u> </strong>require antibiotics.&nbsp; The wound should be cleaned and protected from becoming infected.</p>

<p><u><strong>Infected laceration</strong></u></p>

<p>If a previously clean laceration becomes infected, the most likely organism is Staph aureus and therefore this should be treated as cellulitis. &nbsp;Please refer to section on cellulilitis above.</p>

<p><u><strong>Contaminated/infected laceration</strong></u></p>

<p>If a laceration is contaminated it should be treated as follows:</p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav 625mg po tds for 5 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></p>

<p><span style="color:#800080"><strong>Cefalexin 1g po tds for 5 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></p>

<p><strong><span style="color:#e74c3c">Co-trimoxazole 960mg po bd</span><span style="color:#800080">&nbsp;</span><span style="color:#000000"><u>plus</u></span><span style="color:#800080">&nbsp;</span><span style="color:#e74c3c">clindamycin 450mg po qds for 5 days.</span></strong></p>
</div>
</div>

<div class="card-header" id="HCScarletFever">
<h5 class="mb-0"><button aria-controls="collapseHCScarletFever" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCScarletFever" data-toggle="collapse" type="button">Scarlet Fever</button></h5>
</div>

<div aria-labelledby="HCScarletFever" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCScarletFever">
<div class="card-body text-left">
<p>See <a href="#HCentSection">sore throat</a> in Ear, Nose and Throat section</p>
</div>
</div>

<div class="card-header" id="HCStrepAInf">
<h5 class="mb-0"><button aria-controls="collapseHCStrepAInf" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCStrepAInf" data-toggle="collapse" type="button">Strep Group A Infection</button></h5>
</div>

<div aria-labelledby="HCStrepAInf" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCStrepAInf">
<div class="card-body text-left">
<p>Strep Group A infections can be clinically classified into 2 main groups:</p>

<ul>
    <li>Non-invasive and treatable with oral antibiotics in the GP/outpatient setting and includes:
    <ul>
        <li>Pharyngotonsillitis</li>
        <li>Cellulitis</li>
        <li>Skin and wound infections (such as impetigo and chronic leg ulcers)</li>
        <li>Scarlet fever (toxin mediated infection).</li>
    </ul>
    </li>
    <li>Invasive and potentially life-threatening including:
    <ul>
        <li>Necrotizing fasciitis</li>
        <li>Bacteraemia (including bacteraemic pneumonia)</li>
        <li>Facial erysipelas</li>
        <li>Streptococcal toxic shock syndrome.</li>
    </ul>
    </li>
</ul>

<p>Differentiation between non-invasive and invasive Strep Group A infection is important for appropriate clinical management. Because of the potential for non-invasive Strep Group A infections to be become invasive all clinical laboratory&nbsp;<u>culture proven</u>&nbsp;Strep Group A infections must be treated with antibiotics as follows:</p>

<p><strong><span style="color:#0033ff">Amoxicillin 1g po tds</span>&nbsp;</strong>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a href="#HCentSection"> Strep Group A Pharyngo-tonsillitis </a>section, under ENT - Sore throat section in the A&amp;E guideline).</p>

<p><u><strong>Penicillin allergy (rash)</strong></u></p>

<p><span style="color:#800080"><strong>Cefalexin 1g po tds </strong></span>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a href="#HCentSection"> Strep Group A Pharyngo-tonsillitis </a>section, under ENT - Sore throat section in the A&amp;E guideline).</p>

<p><u><strong>Penicillin allergy (anaphylaxis)</strong></u></p>

<p><span style="color:#b22222"><strong>Clarithromycin 500mg po bd </strong></span>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a href="#HCentSection"> Strep Group A Pharyngo-tonsillitis </a>section, under ENT - Sore throat section in the A&amp;E guideline).</p>
</div>
</div>

<div class="card-header" id="HCInsectBites">
<h5 class="mb-0"><button aria-controls="collapseHCInsectBites" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCInsectBites" data-toggle="collapse" type="button">Insect Bites/Stings</button></h5>
</div>

<div aria-labelledby="HCInsectBites" class="collapse" data-parent="#accordionHCLRTI" id="collapseHCInsectBites">
<div class="card-body text-left">
<p>A rapid-onset skin reaction is likely to be an inflammatory or allergic reaction rather than an infection.</p>

<p>Most insect bites or stings will&nbsp;<u><strong>not</strong></u>&nbsp;require antibiotics.</p>

<p>Advise patients:</p>

<ol>
    <li>That skin redness and itching are common and may last for up to 10 days</li>
    <li>Avoid scratching as this may&nbsp;help reduce inflammation and the risk of infection</li>
    <li>They should seek medical help if symptoms worsen significantly at any time or they become systemically unwell</li>
</ol>

<p>Do not routinely offer antibiotics if there are no signs or symptoms of spreading cellulitis.</p>

<p>Patients may wish to consider oral antihistamines&nbsp;(in those over 1 year old) to help relieve itching.</p>

<p>If signs or symptoms of infection are present, treat as cellulitis.&nbsp; See cellulitis tab above.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Skin & soft tissue-->
<div class="text-left border border-info rounded" id="HCUTI">
<h2 class="text-center" id="HCUTILabel">Urinary Tract Infection</h2>
<!--Inner accordian-->

<div id="accordionHCUTI">
<div class="card">
<div class="card-header" id="HCUncomUTI">
<h5 class="mb-0"><button aria-controls="collapseHCUncomUTI" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCUncomUTI" data-toggle="collapse" type="button">Uncomplicated UTI</button></h5>
</div>

<div aria-labelledby="HCUncomUTI" class="collapse" data-parent="#accordionHCUTI" id="collapseHCUncomUTI">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Pivmecillinam 400mg po stat for the first dose followed by 200mg po&nbsp;tds thereafter&nbsp;for 3 days.</span></strong></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Nitrofurantoin M/R 100mg po bd for 3 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCAcutePye">
<h5 class="mb-0"><button aria-controls="collapseHCAcutePye" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAcutePye" data-toggle="collapse" type="button">Acute Pyelonephritis</button></h5>
</div>

<div aria-labelledby="HCAcutePye" class="collapse" data-parent="#accordionHCUTI" id="collapseHCAcutePye">
<div class="card-body text-left">
<p>Acute pyelonephritis is an infection of one or both kidneys usually resulting from ascending urinary tract infection.&nbsp;&nbsp;A urine specimen <strong><u>MUST</u></strong> be sent&nbsp;to the laboratory for microbiologic culture and sensitivity prior to commencing antibiotic treatment.</p>

<p><span style="color:#000000"><strong>1st line:</strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#0000ff"><strong>Cefalexin 1g po tds for 10 days - this is suitable in&nbsp;penicillin allergy (rash).</strong></span></p>

<p><span style="color:#000000"><strong>2nd&nbsp;line:</strong></span><span style="color:#800080"><strong> Ciprofloxacin 500mg po bd for 7 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCMenUTI">
<h5 class="mb-0"><button aria-controls="collapseHCMenUTI" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCMenUTI" data-toggle="collapse" type="button">UTI in Men</button></h5>
</div>

<div aria-labelledby="HCMenUTI" class="collapse" data-parent="#accordionHCUTI" id="collapseHCMenUTI">
<div class="card-body text-left">
<p><strong><span style="color:#000000">1st line:</span></strong><span style="color:#0000ff"><strong> Pivmecillinam 400mg po stat for the first dose followed by 200mg po&nbsp;tds thereafter&nbsp;for&nbsp;7 days.</strong></span></p>

<p><strong><span style="color:#000000">2nd line:</span> <span style="color:#800080">Nitrofurantoin M/R 100mg po bd for 7 days.</span></strong></p>
</div>
</div>

<div class="card-header" id="HCPregUTI">
<h5 class="mb-0"><button aria-controls="collapseHCPregUTI" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPregUTI" data-toggle="collapse" type="button">UTI in Pregnancy</button></h5>
</div>

<div aria-labelledby="HCPregUTI" class="collapse" data-parent="#accordionHCUTI" id="collapseHCPregUTI">
<div class="card-body text-left">
<p><span style="color:#000000"><u><strong>ORAL TREATMENT:</strong></u></span></p>

<p><span style="color:#000000"><strong>1st line:</strong>&nbsp;</span><span style="color:#800080"><strong>Nitrofurantoin 100mg MR BD - </strong></span><u><span style="color:#000000"><strong>AVOID AT TERM (from 37 weeks).</strong></span></u></p>

<p><span style="color:#000000"><strong>2nd line: </strong></span><span style="color:#c0392b"><strong>Pivmecillinam 400mg STAT then 200mg TDS</strong></span><strong> <span style="color:#000000">(this is a penicillin-containing antibiotic)</span></strong></p>

<p><span style="color:#000000"><strong>3rd line: </strong></span><span style="color:#0000ff"><strong>Cefalexin 500mg TDS</strong></span> <span style="color:#000000">- <strong>avoid if penicillin allergy anaphylaxis.</strong></span></p>

<p><span style="color:#000000"><strong>Treatment duration is a total of 7 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCAcBacPros">
<h5 class="mb-0"><button aria-controls="collapseHCAcBacPros" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAcBacPros" data-toggle="collapse" type="button">Acute Bacterial Prostatitis</button></h5>
</div>

<div aria-labelledby="HCAcBacPros" class="collapse" data-parent="#accordionHCUTI" id="collapseHCAcBacPros">
<div class="card-body text-left">
<p><strong><span style="color:black">1st line:</span></strong><strong> </strong><strong><span style="color:blue">Co-trimoxazole 960mg BD</span></strong> <span style="color:#333333">for 14 days.</span></p>

<p><strong><span style="color:black">2nd line:</span></strong><strong> </strong><strong><span style="color:#8e44ad">Ciprofloxacin 500mg BD</span></strong> <span style="color:#333333">for 14 days.</span></p>

<p><strong><span style="color:black">3rd line:</span></strong><strong> </strong><strong><span style="color:#e74c3c">Doxycycline 100mg BD</span></strong> <span style="color:#333333">for 14 days.</span></p>

<p><span style="color:#000000"><strong>And refer to Urologist.</strong></span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#HCAdultsSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Hospital Care A&E paeds section-->

<div aria-hidden="true" aria-labelledby="AEPaedsLabel" class="portfolio-modal modal fade " id="HCPaeds" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCSkinLabel">A&amp;E - Paediatrics</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4 id="HCPAdultsSection"><a href="#HCPdentalAbscess">Dental Abscess</a></h4>

<h4><a href="#HCPentSection">Ear, Nose and Throat Infections</a></h4>

<h4><a href="#HCPLRTI">Lower Respiratory Tract Infections</a></h4>

<h4><a href="#HCPSkin">Skin and Soft Tissue</a></h4>

<h4><a href="#HCPUTI">Urinary Tract Infection</a></h4>
<br />
<!--Dental-->
<div class="text-left border border-info rounded" id="HCPdentalAbscess">
<h2 class="text-center" id="HCPdentalAbscess">Dental Abscess</h2>

<p><strong><span style="color:#0000ff">Co-Amoxiclav po tds for 3 days.</span></strong></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Clindamycin po qds&nbsp;for 3 days.</strong></span></p>
</div>
<br />
<!--ENT-->
<div class="text-left border border-info rounded" id="HCPentSection">
<h2 class="text-center" id="HCPentLabel">Ear, Nose and Throat Infections</h2>
<!--Start accordian-->

<div id="accordionPEnt">
<div class="card">
<div class="card-header" id="HCPOtitMedia">
<h5 class="mb-0"><button aria-controls="collapseHCPENT" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPENT" data-toggle="collapse" type="button">Otitis Media</button></h5>
</div>

<div aria-labelledby="HCPEntLabel" class="collapse" data-parent="#accordionPEnt" id="collapseHCPENT">
<div class="card-body text-left">
<p>No antibiotics required unless clinically toxic</p>

<p><span style="color:#0000ff"><strong>Amoxicillin po tds for 3 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Clarithromycin po&nbsp;bd for 3 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCPSinusitis">
<h5 class="mb-0"><button aria-controls="collapseHCPSinusitis" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPSinusitis" data-toggle="collapse" type="button">Sinusitis</button></h5>
</div>

<div aria-labelledby="HCPSinusitis" class="collapse" data-parent="#accordionPEnt" id="collapseHCPSinusitis">
<div class="card-body text-left">
<p>No antibiotics required unless clinically toxic.</p>

<p><span style="color:#0000ff"><strong>Amoxicillin po tds for 3 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><span style="color:#800080"><strong>Clarithromycin po bd for 3 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCPSoreThroat">
<h5 class="mb-0"><button aria-controls="collapseHCPSoreThroat" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPSoreThroat" data-toggle="collapse" type="button">Sore Throat</button></h5>
</div>

<div aria-labelledby="HCPSoreThroat" class="collapse" data-parent="#accordionPEnt" id="collapseHCPSoreThroat">
<div class="card-body text-left">
<p>(not due to group A Streptococci)</p>

<p>No antibiotics required</p>
<!--Inner accordion-->

<div id="accordionHCPStrepA">
<div class="card">
<div class="card-header" id="HCPStrepA">
<h5 class="mb-0"><button aria-controls="collapseHCPStrepA" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPStrepA" data-toggle="collapse" type="button">Group A Strep Pharyngo-tonsillitis</button></h5>
</div>

<div aria-labelledby="HCPStrepA" class="collapse" data-parent="#accordionHCPStrepA" id="collapseHCPStrepA">
<div class="card-body text-left">
<p><strong>Group A Streptococcus positive</strong></p>

<p><span style="color:#0000ff"><strong>Penicillin V po&nbsp;qds for 5&nbsp;days. </strong></span><span style="color:#000000">Treatment duration will be longer in more complicated infections such as scarlet fever (at least 10 days).</span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></p>

<p><strong><span style="color:#800080">Cefalexin po tds for 5&nbsp;days.&nbsp;</span></strong>Treatment duration will be longer in more complicated infections such as scarlet fever (at least 10 days).</p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></p>

<p><span style="color:#b22222"><strong>Clarithromycin po&nbsp;bd for 5&nbsp;days. </strong></span>Treatment duration will be longer in more complicated infections such as scarlet fever (at least 10 days).</p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<br />
<!--LRTI-->
<div class="text-left border border-info rounded" id="HCPLRTI">
<h2 class="text-center" id="HCPLRT">Lower Respiratory Tract Infections</h2>
<!--Inner accordian-->

<div id="accordionHCPLRTI">
<div class="card">
<div class="card-header" id="HCPLoRTI">
<h5 class="mb-0"><button aria-controls="collapseHCPABr" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPABr" data-toggle="collapse" type="button">Community-acquired Pneumonia</button></h5>
</div>

<div aria-labelledby="HCPABr" class="collapse" data-parent="#accordionHCPLRTI" id="collapseHCPABr">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Amoxicillin po&nbsp;tds for 3 days.</strong></span></p>

<p><u><span style="color:#000000"><strong>Penicillin allergy</strong></span></u></p>

<p><span style="color:#800080"><strong>Clarithromycin po bd for 3 days.</strong></span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--Skin & soft tissue-->
<div class="text-left border border-info rounded" id="HCPSkin">
<h2 class="text-center" id="HCSkinLabel">Skin &amp; Soft Tissue</h2>
<!--Inner accordian-->

<div id="accordionHCPSkin">
<div class="card">
<div class="card-header" id="HCPCellulitisHeader">
<h5 class="mb-0"><button aria-controls="collapseHCPCellulitis" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPCellulitis" data-toggle="collapse" type="button">Cellulitis</button></h5>
</div>

<div aria-labelledby="HCPCellulitis" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPCellulitis">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Flucloxacillin po qds for 3 days.</strong></span></p>

<p><u><span style="color:#000000"><strong>Penicillin allergy</strong></span></u></p>

<p><span style="color:#800080"><strong>Clarithromycin po bd for 3 days.</strong></span></p>
</div>
</div>

<div class="card-header" id="HCPFacial">
<h5 class="mb-0"><button aria-controls="collapseHCPFacial" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPFacial" data-toggle="collapse" type="button">Facial Cellulitis / Orbital Cellulitis</button></h5>
</div>

<div aria-labelledby="HCPFacial" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPFacial">
<div class="card-body text-left">
<p><strong><span style="color:#0000ff">Co-amoxiclav po tds for&nbsp;10 days.</span></strong></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><strong><span style="color:#800080">Clindamycin po qds for&nbsp;10 days.</span></strong></p>

<p><strong>&nbsp;</strong><span style="color:#000000">Duration must be 10 days in order to include adequate duration of treatment of Strep&nbsp;group A</span></p>
</div>
</div>

<div class="card-header" id="HCPBites">
<h5 class="mb-0"><button aria-controls="collapseHCPBites" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPBites" data-toggle="collapse" type="button">Animal / Human Bites</button></h5>
</div>

<div aria-labelledby="HCPBites" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPBites">
<div class="card-body text-left">
<p><strong><u><span style="color:black">Note:</span></u></strong><strong><u><span style="color:#e74c3c"> see also section below under the heading animal and human bites to the hand including clenched fist injuries.</span></u></strong></p>

<p><span style="color:#000000"><strong><u>Tetanus Prophylaxis</u></strong></span></p>

<p><span style="color:#000000">See tetanus prophylaxis in the<strong> &#39;Medical Prophylaxis Guideline&#39; </strong>section.</span></p>

<p><span style="color:#0000ff"><strong>Co-amoxiclav po tds for 5 days.</strong></span></p>

<p><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></p>

<p><strong><span style="color:#800080">Co-trimoxazole po BD <u>plus</u> clindamycin po QDS </span><span style="color:#800080">for 5 days.</span></strong></p>
</div>
</div>

<div class="card-header" id="HCPHandBite">
<h5 class="mb-0"><button aria-controls="collapseHCPHandBite" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPHandBite" data-toggle="collapse" type="button">Animal / Human Bites to the Hand</button></h5>
</div>

<div aria-labelledby="HCPHandBite" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPHandBite">
<div class="card-body text-left">
<p><span style="color:#333333">Animal and human bites to the hand including clenched fist injuries (&#39;fight-bite&#39;) are at <u>greater risk for development of complications</u> associated with infection particularly septic arthritis, osteomyelitis and tendon sheath infection.</span></p>

<p><span style="color:#333333">These patients would require <u>hospital admission</u> for intravenous antibiotic treatment as well as <u>orthopaedic review</u> with assessment of surgical intervention including joint washout and tissue debridement.</span></p>

<p>See <a data-dismiss="modal" data-target="#HCPaedSkin" data-toggle="modal" href="#HCPaedSkin"> Animal and Human bites </a>section under Animal and human bite wounds for treatment recommendations.</p>

<p><span style="color:#000000"><strong><u>Tetanus Prophylaxis</u></strong></span></p>

<p>See <a data-dismiss="modal" data-target="#HCMedProph" data-toggle="modal" href="#HCMedProph"> tetanus </a> In the medical prophylaxis section.</p>
</div>
</div>

<div class="card-header" id="HCPLaceration">
<h5 class="mb-0"><button aria-controls="collapseHCPLaceration" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPLaceration" data-toggle="collapse" type="button">Laceration</button></h5>
</div>

<div aria-labelledby="HCPLaceration" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPLaceration">
<div class="card-body text-left">
<p><strong><u><span style="color:#333333">Clean/non-contaminated laceration</span></u></strong></p>

<p><span style="color:#333333">A laceration caused by a clean object e.g. a knife, does <strong><u>not</u></strong><strong> </strong>require antibiotics. The wound should be cleaned and protected from becoming infected.</span></p>

<p><strong><u><span style="color:#333333">Infected laceration</span></u></strong></p>

<p><span style="color:#333333">If a previously clean laceration becomes infected, the most likely organism is Staph aureus and therefore this should be treated as cellulitis. Please refer to section on cellulilitis above.</span></p>

<p><strong><u><span style="color:#333333">Contaminated/infected laceration</span></u></strong></p>

<p><span style="color:#333333">If a laceration is contaminated it should be treated as follows:</span></p>

<p><strong><span style="color:blue">Co-amoxiclav po tds for 5 days.</span></strong></p>

<p><strong><u><span style="color:black">Penicillin allergy (rash):</span></u></strong></p>

<p><strong><span style="color:purple">Cefalexin po tds for 5 days.</span></strong></p>

<p><strong><u><span style="color:black">Penicillin allergy (anaphylaxis):</span></u></strong></p>

<p><strong><span style="color:#e74c3c">Co-trimoxazole&nbsp;po bd</span></strong><strong> </strong><strong><u><span style="color:black">plus</span></u></strong><strong> </strong><strong><span style="color:#e74c3c">clindamycin&nbsp;po qds for 5 days.</span></strong></p>
</div>
</div>
<!--Scarlet fever-->

<div class="card-header" id="HCPScarletFever">
<h5 class="mb-0"><button aria-controls="collapseHCPScarletFever" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPScarletFever" data-toggle="collapse" type="button">Scarlet Fever</button></h5>
</div>

<div aria-labelledby="HCPScarletFever" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPScarletFever">
<div class="card-body text-left">
<p>See <a href="#HCPentSection">tonsillitis</a> in Ear, Nose and Throat section</p>
</div>
</div>
<!--Strep Group A-->

<div class="card-header" id="HCPStrepA">
<h5 class="mb-0"><button aria-controls="collapseHCPStrepA" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPStrepA" data-toggle="collapse" type="button">Strep Group A Infection</button></h5>
</div>

<div aria-labelledby="HCPStrepA" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPStrepA">
<div class="card-body text-left">
<p>Strep Group A infections can be clinically classified into 2 main groups:</p>

<ul>
    <li>Non-invasive and treatable with oral antibiotics in the GP/outpatient setting and includes:
    <ul>
        <li>Pharyngotonsillitis</li>
        <li>Cellulitis</li>
        <li>Skin and wound infections (such as impetigo and chronic leg ulcers)</li>
        <li>Scarlet fever (toxin mediated infection).</li>
    </ul>
    </li>
    <li>Invasive and potentially life-threatening including:
    <ul>
        <li>Necrotizing fasciitis</li>
        <li>Bacteraemia (including bacteraemic pneumonia)</li>
        <li>Facial erysipelas</li>
        <li>Streptococcal toxic shock syndrome.</li>
    </ul>
    </li>
</ul>

<p>Differentiation between non-invasive and invasive Strep Group A infection is important for appropriate clinical management. Because of the potential for non-invasive Strep Group A infections to be become invasive all clinical laboratory&nbsp;<u>culture proven</u>&nbsp;Strep Group A infections must be treated with antibiotics as follows:</p>

<p><strong><span style="color:#0033ff">Amoxicillin po tds</span>&nbsp;</strong>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a href="#HCPentSection"> Strep Group A Pharyngo-tonsillitis </a>section, under ENT - Sore throat section in the A&amp;E guideline).</p>

<p><u><strong>Penicillin allergy (rash)</strong></u></p>

<p><span style="color:#800080"><strong>Cefalexin po tds </strong></span>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a href="#HCPentSection"> Strep Group A Pharyngo-tonsillitis </a>section, under ENT - Sore throat section in the A&amp;E guideline).</p>

<p><u><strong>Penicillin allergy (anaphylaxis)</strong></u></p>

<p><span style="color:#b22222"><strong>Clarithromycin po bd </strong></span>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see <a href="#HCPentSection"> Strep Group A Pharyngo-tonsillitis </a>section, under ENT - Sore throat section in the A&amp;E guideline).</p>
</div>
</div>

<div class="card-header" id="HCPInsectBites">
<h5 class="mb-0"><button aria-controls="collapseHCPInsectBites" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPInsectBites" data-toggle="collapse" type="button">Insect Bites/Stings</button></h5>
</div>

<div aria-labelledby="HCPInsectBites" class="collapse" data-parent="#accordionHCPSkin" id="collapseHCPInsectBites">
<div class="card-body text-left">
<p>A rapid-onset skin reaction is likely to be an inflammatory or allergic reaction rather than an infection.</p>

<p>Most insect bites or stings will&nbsp;<u><strong>not</strong></u>&nbsp;require antibiotics.</p>

<p>Advise patients:</p>

<ol>
    <li>That skin redness and itching are common and may last for up to 10 days</li>
    <li>Avoid scratching as this may&nbsp;help reduce inflammation and the risk of infection</li>
    <li>They should seek medical help if symptoms worsen significantly at any time or they become systemically unwell</li>
</ol>

<p>Do not routinely offer antibiotics if there are no signs or symptoms of spreading cellulitis.</p>

<p>Patients may wish to consider oral antihistamines&nbsp;(in those over 1 year old) to help relieve itching.</p>

<p>If signs or symptoms of infection are present, treat as cellulitis.&nbsp; See cellulitis tab above.</p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--UTI-->
<div class="text-left border border-info rounded" id="HCPUTI">
<h2 class="text-center" id="HCPUTILabel">Urinary Tract Infection</h2>
<!--Inner accordian-->

<div id="accordionHCPUTI">
<div class="card">
<div class="card-header" id="HCPUncomUTI">
<h5 class="mb-0"><button aria-controls="collapseHCPUncomUTI" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPUncomUTI" data-toggle="collapse" type="button">Uncomplicated UTI</button></h5>
</div>

<div aria-labelledby="HCPUncomUTI" class="collapse" data-parent="#accordionHCPUTI" id="collapseHCPUncomUTI">
<div class="card-body text-left">
<p><span style="color:#0000ff"><strong>Cefalexin po bd or tds (see cBNF for dosing) for 3 days - This is suitable for patients with penicillin allergy (rash).</strong></span></p>

<p><strong>If penicillin allergic (anaphylaxis):</strong></p>

<p><span style="color:#800080"><strong>Nitrofurantoin po qds for&nbsp;3 days.</strong></span></p>
</div>
</div>
</div>
</div>
</div>
<br />
<!--floating icon--><a class="float" href="#HCPaedsSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
</div>
</div>
</div>
</div>
</div>
</div>
<!-- Adult inpatient hosp guidelines Blood and sepsissection-->

<div aria-hidden="true" aria-labelledby="HCAdBloodLabel" class="portfolio-modal modal fade " id="HCAdBlood" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><!-- Portfolio Modal - Title-->
<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdBloodLabel">Bloodstream Infections and Sepsis Syndrome</h2>
<!-- Icon Divider-->

<div class="divider-custom">
<div class="divider-custom-line">&nbsp;</div>

<div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>

<div class="divider-custom-line">&nbsp;</div>
</div>

<h4><a href="#HCAdIntraCanInf" id="HCAdBloodSection">Intravascular Cannula Infections</a></h4>

<h4><a href="#HCAdMulDrRes">Multi-Drug Resistant Organisms</a></h4>

<h4><a href="#HCAdSepsisSyn">Sepsis Syndrome</a></h4>
<br />
<!--Intravascular Cannula Infections-->
<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdIntraCanInf">Intravascular Cannula Infections</h2>

<p><u><span style="color:#000000"><strong>For peripherally-inserted cannulae:</strong></span></u></p>

<p><span style="color:#0000ff"><strong>Flucloxacillin 2g IV 6 hourly.</strong></span></p>

<p><u><strong>Penicillin allergy:</strong></u></p>

<p><span style="color:#b22222"><strong>Vancomycin 1g IV stat&nbsp;followed by 1g IV 12 hourly.</strong></span></p>

<p><span style="color:#000000"><strong>Note: this agent should be infused slowly to avoid severe adverse effects.</strong></span></p>

<p><strong>The BNF advises:</strong> Reconstitute each 500&nbsp;mg with 10&nbsp;mL water for injections and dilute with infusion fluid to a concentration of up to 5&nbsp;mg/mL (10&nbsp;mg/mL in fluid restriction but increased risk of infusion-<span style="color:#000000">related effects); give over at least 60 minutes (rate not to exceed 10&nbsp;mg/minute for doses over 500&nbsp;mg).</span></p>

<p><span style="color:#000000"><strong><u>Before</u></strong> commencing antibiotic treatment&nbsp;blood for microbiologic culture should be taken&nbsp;using careful aseptic technique.&nbsp;Blood sampling should be from&nbsp;<u><strong>both</strong></u>&nbsp;the<strong> intravascular cannula </strong>as well as from a <strong>peripheral vein. See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a>for guidance on the dose and the monitoring of drug plasma levels of vancomycin.</strong></span></p>

<p><strong><u><span style="color:#000000"><strong>For centrally placed intravascular catheters (internal jugular, subclavian, Hickman, Tessio central catheters):</strong></span></u></strong></p>

<p><strong><span style="color:#b22222"><strong>Vancomycin 1g IV stat followed by 1g IV 12 hourly.</strong></span></strong></p>

<p><strong><span style="color:#000000"><strong>Note: this agent should be infused slowly to avoid severe adverse effects.</strong></span></strong></p>

<p><strong><strong>The BNF advises:</strong> Reconstitute each 500 mg with 10 mL water for injections and dilute with infusion fluid to a concentration of up to 5 mg/mL (10 mg/mL in fluid restriction but increased risk of infusion-<span style="color:#000000">related effects); give over at least 60 minutes (rate not to exceed 10 mg/minute for doses over 500 mg).</span></strong></p>

<p><strong><span style="color:#000000"><strong><u>Before</u></strong> commencing antibiotic treatment blood for microbiologic culture should be taken using careful aseptic technique. Blood sampling should be from <u><strong>both</strong></u> the<strong> intravascular cannula </strong>as well as from a <strong>peripheral vein.</strong></span></strong></p>

<p><strong><span style="color:#000000"><strong>See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a>for guidance on the dose and the monitoring of drug plasma levels of vancomycin.</strong></span></strong></p>
</div>
<br />
<strong><strong><!--Multi-drug resistant organisms--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdMulDrRes"><strong><strong>Multi-Drug Resistant Organisms</strong></strong></h2>

<p><strong><strong><u><strong>Multi drug resistant Gram negative organisms including Carbapenemase-producing enterobacteriaceae (CPE)</strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Tigecycline 100mg IV stat dose, followed by 50mg IV 12 hourly</span></strong></strong></strong></p>

<p><strong><strong><u><strong>plus</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Gentamicin 5mg/kg IV single, stat dose</strong></span> (4mg/kg in patients <u>&gt;</u> 70 yrs).</strong></strong></p>

<p><strong><strong>If resistant to gentamicin give <span style="color:#0000ff"><strong>Amikacin 15mg/kg IV single, stat dose.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><strong>If the patient is obese then See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose&nbsp;calculation.</strong></strong></span></strong></strong></p>
</div>
<br />
<strong><strong><strong><strong><!--Sepsis syndrome--> </strong></strong></strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdSepsisSyn"><strong><strong><strong><strong>Sepsis Syndrome</strong></strong></strong></strong></h2>
<strong><strong><strong><strong><!--Inner accordian--> </strong></strong></strong></strong>

<div id="accordionHCAdSepsis">
<div class="card">
<div class="card-header" id="HCAdComAcq">
<h5 class="mb-0"><strong><strong><strong><strong><button aria-controls="collapseHCAdComAcq" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdComAcq" data-toggle="collapse" type="button">Community Acquired Sepsis Syndrome</button></strong></strong></strong></strong></h5>
</div>

<div aria-labelledby="HCAdComAcq" class="collapse" data-parent="#accordionHCAdSepsis" id="collapseHCAdComAcq">
<div class="card-body text-left">
<p><strong><strong><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u></strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#800080">Cefuroxime 1.5g IV stat&nbsp;followed by 1.5g IV&nbsp;8 hourly - this is appropriate in penicillin allergy rash</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">PLUS&nbsp;</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#800080"><strong>Gentamicin</strong></span><strong>&nbsp;<span style="color:#800080">5mg/kg IV as a single stat dose once only&nbsp;(4mg/kg if age <u>&gt;</u> 70 years). Max dose 400mg</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u></strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#b22222">Ciprofloxacin 400mg IV stat followed by 400mg IV 12 hourly</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>PLUS</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#b22222">Clindamycin 1.2g IV stat followed by 900mg IV 8 hourly</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>PLUS</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#b22222"><strong>Gentamicin&nbsp;5mg/kg IV as a single stat dose once only&nbsp;(4mg/kg if age <u>&gt;</u> 70 years).&nbsp; Max dose 400mg.</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on gentamicin&nbsp;dose calculation.</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong>Antibiotic step down to oral treatment should be based on the antibiotic sensitivity results of the microbiologic culture. Contact Consultant Microbiologist if advice is required.</strong></strong></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdHospAcq">
<h5 class="mb-0"><strong><strong><strong><strong><button aria-controls="collapseHCAdHospAcq" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdHospAcq" data-toggle="collapse" type="button">Hospital Acquired Sepsis Syndrome</button></strong></strong></strong></strong></h5>
</div>

<div aria-labelledby="HCAdHospAcq" class="collapse" data-parent="#accordionHCAdSepsis" id="collapseHCAdHospAcq">
<div class="card-body text-left">
<p><strong><strong><strong><strong><span style="color:#000000"><strong>This includes&nbsp;patients readmitted after recent hospital discharge and hospital inpatients.</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#0000ff">Piperacillin/tazobactam 4.5g IV stat followed by 4.5g IV&nbsp;8 hourly</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>PLUS </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#0000ff"><strong>Gentamicin 5mg/kg IV as a single</strong></span>&nbsp;<strong><span style="color:#0000ff">stat dose once only (4mg/kg if age <u>&gt;</u>&nbsp;70 years).&nbsp;Max dose 400mg.&nbsp;</span><span style="color:#000000"> </span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u></strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#800080">Meropenem 2g IV stat followed by&nbsp;1g IV 8 hourly</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">PLUS</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#800080"><strong>Gentamicin 5mg/kg IV as a single</strong>&nbsp;<strong>stat dose once only (4mg/kg if age <u>&gt;</u>&nbsp;70 years).&nbsp; Max dose 400mg.&nbsp; </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u></strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV stat followed by 400mg IV 12 hourly </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>PLUS </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#b22222">Clindamycin 1.2g IV stat followed by 900mg IV 8 hourly</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>PLUS</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#b22222"><strong>Gentamicin 5mg/kg IV as a single</strong>&nbsp;<strong>stat dose once only (4mg/kg if age <u>&gt;</u>&nbsp;70 years).&nbsp; Max dose 400mg.&nbsp;</strong></span><strong><span style="color:#000000"> </span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong>Antibiotic step down to oral treatment should be based on the antibiotic sensitivity results of the microbiologic culture. Contact Consultant Microbiologist if advice is required.</strong></strong></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdFebNeuSep">
<h5 class="mb-0"><strong><strong><strong><strong><button aria-controls="collapseHCAdFebNeuSep" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdFebNeuSep" data-toggle="collapse" type="button">Febrile Neutropenic Sepsis</button></strong></strong></strong></strong></h5>
</div>

<div aria-labelledby="HCAdFebNeuSep" class="collapse" data-parent="#accordionHCAdSepsis" id="collapseHCAdFebNeuSep">
<div class="card-body text-left">
<div class="panel-body" data-bind="html: contentHtml">
<p><strong><strong><strong><strong><span style="color:#000000"><strong>This includes all febrile immunocompromised patients.</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><u><span style="color:#000000"><strong>Antibiotic treatment</strong></span></u></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#0000ff">Piperacillin/tazobactam 4.5g IV stat followed by 4.5g IV&nbsp;8 hourly.</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>If severely ill and hypotensive add:</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#0000ff"><strong>Gentamicin 5mg/kg IV as a single</strong></span>&nbsp;<strong><span style="color:#0000ff">stat dose once only (4mg/kg in age <u>&gt;</u>&nbsp;70 years).&nbsp;Max dose&nbsp;400mg. </span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><u><strong>Note:&nbsp;Do not give&nbsp;gentamicin&nbsp;to patients who have&nbsp;received platinum based chemotherapy (oxaliplatin, carboplatin, cisplatin) in the last 7 days due to increased risk of nephrotoxicity and ototoxicity.</strong></u></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u></strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#800080">Meropenem 2g IV stat followed by&nbsp;1g IV 8 hourly</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">If severely ill and hypotensive add:</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#800080"><strong>Gentamicin 5mg/kg IV as a single</strong>&nbsp;<strong>stat dose once only (4mg/kg if age <u>&gt;</u>&nbsp;70 years).&nbsp; Max dose&nbsp;400mg. </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><u><strong>Note:&nbsp;Do not give&nbsp;gentamicin&nbsp;to patients who have&nbsp;received platinum based chemotherapy (oxaliplatin, carboplatin, cisplatin) in the last 7 days due to increased risk of nephrotoxicity and ototoxicity.</strong></u></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u></strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV stat followed by 400mg IV 12 hourly </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>plus </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#b22222">Clindamycin 1.2g IV stat followed by 900mg IV 8 hourly</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><strong>If severely ill and hypotensive add:</strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#b22222"><strong>Gentamicin 5mg/kg IV as a single</strong>&nbsp;<strong>stat dose once only (4mg/kg if age <u>&gt;</u>&nbsp;70 years).&nbsp;Max dose&nbsp;400mg. </strong></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><strong><span style="color:#000000">If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#000000"><u><strong>Note:&nbsp;Do not give&nbsp;gentamicin&nbsp;to patients who have&nbsp;received platinum based chemotherapy (oxaliplatin, carboplatin, cisplatin) in the last 7 days due to increased risk of nephrotoxicity and ototoxicity.</strong></u></span></strong></strong></strong></strong></p>

<p><strong><strong><strong><strong>Antibiotic step down to oral treatment should be based on the antibiotic sensitivity results of the microbiologic culture. Contact Consultant Microbiologist if advice is required.</strong></strong></strong></strong></p>
</div>
</div>
</div>
</div>
</div>
<strong><strong><strong><strong> </strong></strong></strong></strong></div>
<br />
<strong><strong><strong><strong><!--floating icon--><a class="float" href="#HCAdBloodSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></strong></strong></div>
</div>
</div>
</div>
</div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Bone and Joint section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdBoneLabel" class="portfolio-modal modal fade " id="HCAdBoneJoint" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdBoneLabel"><strong><strong>Bone and Joint Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdCCompFrac" id="HCAdBoneSection">Compound/Open Fractures</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdProsJointInf">Prosthetic Joint Infection</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdSepArth">Septic Arthritis and Osteomyelitis</a></strong></strong></h4>
<br />
<strong><strong><!--Compound and Open Fractures--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdCCompFrac"><strong><strong>Compound/Open Fractures</strong></strong></h2>
<strong><strong><span style="color:#000000"><u><strong>Empiric antibiotic treatment</strong></u></span> </strong></strong>

<p><strong><strong>&nbsp;</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong>IV &nbsp;treatment:</strong> <span style="color:#0000ff"><strong>Co-amoxiclav&nbsp;1.2g IV stat followed by 1.2g IV&nbsp;8 hourly.</strong></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#8e44ad"><strong> cefuroxime 1.5g IV stat followed by 1.5g IV 8 hourly.</strong></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span> <span style="color:#ff0000">Co-trimoxazole 960mg IV stat followed by 960mg IV 12 hourly plus clindamycin 1.2g IV stat followed by 600mg IV 6 hourly.</span></strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><strong>Further antibiotic management should be based on microbiologic culture results.</strong></span></strong></strong></p>
<strong><strong> </strong></strong></div>
<br />
<!--Prosthetic Joint Infection--> 
<div class="text-left border border-info rounded">
    <h2 class="text-center" id="HCAdProsJointInf"><strong><strong>Prosthetic Joint Infection</strong></strong></h2>
    <div>
        <p>The commonest organism affecting prothetic joints is Staph epidermidis as well as other coagulase negative Staphylococci such as&nbsp;Staph hominis, Staph haemolyticus, Staph&nbsp;warneri as well as numerous others.</p>

        <p>Other less commonly encountered bacteria include Staph aureus, Streptococci, Entercocci, enteric Gram negative bacilli, Pseudomonas aeruginosa and&nbsp;Propionibacteria.</p>

        <p><span style="color:#000000"><u><strong>Empiric IV treatment:</strong></u></span></p>

        <p><span style="color:#000000"><strong>IV treatment:&nbsp;</strong></span><span style="color:#0033cc"><strong>Teicoplainin IV&nbsp;10mg/kg 12 hourly for 3 doses followed by&nbsp;10mg/kg once daily thereafter plus oral rifampicin 300mg po BD.</strong></span></p>

        <p><strong><u>NOTE:</u></strong></p>

        <p><u>Once culture results are available</u>&nbsp;contact Microbiology for advice regarding further antibiotic management based on sensitivites and for the most appropriate regimen in terms of IV treatment, oral step down and treatment duration&nbsp;for the organism isolated.</p>

        <p>&nbsp;</p>
    </div>
</div>

<br />
<strong><strong><!--Septic Arthritis and Osteomyelitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdSepArth">
<h2 class="text-center" id="HCAdSepArth"><strong><strong>Septic Arthritis and Osteomyelitis</strong></strong></h2>

<p><strong><strong>Treatment duration for <strong>septic arthritis</strong> is <u><strong>4 weeks.</strong></u></strong></strong></p>

<p><strong><strong>Treatment duration for <strong>osteomyelitis </strong>is<strong> <u>6 weeks.</u></strong></strong></strong></p>

<p><strong><strong><u><strong>Antibiotic treatment</strong></u></strong></strong></p>

<p><strong><strong><strong>IV &nbsp;treatment:</strong> <span style="color:#0000ff"><strong>Flucloxacillin 2g IV stat followed by 2g IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral step down:</strong> <span style="color:#0000ff"><strong>Flucloxacillin 2g po qds.&nbsp; If not tolerated at this dose reduce to 1.5g or 1g po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: <span style="color:#800080">Clindamycin 1.2g IV stat followed by 900mg IV 6 hourly.&nbsp; </span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down:</strong> <strong><span style="color:#800080">Clindamycin 450mg po qds.</span></strong></strong></strong></p>
<strong><strong><!--Inner accordian--> </strong></strong>

<div id="accordionHCAdSepArth">
<div class="card">
<div class="card-header" id="HCAdGramNeg">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdGramNeg" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdGramNeg" data-toggle="collapse" type="button">Enteric Gram Negative Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdGramNeg" class="collapse" data-parent="#accordionHCAdSepArth" id="collapseHCAdGramNeg">
<div class="card-body text-left">

    <p>The following patients may be at increased risk of infection&nbsp;due to&nbsp;enteric Gram negative bacilli (coliforms):</p>
    <ul>
        <li>Elderley</li>
        <li>Patients with Diabetes</li>
        <li>Patients with rheumatoid arthritis or osteoarthritis</li>
        <li>Patients with underlying malignancy</li>
        <li>Patients receiving systemic steroid treatment</li>
    </ul>
    <p>&nbsp;</p>
    <p><span style="color:#000000"><u><strong>Antibiotic treatment:</strong></u></span></p>
    <p><span style="color:#000000"><strong>IV treatment: </strong></span></p>
    <p><span style="color:#0000ff"><strong>Flucloxacillin 2g IV stat followed by 2g IV 6 hourly</strong></span></p>
    <p><span style="color:#000000"><u><strong>plus</strong></u></span></p>
    <p><span style="color:#0000ff"><strong>Gentamicin 5mg/kg (4mg/kg if age <u>&gt;</u> 70 years) IV single stat dose once only. </strong></span><strong><span style="color:#0000ff">If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> </a>for guidance on&nbsp;gentamicin dose calculation.</span></strong></p>
    <p><span style="color:#000000"><u><strong>plus</strong></u></span></p>
    <p><span style="color:#0000ff"><strong>Co-amoxiclav 1.2g IV stat followed by 1.2g IV 8 hourly.</strong></span></p>
    <p>&nbsp;</p>
    <p><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#0000ff"><strong> Co-amoxiclav 625mg po tds.</strong></span></p>
    <p>&nbsp;</p>
    <p><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></p>
    <p><span style="color:#000000"><strong>IV treatment:</strong></span></p>
    <p><span style="color:#800080"><strong>Cefuroxime 1.5g IV stat followed by 1.5g IV&nbsp;6 hourly</strong></span></p>
    <p><u><strong>plus</strong></u></p>
    <p><span style="color:#800080"><strong>gentamicin 5mg/kg (4mg/kg if age <u>&gt;</u> 70 years) IV single stat dose once only. If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> </a>for guidance on&nbsp;gentamicin dose calculation.</strong></span></p>
    <p>&nbsp;</p>
    <p><strong><span style="color:#000000">Oral step down:</span> <span style="color:#800080">Cefalexin 1g po qds.</span></strong></p>
    <p>&nbsp;</p>
    <p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></p>
    <p><span style="color:#000000"><strong>IV treatment:</strong></span></p>
    <p><strong><span style="color:#b22222">Clindamycin 1.2g IV stat followed by 900mg IV 8 hourly</span></strong></p>
    <p><span style="color:#000000"><strong><u>plus</u></strong></span></p>
    <p><span style="color:#b22222"><strong>Gentamicin 5mg/kg (4mg/kg if age <u>&gt;</u> 70 years) IV single stat dose once only. If the patient is obese see&nbsp;section on <a data-rowid="1613921" data-objid="IHqjh2H8si" target="_blank">Therapeutic Drug Monitoring </a>for guidance on&nbsp;gentamicin dose calculation.</strong></span></p>
    <p><span style="color:#000000"><u><strong>plus</strong></u></span></p>
    <p><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV stat followed by 400mg IV 12 hourly.</strong></span></p>
    <p>&nbsp;</p>
    <p><span style="color:#000000"><strong>Oral step down:</strong> </span><span style="color:#b22222"><strong>Clindamycin 450mg po qds </strong></span><span style="color:#000000"><u><strong>plus</strong></u> </span><span style="color:#b22222"><strong>ciprofloxacin 500mg po bd.</strong></span></p>
</div>
</div>

<div>
<div class="card-header" id="HCAdAnaer">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAnaer" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAnaer" data-toggle="collapse" type="button">Anaerobic Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAnaer" class="collapse" data-parent="#accordionHCAdSepArth" id="collapseHCAdAnaer">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong><u>Anaerobic infection</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Anaerobic infection should be suspected in the following patients:</span></strong></strong></p>

<ul>
    <li><strong><strong><span style="color:#000000">Immunocompromised</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">Diabetics</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">Recent trauma with devitalised tissue</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">IV drug abusers</span></strong></strong></li>
</ul>

<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Co-amoxiclav 1.2g IV stat followed by 1.2g IV 8 hourly</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>plus</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>plus</u></strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Gentamicin 5mg/kg (4mg/kg if age <u>&gt;</u> 70 years) IV single stat dose once only.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:</span><span style="color:#0000ff"> Co-amoxiclav 625mg po tds </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>plus</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Co-trimoxazole 960mg&nbsp;IV stat followed by 960mg IV 12 hourly</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>plus</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Gentamicin 5mg/kg (4mg/kg if age <u>&gt;</u> 70 years) IV single stat dose once only.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span> <strong><span style="color:#800080">Clindamycin 450mg po qds </span><u>plus</u></strong> <strong><span style="color:#800080">ciprofloxacin 500mg po bd.</span></strong></strong></strong></p>
</div>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdBoneSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Cardio section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdCardioLabel" class="portfolio-modal modal fade " id="HCAdCardio" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdCardioLabel"><strong><strong>Cardiovascular Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdCEndocarditis" id="HCAdCardioSection">Endocarditis</a></strong></strong></h4>
<br />
<strong><strong><!--Endocarditis--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdEndocard"><strong><strong>Endocarditis</strong></strong></h2>
<strong><strong><!--Inner accordian--> </strong></strong>

<div id="accordionHCAdEndocard">
<div class="card">
<div class="card-header" id="HCAdEndoAcute">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdEndoAcute" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdEndoAcute" data-toggle="collapse" type="button">Acute presentation</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdEndoAcute" class="collapse" data-parent="#accordionHCAdEndocard" id="collapseHCAdEndoAcute">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong>In acute presentation the organism is likely to be Staph. aureus.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Flucloxacillin 2g IV 6 hourly. &nbsp;(If weight is over 85kg give flucloxacillin 2g IV <u>4</u> hourly).</strong></span></strong></strong></p>

<p><strong><strong><strong>Gentamicin should NOT be added to flucloxacillin for the initial treatment of native valve staphylococcal infective endocarditis.</strong></strong></strong></p>

<p><strong><strong>There is <strong><u>no</u></strong> evidence that the addition of gentamicin results in improved survival, reduced surgery or reduced complications. This recommendation is unchanged from previous guidelines, but since their publication, analysis of data from a randomized controlled trial has confirmed previous findings of increased nephrotoxicity in patients.&nbsp;Furthermore there is <strong><u>no</u></strong> evidence that the addition of sodium fusidate or rifampicin to flucloxacillin offers any advantage in this setting. (Adapted from BSAC and AMH guidelines for the treatment of endocarditis).</strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy</strong></span></u><span style="color:#000000"><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Vancomycin 1g IV 12 hourly </strong></span><span style="background-color:#ffffff; color:#333333">(modified according to renal function and plasma vancomyin levels)</span><span style="background-color:#ffffff">&nbsp;</span><u><span style="color:#000000"><strong>plus</strong></span></u><strong> rifampicin 450mg IV 12 hourly.</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose&nbsp;calculation.</strong></span></strong></strong></p>

<p><strong><strong><strong><strong>When the patient is deemed fit to step down to oral antibiotic treatment contact Microbiology/Antimicrobial Management Team for advice.</strong></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><strong>Treatment duration is&nbsp;4 weeks or longer.</strong></span></strong></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdSubAcute">
<h5 class="mb-0"><strong><strong><strong><button aria-controls="collapseHCAdSubAcute" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdSubAcute" data-toggle="collapse" type="button">Sub-Acute Presentation</button></strong></strong></strong></h5>
</div>

<div aria-labelledby="HCAdSubAcute" class="collapse" data-parent="#accordionHCAdEndocard" id="collapseHCAdSubAcute">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#000000"><strong>Indolent presentation (sub acute bacterial endocarditis) the organisms are likely to be Streptococci.</strong></span></strong></strong></strong></p>

<p><strong><strong><strong><strong><span style="color:#0000ff">Amoxicillin 2g IV <u>four</u> hourly </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> gentamicin 1mg/kg IV 8 hourly</span></strong><span style="color:#000000"> (modified according to renal function and plasma gentamicin levels).</span></strong></strong></strong></p>

<p><strong><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (rash)</strong></span></u><span style="color:#000000"><strong>:</strong></span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080"><strong>Vancomycin 1g IV 12 hourly&nbsp;</strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#000000"><strong> </strong></span><span style="color:#800080"><strong>ceftriaxone&nbsp;1g IV 12 hourly</strong></span><span style="color:#000000"><strong> - only suitable if penicillin allergy (rash).&nbsp; This combination cannot cannot be given to patients who have anaphylaxis to penicillin</strong></span><strong>.</strong></strong></strong></strong></p>

<p><strong><strong><strong><strong><u>Penicillin allergy (anaphylaxis):</u></strong></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#b22222"><strong>Vancomycin 1g IV 12 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong>&nbsp;ciprofloxacin 400mg IV 12 hourly.</strong></span></strong></strong></strong></p>

<p><strong><strong><strong>See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;the dose&nbsp;and the monitoring&nbsp;of drug plasma levels&nbsp;of aminoglycosides (such as gentamicin)&nbsp;and glycopeptides (such as vancomycin).</strong></strong></strong></p>

<p><strong><strong><strong>When the patient is deemed fit to step down to oral antibiotic treatment contact Microbiology/Antimicrobial Management Team for advice.</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration is&nbsp;4 weeks or longer.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdProsthValve">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdProsthValve" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdProsthValve" data-toggle="collapse" type="button">Prosthetic Valve Endocarditis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdProsthValve" class="collapse" data-parent="#accordionHCAdEndocard" id="collapseHCAdProsthValve">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#0000ff">Vancomycin 1g IV 12 hourly</span></strong> <strong><span style="color:#000000"><u>plus</u> </span><span style="color:#0000ff">gentamicin 1mg/kg IV 8&nbsp;hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#0000ff"> rifampicin 450mg IV&nbsp;12 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Vancomycin and gentamicin doses should be modified according to renal function and plasma vancomycin and gentamicin levels.</span></strong></strong></p>

<p><strong><strong>In patients who have <u>existing renal impairment</u> or who <u>develop renal function deterioration</u> while receiving this combination, the following alternative agents should be considered:</strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Vancomycin 1g IV 12 hourly&nbsp;</strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#000000"><strong> </strong></span><span style="color:#800080"><strong>ceftriaxone&nbsp;1g IV 12 hourly</strong></span><span style="color:#000000"><strong>&nbsp;</strong></span><strong><span style="color:#000000"><u>plus</u></span><span style="color:#0000ff"> </span><span style="color:#800080">rifampicin 450mg IV 12 hourly </span></strong><span style="color:#000000"><strong>- only suitable if penicillin allergy (rash).&nbsp; This combination cannot cannot be given to patients who have anaphylaxis to penicillin</strong></span><strong>.</strong></strong></strong></p>

<p><strong><strong>OR</strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Vancomycin 1g IV 12 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong>&nbsp;ciprofloxacin 400mg IV 12 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> rifampicin 450mg IV 12 hourly.</strong></span></strong></strong></p>

<p><strong><strong>See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;the dose&nbsp;and the monitoring&nbsp;of drug plasma levels&nbsp;of aminoglycosides (such as gentamicin)&nbsp;and glycopeptides (such as vancomycin).</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>When the patient is deemed fit to step down to oral antibiotic treatment contact Microbiology/Antimicrobial Management Team for advice.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration is 6&nbsp;weeks or longer.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdCardioSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines CNS section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdCardioLabel" class="portfolio-modal modal fade " id="HCAdCNS" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdCardioLabel"><strong><strong>Central Nervous System Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdHaemophilus">Haemophilus Influenzae</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdCListeria">Listeria</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdEmpTx" id="HCAdCNSSection">Meningitis - Empiric Treatment</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdMenningococcus">Meningococcus</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdPneumococcus">Pneumococcus</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdViral">Viral Meningitis/Encephalitis</a></strong></strong></h4>
<br />
<strong><strong><!--Endocarditis--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdEmpTx"><strong><strong>Meningitis - Empiric Treatment</strong></strong></h2>

<p><strong><strong><strong><span style="color:#0000ff">Ceftriaxone 2g IV stat followed by&nbsp;2g IV 12 hourly</span></strong></strong></strong></p>

<p><strong><strong><u><strong>plus </strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Amoxicillin 2g stat followed by 2g IV 4 hourly</span></strong><span style="color:#000000"> <strong><u>if <em>Listeria </em>suspected.</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Listeria&nbsp;should be suspected in:</span></strong></strong></p>

<ul>
    <li><strong><strong><span style="color:#000000">elderley patients</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">neonates</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">patients with&nbsp;alcohol dependency</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">immunosuppressed patients (particularly those with solid tumours)</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">diabetic patients</span></strong></strong></li>
</ul>

<p><strong><strong><span style="color:#000000">See section on <a href="#HCAdCListeria"> Listeria.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If <strong><u>herpes simplex virus meningitis/encephalitis</u></strong> is&nbsp;suspected add aciclovir 10mg/kg IV 8 hourly.&nbsp; For more details see section on viral meningitis/encephalitis below.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy:</u></strong></span><br />
&nbsp;</strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Chloramphenicol 1g IV stat followed by 1g IV 6 hourly</strong></span></strong></strong></p>

<p><strong><strong><u><strong>plus</strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#b22222">Moxifloxacin 400mg IV stat followed by 400mg IV OD</span></strong></strong></strong></p>

<p><strong><strong><u><strong>plus </strong></u></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Co-trimoxazole 1.44g IV stat followed by 1.44g 12 hourly </strong></span><strong>(if Listeria suspected).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">If <strong><u>herpes simplex virus meningitis/encephalitis</u> </strong>is&nbsp;suspected add aciclovir 10mg/kg IV 8 hourly.&nbsp; For more details see section on viral meningitis/encephalitis.</span></strong></strong></p>

<p><strong><strong><u><strong><span style="color:#ff0000">Review antibiotic treatment once microbiologic culture results become available</span></strong></u></strong></strong></p>

<p><strong><strong><span style="color:#000000">Consider adjunctive treatment with dexamethasone (particularly if pneumococcal meningitis suspected in adults); starting before or with first dose of antibiotic.&nbsp;Avoid dexamethasone in septic shock, meningococcal septicaemia, or if immunocompromised, or in meningitis following surgery.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Meningococcus--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdMenningococcus"><strong><strong>Meningococcus</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>Meningococcal meningitis is caused by Neisseria meningitidis, a Gram negative diplococcus.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Benzylpenicillin 2.4g IV stat followed by 2.4g&nbsp;IV every 4 hours.</span></strong></strong></strong></p>

<p><strong><strong><strong><u><span style="color:#000000">Penicillin allergy (rash):</span></u></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Ceftriaxone 2g&nbsp;IV stat followed by 2g IV&nbsp;12 hourly.</span></strong></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis)</strong></span></u><span style="color:#000000"><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Chloramphenicol 1g IV stat followed by 1g IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong>Duration of therapy is&nbsp;<strong><u>7 days</u></strong>.</strong></strong></p>

<p><strong><strong><u><strong>Elimination of nasopharyngeal carriage:</strong></u></strong></strong></p>

<p><strong><strong>After treatment with benzylpenicillin give oral <span style="color:#0000ff">rifampicin 600mg twice a day&nbsp;for 2 days </span>before hospital discharge to eliminate nasopharyngeal carriage; or<span style="color:#0000ff"> ciprofloxacin 500mg oral as a single dose</span> before discharge. Patients treated with ceftriaxone or moxifloxacin would <strong><u>not</u></strong> require follow up rifampicin or ciprofloxacin&nbsp;treatment on discharge.</strong></strong></p>
</div>
<br />
<strong><strong><!--Pneumococcus--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdPneumococcus"><strong><strong>Pneumococcus</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>Pneumococcal meningitis is caused by Strep pneumoniae,&nbsp;a Gram positive diplococcus.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Ceftriaxone 2g IV stat&nbsp;followed by 2g&nbsp;IV 12 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">If the organism is penicillin-sensitive on culture results&nbsp;change to</span>&nbsp;<strong><span style="color:#0000ff">benzylpenicillin&nbsp;2.4g IV&nbsp;every 4 hours instead of ceftriaxone.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Duration of antibiotic&nbsp;therapy is&nbsp;<strong><u>10-14 days</u></strong> then <u>review</u>.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Consider adjunctive treatment with </span><strong><span style="color:#0000ff">dexamethasone</span></strong><span style="color:#000000"> (particularly if pneumococcal meningitis suspected in adults); starting before or with first dose of antibiotic.&nbsp;</span><strong><span style="color:#ff0000">Avoid</span></strong><span style="color:#000000"> dexamethasone in septic shock, meningococcal septicaemia, or if immunocompromised, or in meningitis following surgery.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If the&nbsp;organism is resistant to penicillin and cephalosporin discuss with the Consultant Microbiologist.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy -&nbsp;anaphylaxis</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Moxifloxacin 400mg IV stat followed by 400mg IV OD.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Duration of antibiotic&nbsp;therapy is&nbsp;<strong><u>10-14 days</u></strong> then <u>review</u>.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Listeria--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdCListeria"><strong><strong>Listeria</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Listeria&nbsp;should be suspected in:</span></strong></strong></p>

<ul>
    <li><strong><strong><span style="color:#000000">elderley patients</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">neonates</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">patients with&nbsp;alcohol dependency</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">immunosuppressed patients (particularly those with solid tumours)</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">diabetic patients</span></strong></strong></li>
</ul>

<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#ff0000"><strong>Note: Listeria is resistant to all cephalosporins.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Amoxicillin 2g IV stat followed by 2g IV 4 hourly</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>plus</u></strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Gentamicin 5mg/kg IV&nbsp;once daily </span></strong><span style="color:#000000">(for the first week of treatment).&nbsp; If the patient is <u>&gt;</u> 70 years dose should be 4mg/kg IV once daily.&nbsp; </span></strong></strong></p>

<p><strong><strong>See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a>for guidance on the monitoring of gentamicin levels and also for guidance on gentamicin dose calculation if the patient is obese.</strong></strong></p>

<p><strong><strong><span style="color:#000000">Treatment duration is <u><strong>21 days.</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#b22222">Co-trimoxazole 1.44g IV 12 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Treatment duration is <u><strong>21 days.</strong></u></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Haemophilus Flu--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdHaemophilus"><strong><strong>Haemophilus Influenzae</strong></strong></h2>

<p><strong><strong>Haemophilus influenzae meningitis is rare&nbsp;nowadays due to&nbsp;Hib vaccination.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u></strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Ceftriaxone 2g IV 12 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Consider adjunctive treatment with </span><strong><span style="color:#0000ff">dexamethasone</span></strong><span style="color:#000000"> (particularly if pneumococcal meningitis suspected in adults); starting before or with first dose of antibiotic.&nbsp;</span><strong><span style="color:#ff0000">Avoid</span></strong><span style="color:#000000"> dexamethasone in septic shock, meningococcal septicaemia, or if immunocompromised, or in meningitis following surgery.</span></strong></strong></p>

<p><strong><strong><strong><u><span style="color:#000000">Penicillin allergy</span></u></strong></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Moxifloxacin 400mg IV once daily.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Duration of therapy is <u><strong>10 days</strong></u>.</span></strong></strong></p>

<p><strong><strong><u><strong><span style="color:#000000">Elimination of nasopharyngeal carriage</span></strong></u></strong></strong></p>

<p><strong><strong><span style="color:#000000">For H. influenzae type b, after treatment with chloramphenicol give </span><strong><span style="color:#0000ff">rifampicin 600mg po OD for 4 days&nbsp;</span></strong><span style="color:#000000">before hospital discharge to eliminate nasopharyngeal carriage.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Vital Meningitis--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdViral"><strong><strong>Viral Meningitis/Encephalitis</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Most cases of viral meningitis (&quot;aseptic&quot; meningitis)&nbsp;are due to enteroviruses such as Coxsackie and&nbsp;ECHO viruses, which is usually a self-limiting infection and does <u><strong>not</strong></u> require specific antiviral treatment.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">A&nbsp;CSF sample should be sent for viral PCR testing at Manchester Royal Infirmary laboratory.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If the test is negative for Herpes simplex viruses&nbsp;types 1 and 2 and Varicella zoster virus, stop treatment with aciclovir because this agent&nbsp;is <strong><u>not</u></strong> effective against enteroviruses.</span></strong></strong></p>
<strong><strong><!--Inner accordion--> </strong></strong>

<div id="accordionHCAdCNS">
<div class="card">
<div class="card-header" id="HCAdEnceph">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdEnceph" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdEnceph" data-toggle="collapse" type="button">Encephalitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdEnceph" class="collapse" data-parent="#accordionHCAdCNS" id="collapseHCAdEnceph">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong>Herpes simplex virus type 1 encephalitis</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Treatment</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Aciclovir 10mg/kg IV stat followed by 10mg/kg IV&nbsp;8 hourly </strong></span><span style="color:#000000">for <strong><u>14 to 21&nbsp;days.</u></strong></span></strong></strong></p>

<p><strong><strong>Calculate dose using <strong>Ideal Body Weight</strong> in obese patients&nbsp;</strong></strong></p>

<p><strong><strong><strong>IBW = 45.4 +[0.89 x (height {cm} &ndash; 152.4)]&nbsp;&nbsp;(+4.5 if male)</strong></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdMenin">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdMenin" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdMenin" data-toggle="collapse" type="button">Meningitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdMenin" class="collapse" data-parent="#accordionHCAdCNS" id="collapseHCAdMenin">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong>Herpes simplex virus type 2 meningitis</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Treatment</u>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Aciclovir 10mg/kg IV 8 hourly</span></strong>, (can switch to oral <span style="color:#0000ff"><strong>valaciclovir 1g po tds </strong></span>when patient improves).</strong></strong></p>

<p><strong><strong>Total duration of treatment is&nbsp;<strong><span style="color:#000000"><u>7<strong> days</strong></u></span>.</strong></strong></strong></p>

<p><strong><strong>Calculate dose using <strong>Ideal Body Weight</strong> in obese patients&nbsp;</strong></strong></p>

<p><strong><strong><strong>IBW = 45.4 +[0.89 x (height {cm} &ndash; 152.4)]&nbsp;&nbsp;(+4.5 if male)</strong></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdCNSSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Dental section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdDentalLabel" class="portfolio-modal modal fade " id="HCAdDental" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdDentalLabel"><strong><strong>Dental Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<br />
<strong><strong><!--Dental--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCAdDental"><strong><strong>Dental</strong></strong></h2>
<strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u></span> </strong></strong>

<p><strong><strong>&nbsp;</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong><span style="color:#000000">Oral treatment:</span>&nbsp;<span style="color:#0000ff">Amoxicillin 1g&nbsp;po tds.</span></strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong><span style="color:#000000">IV treatment: </span><span style="color:#0000ff">Amoxicillin 1g&nbsp;IV 8 hourly.</span></strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy:</strong></span></u></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <strong><span style="color:#800080">Clindamycin 450mg po qds.</span></strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><strong> <span style="color:#800080">Clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines ENT section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdENTLabel" class="portfolio-modal modal fade " id="HCAdENT" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdENTLabel"><strong><strong>Ear, Nose and Throat Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdENTSection"><strong><strong><a href="#HCAdAcMast">Acute Mastoiditis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdDeepNeck">Deep Neck Space Abscess</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdEpiglotis">Epiglottitis / Supraglottitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdMalignantOtitisExterna">Malignant / Necrotising Otitis Externa</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdOtiExterna">Otitis Externa</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdOtiMedia">Otitis Media</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdParotitis">Parotitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdPerichondritis">Perichondritis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdPostTonBleed">Post-Tonsillectomy Bleed</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSinusitis">Sinusitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSupNeckAb">Superficial Neck Abscess</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSupNeck">Suppurating Neck Nodes</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdTonsil">Tonsillitis / Quinsy</a></strong></strong></h4>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdAcMast">
<h2 class="text-center" id="HCAdAcMastLabel"><strong><strong>Acute Mastoiditis</strong></strong></h2>


<p><strong><strong><u><span style="color:#000000"><strong>IV treatment:</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Ceftriaxone 2g IV 12 hourly </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#0000ff"><strong> clindamycin 600mg IV&nbsp;6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (an</strong></span></u><u><span style="color:#000000"><strong>aphylaxis):</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Moxifloxacin 400mg IV&nbsp;once daily</strong></span><span style="color:#000000"><strong> </strong><strong>plus</strong></span><span style="color:#e74c3c"><strong> clindamycin 600mg&nbsp;IV 6 hourly.</strong></span></strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdDeepNeck">
<h2 class="text-center" id="HCAdDeepNeckLabel"><strong><strong>Deep Neck Space Abscess</strong></strong></h2>


<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#0000ff">co-amoxiclav 1.2g IV 8 hourly</span> <span style="color:#000000">plus</span> <span style="color:#0000ff">clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:</span><span style="color:#0000ff"> co-amoxiclav 625mg po TDS </span><span style="color:#000000">plus </span><span style="color:#0000ff">clindamycin 450mg po QDS.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><strong><span style="color:#8e44ad">cefuroxime&nbsp;1.5g IV 8 hourly</span> plus <span style="color:#8e44ad">clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down:<span style="color:#0000ff"> </span><span style="color:#8e44ad">cefalexin 1g&nbsp;po TDS</span><span style="color:#0000ff"> </span>plus <span style="color:#8e44ad">clindamycin 450mg po QDS.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><strong>IV treatment:</strong> <strong><span style="color:#e74c3c">co-trimoxazole 960mg IV 12&nbsp;hourly</span> <span style="color:#000000">plus</span><span style="color:#e74c3c"> clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down:<span style="color:#0000ff"> </span><span style="color:#e74c3c">co-trimoxazole&nbsp;960mg&nbsp;po BD</span><span style="color:#0000ff">&nbsp;</span><span style="color:#000000">plus</span> <span style="color:#e74c3c">clindamycin 450mg po QDS.</span></strong></strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdEpiglotis">
<h2 class="text-center" id="HCAdEpiglotisLabel"><strong><strong>Epiglottitis / Supraglottitis</strong></strong></h2>


<p><strong><strong><strong>IV treatment:</strong><span style="color:#0000ff"><strong> Ceftriaxone 2g IV&nbsp;12 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#0000ff"><strong>Cefalexin 1g po tds</strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#000000">(can be used in penicillin allergy where reaction is rash)</span></strong></strong></p>

<p><strong><strong><u><strong><span style="color:#000000">Penicillin allergy</span>&nbsp;(a<span style="color:#000000">naphylaxis)</span></strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment:</strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Moxifloxacin 400mg IV&nbsp;OD</span><span style="color:#000000">&nbsp;</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down:</strong></strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Moxifloxacin 400mg po OD.</strong></span></strong></strong></p>

<p><strong><strong>Since the introduction of Hib vaccination in childhood this infection&nbsp;is rarely caused by Haemophilus influenzae.</strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Treatment duration:&nbsp;7-10 days.</span></strong></strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdMalignantOtitisExterna">
<h2 class="text-center" id="HCAdMalignantOtitisExternaLabel"><strong><strong>Malignant/necrotising otitis externa</strong></strong></h2>


<p><strong><strong><strong><span style="color:#000000">IV treatment:&nbsp; </span><span style="color:#0000ff">Tazocin 4.5g IV 8 hourly</span><span style="color:#000000"> plus </span></strong><span style="color:#0000ff"><strong>clindamycin 600mg IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Also give topical ciprofloxacin 0.3% drops 3 drops QDS into the affected ear(s).</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong> </span><strong><span style="color:#0000ff">ciprofloxacin 500mg po bd</span><span style="color:#0000ff"><strong> </strong></span><span style="color:#000000">plus</span><span style="color:#0000ff"><strong> </strong></span><span style="color:#0000ff">clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong>Also give topical ciprofloxacin 0.3% drops 3 drops QDS into the affected ear(s).</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><span style="color:#9b59b6"><strong>ceftazidime 2g IV 8 hourly </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#9b59b6"><strong>clindamycin 600mg IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Also give topical ciprofloxacin 0.3% drops 3 drops QDS into the affected ear(s).</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong> </span><strong><span style="color:#9b59b6">ciprofloxacin 500mg po bd</span><span style="color:#0000ff"><strong> </strong></span><span style="color:#000000">plus</span><span style="color:#0000ff"><strong> </strong></span><span style="color:#9b59b6">clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong>Also give topical ciprofloxacin 0.3% drops 3 drops QDS into the affected ear(s).</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><span style="color:#e74c3c"><strong>ciprofloxacin 400mg IV 12 hourly</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#e74c3c"><strong>clindamycin 600mg IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Also give topical ciprofloxacin 0.3% drops 3 drops QDS into the affected ear(s).</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong> </span><span style="color:#e74c3c"><strong>ciprofloxacin 500mg po bd</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#e74c3c"><strong>clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Also give topical ciprofloxacin 0.3% drops 3 drops QDS into the affected ear(s).</span></strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdOtiExterna">
<h2 class="text-center" id="HCAdOtiExternaLabel"><strong><strong>Otitis Externa</strong></strong></h2>


<p><strong><strong>First use aural toilet and analgesics.</strong></strong></p>

<p><strong><strong>Cure rates are similar at 7 days for topical acetic acid or antibiotic +/- steroid.</strong></strong></p>

<p><strong><strong>First line:<span style="color:#0000ff"> <strong>Acetic acid 2%</strong> </span>(e.g. Earcalm available over the counter)<span style="color:#0000ff"> <strong>1 spray TDS</strong></span> 7 days</strong></strong></p>

<p><strong><strong>Second line: <span style="color:#0000ff"><strong>Neomycin sulphate with corticosteroid </strong>(e.g. Otomize ear spray, 1 puff TDS or Betnesol N ear drops 3 drops TDS) 7 days min to 14 days max.</span></strong></strong></p>

<p><strong><strong>Advise patient to apply tragal pressure to help remove&nbsp;the debris.</strong></strong></p>

<p><strong><strong><span style="color:#ff0000"><strong>AVOID IF PERFORATED TYMPANIC MEMBRANE. </strong></span></strong></strong></p>

<p><strong><strong>If fungal infection suspected:</strong></strong></p>

<p><strong><strong>Clotrimazole 1% drops.</strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdOtiMedia">
<h2 class="text-center" id="HCAdOtiMediaLabel"><strong><strong>Otitis Media</strong></strong></h2>


<p><strong><strong><span style="color:#0000ff"><strong>Amoxicillin 1g po tds</strong></span></strong></strong></p>

<p><strong><strong><strong>or</strong></strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Clarithromycin 500mg po bd.</strong></span></strong></strong></p>

<p><strong><strong>Most infections are&nbsp;caused by viruses; most uncomplicated cases resolve without antibiotic treatment.</strong></strong></p>

</div>
<br />
<strong><strong><!--TODO - modal doesnt yet open--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdParotitis">
<h2 class="text-center" id="HCAdParotitisLabel"><strong><strong>Parotitis</strong></strong></h2>

<p><strong><strong>See <a data-dismiss="modal" data-target="#HCAdHead" data-toggle="modal" href="#HCAdHead"> Parotitis </a>section on the Head and Neck page</strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdPerichondritis">
<h2 class="text-center" id="HCAdPerichondritisLabel"><strong><strong>Perichondritis</strong></strong></h2>


<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#0000ff"><strong>Tazocin 4.5g IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment:</strong> <span style="color:#0000ff"><strong>ciprofloxacin 500mg po bd</strong></span></strong></strong></p>

<p><strong><strong>If systemically unwell also give&nbsp;<span style="color:#0000ff"><strong>gentamicin 5mg/kg IV</strong></span> as a single stat dose once only.&nbsp; (4mg/kg if age&nbsp;&ge; 70 years).  Max dose 400mg. If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a></strong>for guidance on&nbsp;gentamicin dose calculation.</strong></strong></p>

<p><u><span style="color:#000000">Penicillin allergy (rash):</span></u></p>

<p><span style="color:#000000">IV treatment: </span><span style="color:#8e44ad">ceftazidime 2g IV 8 hourly.</span></p>

<p>Oral treatment: <span style="color:#8e44ad">ciprofloxacin 500mg po bd.</span></p>

<p>If systemically unwell also give&nbsp;<span style="color:#0000ff">gentamicin 5mg/kg IV</span> as a single stat dose once only.&nbsp; (4mg/kg if age&nbsp;&ge; 70 years).&nbsp; Max dose 400mg.&nbsp;&nbsp;If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a>for guidance on&nbsp;gentamicin dose calculation.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong><strong><span style="color:#000000">IV treatment: </span></strong></strong></span><span style="color:#e74c3c"><strong>ciprofloxacin 400mg IV 12 hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment: <span style="color:#e74c3c">ciprofloxacin 500mg po bd.</span></strong></strong></strong></p>

<p><strong><strong>If systemically unwell also give&nbsp;<span style="color:#0000ff"><strong>gentamicin 5mg/kg IV</strong></span> as a single stat dose once only.&nbsp; (4mg/kg if age&nbsp;&ge; 70 years).&nbsp; Max dose 400mg.&nbsp;&nbsp;If the patient is obese See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a></strong>for guidance on&nbsp;gentamicin dose calculation.</strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdPostTonBleed">
    <h2 class="text-center" id="HCAdPostTonBleedLabel"><strong><strong>Post-Tonsillectomy Bleed</strong></strong></h2>
    <p><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#0000ff"><strong>co-amoxiclav 1.2g IV 8 hourly.</strong></span></p>
    <p><strong><span style="color:#000000">Oral step down:</span></strong> <strong><span style="color:#0000ff">co-amoxiclav 625mg po TDS.</span></strong></p>
    <p>&nbsp;</p>
    <p><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></p>
    <p><strong><span style="color:#000000">IV treatment: </span><span style="color:#8e44ad">cefuroxime 1.5g IV 8 hourly.</span></strong></p>
    <p><span style="color:#000000"><strong>Oral step down:</strong></span>&nbsp;<span style="color:#8e44ad"><strong>cefalexin 1g&nbsp;po TDS.</strong></span></p>
    <p>&nbsp;</p>
    <p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></p>
    <p><strong><span style="color:#000000">IV treatment:</span> <span style="color:#e74c3c">clindamycin 600mg IV 6 hourly.</span></strong></p>
    <p><span style="color:#000000"><strong>Oral step down:</strong></span>&nbsp;<span style="color:#e74c3c"><strong>clarithromycin 500mg&nbsp;po bd.</strong></span></p>
</div>
<p>&nbsp;</p>

<div class="text-left border border-info rounded" id="HCAdSinusitis">
<h2 class="text-center" id="HCAdSinusitisLabel"><strong><strong>Sinusitis</strong></strong></h2>

<p><strong><strong>Many cases of sinusitis are viral and two thirds will resolve without antibiotics.</strong></strong></p>

<p><strong><strong>Only treat those with persistent symptoms and purulent discharge lasting at least&nbsp;one week or if symptoms are severe. Treat those at high risk of serious complications&nbsp;notably immunosuppressed patients and those with cystic fibrosis.</strong></strong></p>


<p><strong><strong><strong><span style="color:#0000ff">Amoxicillin 1g po tds</span></strong></strong></strong></p>

<p><strong><strong><strong>or</strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Doxycycline 200mg po stat then 100mg po bd.</span></strong></strong></strong></p>



</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdSupNeckAb">
<h2 class="text-center" id="HCAdSupNeckAbLabel"><strong><strong>Superficial Neck Abscess</strong></strong></h2>


<p><strong><strong><strong><span style="color:#000000">The mainstay of treatment is incision and drainage.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Flucloxacillin 1g po QDS.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy:</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clindamycin 450mg po QDS.</strong></span></strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdSupNeck">
<h2 class="text-center" id="HCAdSupNeckLabel"><strong><strong>Suppurating Neck Nodes</strong></strong></h2>


<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#0000ff">co-amoxiclav 1.2g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:</span><span style="color:#0000ff"> co-amoxiclav 625mg po TDS.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">If no better add</span> c<span style="color:#0000ff">lindamycin 600mg IV 6 hourly to IV treatment with co-amoxiclav.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down: </span><span style="color:#0000ff">co-amoxiclav 625mg po TDS</span><span style="color:#000000">&nbsp;</span></strong><strong><span style="color:#000000">plus</span> <span style="color:#0000ff">clindamycin 450mg po QDS.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#8e44ad">cefuroxime&nbsp;1.5g IV 8 hourly</span><span style="color:#000000"> plus</span> <span style="color:#8e44ad">clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:</span><span style="color:#0000ff"> </span><span style="color:#8e44ad">cefalexin 1g&nbsp;po TDS</span><span style="color:#0000ff"> </span><span style="color:#000000">plus</span> <span style="color:#8e44ad">clindamycin 450mg po QDS.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#e74c3c">co-trimoxazole 960mg IV 12&nbsp;hourly</span><span style="color:#000000"> plus</span><span style="color:#e74c3c"> clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:</span><span style="color:#0000ff"> </span><span style="color:#e74c3c">co-trimoxazole&nbsp;960mg&nbsp;po BD</span><span style="color:#0000ff">&nbsp;</span><span style="color:#000000">plus</span> <span style="color:#e74c3c">clindamycin 450mg po QDS.</span></strong></strong></strong></p>

</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdTonsil">
<h2 class="text-center" id="HCAdTonsilLabel"><strong><strong>Tonsillitis / Quinsy</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><u><strong>Strep Group A (Beta-haemolytic streptococcal) pharyngotonsillitis</strong></u></span></strong></strong></p>

<p><strong><strong>Most throat infections are caused by viruses and do not require antibiotic treatment. Consider antibiotic treatment&nbsp;if there is:</strong></strong></p>

<ul>
    <li><strong><strong>a history of valvular heart disease</strong></strong></li>
    <li><strong><strong>systemic clinical toxicity</strong></strong></li>
    <li><strong><strong>peritonsillar abscess (quinsy)</strong></strong></li>
    <li><strong><strong>immunocompromised patient.</strong></strong></li>
</ul>

<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#0000ff"><strong> Phenoxymethylpenicillin (penicillin V) 1g po QDS.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#0000ff"><strong>Benzylpenicillin 1.2g IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration is 5 days however this may be longer&nbsp;in more complicated infections such as quinsy or scarlet fever (usually at least&nbsp;10 days).</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u></strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment:</span><span style="color:#800080"> Cefalexin 1g po tds.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment: </span><span style="color:#800080">Cefuroxime 1.5g IV 8 hourly</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration is 5 days however this may be longer in more complicated infections such as quinsy&nbsp;or scarlet fever (usually at least 10 days).</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#b22222"><strong>Clarithromycin&nbsp;500mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><strong><span style="color:#b22222">Clindamycin 600mg IV&nbsp;6 hourly (this is preferred for IV treatment in order to avoid risk of macrolide associated phlebitis with IV clarithromycin).</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration is 5 days however this may be longer in more complicated infections such as quinsy or scarlet fever (usually at least 10 days).</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdENTSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Eye section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdEyeLabel" class="portfolio-modal modal fade " id="HCAdEye" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdEyeLabel"><strong><strong>Opthamology Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdEyeSection"><strong><strong><a href="#HCAdFacCell">Facial / Orbital Cellulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdConjunct">Purulent Conjuctivitis</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--TODO sort out new modal opening--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdFacCell">
<h2 class="text-center" id="HCAdFacCellLabel"><strong><strong>Facial / Orbital Cellulitis</strong></strong></h2>

<p><strong><strong>See <a data-dismiss="modal" data-target="#HCAdSkin" data-toggle="modal" href="#HCAdSkinFacialOrb"> Facial / Orbital Cellulitis </a>section on the Skin and Soft Tissue page</strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdConjunct">
<h2 class="text-center" id="HCAdDeepNeckLabel"><strong><strong>Purulent Conjuctivitis</strong></strong></h2>

<p><strong><strong>Chloramphenicol eye drops / ointment.</strong></strong></p>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdENTSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Fungal section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdFungalLabel" class="portfolio-modal modal fade " id="HCAdFungal" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdFungalLabel"><strong><strong>Fungal Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdFungalSection"><strong><strong><a href="#HCAdInvCand">Invasive Candidiasis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdOroPhar">Oropharyngeal Candidiasis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdVagCand">Vaginal / Penile Candidiasis</a></strong></strong></h4>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdInvCand">
<h2 class="text-center" id="HCAdInvCandLabel"><strong><strong>Invasive Candidiasis</strong></strong></h2>

<p><strong><strong><strong><span style="color:#000000">For blood culture positive Candida species:</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>1st line:</strong></u></span>&nbsp;&nbsp;<strong><span style="color:#0000ff">Fluconazole 400mg IV stat followed by 200mg IV 12 hourly for 2 weeks.&nbsp; </span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Repeat blood cultures after 48 hours of treatment to ensure elimination of the organism from the bloodstream.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>2nd line:</u> </span><span style="color:#0000ff">Caspofungin 70mg IV stat followed by 50mg IV once daily&nbsp;(for body weight over 80kg give 70mg IV once daily) for 2 weeks.&nbsp;</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Repeat blood cultures after 48 hours of treatment to ensure elimination of the organism from the bloodstream.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Follow up&nbsp;antifungal agent sensitivity results from the laboratory&nbsp;to ensure treatment is appropriate.</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdOroPhar">
<h2 class="text-center" id="HCAdOroPharLabel"><strong><strong>Oropharyngeal Candidiasis</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><u><strong>1st line:</strong></u></span>&nbsp; <span style="color:#0000ff"><strong>Nystatin oral suspension 1ml QDS for 7 days.</strong></span></strong></strong></p>

<p><strong><strong>If patient does not respond to above treatment or cannot take orally but has NG/PEG access:</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>2nd line:</u></strong></span>&nbsp; <strong><span style="color:#0000ff">Fluconazole 100mg po once daily for up to 7 days.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>For severe thrush</strong></u></span> (oropharyngeal, laryngeal, oesophageal)&nbsp;or if no response to the treatment above:</strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Fluconazole 200mg IV 12&nbsp;hourly for 48 hours.</span></strong></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCAdVagCand">
<h2 class="text-center" id="HCAdVagCandLabel"><strong><strong>Vaginal / Penile Candidiasis</strong></strong></h2>

<p><strong><strong><u><span style="color:#000000"><strong>Vaginal/penile candidiasis</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>1st line:</u></strong></span> <span style="color:#0000ff"><strong>Topical clotrimazole 2% cream to be applied tds plus clotrimazole 500mg pessary single stat dose once only.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>2nd line:</u></strong></span> <strong><span style="color:#0000ff">Fluconazole 150mg po single stat dose once only.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>In severe/unresponsive&nbsp;vaginal candidiasis:</strong></u></span> <strong><span style="color:#0000ff">Fluconazole 200mg IV 12 hourly for 48 hours.</span></strong></strong></strong></p>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdFungalSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Gastro section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdFungalLabel" class="portfolio-modal modal fade " id="HCAdGastro" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdGastroLabel"><strong><strong>Gastrointestinal Tract / Intra-abdominal Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdGastroSection"><strong><strong><a href="#HCAdAcPan">Acute Pancreatitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdApend">Appendicitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdBilTr">Biliary Tract Infections</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdCampy">Campylobacter Enteritis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdCDiff">Clostridium Difficile</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdDivertic">Diverticulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdEntericFever">Enteric Fever (Typhoid / Paratyphoid)</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdGastroenteritis">Gastroenteritis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdLiverAb">Liver Abscess</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdNonTyp">Non-Typhoidal Salmonellosi</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdPeritoneal">Peritoneal Dialysis Peritonitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdPeritonitis">Peritonitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdShigellosis">Shigellosis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSpontBact">Spontaneous Bacterial Peritonitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdVaricealBleed">Variceal Bleeding with Cirrhosis</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Acute Pancreatitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdAcPan">
<h2 class="text-center" id="HCAdInvCandLabel"><strong><strong>Acute Pancreatitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdAcPan">
<div class="card">
<div class="card-header" id="HCAdAcPanA">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAcPan" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAcPan" data-toggle="collapse" type="button">Acute Pancreatitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAcPanLabel" class="collapse" data-parent="#accordionHCAdAcPan" id="collapseHCAdAcPan">
<div class="card-body text-left">
<div class="panel-body" data-bind="html: contentHtml">
<p><strong><strong>Antibiotic treatment is <strong><u>NOT</u> </strong>indicated for acute uncomplicated pancreatitis.&nbsp; Antibiotic treatment is only indicated in necrotising pancreatitis or pseudocyst formation in which secondary infection has occurred.</strong></strong></p>
</div>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCAdPanNec">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdPanNec" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdPanNec" data-toggle="collapse" type="button">Pancreatic Necrosis / Pseudocyst</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdPanNec" class="collapse" data-parent="#accordionHCAdAcPan" id="collapseHCAdPanNec">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#0000ff"> Piperacillin/tazobactam&nbsp;4.5g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u><strong>:</strong><strong> </strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#800080">Ceftazidime 2g&nbsp;IV 8 hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080"> metronidazole 500mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong><strong> </strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#b22222"><strong>Ciprofloxacin&nbsp;400mg IV&nbsp;12 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> metronidazole 500mg IV 8 hourly.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Appendicitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdApend">
<h2 class="text-center" id="HCAdApendLabel"><strong><strong>Appendicitis</strong></strong></h2>


<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#800080">Cefuroxime 1.5g IV 8 hourly </span><u><span style="color:#000000">plus</span></u><span style="color:#800080"> metronidazole 500mg IV 8 hourly </span>- this combination is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span>&nbsp;<span style="color:#800080">&nbsp;<strong>Cefalexin 1g po tds </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> metronidazole 400mg po tds </strong></span><strong>-&nbsp;this combination is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong><strong> </strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#b22222"><strong>Ciprofloxacin 400mg IV 12 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> clindamycin&nbsp;(to cover both Strep milleri and anaerobes) 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#b22222"> <strong>Ciprofloxacin 500mg po bd </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

</div>
<br />
<strong><strong><!--Billary Tract Infections--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdBilTr">
<h2 class="text-center" id="HCAdBilTrLabel"><strong><strong>Billary Tract Infections</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdBillary">
<div class="card">
<div class="card-header" id="HCAdAcuChole">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAcuChole" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAcuChole" data-toggle="collapse" type="button">Acute cholecystitis and biliary sepsis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAcuChole" class="collapse" data-parent="#accordionHCAdBillary" id="collapseHCAdAcuChole">
<div class="card-body text-left">

<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment:</u></strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Cefuroxime 1.5g IV 8 hourly then cefalexin&nbsp;1g po tds</span> <span style="color:#000000">- this is suitable for patients with penicillin allergy (rash).</span></strong></strong></strong></p>

<p><strong><strong>If biliary infection is associated with sepsis syndrome also give <span style="color:#800080"><strong>gentamicin</strong></span><strong>&nbsp;<span style="color:#800080">5mg/kg IV as a single stat dose once only&nbsp;(4mg/kg if age <u>&gt;</u> 70 years). Max dose 400mg</span></strong></strong></strong></p>

<p><strong><strong><strong>If the patient is obese see section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV 12 hourly then ciprofloxacin po 500mg bd.</strong></span></strong></strong></p>

<p><strong><strong>If biliary infection is associated with sepsis syndrome also give&nbsp;<span style="color:#c0392b"><strong>gentamicin&nbsp;5mg/kg IV as a single stat dose once only&nbsp;(4mg/kg if age <u>&gt;</u> 70 years). Max dose 400mg.</strong></span></strong></strong></p>

<p><strong><strong><strong>If the patient is obese see section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose calculation.</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Note: </strong></span><span style="color:#ff0000"><strong><u>avoid&nbsp;ceftriaxone</u></strong></span><span style="color:#000000"><strong> due to risk of biliary sludging.</strong></span></strong></strong></p>

</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCAdAscChole">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAscChole" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAscChole" data-toggle="collapse" type="button">Ascending Cholangitis</button></strong></strong></h5>
</div>

<div aria-labelledby="acTreatment" class="collapse" data-parent="#accordionHCAdBillary" id="collapseHCAdAscChole">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#800080"> Cefuroxime 1.5g IV 8 hourly</span>&nbsp;<u><span style="color:#000000">plus</span></u><span style="color:#0000ff">&nbsp;</span><span style="color:#800080">metronidazole 500mg IV 8 hourly </span>-&nbsp;this combination is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment:</span><span style="color:#800080">&nbsp;Cefalexin&nbsp;1g po tds</span>&nbsp;<u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> </span><span style="color:#800080">metronidazole 400mg po tds </span>-&nbsp;this combination is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#b22222"><strong> Ciprofloxacin 400mg IV 12 hourly </strong></span><strong><span style="color:#000000"><u>plus</u></span><span style="color:#0000ff">&nbsp;</span><span style="color:#b22222">metronidazole 500mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment:</span><span style="color:#b22222"> C</span></strong><span style="color:#b22222"><strong>iprofloxacin po 500mg bd </strong></span><strong><span style="color:#000000"><u>plus</u></span><span style="color:#0000ff"> </span><span style="color:#b22222">metronidazole 400mg po tds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Note: </strong></span><span style="color:#ff0000"><strong><u>avoid&nbsp;ceftriaxone</u></strong></span><span style="color:#000000"><strong> due to risk of biliary sludging.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Campylobacter Enteritis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdCampy">
<h2 class="text-center" id="HCAdCampyLabel"><strong><strong>Campylobacter Enteritis</strong></strong></h2>

<p><strong><strong>Antibiotics are&nbsp;<u>not</u> indicated&nbsp;in uncomplicated&nbsp;cases; however if antibiotic treatment is necessary such as in severe or relapsing illness:</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>1st line:</strong></span><span style="color:#0000ff"><strong>&nbsp;Azithromycin 500mg po od for 3 days.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">2nd line:</span><span style="color:#0000ff"> Ciprofloxacin 500mg po bd for 3 days (note there is increasing resistance to ciprofloxacin in Campylobacter organisms).</span></strong></strong></strong></p>
</div>
<br />
<strong><strong><!--C Diff--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdCDiff">
<h2 class="text-center" id="HCAdCDiffLabel"><strong><strong>Clostridium Difficile</strong></strong></h2>


<ul>
    <li><strong><strong>Stop offending antibiotics if possible.</strong></strong></li>
    <li><strong><strong>Stop proton pump inhibitors if possible.</strong></strong></li>
    <li><strong><strong>Antibiotics should be given until the diarrhoea has resolved or is resolving, but can be continued for up to 10 days.</strong></strong></li>
</ul>

<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdCdiff">
<div class="card">
<div class="card-header" id="HCAdMildMod">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdMildMod" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdMildMod" data-toggle="collapse" type="button">Mild and Moderate Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdMildMod" class="collapse" data-parent="#accordionHCAdCdiff" id="collapseHCAdMildMod">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000">WCC <u>&lt;</u> 15, absence of rising creatinine and/or colitis.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Mild or resolving cases:</strong></span> <span style="color:#0000ff"><strong>No antibiotic treatment.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>First episode or first relapse:</strong></span><span style="color:#0000ff"> M<strong>etronidazole 400mg po tds (or 500mg 8 hourly IV).</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Second relapse/unresponsive to metronidazole: </strong></span><span style="color:#0000ff"><strong>Vancomycin 125mg po (<u>not</u> IV) qds.</strong></span></strong></strong></p>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCAdSevere">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdSevere" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdSevere" data-toggle="collapse" type="button">Severe Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdSevere" class="collapse" data-parent="#accordionHCAdCdiff" id="collapseHCAdSevere">
<div class="card-body text-left">
<p><strong><strong>Rapidly rising white cell count (often greater than 30x10*8/L), presence of rising creatinine and/or colitis.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Severe cases: </strong></span><span style="color:#0000ff"><strong>Metronidazole 500mg IV 8 hourly <u>plus</u> vancomycin 500mg po (<u>not</u> IV) qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Consideration should also be given to the early administration of </span><span style="color:#0000ff"><strong>intravenous immunoglobulin 400mg/kg stat</strong> </span><span style="color:#000000">in cases of severe/life threatening pseudomembranous colitis and toxic megacolon.</span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">If multiple relapses:</span><span style="color:#0000ff"> Fidaxomicin 200mg po bd&nbsp;for 10 days.&nbsp;</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#ff0000">FIDAXOMICIN MUST ONLY BE PRESCRIBED ON THE ADVICE OF THE CONSULTANT MICROBIOLOGIST.</span></strong></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Diverticulitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdDivertic">
<h2 class="text-center" id="HCAdDiverticLabel"><strong><strong>Diverticulitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdDivertic">
<div class="card">
<div class="card-header" id="HCAdDiverticMild">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdDiverticMild" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdDiverticMild" data-toggle="collapse" type="button">Mild and Moderate Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdDiverticMild" class="collapse" data-parent="#accordionHCAdDivertic" id="collapseHCAdDiverticMild">
<div class="card-body text-left">
<p><strong><strong><u><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#800080"><strong>Cefalexin 1g po tds </strong></span><strong>- this is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">if unable to take orally</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#800080"><strong>Cefuroxime 1.5g IV 8 hourly </strong></span><strong>- this is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis):</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#b22222"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong><u>plus</u> </strong></span><span style="color:#b22222"><strong>metronidazole 400mg po tds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If unable to take orally</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#b22222"><strong> Ciprofloxacin 400mg IV 12 hourly</strong></span><span style="color:#000000"><strong> <u>plus</u> </strong></span><span style="color:#b22222"><strong>metronidazole 500mg IV 8 hourly.</strong></span></strong></strong></p>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCAdDiverticSevere">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdDiverticSevere" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdDiverticSevere" data-toggle="collapse" type="button">Severe Infections</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdDiverticSevere" class="collapse" data-parent="#accordionHCAdDivertic" id="collapseHCAdDiverticSevere">
<div class="card-body text-left">
<div class="panel-body" data-bind="html: contentHtml">
<p><strong><strong><u><strong><span style="color:#000000">Antibiotic treatment</span></strong></u><strong>:</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment</strong></span><strong>:</strong><span style="color:#800080"><strong> Cefuroxime 1.5g IV 8 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> metronidazole 500mg IV 8 hourly </strong></span><strong>- this combination is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#800080">&nbsp;<strong>Cefalexin 1g po tds </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#800080"><strong> metronidazole 400mg po tds </strong></span><strong>- this combination is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u></strong></span>:</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#b22222"><strong>Ciprofloxacin 400mg IV 12 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> metronidazole 500mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#b22222"> <strong>Ciprofloxacin 500mg po bd </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> metronidazole 400mg po tds.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Enteric Fever--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdEntericFever">
<h2 class="text-center" id="HCAdEntericFeverLabel"><strong><strong>Enteric Fever (Typhoid / Paratyphoid)</strong></strong></h2>


<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Empiric therapy:</strong></span><span style="color:#0000ff"><strong> Ceftriaxone 2g IV od for 14 days</strong></span><strong>.</strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">If organism is susceptible:</span><span style="color:#0000ff"><strong> </strong></span><span style="color:#0000ff">Ciprofloxacin orally if possible 500mg bd; otherwise 400mg IV bd, for a&nbsp;total of 7 to 10 days</span>.</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Enteric fever from Indian subcontinent, Middle-East, and South-East Asia may be multiply-antibiotic-resistant and susceptibility should be tested. If infection occurs after travel to these areas give: </br></span><strong><span style="color:#0000ff">Azithromycin 1g po stat on the first day followed by 500mg po od thereafter (unlicensed indication).&nbsp; Treat for&nbsp;a total of 5 to 7 days.&nbsp; </span></strong><span style="color:#000000">This<strong><span style="color:#0000ff"> </span></strong>may be an option in mild or moderate disease caused by multidrug-resistant organisms.</span></strong></strong></p>

</div>
<br />
<strong><strong><!--Gastroenteritits--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdGastroenteritis">
<h2 class="text-center" id="HCAdGastroenteritisLabel"><strong><strong>Gastroenteritits</strong></strong></h2>


<p><strong><strong>Antibiotics are usually <strong><u>not</u></strong>&nbsp;indicated in uncomplicated/mild cases which are self-limiting and do not require antibiotic treatment.</strong></strong></p>

</div>
<br />
<strong><strong><!--Liver Abscess--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdLiverAb">
<h2 class="text-center" id="HCAdLiverAbLabel"><strong><strong>Liver Abscess</strong></strong></h2>


<p><strong><strong><span style="color:#0000ff"><strong>The antibiotic treatment below should be used until abscess is&nbsp;drained and&nbsp;culture and sensitivity&nbsp;results are available to guide further antibiotic treatment.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>1st line:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#0000ff"><strong>Piperacillin/tazobactam 4.5g IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (rash)</strong></span></u><span style="color:#000000"><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Cefuroxime 1.5g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV 12 hourly plus clindamycin 1.2g IV stat then 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration:</strong></span><span style="color:#b22222"><strong> </strong></span><span style="background-color:#ffffff; color:#333333">The duration of antibiotics will depend on the patient&#39;s clinical response and the adequacy of drainage. Parenteral therapy&nbsp;should be&nbsp;given initially. If the patient improves and fever and leukocytosis resolves, the patient can be stepped down&nbsp;to oral antibiotics guided by culture and sensitivity results.&nbsp; The typical duration of&nbsp;treatment is&nbsp;<strong><u>4 to 6 weeks</u></strong> of total antibiotic therapy including IV and oral antibiotics.</span></strong></strong></p>

</div>
<br />
<strong><strong><!--Non Typhoidal salmonella--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdNonTyp">
<h2 class="text-center" id="HCAdNonTypLabel"><strong><strong>Non-Typhoidal salmonellosis</strong></strong></h2>


<p><strong><strong>If the patient is asymptomatic or the illness&nbsp;is mild, antibiotics are not indicated.</strong></strong></p>

<p><strong><strong>Treatment should be given to the following patients:</strong></strong></p>

<ul>
    <li><strong><strong>infants less than&nbsp;one year old</strong></strong></li>
    <li><strong><strong>patients over 50 years old</strong></strong></li>
    <li><strong><strong>immunocompromised patients</strong></strong></li>
    <li><strong><strong>patients with vascular grafts or prosthetic joints</strong></strong></li>
    <li><strong><strong>patients with Salmonella&nbsp;bacteraemia</strong></strong></li>
    <li><strong><strong>patients with&nbsp;haemoglobinopathy (such as sickle cell disease)</strong></strong></li>
    <li><strong><strong>patients with clinical toxicity who are hospitalised with fever and severe diarrhoea.</strong></strong></li>
</ul>

<p><strong><strong>Antibiotic treatment:</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>1st line:</strong></span><span style="color:#0000ff"><strong>&nbsp;Co-trimoxazole 960mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>If IV treatment&nbsp;needed:</strong></span><span style="color:#0000ff"><strong> Co-trimoxazole 960mg IV 12 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>2nd line: </strong></span><span style="color:#8e44ad"><strong>Azithromycin 500mg po od.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>If IV treatment&nbsp;needed: </strong></span><span style="color:#8e44ad"><strong>Azithromycin 500mg IV once daily.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>3rd&nbsp;line:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#c0392b"><strong>Ciprofloxacin 500mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>If IV treatment needed:</strong></span><span style="color:#c0392b"><strong> Ciprofloxacin 400mg IV 12 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><span style="color:#000000"><strong>4th&nbsp;line:</strong></span><span style="color:#0000ff"><strong> </strong></span></span><span style="color:#27ae60"><strong>Ceftriaxone 2g IV once daily.</strong></span></strong></strong></p>

</div>
<br />
<strong><strong><!--Peritoneal Dialysis Peritonitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdPeritoneal">
<h2 class="text-center" id="HCAdPeritonealLabel"><strong><strong>Peritoneal Dialysis Peritonitis</strong></strong></h2>


<p><strong><strong><u><strong>Peritoneal dialysis-associated peritonitis</strong></u></strong></strong></p>

<p><strong><strong>Discuss with Renal unit at Central Manchester.</strong></strong></p>

</div>
<br />
<strong><strong><!--Perotinitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdPeritonitis">
<h2 class="text-center" id="HCAdPeritonitisLabel"><strong><strong>Peritonitis</strong></strong></h2>


<p><strong><strong><u><strong>Antibiotic treatment</strong></u><strong>:</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#800080"><strong>Cefuroxime 1.5g IV 8 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#800080"><strong> metronidazole 500mg IV 8 hourly</strong></span><strong> - this combination is suitable for patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:&nbsp;</strong></span><span style="color:#800080">&nbsp;<strong>Cefalexin 1g po tds </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#800080"><strong> metronidazole 400mg po tds </strong></span><strong>- this combination is suitable for patient&#39;s with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#b22222"><strong>Ciprofloxacin 400mg IV 12 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> metronidazole 500mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment</strong></span><strong>:</strong> <span style="color:#b22222"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> metronidazole 400mg po tds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>In severe cases and those requiring&nbsp;critical care</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Piperacillin/tazobactam 4.5g IV 8 hourly </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> </span><span style="color:#0000ff">metronidazole 500mg IV 8 hourly.&nbsp;</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u>:</strong><strong> </strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Meropenem 1g IV 8 hourly </span><u><span style="color:#000000">plus</span></u><span style="color:#800080"> metronidazole 500mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV 12 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> metronidazole 500mg IV 8 hourly.</strong></span></strong></strong></p>

</div>
<br />
<strong><strong><!--Shigellosis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdShigellosis">
<h2 class="text-center" id="HCAdShigellosisLabel"><strong><strong>Shigellosis</strong></strong></h2>


<p><strong><strong>Antibiotics are&nbsp;not indicated in&nbsp;uncomplicated disease. Treat according to sensitivities.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Antibiotic treatment</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>1st line:</strong></span><span style="color:#0000ff"><strong>&nbsp;Co-trimoxazole 960mg po bd for 3 days.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>2nd&nbsp;line:</strong></span><span style="color:#0000ff"><strong> Amoxicillin 1g po tds for 3 days.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>3rd line:</strong></span><span style="color:#0000ff"><strong> Ciprofloxacin 500mg po bd for 3 days.</strong></span></strong></strong></p>

<p><strong><strong><u>In children</u> amoxicillin or trimethoprim may be used if the organism is sensitive.&nbsp; Ciprofloxacin or azithromycin (unlicensed indication) are alternatives.</strong></strong></p>

</div>
<br />
<strong><strong><!--Spontaneous Bacterial Peritonitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdSpontBact">
<h2 class="text-center" id="HCAdSpontBactLabel"><strong><strong>Spontaneous Bacterial Peritonitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdSponBac">
<div class="card">
<div class="card-header" id="HCAdSponBacTx">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdSponBacTx" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdSponBacTx" data-toggle="collapse" type="button">Treatment</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdSponBacTx" class="collapse" data-parent="#accordionHCAdSponBac" id="collapseHCAdSponBacTx">
<div class="card-body text-left">
<div class="panel-body" data-bind="html: contentHtml">
<p><strong><strong><u><strong>Treatment:</strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Cefuroxime 1.5g IV 8 hourly then step down to cefalexin 1g po tds </span>- this is suitable in patients with penicillin allergy (rash).</strong></strong></strong></p>

<p><strong><strong><strong><u><span style="color:black">Penicillin allergy</span></u><span style="color:black">:</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:firebrick">Ciprofloxacin 400mg IV 12 hourly then step down to ciprofloxacin 500mg po bd.</span></strong></strong></strong></p>
</div>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCAdSponBacProph">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdSponBacProph" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdSponBacProph" data-toggle="collapse" type="button">Prophylaxis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdSponBacProph" class="collapse" data-parent="#accordionHCAdSponBac" id="collapseHCAdSponBacProph">
<div class="card-body text-left">
<div class="panel-body" data-bind="html: contentHtml">
<p><strong><strong><strong><span style="color:black">Prophylaxis after initial&nbsp;episode of SBP: </span></strong><span style="color:#800080"><strong>Ciprofloxacin 500mg po od.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Variceal Bleeding with Cirrhosis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdVaricealBleed">
<h2 class="text-center" id="HCAdVaricealBleedLabel"><strong><strong>Variceal Bleeding with Cirrhosis</strong></strong></h2>


<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><span style="color:#800080"><strong>Cefuroxime 1.5g IV 8 hourly.</strong></span></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong> </span></strong></strong></p>

<p><strong><strong><strong><span style="color:#b22222">Ciprofloxacin 400mg IV 12 hourly.</span></strong></strong></strong></p>

</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdGastroSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Gynae section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdFungalLabel" class="portfolio-modal modal fade " id="HCAdGynae" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdGastroLabel"><strong><strong>Gynaecological Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdGynaeSection"><strong><strong><a href="#HCAdBV">Bacterial Vaginosis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdInfBaCyst">Infected Bartholin&#39;s cyst/abscess</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Bacterial Vaginosis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdBV">
<h2 class="text-center" id="HCAdApendLabel"><strong><strong>Bacterial Vaginosis</strong></strong></h2>

<p><span style="color:rgb(0, 0, 255)"><strong>Metronidazole 400mg BD</strong></span> for 7 days</p>

<p>or</p>

<p><span style="color:rgb(0, 128, 0)"><strong>Metronidazole 2g STAT</strong></span></p>

<p>or</p>

<p><span style="color:rgb(128, 0, 128)"><strong>Metronidazole vaginal gel 0.75% 5g</strong></span> nightly for 5 nights</p>

<p>or</p>

<p><span style="color:rgb(178, 34, 34)"><strong>Clindamycin 2 % vaginal cream 5g </strong></span>nightly for 7 nights (expensive)</p>

<p>During pregnancy /breastfeeding avoid high dose regimens of metronidazole (2g stat dose). During lactation metronidazole enters breast milk and can alter the taste of breast milk, therefore avoid oral treatment in lactating women and use topical treatment instead.</p>
</div>
<br />
<strong><strong><!--Infected Bartholin&apos;s cyst/abscess--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdInfBaCyst">
<h2 class="text-center" id="HCAdInfBaCystLabel"><strong><strong>Infected Bartholin&#39;s cyst/abscess</strong></strong></h2>


<p><strong><strong><u><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment: </span><span style="color:#0000ff">cefalexin 1g po tds </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#0000ff"> cefuroxime 1.5g IV 8 hourly </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Note:</strong> cephalosporins can be given in penicillin allergy with a rash.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis):</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#c0392b"><strong>co-trimoxazole 960mg po bd </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#c0392b"><strong>clindamycin&nbsp;450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment: </span><span style="color:#c0392b">co-trimoxazole 960mg IV 12 hourly</span><span style="color:#000000">&nbsp;</span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> </span><span style="color:#c0392b">clindamycin 600mg IV&nbsp;6 hourly.</span></strong></strong></strong></p>

</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdGynaeSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Head and Neck section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdHeadNeckLabel" class="portfolio-modal modal fade " id="HCAdHead" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdHeadNeckLabel"><strong><strong>Head &amp; Neck Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdHeadSection"><strong><strong><a href="#HCAdFacialCellulitis">Facial / Orbital Cellulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdParot">Parotitis</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Facial / Orbital Cellulitis--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdFacialCellulitis">
<h2 class="text-center" id="HCAdFacCellLabel"><strong><strong>Facial / Orbital Cellulitis</strong></strong></h2>


<p><strong><strong><u><strong>Antibiotic treatment</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#0000ff"><strong>Co-amoxiclav 1.2g IV 8 hourly&nbsp;</strong></span><u><strong>plus</strong></u><span style="color:#0000ff"><strong> c</strong></span><strong><span style="color:#0000ff">lindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral treatment:&nbsp;</strong><span style="color:#0000ff"><strong>Co-amoxiclav</strong></span><strong><span style="color:#0000ff"> 625mg po tds&nbsp;</span><u>plus</u><span style="color:#0000ff"> clindamycin&nbsp;450mg po&nbsp;qds.&nbsp;</span></strong></strong></strong></p>

<p><strong><strong><strong>If intracranial extension of infection is suspected give: </strong><span style="color:#0000ff"><strong>ceftriaxone 2g IV stat then 2g IV 12 hourly </span><u>plus</u><span style="color:#0000ff"> clindamycin 1.2g IV stat </strong></span><u><strong>plus</strong></u><span style="color:#0000ff"><strong> 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (rash)</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#800080"><strong>Ceftriaxone&nbsp;2g&nbsp;IV 12 hourly&nbsp;</strong></span><u><strong>plus</strong></u><span style="color:#800080"><strong> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</strong></span><strong><span style="color:#0000ff"> </span></strong></strong></strong></p>

<p><strong><strong><strong>Oral treatment:<span style="color:#800080"> Cefalexin 1g po tds&nbsp;</span><u>plus</u><span style="color:#800080"> clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis)</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#ff0000"><strong>Levofloxacin 500mg IV 12 hourly</strong></span><span style="color:#b22222"><strong>&nbsp;</strong></span><strong><u>plus</u></strong><span style="color:#b22222"><strong> </strong></span><span style="color:#ff0000"><strong>clindamycin&nbsp;1.2g IV stat followed by 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment: </strong><span style="color:#ff0000"><strong>Levofloxacin 500mg po bd </strong></span><strong><u>plus</u></strong><span style="color:#ff0000"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><strong>If intracranial extension of infection is suspected give: </strong><span style="color:#ff0000"><strong>moxifloxacin 400mg IV stat&nbsp;followed by&nbsp;400mg IV once daily&nbsp;</strong></span><strong><u>plus</u></strong><span style="color:#ff0000"><strong> clindamycin 1.2g IV stat&nbsp;followed by&nbsp;900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong>A total of 10 days of antibiotic treatment (IV <u>and</u>&nbsp;oral)&nbsp;to cover both Group A Strep and Staph.aureus would be required in order to prevent recurrence.</strong></strong></strong></p>

</div>
<br />
<strong><strong><!--Infected Bartholin&apos;s cyst/abscess--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdParot">
<h2 class="text-center" id="HCAdParotLabel"><strong><strong>Parotitis</strong></strong></h2>


<p><strong><strong><strong>IV treatment:</strong>&nbsp;&nbsp;<span style="color:#0000ff"><strong>Flucloxacillin 2g IV 6 hourly </strong></span><span style="color:#000000"><strong>(note Staph aureus is the most common&nbsp;cause of acute suppurative parotitis).</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral step down: <span style="color:#0000ff">Flucloxacillin 1g po&nbsp;qds.</span></strong></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (rash):</strong></span></u></strong></strong></p>

<p><strong><strong><strong>IV treatment:&nbsp;&nbsp;<span style="color:#8e44ad">Cefuroxime 1.5g IV&nbsp;8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down:</strong>&nbsp;<span style="color:#8e44ad"><strong>Cefalexin 1g po tds.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis):</strong></span></u></strong></strong></p>

<p><strong><strong><strong>IV treatment:&nbsp;&nbsp;<span style="color:#e74c3c">Clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down:</strong>&nbsp;<span style="color:#e74c3c"><strong>Clindamycin 450mg po qds.</strong></span></strong></strong></p>

</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdHeadSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Obstetric section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdObstetricLabel" class="portfolio-modal modal fade " id="HCAdObstetric" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdObstetricLabel"><strong><strong>Obstetric Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left border border-info rounded">
<h3><strong><strong>Post-Partum Endometritis</strong></strong></h3>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdPostPart">
<div class="card">
<div class="card-header" id="HCAdMildPostPart">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdMildPostPart" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdMildPostPart" data-toggle="collapse" type="button">Mild / Moderate (No Sepsis Syndrome)</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdMildPostPart" class="collapse" data-parent="#accordionHCAdPostPart" id="collapseHCAdMildPostPart">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></strong></strong></p>

<p><strong><strong>This combination is also&nbsp;suitable for penicillin allergy (rash).</strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#0000ff"> Cefuroxime 1.5g IV stat then 1.5g IV 8 hourly </span></strong><strong>plus </strong><span style="color:#0000ff"><strong>metronidazole 500mg IV stat then 500mg IV 8 hourly</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span> <strong><span style="color:#0000ff">Cefalexin 1g po tds plus metronidazole 400mg po tds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><strong><span style="color:#b22222">Ciprofloxacin 400mg IV stat, then 400mg IV 12 hourly </span><span style="color:#000000"><u>plus</u></span> <span style="color:#b22222">metronidazole 500mg IV stat, then 500mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#b22222"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#b22222"><strong>metronidazole 400mg po tds.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdSeverePost">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdSeverePost" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdSeverePost" data-toggle="collapse" type="button">Severe / Sepsis Syndrome</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdSeverePost" class="collapse" data-parent="#accordionHCAdPostPart" id="collapseHCAdSeverePost">
<div class="card-body text-left">
<p><strong><strong>Antibiotic treament should cover for Strep Group A puerperal sepsis as well as for&nbsp;histotoxic clostridia (Clostridium perfringens).</strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Antibiotic treament</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Piperacillin/tazobactam&nbsp;4.5g IV stat, then 4.5g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>plus</u></span></strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Clindamycin 1.2g IV stat, plus 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>plus</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Gentamicin 5mg/kg IV single stat dose once only.&nbsp;</strong></span></strong></strong> If the patient is obese&nbsp;see section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose&nbsp;calculation.</p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#0000ff"><strong>Cefalexin 1g po tds&nbsp;</strong></span><span style="color:#000000"><strong><u>plus</u> </strong></span><span style="color:#0000ff"><strong>clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#800080"> </span></strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Ciprofloxacin 400mg IV stat, then 400mg IV 12 hourly</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>plus</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Clindamycin 1.2g IV stat, then 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>plus</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Gentamicin 5mg/kg IV single stat dose once only.</strong></span></strong></strong> If the patient is obese see section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a>for guidance on&nbsp;gentamicin&nbsp;dose calculation.</p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#800080"><strong> Ciprofloxacin 500mg po bd </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#800080"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Respiratory section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdRespitatoryLabel" class="portfolio-modal modal fade " id="HCAdResp" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdRespitatoryLabel"><strong><strong>Respiratory Tract Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdRespSection"><strong><strong><a href="#HCAdAcuteExacAShtma">Acute Exacerbation of Asthma</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdAspPneumon">Aspiration Pneumonia</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdEmpyema">Empyema</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdInfExacCOPD">Infective Exacerbation of COPD</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdInflu">Influenza</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdPneumonia">Pneumonia</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdPVL">PVL-Producing Staph Aureus Pneumonia</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Acute Exacerbation of Asthma--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdAcuteExacAShtma">
<h2 class="text-center" id="HCAdAcuteExacAShtmaLabel"><strong><strong>Acute Exacerbation of Asthma</strong></strong></h2>

<p><strong><strong>If respiratory infection is suspected in acute exacerbation of asthma, antibiotic treatment should follow the pneumonia guidelines. </strong></strong></p>

<p><strong><strong>See section on <a href="#HCAdPneumonia"> Treatment of pneumonia </a></strong></strong></p>

<p>&nbsp;</p>
</div>
<br />
<strong><strong><!--Aspiration Pneumonia--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdAspPneumon">
<h2 class="text-center" id="HCAdAspPneumonLabel"><strong><strong>Aspiration Pneumonia</strong></strong></h2>

<div class="accordion"><strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdAspPneu">
<div class="card">
<div class="card-header" id="HCAdAspPnCom">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAspPnCom" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAspPnCom" data-toggle="collapse" type="button">Community Acquired</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAspPnCom" class="collapse" data-parent="#accordionHCAdAspPneu" id="collapseHCAdAspPnCom">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#0000ff"> Co-amoxiclav 1.2g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <span style="color:#0000ff"><strong>Doxycycline 200mg po stat for the first dose&nbsp;then&nbsp;100mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><strong><u><span style="color:#000000">Penicillin allergy (rash)</span></u><span style="color:#000000">:</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#800080">Cefuroxime 1.5g IV 8 hourly</span> <u><span style="color:#000000">plus</span></u><span style="color:#800080"> </span></strong><span style="color:#800080"><strong>clindamycin 600mg IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <span style="color:#800080"><strong>Doxycycline 200mg po stat for the first dose&nbsp;then 100mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><strong><u>Penicillin allergy (anaphylaxis)</u>:<u><span style="color:#b22222"> </span></u></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#b22222"><strong>Co-trimoxazole 960mg IV&nbsp;12 hourly</strong></span>&nbsp;<strong><u><span style="color:#000000">plus</span></u><span style="color:#b22222"> </span></strong><span style="color:#b22222"><strong>clindamycin 600mg IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <span style="color:#b22222"><strong>Doxycycline 200mg po stat for the first dose then 100mg po bd.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdAspPnHosp">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAspPnHosp" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAspPnHosp" data-toggle="collapse" type="button">Hospital Acquired</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAspPnHosp" class="collapse" data-parent="#accordionHCAdAspPneu" id="collapseHCAdAspPnHosp">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong>IV treatment</strong>:</span><strong><span style="color:#0000ff"> Piperacillin/tazobactam 4.5g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <span style="color:#0000ff"><strong>Doxycycline 200mg po stat for the first dose&nbsp;then 100mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:&nbsp;</span><span style="color:#800080">Ceftazidime 2g IV 8 hourly </span><u><span style="color:#000000">plus</span></u><span style="color:#800080"> </span></strong><span style="color:#800080"><strong>clindamycin 600mg IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:<strong>&nbsp;</strong></strong></span><span style="color:#800080"><strong>Doxycycline 200mg po stat for the first dose then 100mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#b22222"><strong>Levofloxacin 500mg IV 12 hourly </strong></span><strong><u>plus</u><span style="color:#b22222"><strong> </strong></span><span style="color:#b22222">clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span>&nbsp;<span style="color:#b22222"><strong>Doxycycline 200mg po stat for the first dose then 100mg po bd.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
<br />
<strong><strong><!--Empyema--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdEmpyema">
<h2 class="text-center" id="HCAdEmpyemaLabel"><strong><strong>Empyema</strong></strong></h2>

<div class="accordion"><strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdEmp">
<div class="card">
<div class="card-header" id="HCAdEmpCom">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdEmpCom" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdEmpCom" data-toggle="collapse" type="button">Community Acquired</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdEmpCom" class="collapse" data-parent="#accordionHCAdEmp" id="collapseHCAdEmpCom">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#ff0000">Empiric antibiotic treatment should be modified by culture results.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#0000ff"> Co-amoxiclav 1.2g IV 8 houly </span><span style="color:#000000"><u>plus</u></span><span style="color:#0000ff"> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <strong><span style="color:#0000ff">Co-amoxiclav 625mg po tds </span><span style="color:#000000"><u>plus</u></span><span style="color:#0000ff"> clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (rash)</strong></span></u><span style="color:#000000"><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#800080"> C</span></strong><strong><span style="color:#800080">efuroxime 1.5g IV 8 hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080"> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span>&nbsp;<span style="color:#800080"><strong>Cefalexin 1g po tds </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong>&nbsp;clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:&nbsp;</strong></span><strong><span style="color:#a52a2a">Levofloxacin 500mg IV 12 hourly</span> <span style="color:#000000"><u>plus</u></span></strong>&nbsp;<strong><span style="color:#b22222">clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <span style="color:#b22222"><strong>Levofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong>&nbsp;</strong></span><span style="background-color:#ffffff; color:#b22222"><strong>clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Duration of treatment depends on the clinical response of the patient but may need to be continued for a number of weeks.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdEmpHosp">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdEmpHosp" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdEmpHosp" data-toggle="collapse" type="button">Hospital Acquired</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdEmpHosp" class="collapse" data-parent="#accordionHCAdEmp" id="collapseHCAdEmpHosp">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#ff0000">Empiric antibiotic treatment should be modified by culture results.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#0000ff">&nbsp;Piperacillin/tazobactam 4.5g IV 8 hourly &nbsp;</span><span style="color:#000000"><u>plus</u></span><span style="color:#0000ff">&nbsp;clindamycin 1.2g IV stat followed by 900mg IV 8 hourly</span></strong><span style="color:#0000ff"><strong>.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#0000cd"><strong> Levofloxacin 500mg po bd </strong></span><strong><span style="color:#000000"><u>plus</u></span></strong><span style="color:#0000cd"><strong>&nbsp;clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><strong><span style="color:#000000">Penicillin allergy (rash)</span></strong></u><strong><span style="color:#000000">:</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#800080"> Ceftazidime 2g IV 8 hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080"> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><strong><span style="color:#800080">Levofloxacin 500mg po bd </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080"> clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#b22222">Levofloxacin 500mg IV 12 hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#b22222"> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><strong><span style="color:#b22222"> Levofloxacin 500mg po bd </span><span style="color:#000000"><u>plus</u></span><span style="color:#b22222"> clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Duration of treatment depends on the clinical response of the patient but may need to be continued for a number of weeks.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
<br />
<strong><strong><!--Infective Exacerbation of COPD--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdInfExacCOPD">
<h2 class="text-center" id="HCAdInfExacCOPDLabel"><strong><strong>Infective Exacerbation of COPD</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong><u>Infective exacerbation of chronic obstructive pulmonary disease (COPD)</u></strong></span></strong></strong></p>

<p><strong><strong><strong>Degree of severity of COPD exacerbation is based on the following criteria (BAP65 score) each&nbsp;scoring one if&nbsp;present:</strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>B </strong></span><span style="color:#000000">= Blood urea &gt; 9mmol/L</span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">A</span> </strong><span style="color:#000000">= Altered mental state</span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">P</span><span style="color:#000000"> </span></strong><span style="color:#000000">= Pulse &gt; 109/min</span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">65</span> <span style="color:#000000">= </span></strong><span style="color:#000000">Age <u>&gt;</u> 65 years</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Mild Infection (BAP65 = 0-1)</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Amoxicillin po 1g tds,</strong></span><span style="color:#000000"><strong> </strong>if&nbsp;IV treatment necessary&nbsp;give </span><strong><span style="color:#0000ff">amoxicillin 1g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Severe Infection (BAP65 = 2-3)</strong></u></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment:</strong> <span style="color:#0000ff"><strong>Doxycycline 200mg po stat for the first dose then 100mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><strong>IV treatment:</strong> <strong><span style="color:#0000ff">Co-amoxiclav 1.2g IV 8 hourly. &nbsp;</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Mild infection (BAP65 = 0-1)</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Clarithromycin 500mg po bd </strong></span><span style="color:#000000">if IV treatment necessary&nbsp;give</span><strong><span style="color:#0000ff">&nbsp;</span><span style="color:#b22222">co-trimoxazole 960mg IV 12 hourly <span style="color:#000000">due to risk of macrolide associated phlebitis with IV clarithromycin.</span></span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Severe Infection (BAP65 = 2-3)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <strong><span style="color:#800080">Doxycycline 200mg po stat for the first dose then 100mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#b22222">Co-trimoxazole&nbsp;960mg IV 12 hourly.</span></strong></strong></strong></p>

<h2><strong><strong>Prophylaxis</strong></strong></h2>

<p><strong><strong>If a patient is deemed as being suitable for long-term antibiotic prophylaxis refer the patient to the respiratory physicians.</strong></strong></p>
</div>
<br />
<strong><strong><!--Influenza--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdInflu">
<h2 class="text-center" id="HCAdInfluLabel"><strong><strong>Influenza</strong></strong></h2>

<p><strong><strong>It is important to treat severely unwell patients with antiviral drugs where possible. Public Health England (PHE) recommends the early use of antivirals for patients with proven or suspected seasonal influenza who are in high risk groups or who are considerably unwell, (even if not in a high risk group);</strong></strong></p>

<p><strong><strong>Risk factors for complicated influenza are:</strong></strong></p>

<p><strong><strong>Neurological, hepatic, renal, pulmonary and chronic cardiac disease.</strong></strong></p>

<p><strong><strong>Diabetes mellitus.</strong></strong></p>

<p><strong><strong>Immunosuppression.</strong></strong></p>

<p><strong><strong>Age over 65 years.</strong></strong></p>

<p><strong><strong>Pregnancy (including up to two weeks post partum)</strong></strong></p>

<p><strong><strong>Morbid obesity (BMI &gt;=40).</strong></strong></p>

<p><strong><strong>Check the Trust intranet for the latest version of this guideline.</strong></strong></p>

<p><strong><strong>For more detailed guidance see:</strong></strong></p>

<p><strong><strong><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/370370/Guidance_antiviral.pdf" target="_blank">Antiviral Guidance PDF</a></strong></strong></p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdRespFlu">
<div class="card">
<div class="card-header" id="HCAdRespFluTx">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdRespFluTx" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdRespFluTx" data-toggle="collapse" type="button">Treatment</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdRespFluTx" class="collapse" data-parent="#accordionHCAdRespFlu" id="collapseHCAdRespFluTx">
<div class="card-body text-left">
<p><strong><strong>Treatment should be commenced within 48 hours of symptom onset.</strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Oseltamivir 75mg po BD for 5 days.</span></strong></strong></strong></p>

<p><strong><strong><strong>If the patient is unable to take orally </strong>or oseltamivir is not suitable for other reasons:</strong></strong></p>

<p><strong><strong><strong><span style="color:#990099">Zanamivir 10 mg (2 inhalations via diskhaler) BD for 5 days</span><span style="color:#0000ff"> </span></strong>(caution in asthma and COPD: there is a risk of bronchospasm so a short-acting bronchodilator should be available).</strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdRespFluProph">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdRespFluProph" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdRespFluProph" data-toggle="collapse" type="button">Prophylaxis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdRespFluProph" class="collapse" data-parent="#accordionHCAdRespFlu" id="collapseHCAdRespFluProph">
<div class="card-body text-left">
<ul>
    <li><strong><strong>Prophylaxis is normally not considered in at-risk groups (see below for these groups)&nbsp;who have been vaccinated against seasonal influenza at least 14 days before exposure.&nbsp;</strong></strong></li>
    <li><strong><strong>Prescribe an antiviral drug for post-exposure prophylaxis if all of the following circumstances apply:&nbsp; </strong></strong>
    <ul>
        <li><strong><strong>The national surveillance scheme indicates that influenza is circulating.</strong></strong></li>
        <li><strong><strong>The person has been exposed to a person (in the same household or residential setting) with&nbsp;an influenza-like illness.</strong></strong></li>
        <li><strong><strong>The person is in an &#39;at risk&#39; group&nbsp;(see below for these groups)&nbsp;and has not been&nbsp;adequately protected by vaccination, that is: </strong></strong>
        <ul>
            <li><strong><strong>They have not been vaccinated since the previous influenza season.</strong></strong></li>
            <li><strong><strong>The vaccination is not well matched to the circulating strain.</strong></strong></li>
            <li><strong><strong>There has been less than 14 days between vaccination and date of contact with influenza.</strong></strong></li>
        </ul>
        <strong><strong> </strong></strong></li>
        <li><strong><strong>The person is able to start treatment within 48&nbsp;hours of this contact (for oseltamivir) or 36&nbsp;hours of this contact (for zanamivir). </strong></strong>
        <ul>
            <li><strong><strong>Treatment after 48&nbsp;hours of this contact (for oseltamivir) or 36&nbsp;hours of this contact (for zanamivir) is an off-label use and should be done on specialist advice only.</strong></strong></li>
        </ul>
        <strong><strong> </strong></strong></li>
    </ul>
    <strong><strong> </strong></strong></li>
</ul>

<p><strong><strong>Prophylaxis is also recommended for residents in chronic care establishments (regardless of influenza vaccination) using oseltamivir within 48 hours of influenza-like illness being present in the establishment.</strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Oseltamivir 75mg OD for 10 days</strong></span> (within 48 hours of contact)</strong></strong></p>

<p><strong><strong><strong>or</strong></strong></strong></p>

<p><strong><strong><span style="color:#990099"><strong>Zanamivir 10mg (via diskhaler) OD for 10 days</strong></span> (within 36 hours of contact).</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>At risk groups include the following:</strong></u></span></strong></strong></p>

<ul>
    <li><strong><strong><span style="color:#000000"><strong>Chronic respiratory disease</strong>, including:</span> </strong></strong>

    <ul>
        <li><strong><strong><span style="color:#000000">Chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis, and bronchopulmonary dysplasia.</span></strong></strong></li>
        <li><strong><strong><span style="color:#000000">Asthma that requires continuous or repeated use of inhaled corticosteroids or with previous exacerbations requiring hospital admission.</span></strong></strong></li>
        <li><strong><strong><span style="color:#000000">Children who have previously been admitted to hospital for lower respiratory tract disease.</span></strong></strong></li>
    </ul>
    <strong><strong> </strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Chronic heart disease</strong>, including congenital heart disease, hypertension with cardiac complications, chronic heart failure, and individuals requiring regular medication or follow up for ischaemic heart disease.</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Chronic kidney disease</strong>, including nephrotic syndrome, chronic renal failure, and renal transplantation.</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Chronic liver disease</strong>, including cirrhosis, biliary atresia, and chronic hepatitis.</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Chronic neurological disease</strong>, including stroke and transient ischaemic attack.</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Diabetes</strong>, including type&nbsp;1 diabetes and type&nbsp;2 diabetes (requiring oral hypoglycaemic drugs or a controlled diet).</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Immunosuppression</strong>&nbsp;due to disease or treatment, including:</span> </strong></strong>
    <ul>
        <li><strong><strong><span style="color:#000000">People undergoing chemotherapy (or radiotherapy) leading to immunosuppression.</span></strong></strong></li>
        <li><strong><strong><span style="color:#000000">People with asplenia or splenic dysfunction.</span></strong></strong></li>
        <li><strong><strong><span style="color:#000000">HIV infection (all stages).</span></strong></strong></li>
        <li><strong><strong><span style="color:#000000">Individuals treated with, or likely to be treated with, systemic steroids for more than 1&nbsp;month at dosages equivalent to 20&nbsp;mg prednisolone daily (at any age) or, for children weighing less than 20&nbsp;kg, a dose of 1&nbsp;mg or more per kg body weight per day.</span></strong></strong></li>
    </ul>
    <strong><strong> </strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Morbid obesity (body mass index of 40 or more).</strong></span></strong></strong></li>
</ul>

<p><strong><strong><span style="color:#000000"><strong>Consideration should also be given to:</strong></span></strong></strong></p>

<ul>
    <li><strong><strong><span style="color:#000000">People living in long-stay residential or nursing homes.</span></strong></strong></li>
    <li><strong><strong><span style="color:#000000">People who receive a carer&rsquo;s allowance or care for disabled or elderley people, whose welfare may be at risk if the carer falls ill.</span></strong></strong></li>
</ul>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Pneumonia--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdPneumonia">
<h2 class="text-center" id="HCAdPneumoniaLabel"><strong><strong>Pneumonia</strong></strong></h2>
<strong><strong><!--Empyema--> </strong></strong>

<div class="text-left" id="HCAdPneu">
<div class="accordion"><strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdPneu">
<div class="card">
<div class="card-header" id="HCAdPneuCom">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdPneuCom" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdPneuCom" data-toggle="collapse" type="button">Community Acquired</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdPneuCom" class="collapse" data-parent="#accordionHCAdPneu" id="collapseHCAdPneuCom">
<div class="card-body text-left">
<p><strong><strong><strong>Degree of severity of&nbsp;pneumonia is based on the following criteria (CURB65 score) each&nbsp;scoring one if&nbsp;present:</strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>C </strong></span>= confusion (new or Mental Test Score <u>&lt;</u> 8)</strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">U</span> </strong>= urea &gt;7mmol/l</strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">R</span> </strong>= resp. rate 30/min</strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">B</span> </strong>= BP: SBP &lt; 90mmHg and/or DBP <u>&lt;</u> 60mmHg</strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">65</span> = </strong>Age <u>&gt;</u> 65 years</strong></strong></p>

<p><strong><strong><strong><span style="color:#c0392b"><u>Important specimens to be submitted to the laboratory</u>:</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#c0392b"><strong>1) Urine for Legionella and Pneumococcal <u>antigen</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#c0392b"><strong>2) Respiratory secretions (sputum or throat/nasal swab) for:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#c0392b"><strong>&nbsp;&nbsp;&nbsp; a)&nbsp;Respiratory virus PCR</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#c0392b"><strong>&nbsp;&nbsp;&nbsp; b) Mycoplasma pneumoniae PCR</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#c0392b"><strong>3) Sputum for culture (if patient is expectorating)</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#c0392b"><strong>4) Blood cultures (if clinical sepsis present).</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Low-severity (CURB65=0 to 1) outpatient treatment or admitted for&nbsp;other illness</strong></u></span><strong>:</strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Amoxicillin 1g po tds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Moderate-severity (CURB65=2)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment:</strong> <strong><span style="color:#0000ff">Amoxicillin 1g po tds </span><u><span style="color:#000000">plus</span></u> <span style="color:#0000ff">clarithromycin 500mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><strong>If unable to take orally and IV treatment needed:</strong> <strong><span style="color:#0000ff">Amoxicillin 1g IV 8 hourly</span><span style="color:#000000"> </span><u><span style="color:#000000">plus</span></u> <span style="color:#0000ff">clarithromycin</span><span style="color:#0000ff"> 500mg IV 12 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Note: </span><span style="color:#000000">Clarithromycin can&nbsp;be given IV; however oral administration is preferred because of <strong>risk of severe clarithromycin-associated phlebitis</strong> when given IV.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>High-severity (CURB65=3-5)</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Co-amoxiclav 1.2g IV 8 hourly </span><u><span style="color:#000000">plus</span></u> <span style="color:#0000ff">clarithromycin</span><span style="color:#0000ff"> 500mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Note: </span><span style="color:#000000">Clarithromycin can be given IV; however oral administration is preferred because of <strong>risk of severe clarithromycin-associated phlebitis</strong> when given IV.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span> <span style="color:#0000ff"><strong>Doxycycline 200mg po stat for the first dose then </strong></span><span style="color:#0000ff"><strong>100mg po bd</strong> </span><span style="color:#0000ff"><strong>as a </strong></span><strong><span style="color:#ff0000"><u>single agent</u>.</span></strong><span style="color:#ff0000"> </span>(Stop other antibiotics as clarithromycin plus doxycycline&nbsp;constitutes duplicative treatment).</strong></strong></p>

<p><strong><strong>In suspected or confirmed pneumococcal pneumonia antibiotic treatment may need to continue for 7-10 days in the more severely ill patient.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u><strong>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>Low-severity (CURB65=0 to 1) outpatient treatment or admitted for&nbsp;other illness</u>:</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#ff0000"><strong>Clarithromycin 500mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><strong><u>Moderate-severity (CURB65=2)</u>:</strong></strong></strong></p>

<p><strong><strong><strong>Oral treatment:</strong> <span style="color:#ff0000"><strong>Doxycycline 200mg po stat for the first dose then</strong></span><span style="color:#ff0000"><strong> 100mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#b22222"> </span><span style="color:#ff0000"><strong>Levofloxacin 500mg IV 12 hourly.&nbsp;</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>High-severity (CURB65=3 to 5):</u></strong></span></strong></strong></p>

<p><strong><strong><strong>IV treatment:</strong><span style="color:#ff0000"><strong> Levofloxacin&nbsp;500mg IV 12 hourly</strong></span><span style="color:#ff0000"><strong>.</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral step down:<span style="background-color:#ffffff">&nbsp;</span></strong><span style="background-color:#ffffff; color:#ff0000"><strong>Doxycycline 200mg po stat for the first dose then 100mg po bd </strong></span><span style="background-color:#ffffff"><strong>(as a single agent).</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">In suspected or confirmed pneumococcal pneumonia antibiotic treatment may need to continue for 7-10 days in the more severely ill patient.</span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdPneuHosp">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdPneuHosp" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdPneuHosp" data-toggle="collapse" type="button">Hospital Acquired</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdPneuHosp" class="collapse" data-parent="#accordionHCAdPneu" id="collapseHCAdPneuHosp">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong><u>IV treatment</u>:</strong></span><span style="color:#0000ff"><strong> Piperacillin/tazobactam 4.5g IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Oral treatment</u>:</strong></span><span style="color:#0000ff"><strong>&nbsp;</strong></span><span style="color:#0000ff"><strong>Doxycycline 200mg po stat for the first dose then 100mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><u><strong><span style="color:#000000">Penicillin allergy (rash)</span></strong></u><strong><span style="color:#000000">:</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>IV treatment</u>:</strong></span> <strong><span style="color:#800080">Ceftazidime 2g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Oral treatment</u>:</strong></span> <strong><span style="color:#800080">Doxycycline 200mg po&nbsp;stat for the first dose then 100mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u>:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>IV treatment</u>:</span></strong> <span style="color:#ff0000"><strong>Levofloxacin 500mg IV 12 hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>Oral step down</u>:</span><span style="color:#008000">&nbsp;</span><span style="color:#ff0000">Doxycycline 200mg po stat for the first dose then&nbsp;100mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Please note: Levofloxacin for hospital-acquired pneumonia is unlicensed use.</span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--PVL-Producing Staph Aureus Pneumonia--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdPVL">
<h2 class="text-center" id="HCAdPVLLabel"><strong><strong>PVL-Producing Staph Aureus Pneumonia</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong><u>Panton-Valentine leucocidin producing Staph. aureus-associated pneumonia</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Linezolid 600mg IV 12 hourly </span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>plus</u></span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Rifampicin 600mg IV 12 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Linezolid 600mg po bd </span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>plus</u></span></strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Rifamipicin 600mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#ff0000">Treatment duration is for 10 to 14 days.</span></strong></strong></strong></p>

</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdRespSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines STI section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdSTILabel" class="portfolio-modal modal fade " id="HCAdSTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdSTILabel"><strong><strong>Sexually Transmitted Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdSTISection"><strong><strong><a href="#HCAdSTIChlamid">Chlamydia</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSTIEpidid">Epididymo-Orchitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSTIGonorrhoea">Gonorrhoea</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSTIMycoplasma">Mycoplasma Genitalium</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSTIUreth">Non-Specific Urethritis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSTIPID">Pelvic Inflammatory Disease</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSTISyph">Syphilis</a></strong></strong></h4>

<p><strong><strong><strong>Written by Dr R. Rani GUM consultant</strong></strong></strong></p>

<p><strong><strong>Refer patients to Tameside &amp; Glossop centre for sexual health at:</strong></strong></p>

<p><strong><strong><span style="color:#ff0000"><strong>Ashton Primary Care Centre, 193 Old Street, Ashton-under-Lyne, OL6 7SR</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#ff0000"><strong>0161 342 7101</strong></span></strong></strong></p>

<p><strong><strong>for contact tracing and further management.</strong></strong></p>
</div>
<br />
<strong><strong><!--Chlamydia--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdSTIChlamid">
<h2 class="text-center" id="HCAdSTIChlamidLabel"><strong><strong>Chlamydia</strong></strong></h2>

<p><strong><strong><span style="color:#0000ff"><strong>Azithromycin 1g po stat</strong></span></strong></strong></p>

<p><strong><strong><strong>or</strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Doxycycline 100mg po bd for 7 days </strong></span>(note sunlight sensitivity).</strong></strong></p>

<p><strong><strong>Pregnancy: <span style="color:#0000ff"><strong>Azithromycin 1g po stat</strong></span></strong></strong></p>

<p><strong><strong>Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</strong></strong></p>
</div>
<br />
<strong><strong><!--Epididymo Orchitis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSTIEpidid">
<h2 class="text-center" id="HCAdSTIGonorrhoeaLabel"><strong><strong>Epididymo-Orchitis</strong></strong></h2>

<p><strong><strong><u><span style="color:black">Due to chlamydial infection</span></u><span style="color:black">:</span></strong></strong></p>

<p><strong><strong><strong><span style="color:blue">Ceftriaxone 500mg IM stat</span></strong><span style="color:black"> then </span><strong><span style="color:blue">Doxycycline 100mg po bd</span></strong><span style="color:black"> for <u>14 days.</u></span></strong></strong></p>

<p><strong><strong><span style="color:black">Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</span></strong></strong></p>

<p><strong><strong><u><span style="color:#333333">Due to Gram negative enteric organisms (urinary pathogens):</span></u></strong></strong></p>

<p><strong><strong><strong><u><span style="color:black">1st line:</span></u></strong><strong><span style="color:blue"> Co-trimoxazole 960mg po bd </span></strong><span style="color:black">for 10 days.</span></strong></strong></p>

<p><strong><strong><strong><u><span style="color:black">2nd line:</span></u></strong> <strong><span style="color:#8e44ad">Ciprofloxacin 500mg po bd </span></strong><span style="color:black">for 10 days</span></strong></strong></p>

<p><strong><strong><strong><span style="color:#333333">or</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#8e44ad">ofloxacin 200mg po bd</span></strong><strong> </strong><span style="color:black">for <u>14 days.</u></span></strong></strong></p>

<p><strong><strong><strong><u><span style="color:black">3rd line:</span></u></strong><strong> </strong><strong><span style="color:#e74c3c">Doxycycline 100mg BD</span></strong><span style="color:#333333"> for 10 days.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Gonorrhoea--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSTIGonorrhoea">
<h2 class="text-center" id="HCAdEmpyemaLabel"><strong><strong>Gonorrhoea</strong></strong></h2>

<div class="accordion"><strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdGonorrhoea">
<div class="card">
<div class="card-header" id="HCAdGonUncom">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdGonUncom" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdGonUncom" data-toggle="collapse" type="button">Uncomplicated Gonorrhoea</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdGonUncom" class="collapse" data-parent="#accordionHCAdGonorrhoea" id="collapseHCAdGonUncom">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:rgb(0, 0, 255)">Ceftriaxone 500mg IM single dose </span></strong>(with lignocaine as directed) <u><span style="color:rgb(0, 0, 0)"><strong>plus</strong></span></u><span style="color:rgb(0, 0, 255)"><strong> azithromycin 1g po&nbsp;stat once only.</strong></span></strong></strong></p>

<p><strong><strong>Same treatment in pregnancy and breastfeeding.</strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdGonPharyn">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdGonPharyn" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdGonPharyn" data-toggle="collapse" type="button">Pharyngeal Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdGonPharyn" class="collapse" data-parent="#accordionHCAdGonorrhoea" id="collapseHCAdGonPharyn">
<div class="card-body text-left">
<p><strong><strong><span style="color:rgb(0, 0, 255)"><strong>Ceftriaxone 500mg IM single dose </strong></span><u><span style="color:rgb(0, 0, 0)"><strong>plus</strong></span></u><span style="color:rgb(0, 0, 255)"><strong> azithromycin 1g po stat once only.</strong></span></strong></strong></p>

<p><strong><strong>Single dose treatment in uncomplicated infection.</strong></strong></p>

<p><strong><strong>Refer to Tameside &amp; Glossop centre for sexual health for partner notification.</strong></strong></p>

<p><strong><strong><span style="color:rgb(255, 0, 0)"><strong>Gonorrhoea may be associated with Chlamydia infection and therefore always treat for Chlamydia infection&nbsp;concomitantly.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
<br />
<strong><strong><!--Mycoplasma Genitalium--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSTIMycoplasma">
<h2 class="text-center" id="HCAdSTIMycoplasmaLabel"><strong><strong>Mycoplasma Genitalium</strong></strong></h2>

<p><strong><strong><strong><u><span style="color:#000000">1st line:</span></u><span style="color:#0033cc">&nbsp; <strong><span style="color:#0033cc">Doxycycline 100mg po bd for 7 days</span>&nbsp;</strong>(note sunlight sensitivity) followed by&nbsp;<span style="color:#0033cc"><strong>azithromycin 1g po single stat then&nbsp;500mg po od for 2 days.</strong></span></span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Or</strong></span></strong></strong></p>

<p><strong><strong><strong><u><span style="color:#000000">2nd line:</span></u><span style="color:#e74c3c"> Moxifloxacin 400mg po od&nbsp;for 10 days.</span></strong></strong></strong></p>

<p><strong><strong>Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</strong></strong></p>
</div>
<br />
<strong><strong><!--Non-Specific Urethritis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSTIUreth">
<h2 class="text-center" id="HCAdSTIUrethLabel"><strong><strong>Non-Specific Urethritis</strong></strong></h2>

<p><strong><strong><strong><span style="color:#0033ff">1. Ceftriaxone 500mg IM stat</span></strong>&nbsp;(to cover for Gonorrhoea)</strong></strong></p>

<p><strong><strong>plus&nbsp;</strong></strong></p>

<p><strong><strong><strong><span style="color:#0033ff">Doxycycline 100mg po bd for 7 days</span>&nbsp;</strong>(note sunlight sensitivity) followed by <span style="color:#0033ff"><strong>azithromycin 1g po single stat then&nbsp;500mg po od for 2 days </strong></span><span style="color:#000000">(to cover for Chlamydia and Mycoplasma genitalium).</span></strong></strong></p>

<p><strong><strong><strong>Or</strong></strong></strong></p>

<p><strong><strong><span style="color:#9b59b6"><strong>2. Ceftriaxone 500mg IM stat </strong></span><span style="color:#000000">(to cover for Gonorrhoea)</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">plus&nbsp;</span></strong></strong></p>

<p><strong><strong><span style="color:#9b59b6"><strong>Moxifloxacin 400mg po od&nbsp;for 10 days </strong></span><span style="color:#000000">(to cover for Chlamydia and Mycoplasma genitalium).</span></strong></strong></p>

<p><strong><strong>Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</strong></strong></p>
</div>
<br />
<strong><strong><!--PID--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSTIPID">
<h2 class="text-center" id="HCAdSTIPIDLabel"><strong><strong>Pelvic Inflammatory Disease</strong></strong></h2>

<p><strong><strong><strong><span style="color:#0000ff">Ceftriaxone 1g intramuscular or intravenous stat dose once only&nbsp;</span>plus </strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Doxycycline 100mg po bd</strong> </span><strong>plus </strong></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Metronidazole 400mg po bd</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Treatment duration is 14 days.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#ff0000"><strong>Avoid tetracyclines in pregnancy</strong></span></strong></strong></p>

<p><strong><strong>Refer to Tameside &amp; Glossop centre for sexual health for contact tracing.</strong></strong></p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdPID">
<div class="card">
<div class="card-header" id="HCAdPIDSever">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdPIDSever" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdPIDSever" data-toggle="collapse" type="button">Severe pelvic inflammatory disease requiring hospitalisation</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdPIDSever" class="collapse" data-parent="#accordionHCAdPID" id="collapseHCAdPIDSever">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#000000"><u>IV treatment:</u> </span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#800080">Ceftriaxone 2g&nbsp;IV&nbsp;once daily&nbsp;</span><span style="color:#000000">plus</span> <span style="color:#800080">doxycycline 100mg po bd</span></strong><span style="color:#800080"><strong>.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>Followed by oral treatment with</u>:</span><span style="color:#b22222"> </span></strong><span style="color:#800080"><strong>Doxycycline 100mg po bd </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#800080"><strong> metronidazole 400mg po bd.</strong></span></strong></strong></p>

<p><strong><strong>If patient is allergic to or cannot tolerate doxycycline:</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>IV treatment:</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#008000">Ceftriaxone 1g IV stat dose once only </span><span style="color:#000000">plus</span><span style="color:#008000"> ofloxacin 400mg IV 12 hourly&nbsp;</span>plus&nbsp;</strong><span style="color:#008000"><strong>metronidazole 500mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Followed by oral treatment with</u>:&nbsp; </strong></span><strong><span style="color:#008000">Ofloxacin 400mg&nbsp;po bd&nbsp;</span>plus&nbsp;</strong><span style="color:#008000"><strong>metronidazole 400mg po bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>If pregnant:</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Ceftriaxone 2g IV once daily</span><span style="color:#3300ff"> </span>plus<span style="color:#3300ff">&nbsp;</span><span style="color:#0000ff">clindamycin 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><u><strong>Followed by oral treatment with:</strong></u> <strong><span style="color:#0000ff">azithromycin 250mg od<strong> </strong></span>plus<span style="color:#3300ff"><strong> </strong></span><span style="color:#0000ff">metronidazole 400mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration&nbsp;is 14 days in total including both IV and oral treatment.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>NOTE:</u> If patients fail to respond to treatment with the above antibiotic regimens, please contact the Antimicrobial Management Team for further guidance.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Syphilis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSTISyph">
<h2 class="text-center" id="HCAdSTISyphLabel"><strong><strong>Syphilis</strong></strong></h2>

<p><strong><strong>Refer to Tameside &amp; Glossop centre for sexual health (gum clinic) for contact tracing and further management.</strong></strong></p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdSyph">
<div class="card">
<div class="card-header" id="HCAdSTISyphPrimary">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdSTISyphPrimary" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdSTISyphPrimary" data-toggle="collapse" type="button">Primary, Secondary or Latent Syphilis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdSTISyphPrimary" class="collapse" data-parent="#accordionHCAdSyph" id="collapseHCAdSTISyphPrimary">
<div class="card-body text-left">
<p><strong><strong><u>Incubating + primary, secondary or early latent syphilis</u></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Benzathine penicillin 2.4MU IM stat</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy</u></strong>: </span>Doxycycline 100mg po bd 14 days</strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdSTISyphLatent">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdSTISyphLatent" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdSTISyphLatent" data-toggle="collapse" type="button">Late Latent Syphilis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdSTISyphLatent" class="collapse" data-parent="#accordionHCAdSyph" id="collapseHCAdSTISyphLatent">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#0000ff">Benzathine penicillin 2.4MU IM weekly x3 (day 1,8 +15)</span></strong></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdSTISection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines Soft Tissue section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdSkinLabel" class="portfolio-modal modal fade " id="HCAdSkin" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdSTILabel"><strong><strong>Skin and Soft Tissue Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCAdSkinSection"><strong><strong><a href="#HCAdBites">Bite Wounds</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdCellulitis">Cellulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdClosMyo">Clostridial Myonecrosis (Gas Gangrene)</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdDiabeticFoot">Diabetic Foot Infections</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdErysipelas">Erysipelas</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSkinFacialOrb">Facial / Orbital Cellulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSkinGroupA">Invasive Strep Group A Infections (iGAS)</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdNecrotising">Necrotising Fasciitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdSkinNoneGroupA">Non-invasive Strep Group A Infections.</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdScarletFever">Scarlet Fever</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdShingles">Shingles</a></strong></strong></h4>

<h4><strong><strong><a href="#HCAdWoundInf">Wound Infections</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Bite Wounds--> </strong></strong>

<div class="text-left border border-info rounded" id="HCAdBites">
<h2 class="text-center" id="HCAdBitesLabel"><strong><strong>Bite Wounds</strong></strong></h2>

<p><strong><strong><strong><u><span style="color:black">Note:</span></u></strong><strong><u><span style="color:#e74c3c"> see also section below under the heading animal and human bites to the hand including clenched fist injuries.</span></u></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Tetanus Prophylaxis</u></strong></span></strong></strong></p>

<p><strong><strong>See tetanus prophylaxis section on <a data-dismiss="modal" data-target="#HCMedProph" data-toggle="modal" href="#HCMedProph"> in the &#39;Medical Prophylaxis Guideline&#39; section.</a></strong></strong></p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdBite">
<div class="card">
<div class="card-header" id="HCAdAnBites">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAnBites" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAnBites" data-toggle="collapse" type="button">Animal and Human Bites</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAnBites" class="collapse" data-parent="#accordionHCAdBite" id="collapseHCAdAnBites">
<div class="card-body text-left">
<p><strong><strong><u><span style="color:#000000"><strong>Antibiotic treatment</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#0000ff"><strong>Co-amoxiclav 625mg po tds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment (if cannot take orally): </strong></span><span style="color:#0000ff"><strong>Co-amoxiclav 1.2g IV 8 hourly.&nbsp;</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment: </span><span style="color:#800080">Doxycycline 200mg po for the first dose then 100mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment (if cannot take orally):</span> <span style="color:#800080">Co-trimoxazole 960mg IV 12 hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080"> clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdAnBitesHand">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAnBitesHand" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAnBitesHand" data-toggle="collapse" type="button">Animal and Human Bites to the Hand</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAnBitesHand" class="collapse" data-parent="#accordionHCAdBite" id="collapseHCAdAnBitesHand">
<div class="card-body text-left">
<p><strong><strong><span style="color:#333333">Animal and human bites to the hand including clenched fist injuries (&#39;fight-bite&#39;) are at <u>greater risk for development of complications</u> associated with infection particularly septic arthritis, osteomyelitis and tendon sheath infection.</span></strong></strong></p>

<p><strong><strong><span style="color:#333333">These patients would require <u>hospital admission</u> for intravenous antibiotic treatment as well as <u>orthopaedic review</u> with assessment of surgical intervention including joint washout and tissue debridement.</span></strong></strong></p>

<p><strong><strong><u><u><span style="color:#000000"><strong>Antibiotic treatment</strong></span></u></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#0000ff"><strong>Co-amoxiclav 1.2g IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span> <span style="color:#800080">Co-trimoxazole 960mg IV 12 hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080"> clindamycin 600mg IV 6 hourly.</span></strong></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Cellulitis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdCellulitis">
<h2 class="text-center" id="HCAdCellulitisLabel"><strong><strong>Cellulitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdCell">
<div class="card">
<div class="card-header" id="HCAdAnCellMild">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAnCellMild" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAnCellMild" data-toggle="collapse" type="button">Mild / Moderate Infections</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAnCellMild" class="collapse" data-parent="#accordionHCAdCell" id="collapseHCAdAnCellMild">
<div class="card-body text-left">
<p><strong><strong><span style="color:#0000ff"><strong>Flucloxacillin 1g po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#800080"><strong>Clindamycin 300mg po qds.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdAnCellSevere">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdAnCellSevere" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdAnCellSevere" data-toggle="collapse" type="button">Severe Infections</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdAnCellSevere" class="collapse" data-parent="#accordionHCAdCell" id="collapseHCAdAnCellSevere">
<div class="card-body text-left">
<p><strong><strong><u><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#0000ff"><strong> Flucloxacillin 2g IV stat followed by 2g IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#0000ff"><strong>Flucloxacillin 1g po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><strong><span style="color:#000000">Penicillin allergy</span></strong></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#800080"><strong> Clindamycin 600mg IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#800080"><strong>Clindamycin 450mg po qds.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Clostridial Myonecrosis (Gas Gangrene)--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdClosMy">
<h2 class="text-center" id="HCAdClosMyLabel"><strong><strong>Clostridial Myonecrosis (Gas Gangrene)</strong></strong></h2>

<p><strong><strong><u><span style="color:#000000"><strong>Antibiotic treatment</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#0000ff">Benzypenicillin 2.4g IV stat followed by 2.4g IV 4 hourly </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span> <strong><span style="color:#0000ff">Amoxicillin 2g po tds </span><u><span style="color:#000000">plus</span></u><span style="color:#0000ff"> clindamycin 450mg po qds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#800080"><strong>Cefuroxime 1.5g IV stat followed by 1.5g IV 6 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#800080"><strong> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span> <span style="color:#800080"><strong>Cefalexin 1g po tds</strong></span><span style="color:#000000"><strong> <u>plus</u> </strong></span><span style="color:#800080"><strong>clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis)</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#b22222"><strong>Chloramphenicol 1g IV stat followed by 1g IV 6 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> clindamycin 1.2g&nbsp;IV stat followed by 900mg IV 8 hourly.</strong></span><span style="color:#0000ff"><strong> </strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on the dose and the monitoring of drug plasma levels of glycopeptides (such as vancomycin).</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#b22222"><strong> Chloramphenicol 500mg&nbsp;po qds&nbsp;</strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Diabetic Foot Infections--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdDiabeticFoot">
<h2 class="text-center" id="HCAdDiabeticFootLabel"><strong><strong>Diabetic Foot Infections</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Diabetic foot infections&nbsp;in&nbsp;a large measure follow the antibiotic treatment guidelines of wound infections, however consultation of&nbsp;the <strong>Clinical guidelines for the in-patient management of diabetic foot infections</strong> is also advised.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Erysipelas--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdErysipelas">
<h2 class="text-center" id="HCAdErysipelasLabel"><strong><strong>Erysipelas</strong></strong></h2>

<p><strong><strong><strong>Erysipelas is caused by Strep Group A.</strong></strong></strong></p>

<p><strong><strong><u><strong>Antibiotic treatment</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#0000ff"><strong>Benzylpenicillin </strong></span><span style="color:#0000ff"><strong>1.2 g IV stat followed by 1.2g IV 6 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:&nbsp;</strong></span><span style="color:#0000ff"><strong>A</strong></span><strong><span style="color:#0000ff">moxicillin 1g po tds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#800080"><strong>Cefuroxime 1.5g IV stat followed by 1.5g IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment:</span><span style="color:#800080"> Cefalexin 1g po tds.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#b22222"><strong>Clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#b22222"><strong>Clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>A total of 10 days of antibiotic treatment would be required in order to prevent recurrence of infection by Group A Strep.</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Facial / Orbital Cellulitis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSkinFacialOrb">
<h2 class="text-center" id="HCAdSkinFacialOrbLabel"><strong><strong>Facial / Orbital Cellulitis</strong></strong></h2>

<p><strong><strong>See <a data-dismiss="modal" data-target="#HCAdHead" data-toggle="modal" href="#HCAdHead"> Facial / Orbital cellulitis </a> in head and neck section.</strong></strong></p>
</div>
<br />
<strong><strong><!--iGas--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSkinGroupA">
<h2 class="text-center" id="HCAdNecrotisingLabel"><strong><strong>Invasive Group A Strep Infections (iGAS)</strong></strong></h2>

<p><strong><strong><strong><u>Management of Invasive Group A Strep (iGAS) Infections is as follows:</u></strong></strong></strong></p>

<p><strong><strong>Invasive Group A Strep infections include:</strong></strong></p>

<ul>
    <li><strong><strong>Strep Group A bacteraemia</strong></strong></li>
    <li><strong><strong>Bacteraemic spreading cellulitis with a well-demarcated intensely erythematous edge</strong></strong></li>
    <li><strong><strong>Bacteraemic facial erysipelas</strong></strong></li>
    <li><strong><strong>Necrotizing fasciitis.</strong></strong></li>
    <li><strong><strong>Pneumonia and empyema.</strong></strong></li>
    <li><strong><strong>Strep Group A toxic shock syndrome.</strong></strong></li>
    <li><strong><strong>Bacteraemic puerperal sepsis.</strong></strong></li>
</ul>

<p><strong><strong><u><strong>Management:</strong></u></strong></strong></p>

<p><strong><strong><strong>1) Antibiotic treatment with:</strong>&nbsp;h<span style="color:#000000">igh dose </span><strong><span style="color:#0033ff">benzylpenicillin 2.4g IV stat, then 2.4g IV <u>4 hourly</u></span></strong><span style="color:#000000"> <strong>plus</strong> high dose </span><strong><span style="color:#0033ff">clindamycin 1.2g IV stat, then 1.2g IV <u>6 hourly</u>.</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down:&nbsp;</strong><span style="color:#0000ff"><strong>amoxicillin 2g po&nbsp;tds </strong></span><strong>plus</strong><strong> </strong><span style="color:#0000ff"><strong>clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (rash)</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#800080"><strong>cefuroxime 1.5g IV&nbsp;stat followed by 1.5g IV&nbsp;6 hourly </strong></span><strong>plus</strong><span style="color:#800080"><strong>&nbsp;</strong></span><span style="color:#800080"><strong>clindamycin 1.2g IV stat followed by 1.2g&nbsp;IV 6&nbsp;hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral step down:</strong><span style="color:#800080"><strong> cefalexin 1g po qds </strong></span><strong>plus</strong><span style="color:#800080"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis)</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><strong><span style="color:#c0392b">linezolid 600mg IV&nbsp;stat followed by 600mg&nbsp;IV 12&nbsp;hourly</span><span style="color:#800080"><strong> </strong></span>plus</strong><span style="color:#800080"><strong>&nbsp;</strong></span><span style="color:#c0392b"><strong>clindamycin 1.2g IV stat followed by 1.2g&nbsp;IV 6&nbsp;hourly.</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral step down:</strong><span style="color:#c0392b"><strong> linezolid 600mg po bd</strong></span><span style="color:#800080"><strong>&nbsp;</strong></span><strong>plus</strong><span style="color:#c0392b"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><strong>2) Urgent surgical review in cases of:</strong></strong></strong></p>

<ul>
    <li><strong><strong>Necrotizing fasciitis</strong></strong></li>
    <li><strong><strong>Thoracic empyema.</strong></strong></li>
</ul>

<p><strong><strong><strong>3) Consider immunoglobulin administration in a single dose of 400mg/kg IV stat</strong></strong></strong></p>

<p><strong><strong>iGAS is a notifiable condition and must be reported to Public Health England (tel: 0344 225 0562).</strong></strong></p>
</div>
<br />
<strong><strong><!--Necrotising Fasciitis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdNecrotising">
<h2 class="text-center" id="HCAdNecrotisingLabel"><strong><strong>Necrotising Fasciitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdNecrotising">
<div class="card">
<div class="card-header" id="HCAdNecGrpA">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdNecGrpA" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdNecGrpA" data-toggle="collapse" type="button">Necrotising Fasciitis - Group A Strep</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdNecGrpA" class="collapse" data-parent="#accordionHCAdNecrotising" id="collapseHCAdNecGrpA">
<div class="card-body text-left">
<p><strong><strong><u><span style="color:#000000"><strong>Necrotising fasciitis due to Strep Group A</strong></span></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000"><u>Antibiotic treatment</u></span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>&nbsp;IV treatment:&nbsp;</strong></span><strong><span style="color:#0000ff">benzylpenicillin 2.4g IV stat followed by 2.4g&nbsp;IV 4&nbsp;hourly&nbsp;</span></strong><span style="color:#000000"><u><strong>plus</strong></u><strong>&nbsp;</strong></span><strong><span style="color:#0000ff">clindamycin 1.2g IV stat followed by 1.2g IV 6&nbsp;hourly</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:&nbsp;</span></strong><span style="color:#0000ff"><strong>amoxicillin 2g po&nbsp;tds </strong></span><span style="color:#000000"><strong>plus</strong><strong> </strong></span><span style="color:#0000ff"><strong>clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (rash)</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#800080"><strong>cefuroxime 1.5g IV&nbsp;stat followed by 1.5g IV&nbsp;6 hourly </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#800080"><strong>&nbsp;</strong></span><span style="color:#800080"><strong>clindamycin 1.2g IV stat followed by 1.2g&nbsp;IV 6&nbsp;hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#800080"><strong> cefalexin 1g po qds </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#800080"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><strong><span style="color:#c0392b">linezolid 600mg IV&nbsp;stat followed by 600mg&nbsp;IV 12&nbsp;hourly</span><span style="color:#800080"><strong> </strong></span>plus</strong><span style="color:#800080"><strong>&nbsp;</strong></span><span style="color:#c0392b"><strong>clindamycin 1.2g IV stat followed by 1.2g&nbsp;IV 6&nbsp;hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#c0392b"><strong> linezolid 600mg po bd</strong></span><span style="color:#800080"><strong>&nbsp;</strong></span><strong>plus</strong><span style="color:#800080"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdNecPoly">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdNecPoly" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdNecPoly" data-toggle="collapse" type="button">Necrotising Fasciitis  Polymicrobial.</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdNecPoly" class="collapse" data-parent="#accordionHCAdNecrotising" id="collapseHCAdNecPoly">
<div class="card-body text-left">
<p><strong><strong>Polymicrobial necrotizing fasciitis is caused by mixed aerobic and anaerobic bacteria.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#0000ff">Piperacillin/Tazobactam 4.5g IV stat followed by 4.5g IV&nbsp;</span><span style="color:#ff0000">6 hourly (QDS)</span><span style="color:#0000ff"><strong> </strong></span><u><span style="color:#000000">plus</span></u><span style="color:#000000"> </span><span style="color:#0000ff">clindamycin 1.2g IV stat followed by 1.2g&nbsp;IV 6&nbsp;hourly.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treament: </strong></span><span style="color:#0000ff"><strong>Co-amoxiclav 625mg po tds </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#0000ff"><strong> clindamycin&nbsp;450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#800080"><strong>Ceftazidime 2g IV stat followed by 2g IV&nbsp;8 hourly </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#800080"><strong> clindamycin 1.2g IV stat followed by 1.2g&nbsp;IV 6&nbsp;hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#800080"><strong> Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#800080"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis)</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV stat followed by 400mg IV 12 hourly </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#b22222"><strong> clindamycin 1.2g IV stat followed by 1.2g&nbsp;IV 6&nbsp;hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#b22222"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#b22222"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Non-Invasive Strep A Infections--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdSkinNoneGroupA">
<h2 class="text-center" id="HCAdSkinNoneGroupALabel"><strong><strong>Non-Invasive Strep Group A Infections</strong></strong></h2>

<p><strong><strong>Strep Group A infections can be clinically classified into 2 main groups:</strong></strong></p>

<ul>
    <li><strong><strong>Non-invasive and treatable with oral antibiotics and includes: </strong></strong>

    <ul>
        <li><strong><strong>Pharyngotonsillitis</strong></strong></li>
        <li><strong><strong>Cellulitis</strong></strong></li>
        <li><strong><strong>Skin and wound infections (such as impetigo and chronic leg ulcers)</strong></strong></li>
        <li><strong><strong>Scarlet fever (toxin mediated infection).</strong></strong></li>
    </ul>
    <strong><strong> </strong></strong></li>
    <li><strong><strong>Invasive and potentially life-threatening including: </strong></strong>
    <ul>
        <li><strong><strong>Necrotizing fasciitis</strong></strong></li>
        <li><strong><strong>Bacteraemia (including bacteraemic pneumonia)</strong></strong></li>
        <li><strong><strong>Facial erysipelas</strong></strong></li>
        <li><strong><strong>Streptococcal toxic shock syndrome.</strong></strong></li>
    </ul>
    <strong><strong> </strong></strong></li>
</ul>

<p><strong><strong>Differentiation between non-invasive and invasive Strep Group A infection is important for appropriate clinical management. Because of the potential for non-invasive Strep Group A infections to be become invasive all clinical laboratory&nbsp;<u>culture proven</u>&nbsp;Strep Group A infections must be treated with antibiotics as follows:</strong></strong></p>

<p><strong><strong><span style="color:#0033ff"><strong>Amoxicillin 1g po tds&nbsp;</strong></span>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see section on <a data-dismiss="modal" data-target="#HCAdENT" data-toggle="modal" href="#HCAdENT"> Tonsillitis </a> in the inpatient guideline).</strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (rash)</strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#9b59b6">Cefalexin 1g po tds</span> </strong>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see section on <a data-dismiss="modal" data-target="#HCAdENT" data-toggle="modal" href="#HCAdENT"> Tonsillitis </a> in the inpatient guideline).</strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis)</strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#c0392b">Clarithromycin 500mg po bd</span> </strong>for 10 days. (<strong>NOTE:</strong>&nbsp;for treatment of Strep Group A tonsillitis see section on <a data-dismiss="modal" data-target="#HCAdENT" data-toggle="modal" href="#HCAdENT"> Tonsillitis </a> in the inpatient guideline).</strong></strong></p>
</div>
<br />
<strong><strong><!--Scarlet Fever--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdScarletFever">
<h2 class="text-center" id="HCAdScarletFeverLabel"><strong><strong>Scarlet Fever</strong></strong></h2>

<p><strong><strong>See <a data-dismiss="modal" data-target="#HCAdENT" data-toggle="modal" href="#HCAdENT"> Tonsillitis </a>section on the ENT page</strong></strong></p>
</div>
<br />
<strong><strong><!--Shingles--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdShingles">
<h2 class="text-center" id="HCAdShinglesLabel"><strong><strong>Shingles</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong>&nbsp;</span><span style="color:#0000ff"><strong> Aciclovir 800mg five times a day for 7 days.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><span style="color:#0000ff"><strong>Aciclovir 5mg/kg 8 hourly for 5 days.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">If the patient is&nbsp;immunocompromised:</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment: </span><span style="color:#b22222">Aciclovir 800mg five times a day continued for 2 days after crusting of lesions (usually 10 days).</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment: </span><span style="color:#b22222">Aciclovir 10mg/kg 8 hourly for 5 days.</span></strong></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Infection control measures:</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Only a person who has <u>not</u> had chickenpox or varicella vaccine in the past&nbsp;(i.e. is non-immune)&nbsp;is susceptible to chickenpox infection from a person with active&nbsp;shingles; however spread is via&nbsp;direct skin contact with the lesions and <u>not</u> via the respiratory route as is the case with chickenpox.&nbsp;Infection prevention measures are therefore&nbsp;primarily aimed at skin contact precautions.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>The person with shingles is infectious until lesions have crusted over; however if the rash is covered then the risk of transmission is very low.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>References:</strong></span></u></strong></strong></p>

<p><strong><strong>British National Formulary. Available at URL: <a href="https://www.medicinescomplete.com/mc/bnf/current/" target="_blank">https://www.medicinescomplete.com/mc/bnf/current/</a> &nbsp; [Accessed: 23/08/16]</strong></strong></p>

<p><strong><strong>NICE Clinical Knowledge Summaries.&nbsp; Shingles. (May 2013).</strong></strong></p>
</div>
<br />
<strong><strong><!--Wound Infections--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCAdWoundInf">
<h2 class="text-center" id="HCAdWoundInfLabel"><strong><strong>Wound Infections</strong></strong></h2>
<p>Wound infections include surgical site infections, chronic skin ulcers and infected pressure sores.</p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdWound">
<div class="card">
<div class="card-header" id="HCAdWoundSurg">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdWoundSurg" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdWoundSurg" data-toggle="collapse" type="button">Surgical Site Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdWoundSurg" class="collapse" data-parent="#accordionHCAdWound" id="collapseHCAdWoundSurg">
<div class="card-body text-left">
<p><strong><strong>For superficial surgical&nbsp;site infections the commonest aetiologic organism is Staph aureus and treatment should follow the cellulitis guideline. See section on <a href="#HCAdCellulitis"> Cellulitis </a></strong></strong></p>

<p><strong><strong>For deep surgical site&nbsp;infection antibiotic treatment should cover the organisms associated with that anatomic site such as the GI tract and respiratory tract.&nbsp; See section on <a data-dismiss="modal" data-target="#HCProphSurg" data-toggle="modal" href="#HCProphSurg"> Surgical prophylaxis </a></strong></span></a>&nbsp;and use the same antibiotics recommended for surgical prophylaxis to treat deep surgical site infections.</strong></strong></p>

<p><strong><strong>The&nbsp;duration&nbsp;of antibiotic&nbsp;treatment&nbsp;depends on the clinical response.</strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdWoundInf">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdWoundInf" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdWoundInf" data-toggle="collapse" type="button">Wound Infections</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdWoundInf" class="collapse" data-parent="#accordionHCAdWound" id="collapseHCAdWoundInf">
<div class="card-body text-left">
<p><strong><strong>In the ABSENCE of spreading cellulitis, induration or constitutional symptoms associated with the lesion, NO systemic antibiotic treatment would be required, and <u>TOPICAL/LOCAL MANAGEMENT</u> of the lesion would be more appropriate.&nbsp;<span style="color:#000000"><strong>Topical treatment </strong></span>includes&nbsp;maintenance of good wound toilet together with application of appropriate dressings in consultation with the tissue&nbsp;viability department.&nbsp; <span style="color:#000000"><strong>Local&nbsp;management </strong></span>of the wound includes surgical debridement, vascular surgical assessment as well as close diabetic monitoring.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#0000ff"><strong> Co-amoxiclav 1.2g IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span><span style="color:#0000ff"><strong> Co-amoxiclav 625mg po tds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#800080"><strong>Cefuroxime 1.5g IV 8 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#800080"><strong>Cefalexin 1g po tds </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treament:</strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#b22222"><strong>Ciprofloxacin IV 400mg stat followed by 400mg IV 12 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treament:</strong></span> <span style="color:#b22222"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>If clinical toxicity is present i.e. sepsis syndrome (SIRS plus invasive infection):</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#0000ff"><strong>Piperacillin/tazobactam 4.5g IV stat followed by 4.5g IV 8 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#0000ff"><strong> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#0000ff"><strong> gentamicin 5mg/kg (4mg/kg if <u>&gt;</u> 70 years)&nbsp;IV single stat dose once only. (4mg/kg if > 70 years.) Max dose  400mg&nbsp;<span style="color:#0000ff"><strong>&nbsp;</strong></span></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><strong>If the patient is obese then See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose&nbsp;calculation.</strong></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#800080"><strong>Cefuroxime 1.5g IV 8 hourly </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#800080"><strong> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#800080"><strong>gentamicin 5mg/kg (4mg/kg if <u>&gt;</u> 70 years)&nbsp;IV single stat dose once only. (4mg/kg if > 70 years.) Max dose  400mg&nbsp;<span style="color:#0000ff"><strong>&nbsp;</strong></span></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><strong>If the patient is obese then See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose&nbsp;calculation.</strong></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#800080"><strong>Cefalexin 1g po tds </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treament:</strong></span><span style="color:#800080"><strong> </strong></span><span style="color:#b22222"><strong>Ciprofloxacin IV 400mg stat followed by 400mg IV 12 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> clindamycin 1.2g IV stat followed by 900mg IV 8 hourly </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#0000ff"><strong> </strong></span><span style="color:#b22222"><strong>gentamicin 5mg/kg (4mg/kg if <u>&gt;</u> 70 years)&nbsp;IV single stat dose once only.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><strong>If the patient is obese then See section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> for guidance on&nbsp;gentamicin dose&nbsp;calculation.</strong></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treament:</strong></span> <span style="color:#b22222"><strong>Ciprofloxacin 500mg po bd </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> clindamycin 450mg po qds.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdSkinSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines UTI section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCAdUTILabel" class="portfolio-modal modal fade " id="HCAdUTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAdUTILabel"><strong><strong>Urinary Tract Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<p><strong><strong>In the elderley (&gt;65 years), do not treat asymptomatic bacteriuria; it occurs in 25 % of women and 10 % of men and is not associated with increased morbidity. In the presence of a catheter, antibiotics will not eradicate bacteriuria; only treat if there is dysuria, the patient is systemically unwell or pyelonephritis is likely.</strong></strong></p>

<ul>
    <li><strong><strong>A urine specimen <strong><u>MUST</u></strong> be sent&nbsp;to the laboratory for microbiologic culture and sensitivity prior to commencing antibiotic treatment for urinary tract infection.&nbsp;</strong></strong></li>
    <li><strong><strong>Follow up culture and sensitivity results to review&nbsp;the choice of antibiotic.</strong></strong></li>
    <li><strong><strong>Change the antibiotic according to susceptibility results if the bacteria are resistant.</strong></strong></li>
    <li><strong><strong>Use&nbsp;narrow spectrum antibiotics wherever possible.</strong></strong></li>
</ul>
<strong><strong>&nbsp; </strong></strong>

<h4 id="HCAdUTISection"><strong><strong><a href="#HCAdAcuteBacPros">Acute Bacterial Prostatitis (Non-STI)</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdAcPyelon">Acute Pyelonephritis</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdChronBacPro">Chronic Bacterial Prostatitis</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdRecUTI">Recurrent UTI</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdCathAssoUTI">Urinary Catheter Associated UTI</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdUrinTI">Urinary Tract Infections</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdUrosepsis">Urosepsis</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCAdUTIPreg">UTI in Pregnancy</a></strong></strong></h4>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Acute Bacterial Prostatitis (Non-STI)--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdAcuteBacPros">
<h2 class="text-center" id="HCAdAcuteBacProsLabel"><strong><strong>Acute Bacterial Prostatitis (Non-STI)</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Ensure any sexually transmitted infections are excluded.</span></strong></strong></p>

<p><strong><strong><strong><span style="color:black">1st line:</span></strong><strong> </strong><strong><span style="color:blue">Co-trimoxazole 960mg po BD</span></strong> <span style="color:#333333">for 14 days.</span></strong></strong></p>

<p><strong><strong><strong><span style="color:black">2nd line:</span></strong><strong> </strong><strong><span style="color:#8e44ad">Ciprofloxacin 500mg po BD</span></strong> <span style="color:#333333">for 14 days.</span></strong></strong></p>

<p><strong><strong><strong><span style="color:black">3rd line:</span></strong><strong> </strong><strong><span style="color:#e74c3c">Doxycycline 100mg po BD</span></strong> <span style="color:#333333">for 14 days.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Acute Pyelonephritis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdAcPyelon">
<h2 class="text-center" id="HCAdAcPyelonLabel"><strong><strong>Acute Pyelonephritis</strong></strong></h2>

<p><strong><strong>Acute pyelonephritis is an infection of one or both kidneys usually resulting from ascending urinary tract infection.&nbsp;&nbsp;A urine specimen <strong><u>MUST</u></strong> be sent&nbsp;to the laboratory for microbiologic culture and sensitivity prior to commencing antibiotic treatment.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>1st line:&nbsp;</strong></span> <strong><span style="color:#0000ff">Cefuroxime 1.5g IV 8 hourly then <u>cefalexin</u> 1g po tds </span></strong>for a <u><strong><span style="color:#000000">total 10 days.</span></strong></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>2nd line: </strong></span><span style="color:#0000ff"><strong>Ciprofloxacin 400mg IV 12 hourly then 500mg po bd </strong></span>for a <strong><u><span style="color:#000000">total of 7 days.</span></u></strong></strong></strong></p>
</div>
<br />
<strong><strong><!--Chronic Bacterial Prostatitis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdChronBacPro">
<h2 class="text-center" id="HCAdChronBacProLabel"><strong><strong>Chronic Bacterial Prostatitis</strong></strong></h2>

<p><strong><strong>Only treat if a bacterial etiology has been confirmed as chronic prostatitis has a large inflammatory component and antibiotics may not always be indicated.</strong></strong></p>

<p><strong><strong><strong>1st line:</strong> <span style="color:#990099"><strong>Co-trimoxazole 960mg po&nbsp;bd for&nbsp;4 weeks.</strong></span></strong></strong></p>

<p><strong><strong><strong>2nd&nbsp;line:</strong>&nbsp;<span style="color:#0000ff"><strong>Ciprofloxacin 500mg po bd for&nbsp;4 weeks.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:black">3rd line:</span></strong><strong> </strong><strong><span style="color:#e74c3c">Doxycycline 100mg po bd for 4 weeks.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Refer to Urologist.</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Recurrent UTI--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdRecUTI">
<h2 class="text-center" id="HCAdRecUTILabel"><strong><strong>Recurrent UTI</strong></strong></h2>

<p><strong><strong>Recurrent urinary tract infections (UTI) in adults is defined as repeated UTI with frequency of 2 or more UTIs in the last 6 months or 3 or more UTIs in the last 12 months.</strong></strong></p>

<p><strong><strong>Comprehensively assess the problem and refer to a specialist urologist or gynaecologist (for female patients).</strong></strong></p>

<p><strong><strong><strong>Behavioural and personal hygiene measures:</strong></strong></strong></p>

<p><strong><strong>Patients <span style="color:#282828"><span style="color:#282828"><span style="color:#282828"><span style="color:#282828">should be given advice about behavioural and personal <span style="color:#282828"><span style="color:#282828">hygiene measures to reduce the risk of UTI, such as:</span></span></span></span></span></span></strong></strong></p>

<p><strong><strong><span style="color:#282828"><span style="color:#282828">- drinking enough fluids to avoid dehydration</span></span></strong></strong></p>

<p><strong><strong><span style="color:#282828"><span style="color:#282828">- </span></span><span style="color:#282828"><span style="color:#282828">not delaying habitual and post-coital urination</span></span></strong></strong></p>

<p><strong><strong><span style="color:#282828"><span style="color:#282828">- wiping from front to back after defaecation</span></span></strong></strong></p>

<p><strong><strong><span style="color:#282828"><span style="color:#282828">- not douching or wearing occlusive underwear.</span></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Cranberry products and D-mannose:</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#58595b">Some women find these effective, but there is currently poor evidence to support this and patients should be warned about the sugar content of these products if relevant.&nbsp; Cranberry products should be avoided by patients on warfarin.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Antibiotic treatment:</strong></span></strong></strong></p>

<p><strong><strong>If behavioural and personal hygiene measures do not reduce incidence of UTI, antibiotic treatment may be considered from one of the following recommendations below:</strong></strong></p>

<ul>
    <li><strong><strong>Each episode of UTI may be treated by a healthcare professional as it occurs.</strong></strong></li>
    <li><strong><strong>Patient/carer initiated antibiotic treatment is a cost-effective and safer alternative (in terms of avoiding the development of CDI and antibiotic resistance) compared to continuous antibiotic prophylaxis.&nbsp; This&nbsp;entails self-administration of single high-dose antibiotic treatment; however, if symptoms persist, treatment could continue for up to 3 days, but often 1 or 2 days are sufficient.&nbsp; This should be considered in patients who are compos mentis and are capable of recognising the symptoms of UTI. The patient should be counselled on how and when to self-treat.&nbsp; Antibiotics should be reviewed every 6 months.</strong></strong></li>
    <li><strong><strong>Antibiotic prophylaxis with either trimethoprim 100mg or nitrofurantoin 50mg nocte (provided there is sensitivity to these antibiotics) may be considered where it may be impractical for patients or carers to initiate antibiotics appropriately however antibiotics must be reviewed at least every 6 months.&nbsp; The patient should be counselled on adverse effects&nbsp;and&nbsp;the risk of antibiotic resistance developing.</strong></strong></li>
    <li><strong><strong>If related to sexual intercourse consider a single dose of antibiotic post coital (off-label use).&nbsp; Trimethoprim 200mg or nitrofurantoin 100mg stat&nbsp;may be given&nbsp;after taking into account sensitivity results.&nbsp; Antibiotics should be reviewed every 6 months.</strong></strong></li>
</ul>

<p><strong><strong>For patients who develop and continue to have symptoms of UTI whilst taking antibiotic prophylaxis or treating a UTI, they should be advised to seek medical help.</strong></strong></p>
</div>
<br />
<strong><strong><!--Urinary Catheter Associated UTI--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdCathAssoUTI">
<h2 class="text-center" id="HCAdCathAssoUTILabel"><strong><strong>Urinary Catheter Associated UTI</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Urinary-catheter associated UTI should be treated as an acute urinary tract infection - for antibiotic treatment recommendations see <strong><a href="#HCAdUrinTI"> UTI section </a>.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Note:</u></strong> If the patient&nbsp;is&nbsp;asymptomatic, i.e. no local urinary&nbsp;or systemic manifestations of infection, <u><strong>no antibiotic treatment is required.</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Urine dipstick testing should not be routintely carried out in patients with long term indwelling catheters.&nbsp;This is because there is no relationship between the level of pyruria (white cells in the urine) and infection in people with indwelling catheters.&nbsp; The presence of the catheter induces pyuria without the presence of infection so using urine dipstick testing&nbsp;for UTI in&nbsp;these patients&nbsp;may&nbsp;produce false positive results.&nbsp; If a patient is symptomatic of UTI, a urine specimen&nbsp;must be taken from the catheter tubing&nbsp;<u><strong>not</strong></u> the bag and sent to the microbiology lab for culture and sensitivity.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Unless contraindicated, urinary catheter-associated infection will always require change of catheter.&nbsp; For the procedure of changing the catheter, antibiotic administration should take place just prior to the replacement of the catheter in order to prevent bacteraemic spread of pathogens. For recommendations on which antibiotic to give when changing the catheter please see </span><span style="color:#000000"><strong> section on <a data-dismiss="modal" data-target="#HCProphSurg" data-toggle="modal" href="#HCSurgUrinCatheter"> Urinary catheterisation prophylaxis  </a> on the surgical prophylaxis page </strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Urinary Tract Infection--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdUrinTI">
<h2 class="text-center" id="HCAdUrinTILabel"><strong><strong>Urinary Tract Infections</strong></strong></h2>

<p><strong><strong><u><strong>Patients over 65 years of age</strong></u></strong></strong></p>

<p><strong><strong>If the patient is over 65 years of age, do not carry out urine dipstick analysis for diagnosis of urinary tract infection.&nbsp; This is not a reliable diagnostic test for patients in this age group as up to half of&nbsp;patients in this age group&nbsp;will have the presence of leucocytes and nitrites in the absence of infection - known as asymptomatic bacteriuria.&nbsp; Diagnosis should be based on clinical signs and symptoms as follows:</strong></strong></p>

<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td>
            <ul>
                <li><strong><strong>new onset dysuria alone</strong></strong></li>
            </ul>

            <p><strong><strong>&nbsp; &nbsp; &nbsp; &nbsp; or <u>2 or more</u> of&nbsp;the following:</strong></strong></p>

            <ul>
                <li><strong><strong>pyrexia</strong></strong></li>
                <li><strong><strong>new frequency/urgency</strong></strong></li>
                <li><strong><strong>new incontinence</strong></strong></li>
                <li><strong><strong>new/worsening delirium/debility</strong></strong></li>
                <li><strong><strong>new suprapubic pain</strong></strong></li>
                <li><strong><strong>visible haematuria.</strong></strong></li>
            </ul>
            </td>
        </tr>
    </tbody>
</table>

<ul>
</ul>

<p><strong><strong>A urine specimen should be taken before antibiotic treatment is commenced.</strong></strong></p>

<p><strong><strong><strong><u>Patients under 65 years of age</u></strong></strong></strong></p>

<p><strong><strong>For patients under 65 years of age a&nbsp;preliminary diagnosis of urinary tract infection is&nbsp;made by&nbsp;performing a <strong>urine dipstick </strong>analysis: <strong>Both&nbsp;</strong><strong>leucocyte esterase and nitrite </strong>should be positive for a diagnosis of urinary tract infection to be made, although in a minority of urinary tract infections (such as enterococcal infections) nitrites may be negative.&nbsp;A urine specimen <strong><u>MUST</u></strong> be sent&nbsp;to the laboratory for microbiologic culture and sensitivity.</strong></strong></p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCAdUTI">
<div class="card">
<div class="card-header" id="HCAdUTIUncomFemale">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdUTIUncomFemale" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdUTIUncomFemale" data-toggle="collapse" type="button">Uncomplicated Lower UTI (Female)</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdUTIUncomFemale" class="collapse" data-parent="#accordionHCAdUTI" id="collapseHCAdUTIUncomFemale">
<div class="card-body text-left">
<p><strong><strong>Uncomplicated lower urinary tract infection (cystitis) implies <u><strong>no</strong></u><strong> </strong>evidence of pyelonephritis (i.e.&nbsp;upper tract disease) or urosepsis (i.e. sytemic involvement of infection = SIRS).</strong></strong></p>

<p><strong><strong><strong>Oral treatment:</strong></strong></strong></p>

<p><strong><strong>1st line:&nbsp;<strong><span style="color:#0000ff">Nitrofurantoin M/R 100mg BD for 3 days</span></strong></strong></strong></p>

<p><strong><strong>2nd line: <strong><span style="color:#0000ff">Pivmecillinam 400mg stat for the first dose then 200mg TDS for 3 days.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:&nbsp;</strong></span><span style="background-color:#ffffff; color:#800080"><strong>Cefuroxime 1.5g IV stat, followed by 1.5g IV 8 hourly for 2 further doses&nbsp;</strong></span><span style="background-color:#ffffff; color:#333333">(3 doses in total).</span></strong></strong></p>

<p><strong><strong>Where nitrofurantoin is not suitable and the patient is allergic to penicillin see below.</strong></strong></p>

<p><strong><strong><strong><u><span style="color:#000000">Penicillin allergy (rash)</span></u></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral treatment:</span><span style="color:#800080"> Cefalexin 1g po stat, followed by 1g po 8 hourly for a further 2 doses</span><span style="color:#0000ff"> </span></strong>(3 doses in total).</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span>&nbsp;<span style="color:#800080"><strong>Cefuroxime 1.5g IV stat, followed by 1.5g IV 8 hourly for 2 further doses </strong></span>(3 doses in total).</strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis)</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#b22222"><strong>Fosfomycin 3g po stat (one dose only)</strong></span>.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#b22222"><strong>Ciprofloxacin 400mg, IV, stat followed by 400mg, IV, 12 hours later </strong></span>(2 doses in total).</strong></strong></p>
</div>
</div>

<div class="card-header" id="HCAdUTIAcuMale">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCAdUTIAcuMale" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCAdUTIAcuMale" data-toggle="collapse" type="button">Acute UTI (male)</button></strong></strong></h5>
</div>

<div aria-labelledby="HCAdUTIAcuMale" class="collapse" data-parent="#accordionHCAdUTI" id="collapseHCAdUTIAcuMale">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">1st line:</span></strong> <strong><span style="color:#0000ff">Nitrofurantoin M/R 100mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">2nd line:</span></strong> <strong><span style="color:#0000ff">Pivmecillinam 400mg for the first dose then 200mg TDS.</span></strong></strong></strong></p>

<p><strong><strong><strong>IV treatment:&nbsp;<span style="color:#800080">Cefuroxime 1.5g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong>Men with upper UTI should be referred to a urologist.</strong></strong></p>

<p><strong><strong><span style="background-color:#ffffff; color:#333333">Where nitrofurantoin is not suitable and the patient is allergic to penicillin see below.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <span style="color:#800080"><strong>Cefalexin 500mg po tds.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#800080">Cefuroxime 1.5g IV 8 hourly.</span></strong></strong></strong></p>

<p><strong><strong><u><strong><span style="color:#000000">Penicillin allergy (anaphylaxis)</span></strong></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong></span> <strong><span style="color:#b22222">Ciprofloxacin 500mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><strong><span style="color:#b22222">&nbsp;Ciprofloxacin 400mg IV 12 hourly </span></strong></strong></strong></p>

<p><strong><strong>Treatment duration is for up to 7 days. <strong>NOTE:</strong> in the absence of fever, flank pain, or systemic toxicity, duration of treatment of acute lower urinary tract infection in males can be less than 7 days e.g. even <u>3 days</u> if the patient has clinically responded to treatment.</strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Urosepsis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdUrosepsis">
<h2 class="text-center" id="HCAdUrosepsisLabel"><strong><strong>Urosepsis</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span>&nbsp;<span style="color:#800080">Cefuroxime 1.5g IV 8 hourly - this is suitable for patients with penicillin allergy (rash)&nbsp;</span><span style="color:#000000"><u>plus</u></span>&nbsp;</strong><span style="color:#800080"><strong>gentamicin</strong></span><strong>&nbsp;<span style="color:#800080">5mg/kg IV as a single stat dose once only&nbsp;(4mg/kg if age <u>&gt;</u> 70 years). Max dose 400mg</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">If the patient is obese see section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a><span style="color:#000000"> for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:&nbsp;</span><span style="color:#800080">Cefalexin 1g po tds -&nbsp;this is suitable for patients with penicillin allergy (rash).</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#c0392b">&nbsp;Ciprofloxacin 400mg IV 12 hourly</span><span style="color:#b22222">&nbsp;</span><span style="color:#000000"><u>plus</u></span>&nbsp;<span style="color:#c0392b">gentamicin&nbsp;5mg/kg IV as a single stat dose once only&nbsp;(4mg/kg if age <u>&gt;</u> 70 years). Max dose 400mg.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">If the patient is obese see section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring </a> <span style="color:#000000">for guidance on&nbsp;gentamicin dose calculation.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:&nbsp;&nbsp;</span><span style="color:#c0392b">Ciprofloxacin 500mg po bd.</span></strong></strong></strong></p>
</div>
<br />
<strong><strong><!--UTI in Pregnancy--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCAdUTIPreg">
<h2 class="text-center" id="HCAdUTIPregLabel"><strong><strong>UTI in Pregnancy</strong></strong></h2>

<p><span style="color:#000000"><u><strong>ORAL TREATMENT:</strong></u></span></p>

<p><span style="color:#000000">1. </span><span style="color:#800080"><strong>Nitrofurantoin 100mg MR BD</strong></span>&nbsp;- <u><span style="color:#000000"><strong>AVOID AT TERM (from&nbsp;37 weeks).</strong></span></u></p>

<p><span style="color:#000000">2.</span><span style="color:#0000ff"><strong>&nbsp;Pivmecillinam 400mg STAT for the first dose&nbsp;then 200mg TDS</strong></span></p>

<p>3.<span style="color:#0000ff"><strong> </strong></span><span style="color:#c0392b"><strong>Cefalexin 500mg TDS</strong> </span>- <span style="color:#000000"><strong>avoid if penicillin allergy anaphylaxis.</strong></span></p>

<p>&nbsp;</p>

<p><span style="color:#000000"><strong>Treatment duration is a total of 7 days.</strong></span></p>

<p><span style="color:#000000"><strong>Repeat MSU 7 days after completion of antibiotic treatment.</strong></span></p>

<p>&nbsp;</p>

<p><span style="color:#000000"><u><strong>IV TREATMENT (if patient is unable to tolerate oral treatment OR there is urosepsis):</strong></u></span></p>

<p><span style="color:#0033ff"><strong>Cefuroxime 1.5g IV 8 hourly</strong></span><span style="color:#000000"> (oral step down is to cefalexin 1g po tds).</span></p>

<p>&nbsp;</p>

<p><strong>Penicillin allergy (anaphylaxis):</strong></p>

<p><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV 12 hourly </strong></span>(oral step down is to ciprofloxacin 500mg po bd).</p>

<p>&nbsp;</p>

<p><span style="color:#000000"><strong>Treatment duration is a total of 7 days.</strong></span></p>

<p><span style="color:#000000"><strong>Repeat MSU 7 days after completion of antibiotic treatment.</strong></span></p>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCAdUTISection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
 <!--Paediatric Inpatient Modals--> <!-- Paed inpatient hosp guidelines Blood and sepsis section--> 

<div aria-hidden="true" aria-labelledby="HCPaedBloodLabel" class="portfolio-modal modal fade " id="HCPaedBlood" role="dialog" tabindex="-1">
    <div class="modal-dialog modal-xl" role="document">
        <div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>
        <div class="modal-body text-center">
            <div class="container">
                <div class="row justify-content-center">
                    <div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>
                    <h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedBloodLabel"><strong><strong>Blood Infections and Sepsis Syndrome</strong></strong></h2>
                    <strong><strong> <!-- Icon Divider--> </strong></strong>
                    <div class="divider-custom">
                        <div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
                        <div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>
                        <div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
                    </div>
                    
                    <h4><strong><strong><a href="#HCPaedIntraCanInf" id="HCPaedBloodSection">Central Line Infection</a></strong></strong></h4>
                    
                    <h4><strong><strong><a href="#HCPaedMulDrRes">Neutropenic Sepsis / Oncology Patient</a></strong></strong></h4>
                    
                    <h4><strong><strong><a href="#HCPaedSepsisSyn">Sepsis</a></strong></strong></h4>
                    <br />
                    <!--Central Line Infections--> 
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCPaedIntraCanInf"><strong><strong>Central Line Infection</strong></strong></h2>
                        <strong><strong><!--Inner accordian--> </strong></strong>
                        <div id="accordionHCPaedSepsis">
                            <div class="card">
                                <div class="card-header" id="HCPaedComAcq">
                                    <h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedComAcq" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedComAcq" data-toggle="collapse" type="button">Empiric</button></strong></strong></h5>
                                </div>
                                <div aria-labelledby="HCPaedComAcq" class="collapse" data-parent="#accordionHCPaedSepsis" id="collapseHCPaedComAcq">
                                    <div class="card-body text-left">
                                        <p><strong><strong><strong>Vancomycin IV</strong></strong></strong></p>
                                    </div>
                                </div>
                                <div class="card-header" id="HCPaedHospAcq">
                                    <h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedHospAcq" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedHospAcq" data-toggle="collapse" type="button">Coagulase Negative Staphylococcus</button></strong></strong></h5>
                                </div>
                                <div aria-labelledby="HCPaedHospAcq" class="collapse" data-parent="#accordionHCPaedSepsis" id="collapseHCPaedHospAcq">
                                    <div class="card-body text-left">
                                        <p><strong><strong><strong>Vancomycin IV</strong></strong></strong></p>
                                    </div>
                                </div>
                                <div class="card-header" id="HCPaedFebNeuSep">
                                    <h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedFebNeuSep" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedFebNeuSep" data-toggle="collapse" type="button">Staphylococcus Aureus</button></strong></strong></h5>
                                </div>
                                <div aria-labelledby="HCPaedFebNeuSep" class="collapse" data-parent="#accordionHCPaedSepsis" id="collapseHCPaedFebNeuSep">
                                    <div class="card-body text-left">
                                        <p><strong><strong><span style="color:#0033cc"><strong>Flucloxacillin IV</strong></span></strong></strong></p>
                                        <p><strong><strong><u><strong>Penicillin allergy (rash):</strong></u></strong></strong></p>
                                        <p><strong><strong><span style="color:#8e44ad"><strong>Cefuroxime IV</strong></span></strong></strong></p>
                                        <p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>
                                        <p><strong><strong><span style="color:#e74c3c"><strong>Vancomycin IV</strong></span></strong></strong></p>
                                    </div>
                                </div>
                                <div class="card-header" id="HCPaedFebNeuSepp">
                                    <h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedFebNeuSepp" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedFebNeuSepp" data-toggle="collapse" type="button">MRSA</button></strong></strong></h5>
                                </div>
                                <div aria-labelledby="HCPaedFebNeuSepp" class="collapse" data-parent="#accordionHCPaedSepsis" id="collapseHCPaedFebNeuSepp">
                                    <div class="card-body text-left">
                                        <p><strong><strong><strong>Vancomycin IV</strong></strong></strong></p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    <strong><strong> </strong></strong></div>
                    <br />
                    <strong><strong><!--Neutropenic Sepsis--> </strong></strong>
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCPaedMulDrRes"><strong><strong>Neutropenic Sepsis / Oncology Patient</strong></strong></h2>
                        <p><strong><strong><span style="color:#0033cc"><strong>Piperacillin/tazobactam IV.</strong></span></strong></strong></p>
                        <p><strong><strong><span style="color:#000000">Also give stat </span><span style="color:#0033cc"><strong>gentamicin&nbsp;IV</strong></span><span style="color:#000000"><strong> </strong>if severely ill.</span></strong></strong></p>
                        <p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></strong></strong></p>
                        <p><strong><strong><span style="color:#8e44ad"><strong>Meropenem IV.</strong></span></strong></strong></p>
                        <p><strong><strong>Also give stat <span style="color:#8e44ad"><strong>gentamicin IV</strong>&nbsp;</span>if severely ill.</strong></strong></p>
                        <p><strong><strong><u><strong>Penicillin allergy (anaphylaxis):</strong></u></strong></strong></p>
                        <p><strong><strong><span style="color:#e74c3c"><strong>Ciprofloxacin IV plus clindamycin IV.</strong></span></strong></strong></p>
                        <p><strong><strong>Also give stat <span style="color:#e74c3c"><strong>gentamicin IV</strong></span><span style="color:#8e44ad"> </span>if severely ill.</strong></strong></p>
                    </div>
                    <br />
                    <!--Sepsis syndrome-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCPaedSepsisSyn"><strong><strong>Sepsis Syndrome</strong></strong></h2>
                        <!--Inner accordian-->
                        <div id="accordionHCPaedSepsis2">
                            <div class="card">
                                <div class="card-header" id="HCPaedThreePlus">
                                    <h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedThreePlus" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedThreePlus" data-toggle="collapse" type="button">Aged over 3 months</button></strong></strong></h5>
                                </div>
                                <div aria-labelledby="HCPaedThreePlus" class="collapse" data-parent="#accordionHCPaedSepsis2" id="collapseHCPaedThreePlus">
                                    <div class="card-body text-left">
                                        <div><p><span style="color:#000000"><strong>If there is <u>NO</u> central nervous system involvement (meningitis/encephalitis):</strong></span></p>

                                        <p><span style="color:#3333ff"><strong>Cefuroxime IV</strong></span></p>

                                        <p>&nbsp;</p>

                                        <p><u><strong>Penicillin allergy (anaphylaxis):</strong></u></p>

                                        <p><span style="color:#e74c3c"><strong>Ciprofloxacin IV plus vancomycin IV</strong></span></p>

                                        <p>&nbsp;</p>

                                        <p><strong><span style="color:#000000">If central nervous system involvement suspected&nbsp;(meningitis/encephalitis):</span></strong></p>

                                        <p><span style="color:#3333ff"><strong>Ceftriaxone IV</strong></span></p>

                                        <p>&nbsp;</p>

                                        <p><u><strong>Penicillin allergy (anaphylaxis):</strong></u></p>

                                        <p><span style="color:#e74c3c"><strong>Chloramphenicol IV plus co-trimoxazole IV</strong></span></p>
                                        </div>
                                    </div>
                                </div>
                                <div class="card-header" id="HCPaedThreeLess">
                                    <h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedThreeLess" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedThreeLess" data-toggle="collapse" type="button">Aged 3 months and Less</button></strong></strong></h5>
                                </div>
                                <div aria-labelledby="HCPaedThreeLess" class="collapse" data-parent="#accordionHCPaedSepsis2" id="collapseHCPaedThreeLess">
                                    <div class="card-body text-left">
                                        <div><p><span style="color:#000000"><u><strong>Neonatal sepsis post delivery:</strong> </u></span></p>

                                            <p><span style="color:#3333ff"><strong>Benzylpenicillin plus gentamicin</strong></span></p>

                                            <p>&nbsp;</p>

                                            <p><span style="color:#000000"><strong><u>If patient is discharged and admitted with sepsis:</u></strong></span></p>

                                            <p><span style="color:#000000"><strong>Age &lt;28 days:</strong></span> <span style="color:#0033ff"><strong>cefotaxime plus amoxicillin</strong></span></p>

                                            <p><span style="color:#000000"><strong>Age 28 days and over:</strong></span><span style="color:#0033ff"> <strong>ceftriaxone plus amoxicillin</strong></span></p>

                                            <p>&nbsp;</p>

                                            <p><u><strong><span style="color:#000000">Penicillin allergy (anaphylaxis):</span></strong></u></p>

                                            <p><span style="color:#e74c3c"><strong>Ciprofloxacin plus vancomycin</strong></span></p>
                                        </div>
                                    </div>
                                </div>
                                
                                
                                
                                
                            </div>
                        </div>
                    </div>
                    
                    <br />
                    <strong><strong><!--floating icon--><a class="float" href="#HCPaedBloodSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
                </div>
            </div>
        </div>
    <strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Paed inpatient hosp guidelines Bone and Joint section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedBoneLabel" class="portfolio-modal modal fade " id="HCPaedBoneJoint" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedBoneLabel"><strong><strong>Bone and Joint Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCPaedSepArth" id="HCPaedBoneSection">Septic Arthritis and Osteomyelitis</a></strong></strong></h4>
<br />
<strong><strong><!--Septic Arthritis and Osteomyelitis--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCPaedSepArth"><strong><strong>Septic Arthritis and Osteomyelitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Flucloxacillin - maximum dose for weight</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#8e44ad"><strong>Cefuroxime - maximum dose for weight</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clindamycin - maximum dose for weight.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Treatment duration: minimum 4 - 6weeks.</strong></span></strong></strong></p>
</div>
<strong><strong> </strong></strong></div>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedBoneSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Paed inpatient hosp guidelines CNS section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedCNSLabel" class="portfolio-modal modal fade " id="HCPaedCNS" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedCNSLabel"><strong><strong>Central Nervous System</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCPaedEmpTx" id="HCPaedCNSSection">Aged 3 months and Over</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCPaedMenningococcus">Aged Less than 3 Months</a></strong></strong></h4>
<br />
<strong><strong><!--Endocarditis--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCPaedEmpTx"><strong><strong>Aged 3 Months and Over</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Ceftriaxone IV</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis):</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Chloramphenicol IV plus co-trimoxazole IV.</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Endocarditis--> </strong></strong>

<div class="text-left border border-info rounded">
<h2 class="text-center" id="HCPaedMenningococcus"><strong><strong>Aged Less than 3 Months</strong></strong></h2>

<p><strong><strong><u><span style="color:#000000"><strong>Age &lt;28 days:</strong></span></u><span style="color:#0000ff">&nbsp;<strong>cefotaxime plus amoxicillin</strong></span></strong></strong></p>

<p><strong><strong>For suspected Herpes simplex virus and Varicella zoster meningitis/encephalitis give:&nbsp;<strong><span style="color:#0000ff">aciclovir IV.</span></strong></strong></strong></p>

<p><strong><strong><u>Note</u>&nbsp;aciclovir is <u>not</u>&nbsp;effective against any of the other causes of viral meningitis/encephalitis.</strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Age 28 days and over:</strong></span></u>&nbsp;<span style="color:#0000ff"><strong>ceftriaxone plus amoxicillin</strong></span></strong></strong></p>

<p><strong><strong>For suspected Herpes simplex virus and Varicella zoster meningitis/encephalitis give:&nbsp;<strong><span style="color:#0000ff">aciclovir IV.</span></strong></strong></strong></p>

<p><strong><strong><u>Note</u>&nbsp;aciclovir is <u>not</u>&nbsp;effective against any of the other causes of viral meningitis/encephalitis.</strong></strong></p>
</div>
<strong><strong> </strong></strong></div>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedCNSSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Adult inpatient hosp guidelines ENT section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedENTLabel" class="portfolio-modal modal fade " id="HCPaedENT" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedENTLabel"><strong><strong>Ear, Nose and Throat Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCPaedENTSection"><strong><strong><a href="#HCPaedAcLympha">Acute Lymphadenitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedAcMast">Acute Mastoiditis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedDeepNeck">Deep Neck Space Abscess</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedDental">Dental Infections</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedEpiglotis">Epiglottitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedFacialCell">Facial / Orbital Cellulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedOtiExterna">Otitis Externa</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedOtiMedia">Otitis Media</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedPeriTon">Peri-Tonsillar / Retropharyngeal Abscess</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedPostTonBleed">Post-Tonsillectomy Bleed</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedSinusitis">Sinusitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedSupNeck">Suppurating Neck Nodes</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedTonsil">Tonsillitis</a></strong></strong></h4>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedAcLympha">
<h2 class="text-center" id="HCPaedAcLymphaLabel"><strong><strong>Acute Lymphadenitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clindamycin</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedAcMast">
<h2 class="text-center" id="HCPaedAcMastLabel"><strong><strong>Acute Mastoiditis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Co-Amoxiclav IV - if no improvement&nbsp;add clindamycin&nbsp;IV</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (rash):</strong></span></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#8e44ad">Cefuroxime IV - if no improvement&nbsp;add clindamycin IV</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#c0392b">Co-trimoxazole IV plus clindamycin&nbsp;IV</span></strong></strong></strong></p>

<p><strong><strong>If there are any concerns with regards to intracranial spread of infection give the following:</strong></strong></p>

<p><strong><strong><span style="color:#0033cc"><strong>Ceftriaxone IV plus clindamycin IV</strong></span></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>Penicillin allergy (anaphylaxis):</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#c0392b"><strong>Chloramphenicol IV plus clindamycin IV</strong></span></strong></strong></p>

<p><strong><strong>Treatment duration is 2 weeks.&nbsp; If there is evidence of mastoid bone osteomyelitis then treatment duration is 4 weeks.</strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedDeepNeck">
<h2 class="text-center" id="HCPaedDeepNeckLabel"><strong><strong>Deep Neck Space Abscess</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <strong><span style="color:#0000ff">co-amoxiclav</span>&nbsp;<span style="color:#000000">plus</span><span style="color:#0000ff"> clindamycin.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:</span><span style="color:#000000"> </span><span style="color:#0000ff">co-amoxiclav&nbsp;</span><span style="color:#000000">plus</span><span style="color:#0000ff"> clindamycin.</span></strong></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis):</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><span style="color:#8e44ad"><strong>cefuroxime&nbsp;</strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#8e44ad"><strong> clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#8e44ad"><strong>cefalexin </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#8e44ad"><strong> clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#e74c3c"> <strong>co-trimoxazole </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#e74c3c"><strong> clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#e74c3c"><strong>co-trimoxazole </strong></span><span style="color:#000000"><strong>plus</strong></span><span style="color:#e74c3c"><strong> clindamycin.</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedDental">
<h2 class="text-center" id="HCPaedDentalLabel"><strong><strong>Dental Infections</strong></strong></h2>

<p><strong><strong><strong><span style="color:#0033cc">Amoxicillin</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clindamycin</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedEpiglotis">
<h2 class="text-center" id="HCPaedEpiglotisLabel"><strong><strong>Epiglottitis</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><u><strong>IV treatment:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>&lt;28 days:</strong></span> <span style="color:#0033cc"><strong>cefotaxime</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>28 days or older: </strong></span><span style="color:#0033cc"><strong>ceftriaxone</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral&nbsp;step down:</strong></span> <strong><span style="color:#0033cc">co-amoxiclav</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#e74c3c">Ciprofloxacin </span><span style="color:#000000">plus</span><span style="color:#e74c3c"> clindamycin</span></strong></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedFacialCell">
<h2 class="text-center" id="HCPaedFacialCellLabel"><strong><strong>Facial / Orbital Cellulitis</strong></strong></h2>

<p><strong><strong>See <a data-dismiss="modal" data-target="#HCPaedEye" data-toggle="modal" href="#HCPaedEye"> Peri-Orbital / Facial Cellulitis </a> in ophthalmology section.</strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedOtiExterna">
<h2 class="text-center" id="HCPaedOtiExternaLabel"><strong><strong>Otitis Externa</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedOtEx">
<div class="card">
<div class="card-header" id="HCPaedAcPanA">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedAcPan" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedAcPan" data-toggle="collapse" type="button">Mild / Moderate</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedAcPanLabel" class="collapse" data-parent="#accordionHCPaedOtEx" id="collapseHCPaedAcPan">
<div class="card-body text-left">
<p><strong><strong>Oral antibiotics are rarely indicated.&nbsp;&nbsp;Topical therapy is the mainstay of treatment:</strong></strong></p>

<p><strong><strong>Acetic acid 2% (EarCalm) 1 spray TDS&nbsp;</strong></strong></p>

<p><strong><strong>or</strong></strong></p>

<p><strong><strong>Sofradex/Gentisone HC 3 drops TDS</strong></strong></p>

<p><strong><strong>If fungal infection suspected: clotrimazole drops 1%, 3 drops TDS.</strong></strong></p>

<p><strong><strong><strong><span style="color:#0033cc">Co-amoxiclav PO</span></strong></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy:</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clarithromycin PO</strong></span></strong></strong></p>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCPaedPanNec">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedPanNec" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedPanNec" data-toggle="collapse" type="button">Malignant Otitis Externa</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedPanNec" class="collapse" data-parent="#accordionHCPaedOtEx" id="collapseHCPaedPanNec">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000">Cover Pseudomonas aeruginosa</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">IV treatment:</span><strong><span style="color:#0033cc"> ceftazidime IV plus ciprofloxacin 0.3% eye/ear drops, 3 drops QDS.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Oral step down: </span><span style="color:#0033cc"><strong>ciprofloxacin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy:</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">IV treatment:</span><span style="color:#e74c3c"> </span><strong><span style="color:#e74c3c">ciprofloxacin IV plus ciprofloxacin 0.3% eye/ear drops, 3 drops QDS.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Oral step down:</span><strong><span style="color:#e74c3c"> ciprofloxacin</span></strong></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedOtiMedia">
<h2 class="text-center" id="HCPaedOtiMediaLabel"><strong><strong>Otitis Media</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedOtMed">
<div class="card">
<div class="card-header" id="HCPaedOtMedAcute">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedOtMedAcute" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedOtMedAcute" data-toggle="collapse" type="button">Acute Otitis Media</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedOtMedAcute" class="collapse" data-parent="#accordionHCPaedOtMed" id="collapseHCPaedOtMedAcute">
<div class="card-body text-left">
<p><strong><strong>No Antibiotics</strong></strong></p>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCPaedOtMedSevere">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedOtMedSevere" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedOtMedSevere" data-toggle="collapse" type="button">Severe</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedOtMedSevere" class="collapse" data-parent="#accordionHCPaedOtMed" id="collapseHCPaedOtMedSevere">
<div class="card-body text-left">
<p><strong><strong>Less than 2yrs old - <strong><span style="color:#0033cc">amoxicillin</span></strong> 7 days</strong></strong></p>

<p><strong><strong>2yrs and over - <strong><span style="color:#0033cc">amoxicillin</span></strong> 5 days</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clarithromycin </strong></span><span style="color:#000000">7 days</span></strong></strong></p>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCPaedOtMedChronic">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedOtMedChronic" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedOtMedChronic" data-toggle="collapse" type="button">Chronic Otitis Media</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedOtMedChronic" class="collapse" data-parent="#accordionHCPaedOtMed" id="collapseHCPaedOtMedChronic">
<div class="card-body text-left">
<p><strong><strong>Not for antibiotics may trial another course of antibiotics as in severe acute otitis media.</strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedPeriTon">
<h2 class="text-center" id="HCPaedPeriTonLabel"><strong><strong>Peri-Tonsillar / Retropharyngeal Abscess</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#8e44ad"><strong>Cefuroxime</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Ciprofloxacin plus clindamycin.</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedPostTonBleed">
<h2 class="text-center" id="HCPaedPostTonBleedLabel"><strong><strong>Post-Tonsillectomy Bleed</strong></strong></h2>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span> </strong><span style="color:#0000ff"><strong>co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span> <span style="color:#0000ff"><strong>co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span> <span style="color:#8e44ad">cefuroxime</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span>&nbsp;<span style="color:#8e44ad"><strong>cefalexin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span> <span style="color:#e74c3c">clindamycin</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span>&nbsp;<span style="color:#e74c3c"><strong>clarithromycin.</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedSinusitis">
<h2 class="text-center" id="HCPaedSinusitisLabel"><strong><strong>Sinusitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedSinus">
<div class="card">
<div class="card-header" id="HCPaedAcuteSinus">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedAcuteSinus" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedAcuteSinus" data-toggle="collapse" type="button">Acute Sinusitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedAcuteSinus" class="collapse" data-parent="#accordionHCPaedSinus" id="collapseHCPaedAcuteSinus">
<div class="card-body text-left">
<p><strong><strong><span style="color:#0033cc"><strong>Amoxicillin</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy:</strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#e74c3c">Clarithromycin</span></strong></strong></strong></p>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCPaedChronSinus">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedChronSinus" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedChronSinus" data-toggle="collapse" type="button">Chronic Sinusitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedChronSinus" class="collapse" data-parent="#accordionHCPaedSinus" id="collapseHCPaedChronSinus">
<div class="card-body text-left">
<p><strong><strong>Refer to ENT</strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedSupNeck">
<h2 class="text-center" id="HCPaedSupNeckLabel"><strong><strong>Suppurating Neck Nodes</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><span style="color:#0000ff"><strong>co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#0000ff"><strong>co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>If no better add </strong></span><span style="color:#0000ff"><strong>clindamycin</strong></span><span style="color:#000000"><strong>&nbsp;IV to treatment with </strong></span><span style="color:#0000ff"><strong>co-amoxiclav</strong></span><span style="color:#000000"><strong> IV.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#0000ff"><strong> co-amoxiclav</strong></span><span style="color:#000000"><strong> </strong><strong>plus </strong></span><span style="color:#0000ff"><strong>clindamycin</strong></span><span style="color:#000000"><strong>.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><span style="color:#8e44ad"><strong>cefuroxime</strong></span><span style="color:#000000"><strong>&nbsp;plus </strong></span><span style="color:#8e44ad"><strong>clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:&nbsp;</strong></span><span style="color:#8e44ad"><strong>cefalexin</strong></span><strong>&nbsp;plus </strong><span style="color:#8e44ad"><strong>clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong> </span><span style="color:#e74c3c"><strong>co-trimoxazole </strong></span><span style="color:#000000"><strong>plus </strong></span><span style="color:#e74c3c"><strong>clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span> <span style="color:#e74c3c"><strong>co-trimoxazole </strong></span><strong>plus </strong><span style="color:#e74c3c"><strong>clindamycin.</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded" id="HCPaedTonsil">
<h2 class="text-center" id="HCPaedTonsilLabel"><strong><strong>Tonsillitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedTonsil">
<div class="card">
<div class="card-header" id="HCPaedTonsils">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedTonsils" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedTonsils" data-toggle="collapse" type="button">Tonsillitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedTonsils" class="collapse" data-parent="#accordionHCPaedTonsil" id="collapseHCPaedTonsils">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000">No antibiotics/delayed antibiotic prescribing as 90% resolve in 7 days without antibiotics, and pain only reduced by 16 hours.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Note it is most important to submit a <strong><u>THROAT SWAB FOR CULTURE</u></strong>&nbsp;to the laboratory in order to exclude Strep Group A pharyngo-tonsillitis.&nbsp;&nbsp;A positive throat swab culture growing Streptococcus Group A, together with clinical features of acute pharyngotonsillitis almost certainly indicates infection.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If you have taken a throat swab before prescribing antibiotics and it is reported negative for Streptococcus Group A do <u><strong>NOT</strong></u>&nbsp;prescribe antibiotics, and if antibiotics have already been commenced, <u><strong>DISCONTINUE THEM.</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Use the following <a href="https://www.nice.org.uk/guidance/ng143/resources/support-for-education-and-learning-educational-resource-traffic-light-table-pdf-6960664333" target="_blank">table</a>&nbsp;to assess serious illness in children</span></strong></strong></p>
</div>
</div>
</div>

<div class="card">
<div class="card-header" id="HCPaedTonGroupA">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedTonGroupA" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedTonGroupA" data-toggle="collapse" type="button">Group A Strep Tonsillitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedHCPaedTonGroupA" class="collapse" data-parent="#accordionHCPaedTonsil" id="collapseHCPaedTonGroupA">
<div class="card-body text-left">
<p><strong><strong><span style="color:#0000ff"><strong>Penicillin V</strong></span> <span style="color:#000000">(5&nbsp;days).&nbsp; In more complicated infections such as quinsy&nbsp;and scarlet fever, the duration will be longer (at least 10 days).</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#8e44ad"><strong>Cefalexin</strong></span> <span style="color:#000000">(5 days).&nbsp;</span>In more complicated infections such as quinsy&nbsp;and scarlet fever, the duration will be longer (at least 10 days).</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#e74c3c">Clarithromycin </span></strong><span style="color:#000000">(5 days).&nbsp;</span>In more complicated infections such as quinsy and scarlet fever, the duration will be longer (at least 10 days).</strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedENTSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Paed inpatient hosp guidelines Gastro section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedFungalLabel" class="portfolio-modal modal fade " id="HCPaedGastro" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedGastroLabel"><strong><strong>Gastrointestinal Tract / Intra-abdominal Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCPaedGastroSection"><strong><strong>&nbsp;</strong></strong></h4>

<h4><strong><strong><a href="#HCPaedApend">Appendicitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedCampy">Campylobacter Enteritis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedCDiff">Clostridium Difficile</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedNecroEnter">Necrotising Enterocolitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedNonTyp">Non-Typhoidal Salmonellosis / Shigella</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedPeritonitis">Peritonitis</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Appendicitis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedApend">
<h2 class="text-center" id="HCPaedApendLabel"><strong><strong>Appendicitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Cefuroxime plus metronidazole</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis):</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole plus clindamycin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Campylobacter Enteritis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedCampy">
<h2 class="text-center" id="HCPaedCampyLabel"><strong><strong>Campylobacter Enteritis</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Only treat if severe infection or immunocompromised.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">&lt;6 months:</span> <span style="color:#0033cc"><strong>clarithromycin</strong></span><span style="color:#000000"><strong>&nbsp;</strong>for 3 days.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">6 months and over:</span><span style="color:#0033cc"><strong> azithromycin</strong></span> <span style="color:#000000">for 3 days.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--C Diff--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedCDiff">
<h2 class="text-center" id="HCPaedCDiffLabel"><strong><strong>Clostridium Difficile</strong></strong></h2>

<p><strong><strong>Metronidazole</strong></strong></p>
</div>
<br />
<strong><strong><!--Necrotising Enterocolitis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedNecroEnter">
<h2 class="text-center" id="HCPaedNecroEnterLabel"><strong><strong>Necrotising Enterocolitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Benzylpenicillin plus gentamicin&nbsp;plus metronidazole</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis):</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole plus clindamycin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Non Typhoidal salmonella--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedNonTyp">
<h2 class="text-center" id="HCPaedNonTypLabel"><strong><strong>Non-Typhoidal salmonellosis / Shigella</strong></strong></h2>


<p><strong><strong><span style="color:#000000">Most infections are <u><strong>self-limiting</strong></u> and no antibiotics are required however in patients who are severely ill empiric antibiotic treatment includes:</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Oral treatment:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>&lt;6 months:</strong></span>&nbsp;<span style="color:#0033cc"><strong>ciprofloxacin&nbsp;PO</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>6 months or over:</strong></span> <strong><span style="color:#0033cc">azithromycin PO</span></strong></strong></strong></p>

<p><strong><strong><u><span style="color:#000000"><strong>IV treatment:</strong></span></u></strong></strong></p>

<p><strong><strong><span style="color:#0033cc"><strong>Ceftriaxone IV</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole IV</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Perotinitis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedPeritonitis">
<h2 class="text-center" id="HCPaedPeritonitisLabel"><strong><strong>Peritonitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Cefuroxime plus metronidazole</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis):</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole plus clindamycin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedGastroSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Paediatric inpatient hosp guidelines Eye section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedEyeLabel" class="portfolio-modal modal fade " id="HCPaedEye" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedEyeLabel"><strong><strong>Opthamology Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCPaedEyeSection"><strong><strong><a href="#HCPaedBacConjunct">Acute Bacterial Conjunctivitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedConjunctHerp">Herpes Simplex Conjunctivitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedCelltFac">Peri-Orbital / Facial Cellulitis</a></strong></strong></h4>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedBacConjunct">
<h2 class="text-center" id="HCPaedBacConjunctLabel"><strong><strong>Acute Bacterial Conjunctivitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Chloramphenicol eye drops&nbsp;1 drop QDS</strong></span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedConjunctHerp">
<h2 class="text-center" id="HCPaedConjunctHerpLabel"><strong><strong>Herpes Simplex Conjunctivitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Aciclovir IV plus aciclovir topical.</strong></span></strong></strong></p>

<p><strong><strong>Refer to Ophthalmologist.</strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedCelltFac">
<h2 class="text-center" id="HCPaedCelltFacLabel"><strong><strong>Peri-Orbital / Facial Cellulitis</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedFacCell">
<div class="card">
<div class="card-header" id="HCPaedPreSeptal">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedPreSeptal" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedPreSeptal" data-toggle="collapse" type="button">Pre-Septal Mild</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedPreSeptalabel" class="collapse" data-parent="#accordionHCPaedFacCell" id="collapseHCPaedPreSeptal">
<div class="card-body text-left">
<p><strong><strong><span style="color:#0033cc"><strong>Co-amoxiclav </strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Add</span> <span style="color:#0033cc"><strong>clindamycin</strong></span> if <span style="color:#000000">no improvement</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#8e44ad"><strong>Cefuroxime&nbsp;</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Add</span> <span style="color:#8e44ad"><strong>clindamycin</strong></span> if no improvement.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole plus clindamycin.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCPaedPreSeptalSevere">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedPreSeptalSevere" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedPreSeptalSevere" data-toggle="collapse" type="button">Pre-Septal Severe</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedPreSeptalSevere" class="collapse" data-parent="#accordionHCPaedFacCell" id="collapseHCPaedPreSeptalSevere">
<div class="card-body text-left">
<p><strong><strong>Includes risk of intracranial spread.</strong></strong></p>

<p><strong><strong>Age &lt;28 days: <span style="color:#0033cc"><strong>cefotaxime&nbsp;plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong>Age 28 days and over:&nbsp;<span style="color:#e74c3c"><strong>&nbsp;</strong></span><span style="color:#0033cc"><strong>ceftriaxone&nbsp;plus clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><strong><u>Penicillin allergy (anaphylaxis)</u>:</strong></strong></strong></p>

<p><strong><strong>age &lt;28 days: <strong><span style="color:#e74c3c">co-trimoxazole plus clindamycin</span></strong></strong></strong></p>

<p><strong><strong>age 28 days and over:&nbsp;<span style="color:#e74c3c"><strong>&nbsp;c</strong></span><span style="color:#e74c3c"><strong>hloramphenicol plus clindamycin.</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCPaedOrbital">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedOrbital" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedOrbital" data-toggle="collapse" type="button">Orbital Cellulitis</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedOrbital" class="collapse" data-parent="#accordionHCPaedFacCell" id="collapseHCPaedOrbital">
<div class="card-body text-left">
<p><strong><strong>Age &lt;28 days: <span style="color:#0033cc"><strong>cefotaxime&nbsp;plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong>Age 28 days and over:&nbsp;<span style="color:#e74c3c"><strong>&nbsp;</strong></span><span style="color:#0033cc"><strong>ceftriaxone&nbsp;plus clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><strong><u>Penicillin allergy (anaphylaxis)</u>:</strong></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Ciprofloxacin plus clindamycin.</strong></span></strong></strong></p>

<p><strong><strong>If risk of intracranial spread</strong></strong></p>

<p><strong><strong>Age &lt;28 days: <strong><span style="color:#e74c3c">co-trimoxazole plus clindamycin</span></strong></strong></strong></p>

<p><strong><strong>Age 28 days and over:&nbsp;<span style="color:#e74c3c"><strong>&nbsp;</strong></span><span style="color:#e74c3c"><strong>chloramphenicol plus clindamycin.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedEyeSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Paed inpatient hosp guidelines Respiratory section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedRespitatoryLabel" class="portfolio-modal modal fade " id="HCPaedResp" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedRespitatoryLabel"><strong><strong>Respiratory Tract Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCPaedRespSection"><strong><strong><a href="#HCPaedAspPneumon">Aspiration Pneumonia</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedPneumoniaComm">Community-Acquired Pneumonia</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedEmpyema">Empyema</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedPneumoniaHosp">Hospital-Acquired Pneumonia</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedInflu">Influenza</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Aspiration Pneumonia--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedAspPneumon">
<h2 class="text-center" id="HCPaedAspPneumonLabel"><strong><strong>Aspiration Pneumonia</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></strong></strong></p>

<p><strong><strong><strong>IV treatment: <span style="color:#990099">Cefuroxime plus clindamycin</span></strong></strong></strong></p>

<p><strong><strong><strong>Oral step down: <span style="color:#990099">cefalexin plus clindamycin</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin alllergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole plus clindamycin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Comm Acquired Pneumonia--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedPneumoniaComm">
<h2 class="text-center" id="HCPaedPneumoniaCommLabel"><strong><strong>Community Acquired Pneumonia</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedPneumComm">
<div class="card">
<div class="card-header" id="HCPaedCommPneuMild">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedCommPneuMild" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedCommPneuMild" data-toggle="collapse" type="button">Mild</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedCommPneuMild" class="collapse" data-parent="#accordionHCPaedPneumComm" id="collapseHCPaedCommPneuMild">
<div class="card-body text-left">
<p><strong><strong><strong><span style="color:#0033cc">Amoxicillin po</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clarithromycin po</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCPaedRespCommPneuSev">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedRespFluProph" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedRespCommPneuSev" data-toggle="collapse" type="button">Severe</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedRespCommPneuSev" class="collapse" data-parent="#accordionHCPaedPneumComm" id="collapseHCPaedRespCommPneuSev">
<div class="card-body text-left">
<p><strong><strong><span style="color:#0033cc"><strong>Co-amoxiclav plus clarithromycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clarithromycin</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Empyema--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedEmpyema">
<h2 class="text-center" id="HCPaedEmpyemaLabel"><strong><strong>Empyema</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#0033cc"><strong> cefuroxime&nbsp;plus clindamycin </strong></span><span style="color:#000000">until chest drain removed and patient is afebrile.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span><span style="color:#0033cc"><strong> cefalexin plus clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Minimum 2 weeks duration.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If loculated, 4 weeks duration.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span><span style="color:#e74c3c"><strong>&nbsp;ciprofloxacin plus clindamycin </strong></span><span style="color:#000000">until chest drain removed and patient is afebrile.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#e74c3c"><strong>ciprofloxacin plus clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Minimum 2 weeks duration.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If loculated, 4 weeks duration.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Hosp Acquired Pneumonia--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedHospPneum">
<h2 class="text-center" id="HCPaedHospPneumLabel"><strong><strong>Hospital Acquired Pneumonia</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong></span> <span style="color:#0033cc"><strong>Piperacillin/tazobactam</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Oral step down:</span></strong> <strong><span style="color:#0033cc">co-trimoxazole plus clindamycin</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#990099"><strong>ceftazidime</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down:</strong></span> <span style="color:#990099"><strong>co-trimoxazole plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#e74c3c"><strong>co-trimoxazole plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral step down: </strong></span><span style="color:#e74c3c"><strong>co-trimoxazole plus clindamycin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Influenza--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedInflu">
<h2 class="text-center" id="HCPaedInfluLabel"><strong><strong>Influenza</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Suspected influenza: fever, coryza, generalised symptoms (headache, malaise, myalgia, arthralgia) when prevalence of high influenza.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>1st line:</strong> </span><span style="color:#0033cc"><strong>oseltamivir 5 days.</strong></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">2nd line:</span></strong><span style="color:#e74c3c"><strong> zanamivir 5 days.</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedRespSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Paed inpatient hosp guidelines Soft Tissue section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedSkinLabel" class="portfolio-modal modal fade " id="HCPaedSkin" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedSkinLabel"><strong><strong>Skin and Soft Tissue Infection</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCPaedSkinSection"><strong><strong><a href="#HCPaedBites">Animal and Human Bite Wounds</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedCellulitis">Cellulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedErysipelas">Erysipelas</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedSkinFacialOrb">Facial / Orbital Cellulitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedNecrotising">Necrotising Fasciitis</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedScarletFever">Scarlet Fever</a></strong></strong></h4>

<h4><strong><strong><a href="#HCPaedWoundInf">Wound Infections</a></strong></strong></h4>
</div>
<br />
<strong><strong><!--Bite Wounds--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedBites">
<h2 class="text-center" id="HCPaedBitesLabel"><strong><strong>Animal and Human Bite Wounds</strong></strong></h2>

<p style="font-style: normal;"><strong><strong><strong><u><span style="color:black">Note:</span></u></strong><strong><u><span style="color:#e74c3c"> see also section below under the heading animal and human bites to the hand including clenched fist injuries.</span></u></strong></strong></strong></p>

<p style="font-style: normal;"><strong><strong>&nbsp;</strong></strong></p>

<p style="font-style: normal;"><strong><strong><span style="color:#000000"><strong><u>Tetanus Prophylaxis</u></strong></span></strong></strong></p>

<p style="font-style: normal;"><strong><strong><span style="color:#000000">See <a data-dismiss="modal" data-target="#HCMedProph" data-toggle="modal" href="#HCMedProph"> tetanus prophylaxis </a>in the medical prophylaxis guidelines.</span></strong></strong></p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedBite">
<div class="card">
<div class="card-header" id="HCPaedAnBites">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedAnBites" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedAnBites" data-toggle="collapse" type="button">Animal and Human Bite Wounds</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedAnBites" class="collapse" data-parent="#accordionHCPaedBite" id="collapseHCPaedAnBites">
<div class="card-body text-left">
<p><strong><strong><span style="color:#0033cc"><strong>Co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#e74c3c"><strong> clindamycin</strong></span></strong></strong></p>
</div>
</div>

<div class="card-header" id="HCPaedAnBitesHand">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedAnBitesHand" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedAnBitesHand" data-toggle="collapse" type="button">Animal and Human Bites to the Hand</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedAnBitesHand" class="collapse" data-parent="#accordionHCPaedBite" id="collapseHCPaedAnBitesHand">
<div class="card-body text-left">
<p><strong><strong><span style="color:#333333">Animal and human bites to the hand including clenched fist injuries (&#39;fight-bite&#39;) are at <u>greater risk for development of complications</u> associated with infection particularly septic arthritis, osteomyelitis and tendon sheath infection.</span></strong></strong></p>

<p><strong><strong><span style="color:#333333">These patients would require <u>hospital admission</u> for intravenous antibiotic treatment as well as <u>orthopaedic review</u> with assessment of surgical intervention including joint washout and tissue debridement.</span></strong></strong></p>

<p><strong><strong><u><u><span style="color:#000000"><strong>Antibiotic treatment</strong></span></u></u></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#0000ff"><strong>Co-amoxiclav IV.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">IV treatment:</span> <span style="color:#800080">Co-trimoxazole IV. </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080"> clindamycin IV.</span></strong></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--Cellulitis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCPaedCellulitis">
<h2 class="text-center" id="HCPaedCellulitisLabel"><strong><strong>Cellulitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Flucloxacillin</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy:</strong></u></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Clindamycin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Erysipelas--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCPaedErysipelas">
<h2 class="text-center" id="HCPaedErysipelasLabel"><strong><strong>Erysipelas</strong></strong></h2>

<p><strong><strong><strong>Erysipelas is caused by Strep Group A.</strong></strong></strong></p>

<p><strong><strong><u><strong>Antibiotic treatment</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#0033cc"><strong>benzylpenicillin</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment:&nbsp;</strong><span style="color:#0033cc"><strong>a</strong><strong>moxicillin</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (rash)</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#8e44ad"><strong>cefuroxime</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment: <span style="color:#8e44ad">cefalexin</span></strong></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis)</strong></u></strong></strong></p>

<p><strong><strong><strong>IV treatment: </strong><span style="color:#e74c3c"><strong>clindamycin</strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment: </strong><span style="color:#e74c3c"><strong>clindamycin</strong></span></strong></strong></p>

<p><strong><strong><strong>A total of 10 days of antibiotic treatment would be required in order to prevent recurrence of infection by Group A Strep.</strong></strong></strong></p>
</div>
<br />
<strong><strong><!--Facial / Orbital Cellulitis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCPaedSkinFacialOrb">
<h2 class="text-center" id="HCPaedSkinFacialOrbLabel"><strong><strong>Facial / Orbital Cellulitis</strong></strong></h2>

<p><strong><strong>See <a data-dismiss="modal" data-target="#HCPaedEye" data-toggle="modal" href="#HCPaedEye"> Orbital Cellulitis </a> in eye section</strong></strong></p>
</div>
<br />
<strong><strong><!--Necrotising Fasciitis--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCPaedNecrotising">
<h2 class="text-center" id="HCPaedNecrotisingLabel"><strong><strong>Necrotising Fasciitis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Piperacillin/tazobactam plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#8e44ad"><strong>Ceftazidime&nbsp;plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong><u><strong>Penicillin allergy (anaphylaxis)</strong></u><strong>:</strong></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Ciprofloxacin plus clindamycin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Scarlet Fever--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCPaedScarletFever">
<h2 class="text-center" id="HCPaedScarletFeverLabel"><strong><strong>Scarlet Fever</strong></strong></h2>

<p><strong><strong>See <a data-dismiss="modal" data-target="#HCPaedENT" data-toggle="modal" href="#HCPaedENT"> Pharyngitis / Tonsillitis </a> in ENT section</strong></strong></p>
</div>
<br />
<strong><strong><!--Wound Infections--> </strong></strong>

<div class="text-left border border-primary rounded" id="HCPaedWoundInf">
<h2 class="text-center" id="HCPaedWoundInfLabel"><strong><strong>Wound Infections</strong></strong></h2>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionHCPaedWound">
<div class="card">
<div class="card-header" id="HCPaedWoundSurg">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedWoundSurg" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedWoundSurg" data-toggle="collapse" type="button">Surgical Site Infection</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedWoundSurg" class="collapse" data-parent="#accordionHCPaedWound" id="collapseHCPaedWoundSurg">
<div class="card-body text-left">
<p><strong><strong>For superficial surgical&nbsp;site infections the commonest aetiologic organism is Staph aureus and treatment should follow the cellulitis guideline. See section on <span style="color:#0000ff"><strong>cellulitis</strong></span>.</strong></strong></p>

<p><strong><strong>For deep surgical site&nbsp;infection antibiotic treatment should cover the organisms associated with that anatomic site such as the GI tract and respiratory tract.&nbsp; See section on <span style="color:#0000ff"><strong>surgical prophylaxis</strong></span>&nbsp;and use the same antibiotics recommended for surgical prophylaxis to treat deep surgical site infections.</strong></strong></p>

<p><strong><strong>The&nbsp;duration&nbsp;of antibiotic&nbsp;treatment&nbsp;depends on the clinical response.</strong></strong></p>
</div>
</div>

<div class="card-header" id="HCPaedWoundInf">
<h5 class="mb-0"><strong><strong><button aria-controls="collapseHCPaedWoundInf" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseHCPaedWoundInf" data-toggle="collapse" type="button">Wound Infections</button></strong></strong></h5>
</div>

<div aria-labelledby="HCPaedWoundInf" class="collapse" data-parent="#accordionHCPaedWound" id="collapseHCPaedWoundInf">
<div class="card-body text-left">
<p><strong><strong><span style="color:#000000">In the ABSENCE of spreading cellulitis, induration or constitutional symptoms associated with the lesion, <strong><u>NO</u></strong> systemic antibiotic treatment would be required, and <strong><u>TOPICAL/LOCAL MANAGEMENT</u> </strong>of the lesion would be more appropriate.&nbsp;<strong>Topical treatment </strong>includes&nbsp;maintenance of good wound toilet together with application of appropriate dressings in consultation with the tissue&nbsp;viability department.&nbsp; <strong>Local&nbsp;management </strong>of the wound includes surgical debridement, vascular surgical assessment as well as close diabetic monitoring.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Antibiotic treatment</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment:</strong><strong> </strong></span><span style="color:#0033cc"><strong>co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment:</strong><strong> </strong></span><span style="color:#0033cc"><strong>co-amoxiclav</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#8e44ad"><strong>cefuroxime</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#8e44ad"><strong>cefalexin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treament:</strong><strong> </strong></span><span style="color:#e74c3c"><strong>co-trimoxazole plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treament:</strong> </span><span style="color:#e74c3c"><strong>co-trimoxazole plus clindamycin</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>If&nbsp;clinical toxicity is present i.e. sepsis syndrome (SIRS plus invasive infection):</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#0033cc"><strong>piperacillin/tazobactam&nbsp;<u>plus</u></strong><strong> clindamycin <u>plus</u> gentamicin IV single stat dose once only.&nbsp;<strong>&nbsp;</strong></strong></span></strong></strong></p>

<p><strong><strong><strong>Oral treatment: <span style="color:#0033cc">cefalexin <u>plus</u> clindamycin.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treatment: </strong></span><span style="color:#8e44ad"><strong>cefuroxime&nbsp;</strong><u><strong>plus</strong></u><strong> clindamycin&nbsp;<u>plus</u><strong> </strong>gentamicin IV single stat dose once only.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treatment: </strong></span><span style="color:#8e44ad"><strong>cefalexin <u>plus</u> clindamycin.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>IV treament:<strong> </strong></strong></span><span style="color:#e74c3c"><strong>ciprofloxacin&nbsp;<u>plus</u></strong><strong> clindamycin&nbsp;<u>plus</u><strong> </strong>gentamicin IV single stat dose once only.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Oral treament:</strong>&nbsp;</span><span style="color:#e74c3c"><strong>ciprofloxacin <u>plus</u> clindamycin.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedSkinSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Paed inpatient hosp guidelines UTI section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPaedUTILabel" class="portfolio-modal modal fade " id="HCPaedUTI" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedUTILabel"><strong><strong>Urinary Tract Infections</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<ul>
    <li><strong><strong>A urine specimen <strong><u>MUST</u></strong> be sent&nbsp;to the laboratory for microbiologic culture and sensitivity prior to commencing antibiotic treatment for urinary tract infection.&nbsp;</strong></strong></li>
    <li><strong><strong>Follow up culture and sensitivity results to review&nbsp;the choice of antibiotic.</strong></strong></li>
    <li><strong><strong>Change the antibiotic according to susceptibility results if the bacteria are resistant.</strong></strong></li>
    <li><strong><strong>Use&nbsp;narrow spectrum antibiotics wherever possible.</strong></strong></li>
</ul>
<strong><strong>&nbsp; </strong></strong>

<h4 id="HCPaedUTISection"><strong><strong><a href="#HCPaedAcPyelon">Acute Pyelonephritis</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCPaedUrinTI">Urinary Tract Infections</a></strong></strong></h4>
<strong><strong> </strong></strong>

<h4><strong><strong><a href="#HCPaedUrosepsis">Urosepsis</a></strong></strong></h4>
<strong><strong> </strong></strong></div>
<br />
<br />
<strong><strong><!--Acute Pyelonephritis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedAcPyelon">
<h2 class="text-center" id="HCPaedAcPyelonLabel"><strong><strong>Acute Pyelonephritis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Cefuroxime IV</strong></span><span style="color:#000000"> then step down to</span> <span style="color:#0033cc"><strong>cefalexin PO</strong></span>.&nbsp; <span style="color:#000000">Treat for a total of 10 days.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole.&nbsp;&nbsp;</strong></span><span style="color:#000000">Treat for a total of 10 days.</span></strong></strong></p>
</div>
<br />
<strong><strong><!--Urinary Tract Infection--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedUrinTI">
<h2 class="text-center" id="HCPaedUrinTILabel"><strong><strong>Urinary Tract Infections</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><u><strong>1st line:</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0033cc">Cefalexin</span></strong></strong></strong></p>

<p><strong><strong><u><strong>2nd line or if penicillin allergy:</strong></u></strong></strong></p>

<p><strong><strong><strong><span style="color:#8e44ad">Nitrofurantoin tablets </span></strong><span style="color:#000000">(if cannot swallow tablets&nbsp;give 3rd line option)</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>3rd line:</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Ciprofloxacin</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--Urosepsis--> </strong></strong>

<div class="text-left border border-info rounded px-1" id="HCPaedUrosepsis">
<h2 class="text-center" id="HCPaedUrosepsisLabel"><strong><strong>Urosepsis</strong></strong></h2>

<p><strong><strong><span style="color:#0033cc"><strong>Cefuroxime</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>If treatment is amenable to oral antibiotics, give </strong></span><span style="color:#0033cc"><strong>cefalexin.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u>:</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#e74c3c"><strong>Co-trimoxazole</strong></span></strong></strong></p>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCPaedUTISection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Hospital Guidelines Modals--> <!--Editor--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCEditors" class="portfolio-modal modal fade " id="HCEditors" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCEditorsLabel"><strong><strong>Editors</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="row-fluid">
<div class="span8 offset2">
<div class="text-left">
<p><strong><strong><strong><u>About these Guidelines:</u></strong></strong></strong></p>

<ul>
    <li><strong><strong>These guidelines have been revised, rewritten and reformatted by <strong>Dr Howard Sacho</strong>, Consultant Medical Microbiologist and Infection Control Doctor, and <strong>Miss Sarwat Rahman</strong>, Antibiotic Specialist Pharmacist.</strong></strong></li>
    <li><strong><strong>The intial setting up of this app was constructed by <strong>Mrs Saarah Niazi-Ali</strong>, Antibiotic Specialist Pharmacist.</strong></strong></li>
    <li><strong><strong><strong>Dr Philip Unsworth </strong>contributed advice and suggestions to these guidelines.</strong></strong></li>
    <li><strong><strong>These Guidelines are regularly updated under the editorship of Miss Sarwat Rahman and Dr Howard Sacho.</strong></strong></li>
</ul>
</div>
</div>
</div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Updates--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCLatest" class="portfolio-modal modal fade " id="HCLatest" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCUpdatesLabel"><strong><strong>Latest Updates</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="row-fluid">
<div class="span8 offset2">
<div class="text-left">
<p><strong><strong><strong><u>Latest Updates</u></strong></strong></strong></p>

<p><strong><strong>Updates will be shown here</strong></strong></p>
</div>
</div>
</div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Objectives--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCObjectives" class="portfolio-modal modal fade " id="HCObjectives" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCObjectivesLabel"><strong><strong>Objectives</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="row-fluid">
<div class="span8 offset2">
<div class="text-left">
<p><strong><strong><strong><u>Objectives</u></strong></strong></strong></p>

<p><strong><strong>The primary objective of these guidelines is to:</strong></strong></p>

<p><strong><strong>a. Ensure the most appropriate use of antibacterials</strong></strong></p>

<p><strong><strong>b. Avoid antibiotic abuse and overuse, and the unnecessary prolongation of antibiotic treatment</strong></strong></p>

<p><strong><strong>c. Prevent the development of antibiotic-associated <em>Clostridium </em><em>difficile </em>infection and MRSA blood stream infection.</strong></strong></p>

<p><strong><strong>d. Promote antibiotic stewardship programmes.</strong></strong></p>

<h3><strong><strong>Prior To Commencing Antibiotics</strong></strong></h3>

<p><strong><strong><strong>Before commencing antibiotic treatment, the following important issues </strong><strong>need to be considered:</strong></strong></strong></p>

<p><strong><strong>Does the patient have a bacterial infection?</strong></strong></p>

<p><strong><strong>Have relevant specimens been collected for laboratory analysis?</strong></strong></p>

<p><strong><strong>Is the patient allergic to any antibiotics and is the history of allergy accurate?</strong></strong></p>

<p><strong><strong>Is parenteral treatment necessary? Use oral route whenever possible - number of antibiotics have good oral bioavailability and are well absorbed from the gastrointestinal (GI)&nbsp;tract such as&nbsp;metronidazole,&nbsp;ciprofloxacin, rifampicin and fluconazole.&nbsp;Unless the patient cannot absorb these agents enterally&nbsp;or has a malfunctioning GI tract, or is hypotensive with the sepsis syndrome, there is no advantage of using any of these drugs intravenously.</strong></strong></p>

<p><strong><strong>Antibiotics should be prescribed intravenously for severe infections such as bacteraemic sepsis, acute pyelonephritis, endocarditis, bacterial meningitis, septic arthritis/osteomyelitis, neutropenic sepsis</strong></strong></p>

<p><strong><strong>All antibiotic treatment should be reviewed daily. If required for longer than 3 days a new prescription is required and should only be prescribed after discussion with the senior clinician in charge of the patient.</strong></strong></p>

<p><strong><strong><strong>Switching from IV to oral (follow on) antibiotic therapy is encouraged </strong><strong>if the following conditions are met:</strong></strong></strong></p>

<p><strong><strong>(i) Temperature less than 38 , but preferably normal for at least 24 hours;</strong></strong></p>

<p><strong><strong>(ii) No unexplained tachycardia;</strong></strong></p>

<p><strong><strong>(iii) Signs of clinical improvement;</strong></strong></p>

<p><strong><strong>(iv) Oral fluids tolerated;</strong></strong></p>

<p><strong><strong>(v) No ongoing or potential GI tract absorption problems;</strong></strong></p>

<p><strong><strong>(vi) Infection does not need continued IV therapy to maintain high tissue antibiotic levels, such as would be required in endocarditis, meningitis, or severe soft tissue infection;</strong></strong></p>

<p><strong><strong>(vii) Oral formulation or suitable oral alternative is available.</strong></strong></p>

<p><strong><strong><strong>N.B</strong>. <strong>Take samples for culture (e.g. blood, pus, urine, sputum, CSF) </strong><strong>BEFORE commencing or changing antibiotics, and without delaying </strong><strong>start of therapy</strong>. For suspected endocarditis take THREE SETS (pairs) of blood cultures of at least&nbsp;5 ml into each blood culture bottle (i.e. total 30 ml of blood), preferably by separate venepuncture a few minutes apart. In other suspected serious bacteraemic infections, take TWO sets (pairs) of blood cultures of at least 5ml into each blood culture bottle (i.e. 20 ml of blood).</strong></strong></p>

<p><strong><strong>Check the Trust intranet for the latest version of this guideline.</strong></strong></p>

<p><strong><strong><strong>Treat the patient, not the microbiology. The microbiology results </strong><strong>need to be interpreted <u>together</u> with the clinical condition of the </strong><strong>patient. </strong>A positive culture result does not necessarily imply that antibiotic treatment is required. For example chronic leg ulcers and long term indwelling urinary catheters&nbsp;are commonly colonised by bacteria but require no definitive antibiotic treatment. Treatment should depend on <u>clinical</u> infection such as acute cellulitis or underlying osteomyelitis with chronic leg ulcers. Treatment of patients with indwelling urinary catheters should be reserved for those with systemic manifestations infection such as fever, rigors and suprapubic pain. In addition those patients about to undergo instrumentation or surgery of the urinary tract should receive antibiotic prophylaxis just prior to the procedure. Urinary catheters should be removed as soon as they are no longer needed.</strong></strong></p>
</div>
</div>
</div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Decreasing C Diff--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCDecCDiff" class="portfolio-modal modal fade " id="HCDecCDiff" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCDecCDiffsLabel"><strong><strong>Decreasing Clostridium Difficile</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="row-fluid">
<div class="span8 offset2">
<div class="text-left">
<ul>
    <li><strong><strong>In keeping with good antibiotic stewardship strategies antibiotics should NOT be prescribed if there is no clinical or microbiologic evidence of <u>bacterial</u> infection. The majority of sore throats, coughs and colds are generally caused by viruses rather than bacteria, and antibiotics will NOT be beneficial in such cases. Avoid repeated courses of antibiotics where possible. Short course antibiotics are advisable for the majority of acute bacterial infections where as little as 3 days of antibiotic treatment may be sufficient. Use narrow spectrum antibiotics as much as possible such as flucloxacillin to treat Staph. aureus infections and a penicillin for Strep. Group A infections.</strong></strong></li>
</ul>

<ul>
    <li><strong><strong>Meticulous attention by all staff is warranted with hand washing and use of disposable gloves and aprons when in contact with patients with communicable infections (see Infection Prevention and Control Policy). In addition hand washing by all patients before eating and drinking should be encouraged.</strong></strong></li>
</ul>

<ul>
    <li><strong><strong>Avoid antimotility agents in patients with diarrhoea until a definitive aetiology has been established.</strong></strong></li>
</ul>
</div>
</div>
</div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Preventing Resistant Organisms--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCResistantOrgs" class="portfolio-modal modal fade " id="HCResistantOrgs" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCResistantOrgsLabel"><strong><strong>Preventing Resistant Organisms</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="row-fluid">
<div class="span8 offset2">
<div class="text-left">
<p><strong><strong><strong>Preventing emergence of resistant organisms (including Carbapenemase </strong><strong>producing Enterobacteriaceae (CPE)).</strong></strong></strong></p>

<p><strong><strong>1. Maintenance of antibiotic stewardship programs directed at preventing antibiotic abuse and overuse.</strong></strong></p>

<p><strong><strong>2. Maintaining a high index of suspicion for patients transferred to this hospital from tertiary care centres such as Central Manchester Foundation Trust, University Hospital South Manchester, and Stepping Hill Hospital.</strong></strong></p>

<p><strong><strong>3. Close liaison and support for clinicians managing these patients from the departments of Microbiology, Infection Prevention and Laboratory Medicine.</strong></strong></p>
</div>
</div>
</div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Penicillin Allergy--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPenAllergy" class="portfolio-modal modal fade " id="HCPenAllergy" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPenAllergyLabel"><strong><strong>Penicillin Allergy</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<p><strong><strong>The allergy status of all patients should be carefully checked and a&nbsp;careful&nbsp;history of the exact nature of&nbsp;the allergy needs to be determined.&nbsp;If the patient states they are allergic to penicillin they should be asked specifically about their manifestations of the allergy.&nbsp;They may simply report GI symptoms such as nausea or diarrhoea which is <u>NOT</u> an allergic reaction.&nbsp;Only 1-10% of penicillin exposed patients will have an allergic reaction and fewer than 0.05% of these patients will have an anaphylactic reaction.</strong></strong></p>

<h3><strong><strong>Assessment of Penicillin Allergy</strong></strong></h3>

<p><strong><strong>The following questions are suggested:</strong></strong></p>

<ol>
    <li><strong><strong>How do you know that you are penicillin allergic?</strong></strong></li>
    <li><strong><strong>Have you ever taken co-amoxiclav, amoxicillin, ampicillin, flucloxacillin or penicillin V?</strong></strong></li>
    <li><strong><strong>What happens to you when you take penicillin?</strong></strong></li>
</ol>

<p><strong><strong>Pertinent questions for a history of penicillin anaphylaxis should include:</strong></strong></p>

<ul>
    <li><strong><strong>Did you experience tightness in your chest or wheezing (bronchoconstriction)?</strong></strong></li>
    <li><strong><strong>Did you feel that there was a lump in your throat and your voice was hoarse (laryngeal oedema)?</strong></strong></li>
    <li><strong><strong>Did you feel light-headed or feel like fainting (vascular collapse/shock)?</strong></strong></li>
    <li><strong><strong>Was your skin red and face flushed with itching and wheals (urticaria and angiooedema)?</strong></strong></li>
</ul>

<p><strong><strong>It should be noted that as little as 0.5-6.5% of penicillin-allergic patients will also be allergic to cephalosporins.&nbsp; Where penicillin allergy reaction is a rash cephalosporins, carbapenems and monobactams (aztreonam) may be used with caution. Where the reaction is anaphylaxis all beta-lactam antibiotics (penicillins, cephalosporins, carbapenems and monobactams) should be avoided.</strong></strong></p>
</div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Appropriate Prescribing--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCApRx" class="portfolio-modal modal fade " id="HCApRx" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCAPRxLabel"><strong><strong>Appropriate Prescribing</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<p><strong><strong><strong>How to prescribe antibiotics appropriately</strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>1) Antibiotics should be prescribed on the antibiotic section of the treatment sheet or on the stat dose section for immediate administration.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>2)&nbsp; Stat doses of antibiotics:</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>It is important to remember that antibiotic treatment should be commenced as soon as a diagnosis of infection is made especially in the acutely ill hospitalised patient.&nbsp;When prescribing the antibiotic if it is not due immediately on the antibiotic section of the chart, a stat dose must be prescribed on the stat dose section for immediate administration.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>3) Antibiotic treatment that may be prescribed on the regular side of the treatment sheet includes eye/ear drops and treatment which is given for 4 weeks or more. Examples of conditions for which antibiotics are prescribed for prolonged durations include endocarditis, osteomyelitis, septic arthritis, tuberculosis - if antibiotics are prescribed for prolonged periods on the regular side of the treatment sheet, the indication and the intended duration of the antibiotic course should be stated (e.g.&nbsp;4 weeks, 6 weeks) however for the vast majority of infections initial antibiotic treatment should continue for no longer than 3 days without prior clinical review.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>4) All of the relevant sections on the antibiotic treatment sheet should be filled in correctly. Standard details on a prescription such as the drug name, the dose, frequency and route of administration should be completed. Important details notably the indication for treatment and <u>each date</u> upon which the antibiotic should be given must also be filled in.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>5) Antibiotics should be prescribed on the antibiotic chart for 72 hours at a time. At the 72 hour point, antibiotic therapy should be reviewed and a decision made as to whether treatment&nbsp;should be continued, be stopped or changed to another regimen.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>6) Antibiotics should be given for the shortest duration possible and stopped when the patient is clinically better unless there is a specific indication (such as endocarditis, pyelonephritis, septic arthritis, osteomyelitis or lung abscess) which requires more prolonged treatment. The durations of treatment for these indications are stated in the guideline. For indications where the duration is not specified in the guideline, antibiotics should be stopped on clinical improvement. In general most antibiotic treatments should not continue for longer than 3 to 5 days. Single day treatment such as for uncomplicated urinary tract infections is completely acceptable.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>7) Antibiotic treatments should as far as possible be guided by microbiologic culture and antibiotic sensitivity results. Microbiologic results should be accessed and followed up as soon as they become available &ndash; as important as it is to commence empiric antibiotic treatment in the seriously ill patient, it is equally important to:</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>&bull; obtain appropriate specimens for microbiologic analysis before antibiotic&nbsp;treatment is commenced</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>&bull; obtain and interpret microbiologic results as soon as they become available.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>8) In order to be more therapeutically effective it is important to de-escalate therapy to a&nbsp;narrower spectrum antibiotic once cultures and sensitivity results have become available; however both organ function (renal, hepatic and cardiovascular (haemodynamic stability)) and pharmacokinetics (tissue penetration) should be taken into account when making the step down change from broad to narrow spectrum antibiotics. For example,&nbsp;if treating an&nbsp;uncomplicated UTI (that is no evidence of clinical toxicity) the preference based on how narrow spectrum the antibiotic is would be firstly nitrofurantoin, then trimethoprim, then amoxicillin and then only a broad spectrum antibiotic.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>9) Where necessary antibiotic treatment may need to be monitored &ndash; please see <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring"> therapeutic Drug Monitoring</a> for gentamicin and vancomycin monitoring.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>10) When antibiotics are stopped, the antibiotic should be crossed off and the section for stopping antibiotics on the treatment sheet&nbsp;should be completed.</strong></strong></p>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--therapeutic Drug Monitoring--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCDrugMonitoring" class="portfolio-modal modal fade " id="HCDrugMonitoring" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCDrugMonitoringLabel"><strong><strong>Therapeutic Drug Monitoring</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000">Aminoglycosides (such as gentamicin) and glycopeptides (such as vancomycin) require therapeutic drug monitoring,&nbsp;however when aminoglycosides (gentamicin) and glycopeptides (vancomycin) are used together<strong> increased nephrotoxicity is an important risk</strong>.&nbsp; It is therefore advisable<strong> </strong><u><strong>not</strong></u><strong> </strong>to use these two agents in combination if alternative effective treatment is available.</span></strong></strong></p>
<strong><strong> <!--Start accordian--> </strong></strong>

<div id="HCaccordionDrugMon">
<div class="card">
<div class="card-header" id="HCDrugMonGent">
<h5 class="mb-0"><strong><strong><button aria-controls="HCcollapseGent" aria-expanded="false" class="btn btn-link collapsed" data-target="#HCcollapseGent" data-toggle="collapse" type="button">Gentamicin</button></strong></strong></h5>
</div>

<div aria-labelledby="HCGentLabel" class="collapse" data-parent="#HCaccordionDrugMon" id="HCcollapseGent">
<div class="card-body text-left">
<p><strong><strong>Gentamicin&nbsp;can be given using the once daily regimen with the exception of patients receiving&nbsp;gentamicin for the treatment of endocarditis, cystic fibrosis, pancreatitis, and in pregnancy, patients with extensive burns and paediatric patients. For patients who are not suitable for once daily gentamicin dosing, please read the section below &#39;Gentamicin twice (or three times) a day dosing.&#39;&nbsp; Once daily&nbsp;gentamicin dosing is at least as effective as multiple dose therapy, is no more toxic and makes under-treating less likely and assaying simpler.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>GENTAMICIN DOSE AND INTERVAL</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>For patients under 70 years of age and with normal renal function</u>:</strong></span></strong></strong></p>

<p><strong><strong>5 mg/kg once daily (max total daily dose must not exceed 400mg),</strong></strong></p>

<p><strong><strong>EXCEPT, in pregnant women, children, endocarditis and the other conditions referred to above - for these patients use the same total daily dose, divided into 2-3 doses per day.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>For patients 70 years of age and over with normal renal function</u>:</strong></span></strong></strong></p>

<p><strong><strong>4 mg/kg once daily</strong></strong></p>

<p><strong><strong>EXCEPT in the conditions referred to above - for these patients use the same total daily dose, divided into 2-3 doses per day.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>For patients with abnormal renal function</u>:</strong></span></strong></strong></p>

<p><strong><strong>For patients with renal impairment give the normal dose to begin with and then dose based on plasma levels.&nbsp; Do not give doses until levels are available from the laboratory in order to avoid toxicity.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Dose calculation for obese patients</strong></u></span></strong></strong></p>

<p><strong><strong>Where a patient is obese the dose of gentamicin should be calculated using corrected body weight (CBW).&nbsp; The following steps should be followed in order to calculate CBW.</strong></strong></p>

<p><strong><strong>1. Weigh the patient to obtain actual body weight (ABW)</strong></strong></p>

<p><strong><strong>2. Calculate the ideal body weight (IBW) using the&nbsp;formulas below selected based on gender:</strong></strong></p>

<ul>
    <li><strong><strong>IBW Male (kg) = 50 + (2.3 x number of inches above five feet in height)</strong></strong></li>
    <li><strong><strong>IBW Female (kg) = 45.4 + (2.3 x number of inches above five feet in height)</strong></strong></li>
</ul>

<p><strong><strong>3. Calculate corrected body weight (CBW)&nbsp;using the following formula:</strong></strong></p>

<ul>
    <li><strong><strong>CBW (kg) = IBW&nbsp;+ [0.4 x (ABW - IBW)].</strong></strong></li>
</ul>

<p><strong><strong><em>For example, an obese male patient who is 6&rsquo;1&rdquo; tall and weighs 120kg would result in the following calculation:</em></strong></strong></p>

<p><strong><strong><em>IBW = 50 + (2.3 x 13) = 79.9kg</em></strong></strong></p>

<p><strong><strong><em>CBW = 79.9 + 0.4 (120 - 79.9) = 95.9kg when calculating dose.</em></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>MONITORING OF GENTAMICIN</u></strong></span></strong></strong></p>

<p><strong><strong>Monitoring is recommended for all patients in whom it is anticipated that gentamicin will be given for more than 2 days. The main objective is to delay the onset of nephrotoxicity and reduce the risk of ototoxicity.&nbsp; If the patient has adequate renal function do not wait for plasma levels to become available from the laboratory before giving the next dose as this will delay treatment.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Monitoring of plasma levels</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">For once daily dosing only the <strong><u>pre-dose (trough)</u></strong> plasma concentration should be measured. A clotted blood sample must be taken before the second dose is due. The biochemistry department will test and give the result before the next dose is due. <u>Wait</u> for the test result before giving the second and subsequent doses in patients with renal impairment and patients who have had toxicity with gentamicin.&nbsp; Do NOT wait for the test result for patients who have normal renal function and no signs of gentamicin toxicity as this will delay antibiotic treatment.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If the level is:</span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Less than 1 mg /litre (therapeutic range)</strong></span>&nbsp;continue with&nbsp;<span style="color:#000000">the <strong>same dose </strong>and <strong>check pre-dose levels twice weekly</strong>.</span></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Between 1-2 mg/litre </span></strong><span style="color:#000000"><u>give the next dose</u> but <strong>check pre-dose level again prior to the next dose.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Greater than 2mg/litre </strong></span><span style="color:#000000"><u>do not give any more</u>. <strong>Omit the next dose and repeat levels again after 24&nbsp;hours. Do not administer any more gentamicin until the level is in the therapeutic range (less than 1mg/litre).&nbsp; The period of time it takes the plasma concentration to drop to a therapeutic level&nbsp;should be used as the time&nbsp;period between doses.&nbsp;</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">If the patient is very ill or if there are problems monitoring levels please discuss with the microbiologist for an alternative antibiotic regimen.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Duration</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Review the need for gentamicin therapy at&nbsp;72 hours. If it is deemed necessary to continue gentamicin treatment beyond 72 hours discussion with the Consultant Microbiologist.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong><u>Twice (or three times) a day dosing</u></strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Twice or three times a day dosing may be used, particularly in patients given small doses twice daily for endocarditis.&nbsp; Clotted blood samples should be taken just before and 1 hour after the dose (i.e. trough and peak levels). This should be done at dose 2-4; and earlier if there is renal impairment or other factors associated with increased toxicity. The peak level is needed, in multiple daily dosing, to ensure it is high enough for efficacy.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">In<strong> <u>endocarditis</u></strong>, </span><strong><span style="color:#000000">aim for trough &lt;1mg/litre and peak 3-5</span>mg/litre</strong><span style="color:#000000">.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">In other conditions requiring multiple daily doses of gentamicin <strong>aim for trough &lt;2mg/litre and peak 5-10mg/litre</strong>.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Subsequent monitoring of levels is needed 2-3 times weekly.</span></strong></strong></p>

<p><strong><strong>If the pre-dose (&lsquo;trough&rsquo;) concentration is high, the interval between doses must be increased. If the post-dose (&lsquo;peak&rsquo;) concentration is high, the dose must be decreased.</strong></strong></p>
</div>
</div>

<div class="card-header" id="HCDrugMonVanc">
<h5 class="mb-0"><strong><strong><button aria-controls="HCcollapseVanc" aria-expanded="false" class="btn btn-link collapsed" data-target="#HCcollapseVanc" data-toggle="collapse" type="button">Vancomycin</button></strong></strong></h5>
</div>

<div aria-labelledby="HCVancLabel" class="collapse" data-parent="#HCaccordionDrugMon" id="HCcollapseVanc">
<div class="card-body text-left">
<div class="accordion-inner">
<p><strong><strong>Intravenous vancomycin is reserved for severe (bacteraemic) infections due to Methicillin-resistant <em>Staphylococcus aureus </em>(MRSA) and coagulase negative staphylococci (<em>Staph. epidermidis</em>) where there is resistance to flucloxacillin, and when it is indicated as prophylaxis in the penicillin allergic patient, as well as&nbsp;in the treatment of endocarditis including&nbsp;infection&nbsp;with ampicillin-resistant <em>enterococci</em>.</strong></strong></p>

<p><strong><strong>Initial doses, which may have to be altered according to renal function and levels, are 1g IV 12 hourly in patients less than 65 years and 1g IV once daily in patient&nbsp;65 years and over.</strong></strong></p>

<p><strong><strong>Vancomycin is generally not nephrotoxic if used in the absence of other nephrotoxic drugs such as gentamicin.</strong></strong></p>

<p><strong><strong>Measurement of a single trough concentration just before 2nd to 4th dose is recommended for the following adult patients:</strong></strong></p>

<ul>
    <li><strong><strong>Patients receiving concomitant aminoglycosides</strong></strong></li>
    <li><strong><strong>Patients receiving higher than normal doses of vancomycin (i.e. for meningitis)</strong></strong></li>
    <li><strong><strong>Patients with rapidly changing renal function</strong></strong></li>
    <li><strong><strong>Patients with altered volumes of distribution (burn patients, trauma patients, IV drug abusers)</strong></strong></li>
    <li><strong><strong>Patients in whom treatment is failing.</strong></strong></li>
</ul>

<p><strong><strong><u>Levels:</u></strong></strong></p>

<p><strong><strong>Pre dose (trough) concentration 10-15mg/litre</strong></strong></p>

<p><strong><strong>15-20mg/litre for&nbsp;MRSA</strong></strong></p>

<p><strong><strong>Anephric patients receiving haemodialysis should have vancomycin levels done periodically (approximately every 4 to 7 days) to ensure that therapeutic levels are maintained.</strong></strong></p>

<p><strong><strong>Oral vancomycin is effective, but not IV, when used for the treatment of severe <em>C. difficile </em>toxin-positive diarrhoea.&nbsp;It is used as&nbsp;a second line agent to metronidazole&nbsp;in mild&nbsp;<em>C.difficile </em>infection or as a first line agent in severe or relapsing&nbsp;infection. Oral vancomycin is of no use for systemic infections, as it is not significantly absorbed from the GI tract and the only indication for oral vancomycin is in the treatment of <em>Clostridium difficile </em>associated diarrhoea.</strong></strong></p>
</div>
</div>
</div>
</div>
</div>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Probiotics--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCPropbiotics" class="portfolio-modal modal fade " id="HCPropbiotics" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPropbioticsLabel"><strong><strong>Probiotics</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<p><strong><strong>Probiotics are live organisms believed to confer health benefits to the host. They are thought to help with food digestion and in maintaining the balance of gut flora. Antibiotic treatment can disturb the natural balance of organisms in the gut by killing beneficial bacteria which can leave the gut open to colonisation and infection by harmful bacteria. Clostridium difficile (C.difficile) is considered to be one of these harmful bacteria and can result in severe diarrhoea, abdominal pain, colitis and pseudomembranous colitis.</strong></strong></p>
<strong><strong> </strong></strong>

<h3><strong><strong>Prophylactic</strong></strong></h3>
<strong><strong> </strong></strong>

<p><strong><strong><strong>Prophylactic use of probiotics (e.g. Actimel<sup>&reg;</sup>) in patients receiving antibiotic treatment</strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>There is moderate quality evidence which suggests that&nbsp;antibiotic-associated&nbsp;diarrhoea can be reduced with the use of probiotic prophylaxis.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>In order to prevent the incidence of C.difficile infection, patients who are 65 years or over and are receiving antibiotic treatment for an infection should be given Actimel, one bottle of 100ml, twice a day for the duration of antibiotic treatment and for 7 days after stopping antibiotics.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>For patients to receive Actimel, doctors, pharmacists or nurses must&nbsp;show this via&nbsp;a written indication&nbsp;on the medication chart in the regular medicines section.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong>Contraindications</strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>The following patients should <strong><u>not</u></strong> receive probiotics:</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>&bull; Patients who are immunosuppressed</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>&bull; Patients with acute pancreatitis</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>&bull; Patients who have a dairy allergy</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong>Interactions</strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>Dairy products reduce absorption of oral <u>ciprofloxacin</u>. Patients receiving oral ciprofloxacin should not take Actimel at the same time and a 2 hour interval should be maintained between the administration of these two agents.</strong></strong></p>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--IV to Oral--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCIVOral" class="portfolio-modal modal fade " id="HCIVOral" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCIVOralLabel"><strong><strong>IV to Oral Switch</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<p><strong><strong>Intravenous antibiotic treatment should be reviewed on a daily basis.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>Switching from intravenous to oral antibiotic therapy (oral step down) should be undertaken when the following conditions are met:</strong></strong></p>
<strong><strong> </strong></strong>

<ol class="text-left">
    <li><strong><strong>Temperature less than 38<span style="color:#272727">, but preferably normal for at least 24 hours</span></strong></strong></li>
    <li><strong><strong><span style="background-color:white"><span style="color:#272727">Signs of <u>clinical improvement</u></span></span></strong></strong></li>
    <li><strong><strong><span style="background-color:white"><u><span style="color:#272727">Oral</span></u><span style="color:#272727"> fluids tolerated</span></span></strong></strong></li>
    <li><strong><strong><span style="background-color:white"><span style="color:#272727">No ongoing or potential <u>GI tract absorption</u> problems</span></span></strong></strong></li>
    <li><strong><strong><span style="background-color:white"><span style="color:#272727">Infection does <u>not</u> require continued IV therapy to maintain high tissue antibiotic levels, such as would be required in endocarditis, meningitis, severe soft tissue infection or septic arthritis/osteomyelitis.</span></span></strong></strong></li>
    <li><strong><strong><span style="background-color:white"><u><span style="color:#272727">Oral antibiotic formulation</span></u><span style="color:#272727"> or suitable oral alternative is available.</span></span></strong></strong></li>
</ol>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--References--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCReferences" class="portfolio-modal modal fade " id="HCReferences" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCReferencesLabel"><strong><strong>References</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<ol class="text-left">
    <li><strong><strong>British National Formulary. Available at URL: <a href="https://www.medicinescomplete.com/mc/bnf/current/" target="_blank">https://www.medicinescomplete.com/mc/bnf/current/</a> &nbsp; [Accessed: 07/08/15]</strong></strong></li>
    <li><strong><strong>Clostridium difficile infection: How to deal with the problem. DoH and HPA, December 2008. Available at <a href="http://www.dh.gov.uk" target="_blank">http://www.dh.gov.uk</a></strong></strong></li>
    <li><strong><strong>Updated guidance on the management&nbsp;and treatment of Clostridium&nbsp;difficile infection: guidance on management and treatment.&nbsp;&nbsp;Public Health England. May&nbsp;2013.&nbsp; Available at <a href="http://www.dh.gov.uk" target="_blank">http://www.dh.gov.uk</a></strong></strong></li>
    <li><strong><strong>NICE Clinical Guideline 64: Prophylaxis against infective endocarditis: Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. (March 2008).</strong></strong></li>
    <li><strong><strong>Johns Hopkins POC-IT Center. ABX Guide (2013). Available at URL: <a href="http://www.hopkins-abxguide.org" target="_blank">http://www.hopkins-abxguide.org</a> &nbsp;[Accessed 07/08/15].</strong></strong></li>
    <li><strong><strong>The Sanford Guide (July 2015).&nbsp; Available at URL: <u><a href="http://www.webedition-dva-sanfordguide.com/" target="_blank">http://www.webedition-dva-sanfordguide.com/</a></u>&nbsp;[Accessed August 2015].</strong></strong></li>
    <li><strong><strong>British National Formulary for children. Available at <a href="https://www.medicinescomplete.com/mc/bnfc/current/" target="_blank">URL:https://www.medicinescomplete.com/mc/bnfc/current/</a> [Accessed:21/11/14].</strong></strong></li>
    <li><strong><strong>Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison&rsquo;s Principles of Internal Medicine. 17th ed. New York: McGraw-Hill; 2008.</strong></strong></li>
    <li><strong><strong>Elliott T. S. et al. Policy for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. <em>Journal of Antimicrobial Chemotherapy </em>2004;54:971-981.</strong></strong></li>
    <li><strong><strong>NICE Clinical Guideline 12 COPD: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (February 2004).</strong></strong></li>
    <li><strong><strong>British Association for Sexual Health and HIV (BASHH). Clinical Effectiveness Group Policy. (13/07/10) Available at URL: <a href="http://www.bashh.org" target="_blank">http://www.bashh.org</a> &nbsp;[Accessed: July 2010].</strong></strong></li>
    <li><strong><strong>Policy for the Management of Neutropenic Sepsis. Approved by the GMCCN Chemotherapy CCG in January 2009. Due for review in November 2010.</strong></strong></li>
    <li><strong><strong>Management of Infection Guidance for primary care for consultation and local adaptation. Produced by the Association of Medical Microbiologists and the Health Protection Agency. Produced 2001, Latest Review March 2010. Available at <a href="http://www.hpa.org.uk" target="_blank">www.hpa.org.uk</a></strong></strong></li>
    <li><strong><strong>CREST Guidelines on the management of cellulitis in adults (2005). Available at URL: <a href="http://www.gain-ni.org/index.php/crest-cellulitis-guidelines" target="_blank">http://www.gain-ni.org/index.php/crest-cellulitis-guidelines</a> (Accessed 5/8/15)</strong></strong></li>
    <li><strong><strong>Guidance on minimising infection in patients with an absent or dysfunctional spleen. Health Protection Agency. December 2007. Available at <a href="http://www.hpa.org.uk" target="_blank">www.hpa.org.uk</a></strong></strong></li>
    <li><strong><strong>Immunisation against infectious disease (2006) The Stationary Office. Updates are available at <a href="http://www.dh.gov.uk/greenbook" target="_blank">www.dh.gov.uk/greenbook</a></strong></strong></li>
    <li><strong><strong>NICE Clinical Guideline 139. Infection: Prevention and control of healthcare-associated infections in primary and community care. (March 2012).</strong></strong></li>
    <li><strong><strong>ANTIMICROBIAL STEWARDSHIP: &ldquo;START SMART &ndash; THEN FOCUS.&rdquo; Guidance from Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) 2011.</strong></strong></li>
    <li><strong><strong>Guidance on the diagnosis and management of PVL-associated <em>Staphylococcus aureus </em>infections (PVL-SA) in England. Health Protection Agency. November 2008. Available at: <a href="http://www.hpa.org.uk" target="_blank">www.hpa.org.uk</a></strong></strong></li>
    <li><strong><strong>Guidelines for diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. 2011. Available at: <a href="http://jac.oxfordjournals.org" target="_blank">http://jac.oxfordjournals.org</a></strong></strong></li>
    <li><strong><strong>Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest 2011;140(5):1177-1183</strong></strong></li>
    <li><strong><strong>Test and treat for <em>Helicobacter pylori </em>(HP) in dyspepsia.&nbsp; Quick reference guide for primary care: For consultation and local adaptation (PHE) updated October 2019.</strong></strong></li>
</ol>
<br />
<strong><strong><!--floating icon--><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>

<!--Surgical Prophylaxis--> 

<div aria-hidden="true" aria-labelledby="HCProphSurgLabel" class="portfolio-modal modal fade " id="HCProphSurg" role="dialog" tabindex="-1">
    <div class="modal-dialog modal-xl" role="document">
        <div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> 
        <div class="modal-body text-center">
            <div class="container">
                <div class="row justify-content-center">
                    <div class="col-lg-12"><!-- Portfolio Modal - Title--> 
                    <h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCProphObsGynaeLabel">Surgical Prophylaxis</h2>
                     <!-- Icon Divider--> 
                    <div class="divider-custom">
                        <div class="divider-custom-line">&nbsp;</div>
                        <div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>
                        <div class="divider-custom-line">&nbsp;</div>
                    </div>

                   <p>1. In surgical procedures requiring antibiotic prophylaxis it is important to ensure that effective antibiotic&nbsp;concentrations are present in the blood and tissues at the time of the surgical operation.&nbsp;</p>

<p>2. A single stat dose of antibiotic administered at anaesthetic induction is usually sufficient for most indications requiring surgical prophylaxis.</p>

<p>3. A repeat dose of antibiotic should be administered if:&nbsp;</p>

<ul>
    <li>there is blood loss in excess of 1.5 litres for an adult patient - see specific surgery section for each antibiotic.</li>
    <li>the duration of the operation is longer than 2 half-lives of the&nbsp;antibiotic used - see specific surgery section for each antibiotic.</li>
</ul>


<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td rowspan="2" style="background-color:#cccccc">Drug</td>
            <td colspan="2" rowspan="1" style="background-color:#cccccc">Procedure duration</td>
            <td rowspan="2" style="background-color:#cccccc">
            <p>Blood loss of 1.5L</p>

            <p>(Give <strong>after</strong> fluid replacement)</p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#eeeeee">Over 4 hours</td>
            <td style="background-color:#eeeeee">Over 8 hours</td>
        </tr>
        <tr>
            <td>Gentamicin</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>Repeat original dose if eGFR&gt;60ml/min</td>
            <td>Give half of the original dose</td>
        </tr>
        <tr>
            <td>Metronidazole</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Cefuroxime</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Clindamycin</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Give half of the original dose</td>
        </tr>
        <tr>
            <td>Co-amoxiclav</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Piperacillin/tzobactam (Tazocin)</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Flucloxacillin</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Ciprofloxacin</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Teicoplanin</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>
            <td>
            <p>Give half of the original dose if 1.5L blood loss within first hour of surgery</p>
            </td>
        </tr>
    </tbody>
</table>



<p>4. In cases where infection is already present (such as peritonitis) active treatment of the infection rather than prophylaxis should continue both before and after the surgical procedure.</p>



<p><strong>References:</strong></p>

<p>Bratzler DW, Dellinger EP, Olsen KM, et al.&nbsp;Clinical practice guidelines for antimicrobial prophylaxis in surgery. <em>Am J Health Syst Pharm</em>. 2013; 70: 195283.</p>

<p>Scottish Intercollegiate Guidelines Network (SIGN).&nbsp;Antibiotic prophylaxis in surgery. Edinburgh: SIGN; 2014.</p>

<p>Public Health England.&nbsp;Start Smart - Then Focus Antimicrobial Stewardship Toolkit for English Hospitals.&nbsp; March 2015.</p>

<p>Scottish Antimicrobial&nbsp;Prescribing Group (SAPG).&nbsp; Recommendations for re-dosing antibiotics for surgical prophylaxis.&nbsp; October 2018.</p>




                    
                    <h4><a href="#HCSurgClean" id="HCProphSurgSection">Clean Procedures</a></h4>
                    
                    <h4><a href="#HCSurgContaminated">Clean-Contaminated</a></h4>
                    
                    <h4><a href="#HCSurgCompound">Compound/Open Fracture</a></h4>

                    <h4><a href="#HCSurgDental">Dental Endocarditis Prophylaxis</a></h4>

                    <h4><a href="#HCSurgElective">Elective or Emergency Splenectomy</a></h4>

                    <h4><a href="#HCSurgRepeatDose">Repeat Dosing Schedule</a></h4>

                    <h4><a href="#HCSurgUrinCatheter">Urinary Catheterisation Prophylaxis</a></h4>

                    <h4><a href="#HCSurgVascular">Vascular Surgery</a></h4>

                    <br />
                    <!--clean--> 
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgClean">Clean Procedures</h2>
                        <p>No prophylaxis is indicated except for the implementation of prosthesis, prosthetic joint or orthopedic hardware</p>


                        <div id="accordionProthesis">
                            <div class="card">
                                <div class="card-header" id="prothesisTreatment">
                                    <h5 class="mb-0"><button aria-controls="collapseprothesisTreatment" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapseprothesisTreatment" data-toggle="collapse" type="button">Prosthesis / Orthopedic Hardware</button></h5>
                                </div>

                                <div aria-labelledby="prothesisTreatment" class="collapse" data-parent="#accordionProthesis" id="collapseprothesisTreatment">
                                <div class="card-body text-left">

                                    <p><strong><span style="color:#0000ff">Co-amoxiclav 1.2g IV stat</span></strong>, and for a total of 3 doses 8 hourly post-op.</p>



                                    <p><span style="color:#000000"><strong><u>Penicillin allergy (rash)</u></strong></span></p>

                                    <p><strong><span style="color:#800080">Cefuroxime 1.5g IV stat</span></strong>,&nbsp;and for a total of 3 doses 8 hourly post-op.</p>



                                    <p><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u></strong></span></p>

                                    <p><strong><span style="color:#b22222">Clindamycin 600mg IV stat</span></strong>,&nbsp;and for a total of&nbsp;4 doses 6 hourly post-op.</p>
                                </div>
                            </div>
                        </div>
                    </div>




                     </div>
                    <br />
                    <!--clean-contaminated--> 
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgContaminated">Clean-Contaminated</h2>
                        

                        <div id="accordioncleancontam">
                            <div class="card">
                                <div class="card-header" id="cleanConColorectal">
                                    <h5 class="mb-0"><button aria-controls="collapsecleanConColorectal" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsecleanConColorectal" data-toggle="collapse" type="button">Colorectal</button></h5>
                                </div>

                                <div aria-labelledby="cleanConColorectal" class="collapse" data-parent="#accordioncleancontam" id="collapsecleanConColorectal">
                                <div class="card-body text-left">

                                    <p><span style="color:#800080"><strong>Cefuroxime 1.5g IV stat </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> metronidazole 500mg IV stat</strong></span></p>

                                    <p>This combination is suitable for patients with&nbsp;penicillin allergy (rash).</p>

                                    <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                    <p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                                    <p>&nbsp;</p>

                                    <p><strong><u>Penicillin allergy (anaphylaxis)</u></strong></p>

                                    <p><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV stat </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong> metronidazole 500mg IV stat.</strong></span></p>

                                    <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                    <p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                                </div>
                            </div>
                        </div>
                    


                                    
                            <div class="card">
                                <div class="card-header" id="cleanConBillary">
                                    <h5 class="mb-0"><button aria-controls="collapsecleanConBillary" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsecleanConBillary" data-toggle="collapse" type="button">Billary</button></h5>
                                </div>



                                <div aria-labelledby="cleanConBillary" class="collapse" data-parent="#accordioncleancontam" id="collapsecleanConBillary">
                                <div class="card-body text-left">

                                    <p><span style="color:#800080"><strong>Cefuroxime 1.5g IV stat.</strong></span></p>

                                    <p>This is appropriate for patients with penicillin allergy (rash).</p>

                                    <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                    <p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                                    <p>&nbsp;</p>

                                    <p><u><strong>Penicillin allergy (anaphylaxis)</strong></u></p>

                                    <p><strong><span style="color:#b22222">Ciprofloxacin 400mg IV stat </span></strong><span style="color:#000000"><strong><u>plus</u></strong></span><strong><span style="color:#b22222"> metronidazole 500mg IV stat.</span></strong></p>

                                    <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                    <p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>


                                </div>
                            </div>
                        </div>

                                    
                            <div class="card">
                                <div class="card-header" id="cleanConERCP">
                                    <h5 class="mb-0"><button aria-controls="collapsecleanConERCP" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsecleanConERCP" data-toggle="collapse" type="button">ERCP</button></h5>
                                </div>

                                <div aria-labelledby="cleanConERCP" class="collapse" data-parent="#accordioncleancontam" id="collapsecleanConERCP">
                                <div class="card-body text-left">

                                       <p>No antibiotic prophylaxis is required&nbsp;in patients undergoing ERCP unless there is evidence of the following:</p>

                                        <ul>
                                            <li>hepatobiliary-pancreatic obstruction</li>
                                            <li>previous hepatobiliary-pancreatic instrumentation</li>
                                            <li>biliary stasis</li>
                                            <li>pancreatic pseudocyst.</li>
                                        </ul>

                                        

                                        <p><strong><span style="color:#0000ff">Piperacillin/tazobactam 4.5g IV stat </span></strong>just prior to the procedure.</p>

                                        <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                        <p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                                        

                                        <p><u><strong>Penicillin allergy</strong></u></p>

                                        <p><span style="color:#800080"><strong>Ciprofloxacin 400mg IV stat </strong></span>just prior to the procedure.</p>

                                        <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                        <p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>



                                </div>
                            </div>
                        </div>

                                    
                            <div class="card">
                                <div class="card-header" id="cleanconHead">
                                    <h5 class="mb-0"><button aria-controls="collapsecleanconHead" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsecleanconHead" data-toggle="collapse" type="button">Head and Neck Surgery</button></h5>
                                </div>

                                <div aria-labelledby="cleanconHead" class="collapse" data-parent="#accordioncleancontam" id="collapsecleanconHead">
                                <div class="card-body text-left">

                                    <p><span style="color:#0000ff"><strong>Co-amoxiclav 1.2g IV stat </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#0000ff"><strong> clindamycin&nbsp;600mg IV stat </strong></span></p>

                                    <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                    <p>Further continuation of antibiotic prophylaxis is not necessary unless it is a complicated surgical procedure in which case antibiotics must <u><strong>not</strong></u>&nbsp;exceed&nbsp;24 hours post-operatively.</p>

                                    <p>&nbsp;</p>

                                    <p><u><strong>Penicillin allergy (rash)</strong></u></p>

                                    <p><span style="color:#800080"><strong>Cefuroxime 1.5g IV stat </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> clindamycin 600mg IV stat </strong></span></p>

                                    <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                    <p>Further continuation of antibiotic prophylaxis is not necessary unless it is a complicated surgical procedure in which case antibiotics must <u><strong>not</strong></u>&nbsp;exceed&nbsp;24 hours post-operatively.</p>

                                    <p>&nbsp;</p>

                                    <p><u><strong>Penicillin allergy (anaphylaxis)</strong></u></p>

                                    <p><span style="color:#b22222"><strong>Ciprofloxacin 400mg IV stat </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#b22222"><strong>&nbsp;clindamycin 600mg IV stat</strong></span></p>

                                    <p>For repeat dosing see&nbsp;table in <a href="#HCSurgRepeatDose">repeat dosing schedule</a>&nbsp;section.</p>

                                    <p>Further continuation of antibiotic prophylaxis is not necessary unless it is a complicated surgical procedure in which case antibiotics must <u><strong>not</strong></u>&nbsp;exceed&nbsp;24 hours post-operatively.</p>


                                </div>
                            </div>
                        </div>

                                    
                            <div class="card">
                                <div class="card-header" id="cleanConUro">
                                    <h5 class="mb-0"><button aria-controls="collapsecleanConUro" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsecleanConUro" data-toggle="collapse" type="button">Urology</button></h5>
                                </div>

                                <div aria-labelledby="cleanConUro" class="collapse" data-parent="#accordioncleancontam" id="collapsecleanConUro">
                                <div class="card-body text-left">

                                    <p>No antibiotic prophylaxis is indicated in patients with sterile urine. However, in patients with infected urine antibiotic treatment should be administered according to the microbiologic susceptibility pattern.  If no microbiologic results are available refer to the section on treatment of urinary tract infections.</p>

                                </div>
                            </div>
                        </div>

                        <div class="card">
                                <div class="card-header" id="cleanConRectal">
                                    <h5 class="mb-0"><button aria-controls="collapsecleanConRectal" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsecleanConRectal" data-toggle="collapse" type="button">Transrectal Prostate Biopsy</button></h5>
                                </div>

                                <div aria-labelledby="cleanConRectal" class="collapse" data-parent="#accordioncleancontam" id="collapsecleanConRectal">
                                <div class="card-body text-left">

                                    <p><u><strong>Transrectal prostate biopsy/transurethral resection of the prostate (TURP)</strong></u></p>

                                    <p><span style="color:#0000ff"><strong>Ciprofloxacin 500mg po 12 hours prior to biopsy/procedure and repeated 12 hours after first dose.</strong></span></p>

                                    <p><strong>In cases of suspected antibiotic resistance to ciprofloxacin give <span style="color:#0000ff">gentamicin 5mg/kg IV stat </span>(4mg/kg if age <u>&gt;</u> 70yrs). Max dose 400mg.</strong></p>



                                </div>
                            </div>
                        </div>

                        <div class="card">
                                <div class="card-header" id="cleanConCardiac">
                                    <h5 class="mb-0"><button aria-controls="collapsecleanConCardiac" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsecleanConCardiac" data-toggle="collapse" type="button">Cardiac Pacemaker Implantation</button></h5>
                                </div>

                                <div aria-labelledby="cleanConCardiac" class="collapse" data-parent="#accordioncleancontam" id="collapsecleanConCardiac">
                                <div class="card-body text-left">

                                    <p><span style="color:#0000ff"><strong>Teicoplanin 400mg IV stat </strong></span>one hour&nbsp;prior to the procedure <span style="color:#000000"><strong><u>plus</u></strong></span> <strong><span style="color:#0000ff">gentamicin 80mg&nbsp;</span></strong>to be infiltrated into the pocket.</p>


                                </div>
                            </div>
                        </div>
                    </div>
                </div>
                    <br />


                    <!--Fractures-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgCompound">Compound/Open Fractures</h2>
                        <p><strong><span style="color:#0000ff">Co-amoxiclav 1.2g IV stat followed by 1.2g IV 8 hourly.</span></strong>&nbsp; Treatment duration will depend on the clinical response.</p>

                        <p><u><strong>Penicillin allergy (rash)</strong></u></p>

                        <p><strong><span style="color:#800080">Cefuroxime 1.5g IV&nbsp;stat followed by 1.5g IV 8 hourly </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080">&nbsp;clindamycin 600mg IV stat&nbsp;followed&nbsp;by 600mg IV 6 hourly.&nbsp;</span></strong>Treatment duration will depend on the clinical response.</p>

                        <p><u><strong>Penicillin allergy (anaphylaxis)</strong></u></p>

                        <p><span style="color:#b22222"><strong>Co-trimoxazole 960mg IV stat followed 960mg IV 12 hourly</strong></span><strong><span style="color:#800080"> </span><span style="color:#000000"><u>plus</u></span><span style="color:#800080">&nbsp;</span><span style="color:#b22222">clindamycin 600mg IV stat&nbsp;followed&nbsp;by 600mg IV 6 hourly.</span><span style="color:#800080">&nbsp;</span></strong>Treatment duration will depend on the clinical response.</p>


                    </div>
                </br>
                    <!--Strep B-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgDental">Dental Endocarditis Prophylaxis</h2>
                        <p><span style="color:#000000"><strong>Adults and children with structural cardiac defects at risk of developing infective endocarditis</strong></span></p>

                        <p><span style="color:#000000">Healthcare professionals should regard people with the following cardiac conditions as being at risk of developing infective endocarditis:</span></p>

                        <ul>
                            <li><span style="color:#000000">acquired valvular heart disease with stenosis or regurgitation</span></li>
                            <li><span style="color:#000000">valve replacement</span></li>
                            <li><span style="color:#000000">structural congenital heart disease, including surgically corrected or palliated structural conditions, but excluding isolated atrial septal defect, fully repaired ventricular septal defect or fully repaired patent ductus arteriosus, and closure devices that are judged to be endothelialised</span></li>
                            <li><span style="color:#000000">previous infective endocarditis</span></li>
                            <li><span style="color:#000000">hypertrophic cardiomyopathy</span></li>
                            <li><span style="color:#000000">cardiac transplantation recipients who develop cardiac valvulopathy.</span></li>
                        </ul>

                        <p><span style="color:#000000"><u><strong>Antibiotic prophylaxis</strong></u></span></p>

                        <p><strong><span style="color:#0000ff">Amoxicillin 2g po stat one hour before the procedure.</span></strong></p>

                        <p><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></p>

                        <p><strong><span style="color:#800080">Cefalexin 2g po stat one hour before the procedure.</span></strong></p>

                        <p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></p>

                        <p><strong><span style="color:#b22222">Clindamycin 600mg po stat one hour before the procedure.</span></strong></p>

                    </div>

                    
                    
                    <br />

                        <!--Strep A-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgElective">Elective or Emergency Splenectomy</h2>
                        <p><strong>Peri-operative antibiotic prophylaxis is <u>not</u> necessary for splenectomy and should <u>not</u> be given.</strong></p>



                        <p><u><strong>Elective or emergency splenectomy</strong></u></p>

                        <ol>
                            <li>Dual pneumococcal vaccination should be given for maximum protection from pneumococcal infection.&nbsp;&nbsp;The first vaccine should be&nbsp;the <span style="color:#000000"><strong>13 valent pneumococcal polysaccharide conjugate vaccine (adsorbed) such as Prevenar 13</strong></span> administered at least 2 weeks after splenectomy.&nbsp; After 8 weeks, the second vaccine should be administered which is <span style="color:#000000"><strong>23 valent&nbsp;pneumococcal polysaccharide vaccine&nbsp;such as Pneumovax</strong> </span>and subsequent booster doses of this vaccine should be given at 5 year intervals thereafter.</li>
                            <li>A combined&nbsp;<strong>Haemophilus influenzae type B (Hib)</strong>&nbsp;and&nbsp;<strong>meningitis serotype C vaccine&nbsp;called Menitorix&nbsp;</strong>should be given before&nbsp;splenectomy, if possible; or if not, soon after.&nbsp;&nbsp;This should be followed one month later by a single stat&nbsp;dose of&nbsp;<strong>meningococcal serotypes A, C, W135 and Y conjugate vaccine&nbsp;</strong>which can be administered by the patient's GP if the patient has been discharged before the one month stage.&nbsp; The patient's GP must be informed&nbsp;so that the vaccine can be given timeously.</li>
                            <li><strong>Influenza vaccine&nbsp;</strong>annually (unlicensed use)</li>
                            <li>Prophylactic antibiotic<span style="color:#0000ff"><strong>&nbsp;</strong></span>is recommended (see below).</li>
                        </ol>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><u><strong>Prophylactic antibiotic:</strong></u></span></p>

                        <p>Age&nbsp;1-11 months: <span style="color:#0000ff"><strong>phenoxymethylpenicillin 62.5mg po bd.</strong></span></p>

                        <p>Age&nbsp;1-4 years:&nbsp;<span style="color:#0000ff"><strong>phenoxymethylpenicillin 125mg po bd.</strong></span></p>

                        <p>Age 5 years and over:<span style="color:#0000ff">&nbsp;<strong>phenoxymethylpenicillin 250mg po bd.</strong></span></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

                        <p><span style="color:#000000">Age up to 12 years:</span><span style="color:#800080"><strong>&nbsp;clarithromycin as per kg of&nbsp;body weight given as half of total daily dose once daily.</strong></span></p>

                        <p><span style="color:#000000">Age 12 years and over:</span><span style="color:#800080"><strong>&nbsp;clarithromycin 500mg po od.</strong></span></p>

                        <p>&nbsp;</p>

                        <p>At all ages give prophylactic phenoxymethylpenicillin or clarithromycin for at least&nbsp;2 years or at least up to the age of 18 years.</p>

                        <p>&nbsp;</p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><u><strong>Rescue antibiotic pack</strong></u></span></p>

                        <p><span style="color:#000000">Patients with asplenia should be given&nbsp;a one day supply of&nbsp;antibiotics (see below) with instructions to start taking immediately if symptoms of infection occur such as fever,&nbsp;feeling unwell&nbsp;or shivering. If a non-blanching rash (=a rash that does not disappear under pressure from a drinking glass) occurs&nbsp;patients should&nbsp;immediately see their GP or report to an&nbsp;A&amp;E&nbsp;department as soon as possible in order to exclude meningococcal disease.</span></p>

                        <p>&nbsp;</p>

                        <p><strong><span style="color:#0000ff">Amoxicillin 1g&nbsp;po tds.</span></strong></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><u><strong>Penicillin allergy (rash):</strong></u></span></p>

                        <p><span style="color:#800080"><strong>Cefalexin 1g&nbsp;po tds.</strong></span></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis):</strong></u></span></p>

                        <p><span style="color:#b22222"><strong>Moxifloxacin 400mg&nbsp;po OD.</strong></span></p>


                    </div>

                </br>

                        <!--Repeat dosing-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgRepeatDose">Repeat Dosing Schedule</h2>
                       <table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td rowspan="2" style="background-color:#cccccc">Drug</td>
            <td colspan="2" rowspan="1" style="background-color:#cccccc">Procedure duration</td>
            <td rowspan="2" style="background-color:#cccccc">
            <p>Blood loss of 1.5L</p>

            <p>(Give <strong>after</strong> fluid replacement)</p>
            </td>
        </tr>
        <tr>
            <td style="background-color:#eeeeee">Over 4 hours</td>
            <td style="background-color:#eeeeee">Over 8 hours</td>
        </tr>
        <tr>
            <td>Gentamicin</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>Repeat original dose if eGFR&gt;60ml/min</td>
            <td>Give half of the original dose</td>
        </tr>
        <tr>
            <td>Metronidazole</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Cefuroxime</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Clindamycin</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Give half of the original dose</td>
        </tr>
        <tr>
            <td>Co-amoxiclav</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Piperacillin/tzobactam (Tazocin)</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Flucloxacillin</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Ciprofloxacin</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>Repeat original dose</td>
            <td>Repeat original dose</td>
        </tr>
        <tr>
            <td>Teicoplanin</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
            <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>
            <td>
            <p>Give half of the original dose if 1.5L blood loss within first hour of surgery</p>
            </td>
        </tr>
    </tbody>
</table>



                    </div>

                </br>
                    <!--Catheter-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgUrinCatheter">Urinary Catheterisation Prophylaxis</h2>
                        <p>Antibiotic prophylaxis for insertion or removal of a catheter is <strong>not </strong>routinely recommended.&nbsp; However antibiotic prophylaxis for urinary catheterisation should only&nbsp;be given to patients who:</p>

<p> have mechanical catheter problems (blockage)</p>

<p> have infection-related catheter problems (urethral discharge)</p>

<p> have a history of symptomatic UTI after catheter change</p>

<p> experience trauma associated with insertion or removal of&nbsp;urinary catheter.</p>

<p>A single stat dose of <span style="color:#0000ff"><strong>gentamicin 5mg/kg IV (4mg/kg for patients <u>&gt;</u> 70yrs</strong></span><strong><span style="color:#0000ff">)</span> </strong>should be given once only just prior to catheterisation.&nbsp; Maximum dose should not exceed 400mg.</p>

<p>If the patient is overweight see section on <a data-dismiss="modal" data-target="#HCDrugMonitoring" data-toggle="modal" href="#HCDrugMonitoring">therapeutic Drug Monitoring </a></strong> for guidance on gentamicin dose calculation.</p>



<p><span style="color:#b22222"><u><strong>Staph aureus (MSSA &amp; MRSA) urinary catheter-associated urethritis</strong></u></span></p>

<p><span style="color:#000000">Staph aureus (MSSA &amp; MRSA) cultured from urine is associated with urinary catheter-related urethral discharge due to catheter-induced urethritis.&nbsp; Therefore catheter change in these circumstances would require antibiotic prophylaxis with&nbsp;</span><strong><span style="color:#0000ff">teicoplanin 800mg IV single stat dose just prior to the procedure</span></strong><span style="color:#000000">, in order to prevent the serious consequence of Staph aureus&nbsp;bacteraemia.</span></p>




                    </div>
                    </br>


                    <!--Vascular surgery-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCSurgVascular">Vascular Surgery</h2>
                    <p><span style="color:#0000ff"><strong>Co-amoxiclav 1.2g IV stat dose at anaesthetic induction.</strong></span></p>

<p>For repeat dosing schedule see&nbsp;table in <a href="#HCSurgRepeatDose">here.</a></p>

<p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given..</strong></span></p>

<p>&nbsp;</p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (rash)</strong></u></span></p>

<p><strong><span style="color:#800080">Cefuroxime 1.5g IV stat dose at anaesthetic induction.</span></strong></p>

<p>For repeat dosing schedule see&nbsp;table in <a href="#HCSurgRepeatDose">here.</a></p>

<p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

<p>&nbsp;</p>

<p><span style="color:#000000"><u><strong>Penicillin allergy (anaphylaxis)</strong></u></span></p>

<p><strong><span style="color:#b22222">Clindamycin 600mg IV stat dose at anaesthetic induction.</span></strong></p>

<p>For repeat dosing schedule see&nbsp;table in <a href="#HCSurgRepeatDose">here.</a></p>

<p><span style="color:#000000"><strong>Post-op prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>
</div>



                </br>



                    <!--floating icon--><a class="float" href="#HCProphSurgSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
                </div>
            </div>
        </div>
    </div>
</div>
</div>

<!--Obstetrics and Gynae Prophylaxis--> 

<div aria-hidden="true" aria-labelledby="HCProphObsGynaeLabel" class="portfolio-modal modal fade " id="HCProphObsGynae" role="dialog" tabindex="-1">
    <div class="modal-dialog modal-xl" role="document">
        <div class="modal-content"><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> 
        <div class="modal-body text-center">
            <div class="container">
                <div class="row justify-content-center">
                    <div class="col-lg-12"><!-- Portfolio Modal - Title--> 
                    <h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCProphObsGynaeLabel">Obstetrics and Gynaecology</h2>
                     <!-- Icon Divider--> 
                    <div class="divider-custom">
                        <div class="divider-custom-line">&nbsp;</div>
                        <div class="divider-custom-icon"><i class="fas fa-star">&nbsp;</i></div>
                        <div class="divider-custom-line">&nbsp;</div>
                    </div>

                    <p>1. In surgical procedures requiring antibiotic prophylaxis it is important to ensure that effective antibiotic&nbsp;&nbsp; concentrations are present in the blood and tissues at the time of the surgical operation.&nbsp;</p>

                    <p>2. A single stat dose of antibiotic administered at anaesthetic induction is usually sufficient for most indications requiring surgical prophylaxis.</p>

                    <p>3. A repeat dose of antibiotic should be administered if:&nbsp;</p>

                    <ul>
                        <li>there is blood loss in excess of 1.5 litres for an adult patient - see specific surgery section for each antibiotic.</li>
                        <li>the duration of the operation is longer than 2 half-lives of the&nbsp;antibiotic used - see specific surgery section for each antibiotic.</li>
                    </ul>

                    <table border="1" class="table table-striped table-bordered">
                        <tbody>
                            <tr>
                                <td rowspan="2" style="background-color:#cccccc">Drug</td>
                                <td colspan="2" rowspan="1" style="background-color:#cccccc">Procedure duration</td>
                                <td rowspan="2" style="background-color:#cccccc">
                                <p>Blood loss of 1.5L</p>

                                <p>(Give <strong>after</strong> fluid replacement)</p>
                                </td>
                            </tr>
                            <tr>
                                <td style="background-color:#cccccc">Over 4 hours</td>
                                <td style="background-color:#cccccc">Over 8 hours</td>
                            </tr>
                            <tr>
                                <td>Gentamicin</td>
                                <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
                                <td>Repeat original dose if eGFR&gt;60ml/min</td>
                                <td>Give half of the original dose</td>
                            </tr>
                            <tr>
                                <td>Metronidazole</td>
                                <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                            </tr>
                            <tr>
                                <td>Cefuroxime</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                            </tr>
                            <tr>
                                <td>Clindamycin</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                                <td>Give half of the original dose</td>
                            </tr>
                            <tr>
                                <td>Co-amoxiclav</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                            </tr>
                            <tr>
                                <td>Piperacillin/tzobactam (Tazocin)</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                            </tr>
                            <tr>
                                <td>Flucloxacillin</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                            </tr>
                            <tr>
                                <td>Ciprofloxacin</td>
                                <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
                                <td>Repeat original dose</td>
                                <td>Repeat original dose</td>
                            </tr>
                            <tr>
                                <td>Teicoplanin</td>
                                <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>
                                <td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>
                                <td>
                                <p>Give half of the original dose if 1.5L blood loss within first hour of surgery</p>
                                </td>
                            </tr>
                        </tbody>
                    </table>

                    <p>&nbsp;</p>

                    <p>4. In cases where infection is already present (such as peritonitis) active treatment of the infection rather than prophylaxis should continue both before and after the surgical procedure.</p>

                    <p>&nbsp;</p>

                    <p><strong>References:</strong></p>

                    <p>Bratzler DW, Dellinger EP, Olsen KM, et al.&nbsp;Clinical practice guidelines for antimicrobial prophylaxis in surgery.&nbsp;<em>Am J Health Syst Pharm</em>. 2013; 70: 195283.</p>

                    <p>Scottish Intercollegiate Guidelines Network (SIGN).&nbsp;Antibiotic prophylaxis in surgery. Edinburgh: SIGN; 2014.</p>

                    <p>Public Health England.&nbsp;Start Smart - Then Focus Antimicrobial Stewardship Toolkit for English Hospitals.&nbsp; March 2015.</p>

                    <p>Scottish Antimicrobial&nbsp;Prescribing Group (SAPG).&nbsp; Recommendations for re-dosing antibiotics for surgical prophylaxis.&nbsp; October 2018.</p>

                    
                    <h4><a href="#HCGynaeSurgery" id="HCProphObsGynaeSection">Gynaecologic Surgery</a></h4>
                    
                    <h4><a href="#HCGynaeCSection">Caesarean Section</a></h4>
                    
                    <h4><a href="#HCGyanaePlacRemoval">Placental Removal/Perineal Tears</a></h4>

                    <h4><a href="#HCGyanaeStrepB">Strep Group B Colonisation</a></h4>

                    <h4><a href="#HCGyanaeStrepA">Strep Group B Colonisation</a></h4>

                    <h4><a href="#HCGyanaePyrexia">Pyrexia in Labour</a></h4>

                    <h4><a href="#HCGyanaeVagDelivery">Assisted Vaginal Delivery</a></h4>

                    <br />
                    <!--Surgery--> 
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCGynaeSurgery">Gynaecologic Surgery</h2>
                        <p><span style="color:#800080"><strong>Cefuroxime 1.5g IV&nbsp;stat </strong></span><span style="color:#000000"><strong><u>plus</u></strong></span><span style="color:#800080"><strong> metronidazole 500mg IV stat</strong></span></p>

                        <p><span style="color:#000000">This combination is suitable for patients with penicillin allergy (rash).</span></p>

                        <p>For repeat dosing schedule see&nbsp;table above.</p>

                        <p><span style="color:#000000"><strong>Post-op antibiotic prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><strong><u>Penicillin allergy (anaphylaxis)</u></strong></span></p>

                        <p><span style="color:#b22222"><strong>Clindamycin 900mg IV </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> gentamicin 5mg/kg IV stat </strong></span><span style="color:#000000"><strong>(dose&nbsp;of gentamicin should NOT exceed 400mg).</strong></span></p>

                        <p>For repeat dosing schedule see&nbsp;table above.</p>

                        <p><span style="color:#000000"><strong>Post-op antibiotic prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                     </div>
                    <br />
                    <!--C-Section--> 
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCGynaeCSection">Caesarean Section</h2>
                        <p><span style="color:#0000ff"><strong>Cefuroxime 1.5g IV stat. </strong></span></p>

                        <p><span style="color:#000000">This is suitable in penicillin allergy (rash).</span></p>

                        <p>For repeat dosing schedule see&nbsp;table above.</p>

                        <p><span style="color:#000000"><strong>Post-op antibiotic prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                        <p>&nbsp;</p>

                        <p><u><strong><span style="color:#000000">Penicillin allergy (anaphylaxis)</span></strong></u></p>

                        <p><span style="color:#b22222"><strong>Clindamycin 900mg IV </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#b22222"><strong> gentamicin 5mg/kg IV stat </strong></span><span style="color:#000000"><strong>(dose&nbsp;of gentamicin should NOT exceed 400mg).</strong></span></p>

                        <p>For repeat dosing schedule see&nbsp;table above.</p>

                        <p><span style="color:#000000"><strong>Post-op antibiotic prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>
                        
                    </div>
                    <br />
                    <!--Placental Removal-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCGyanaePlacRemoval">Placental Removal / Perineal Tears</h2>
                        <p><span style="color:#000000"><u><strong>Manual removal o</strong><strong>f placenta and/</strong><strong>or suturing of </strong><strong>3rd/4th degree </strong><strong>perineal tear</strong></u></span></p>

                        <p><span style="color:#0000ff"><strong>Cefuroxime 1.5g IV stat </strong></span><u><span style="color:#000000"><strong>plus</strong></span></u><span style="color:#0000ff"><strong> clindamycin 900mg IV stat.&nbsp;</strong></span><span style="color:#800080"><strong> </strong></span></p>

                        <p><span style="color:#000000">This regimen is suitable in penicillin allergy (rash).</span></p>

                        <p>For repeat dosing schedule see&nbsp;table above.</p>

                        <p><span style="color:#000000"><strong>Post-op antibiotic prophylaxis should&nbsp;<u>NOT</u> be given.</strong></span></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000">In cases of suspected contamination/alternative reasons for requiring oral antibiotics:</span></p>

                        <p><span style="color:#0000ff"><strong>Cefalexin 1g po tds&nbsp;</strong></span><u><strong>plus</strong></u><span style="color:#0000ff"><strong> clindamycin 450mg po qds </strong></span><span style="color:#000000"><strong>for 3 days.</strong></span></p>

                        <p>&nbsp;</p>

                        <p><strong><u><span style="color:#000000">Penicillin allergy (anaphylaxis)</span></u></strong></p>

                        <p><span style="color:#b22222"><strong>Clindamycin 900mg IV stat </strong></span><strong><span style="color:#000000"><u>plus</u></span><span style="color:#b22222"> </span></strong><span style="color:#b22222"><strong>g</strong></span><strong><span style="color:#b22222">entamicin 5mg/kg IV&nbsp;stat </span></strong><span style="color:#000000"><strong>(dose&nbsp;of gentamicin should NOT exceed 400mg).</strong></span></p>

                        <p>For repeat dosing schedule see&nbsp;table above.</p>

                        <p><span style="color:#000000"><strong>Post-op antibiotic prophylax</strong></span><span style="color:#000000"><strong>is should&nbsp;<u>NOT</u> be given.</strong></span></p>

                        <p>&nbsp;</p>

                        <p>In cases of suspected contamination/alternative reasons for requiring oral antibiotics:</p>

                        <p><span style="color:#000000">True/anaphylactic penicillin allergy and breastfeeding:</span></p>

                        <p><span style="color:#b22222"><strong>Ciprofloxacin 500mg po bd </strong></span><strong><u>plus</u><span style="color:#b22222">&nbsp;clindamycin 450mg po qds</span><span style="color:#1f497d">&nbsp;</span>for 3 days.</strong></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000">True/anaphylactic penicillin allergy and <u>not</u> breastfeeding:</span></p>

                        <p><span style="color:#8e44ad"><strong>Co-trimoxazole 960mg po BD</strong></span><span style="color:#1f497d"> </span><u><strong><span style="color:#000000">plus </span></strong></u><span style="color:#8e44ad"><strong>clindamycin 450mg po QDS&nbsp;</strong></span><strong>for 3 days.</strong></p>

                    </div>
                </br>
                    <!--Strep B-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCGyanaeStrepB">Strep Group B Colonisation</h2>
                        <p><span style="color:#0000ff"><strong>Benzylpenicillin 3g IV stat followed by 1.5g IV 4 hourly until delivery.</strong></span></p>

                        <p><span style="color:#000000"><strong>Further antibiotic prophylaxis should&nbsp;<u>NOT</u> be given post-delivery.</strong></span></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

                        <p><strong><span style="color:#800080">Clindamycin 900 mg IV stat followed by 900mg IV&nbsp;8&nbsp;hourly until delivery.</span></strong></p>

                        <p><span style="color:#000000"><strong>Further antibiotic prophylaxis should&nbsp;<u>NOT</u> be given post-delivery.</strong></span></p>
                    </div>

                    
                    
                    <br />

                        <!--Strep A-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCGyanaeStrepA">Strep Group A Colonisation</h2>
                        <p>Strep group A&nbsp;(Strep pyogenes) in the genital tract at the time of delivery is a risk factor for development of puerperal sepsis.</p>

                        <p><span style="color:#000000"><u><strong>Antibiotic prophylaxis</strong></u></span></p>

                        <p><span style="color:#0000ff"><strong>Benzylpenicillin 2.4g IV stat followed by 1.2g IV 4 hourly until delivery.</strong></span></p>

                        <p><span style="color:#000000"><strong>Oral step down post-delivery:</strong></span><span style="color:#0000ff"><strong>&nbsp;amoxicillin 1g po tds.</strong></span></p>

                        <p><span style="color:#000000">Complete <u>10 days</u> of antibiotic treatment including IV already given.</span></p>

                        <p>&nbsp;</p>

                        <p><span style="color:#000000"><strong><u>Penicillin allergy</u></strong></span></p>

                        <p><strong><span style="color:#800080">Clindamycin 900 mg IV stat followed by 900mg IV 8 hourly until delivery.</span></strong></p>

                        <p><strong><span style="color:#000000">Oral step down (post-delivery): </span><span style="color:#800080">clindamycin 450mg po qds.</span></strong></p>

                        <p><span style="color:#000000">Complete <u>10 days</u> of antibiotic treatment including IV already given.</span></p>

                    </div>

                </br>

                        <!--Pyrexia-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCGyanaePyrexia">Pyrexia in Labour</h2>
                        <p><strong><span style="color:#0000ff">Cefuroxime 1.5g IV stat followed by 1.5g IV 8 hourly</span></strong></p>

                        <p><strong><u>plus</u></strong></p>

                        <p><span style="color:#0000ff"><strong>Metronidazole 500mg IV stat followed by 500mg IV 8 hourly.&nbsp; </strong></span></p>

                        <p><span style="color:#000000">This regimen is suitable in penicillin allergy (rash).</span></p>

                        <p><strong><span style="color:#000000">Continue until clinically settled.</span></strong></p>

                        <p>&nbsp;</p>

                        <p><u><strong>Penicillin allergy (anaphylaxis)</strong></u></p>

                        <p><strong><span style="color:#b22222">Clindamycin 900mg IV stat followed by 900mg IV 8 hourly</span></strong></p>

                        <p><u><strong>plus</strong></u></p>

                        <p><strong><span style="color:#b22222">Gentamicin 5mg/kg IV stat.&nbsp;</span><span style="color:#000000"> (Dose of gentamicin should NOT exceed 400mg).&nbsp; <span style="color:#000000">Caution is advised with further&nbsp;dosing of gentamicin because of gentamicin-associated foetal ototoxicity.</span></span></strong></p>

                        <p><strong>Continue&nbsp;until clinically settled (caution with gentamicin).</strong></p>


                    </div>

                </br>
                    <!--Vaginal Delivery-->
                    <div class="text-left border border-info rounded">
                        <h2 class="text-center" id="HCGyanaeVagDelivery">Assisted Vaginal Delivery</h2>
                        <p><span style="color:#0000ff"><strong>Cefuroxime 1.5g IV stat </strong></span><u><strong>plus</strong></u><span style="color:#0000ff"><strong> clindamycin 900mg IV stat.&nbsp;</strong></span><span style="color:#800080"><strong> </strong></span></p>

                        <p>This regimen is suitable in penicillin allergy (rash).</p>

                        <p><strong>Post-op antibiotic prophylaxis should&nbsp;<u>NOT</u> be given.</strong></p>

                        <p>&nbsp;</p>

                        <p><strong><u>Penicillin allergy (anaphylaxis)</u></strong></p>

                        <p><span style="color:#b22222"><strong>Clindamycin 900mg IV stat </strong></span><strong><u>plus</u><span style="color:#b22222"> </span></strong><span style="color:#b22222"><strong>g</strong></span><strong><span style="color:#b22222">entamicin 5mg/kg IV&nbsp;stat </span></strong><strong>(dose&nbsp;of gentamicin should NOT exceed 400mg).</strong></p>

                        <p><strong>Post-op antibiotic prophylaxis should&nbsp;<u>NOT</u> be given.</strong></p>



                    </div>

                </br>



                    <!--floating icon--><a class="float" href="#HCProphObsGynaeSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></div>
                </div>
            </div>
        </div>
    </div>
</div>
</div>



<strong><strong> <!-- Portfolio Modal Gen Guidelines Info--> </strong></strong>

<div aria-hidden="true" aria-labelledby="IntroductionLabel" class="portfolio-modal modal fade" id="PCIntro" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="IntroductionLabel"><strong><strong>Introduction</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> <!-- Portfolio Modal - Text--> </strong></strong>

<p class="mb-5"><strong><strong>These guidelines have been produced for General Practitioners in Tameside and Glossop Primary Care Trust as a simple guide to antimicrobial prescribing. Much of the advice has come from Public Health England (PHE) template guidelines and the Clinical Knowledge Summaries service (CKS - the successor to Prodigy) which are both evidence based. However local antibiotic sensitivity data has been used to provide advice specific to the local area at this time.</strong></strong></p>
<strong><strong> </strong></strong>

<p class="mb-5"><strong><strong>The Consultant Medical Microbiologists at Tameside and Glossop Acute Services NHS Trust are always happy to help general practice colleagues and are available during office hours on the numbers below.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong>Dr H Sacho</strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><a href="tel:01619224086">0161 922 4086</a> or contact via hospital switchboard <a href="tel:01619226000">0161 922 6000</a></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><strong>Dr P F Unsworth</strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><a href="tel:01619224086">0161 922 6500</a> or contact via hospital switchboard <a href="tel:01619226000">0161 922 6000</a></strong></strong></p>
<strong><strong><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Portfolio Modal Gen Guidelines Aims--> </strong></strong>

<div aria-hidden="true" aria-labelledby="AimsOfGuidelinesLabel" class="portfolio-modal modal fade" id="PCAims" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="AimsOfGuidelinesLabel"><strong><strong>Aims of the Guidelines</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> <!-- Portfolio Modal - Text--> </strong></strong>

<ul class="text-left">
    <li><strong><strong>To provide a simple, empiric (best guess) approach to the treatment of common infections.</strong></strong></li>
    <li><strong><strong>To promote the safe, effective and economic use of antibiotics (and to use antibiotics only if indicated).</strong></strong></li>
    <li><strong><strong>To minimise the emergence of bacterial resistance in the community and to prevent the development of antibiotic associated Clostridium difficile infection (CDI).</strong></strong></li>
</ul>
<strong><strong><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Portfolio Modal Gen Guidelines Principles--> </strong></strong>

<div aria-hidden="true" aria-labelledby="PrinciplesLabel" class="portfolio-modal modal fade" id="PCPrinciples" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="PrinciplesLabel"><strong><strong>Principles</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> <!-- Portfolio Modal - Text--> </strong></strong>

<div class="text-left">
<p><strong><strong>This guidance is based on the best available evidence at the time and its application must be modified by professional judgement.</strong></strong></p>

<ol>
    <li><strong><strong>Prescribe an antibiotic only when there is likely to be a clear clinical benefit, and most notably when there is a bacterial infection present.</strong></strong></li>
    <li><strong><strong>A dose and duration of treatment is suggested - however patients should be treated on an individual basis if infection is severe or recurrent.</strong></strong></li>
    <li><strong><strong>Do not prescribe an antibiotic for simple coughs or colds and viral sore throats.</strong></strong></li>
    <li><strong><strong>Do not prescribe antibiotics for chronic lower limb ulcers or pressure sores unless there is an associated spreading cellulitis, induration of the tissues, abscess formation or systemic toxicity with constitutional symptoms.</strong></strong></li>
    <li><strong><strong>Limit prescribing over the telephone to exceptional cases &ndash; rather clinically assess the case first.</strong></strong></li>
    <li><strong><strong>Always prescribe antibiotics generically unless it is necessary to state the brand name to ensure the clarity of formulation.</strong></strong></li>
    <li><strong><strong>Avoid broad spectrum antibiotics e.g. co-amoxiclav, quinolones and cephalosporins, when narrower spectrum antibiotics are as effective, as they increase the risk of CDI, MRSA and resistant UTIs.</strong></strong></li>
    <li><strong><strong>Limit the use of topical antibiotics to selected conditions e.g. Impetigo, fungal skin infections, acne, herpes labialis, especially if they are also available as a systemic preparation.</strong></strong></li>
    <li><strong><strong>In pregnancy avoid tetracyclines, aminoglycosides, quinolones, and high dose metronidazole. Short term use of trimethoprim (theoretical risk in first trimester in patients with a poor diet, as it is a folate antagonist) or nitrofurantoin (at term, theoretical risk of neonatal haemolysis) is unlikely to cause a problem to the foetus. For empiric treatment of UTIs in pregnancy see later in the guidelines.</strong></strong></li>
    <li><strong><strong>Clarithromycin is the macrolide of choice due to it being better tolerated and a lower frequency of administration.</strong></strong></li>
    <li><strong><strong>Alternatives are usually given in these guidelines for use in penicillin allergy.</strong></strong></li>
    <li><strong><strong>If empiric treatment has failed or special circumstances exist contact the Consultant Medical Microbiologists at Tameside General Hospital for advice. See page 3 for contact details.</strong></strong></li>
    <li><strong><strong>If samples are sent to the laboratory they should be collected before antibiotic therapy is started. If the patient is already on antibiotics please give a clear drug history on the request form.</strong></strong></li>
    <li><strong><strong>Where possible antibiotic treatment should be selected or changed based on microbiologic culture and sensitivity results with a preference for the narrowest spectrum antibiotic where appropriate.</strong></strong></li>
    <li><strong><strong>The laboratory usually reports on antibiotic sensitivities for organisms which are thought to be clinically significant, but the clinical picture must always be taken into account before deciding if and how to treat. Treat the patient and not the microbiology result! If you have any queries please speak to either of the Medical Microbiologists.</strong></strong></li>
    <li><strong><strong>Prescribing of long-term antibiotic prophylaxis is not encouraged; however it is accepted that a select number of patients, such as COPD or bronchiectasis patients, may benefit from this. Long-term antibiotic prophylaxis should only be commenced by a hospital consultant and the patient should be closely monitored with regular follow ups.</strong></strong></li>
</ol>

<p><strong><strong><strong>Note to Prescribers about duration of treatment:</strong></strong></strong></p>

<p><strong><strong>In general most antibiotic treatments should not exceed 5 days, and treatment durations for 3 or 4 days may be entirely adequate. However it must be emphasized that the most important determinant for the duration of antibiotic treatment is the clinical response of the patient to therapy. It is vital that patients are educated about their antibiotic treatment and in particular recognising the signs and symptoms of their infection improving. For uncomplicated or infections requiring short duration of treatment with antibiotics, patients should be advised that, although they have been prescribed antibiotics for e .g. 5 days, they c ould stop taking antibiotics e.g. after 3 days if they feel that their symptoms have improved and they are getting better; however, if they are unsure they should consult their doctor. For complicated or infections requiring longer duration of treatment, patients should be advised to complete the prescribed course as advised and explained by their doctor.</strong></strong></p>
</div>
<strong><strong><button class="btn btn-primary" data-dismiss="modal"><i class="fas fa-times fa-fw">&nbsp;</i> Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Portfolio Modal Gen Guidelines References--> </strong></strong>

<div aria-hidden="true" aria-labelledby="ReferencesLabel" class="portfolio-modal modal fade" id="PCReferences" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="ReferencesLabel"><strong><strong>References</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> <!-- Portfolio Modal - Text--> </strong></strong>

<ol class="text-left text">
    <li><strong><strong>PHE Management of infection guidance for primary care for consultation and local adaptation October 2014 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/443046/230415_PHE_Primary_Care_guidance_07_07_15_for_Gateway.pdf</strong></strong></li>
    <li><strong><strong>CKS (Evidence Series) Clinical Knowledge Summaries. http://cks.nice.org.uk/#?char=A (accessed August 2015)</strong></strong></li>
    <li><strong><strong>BNF Sept 2014 (no 68) and cBNF 2014 -15 www.bnf.org/bnf</strong></strong></li>
    <li><strong><strong>Electronic medicines Compendium www.emc.medicines.org.uk</strong></strong></li>
    <li><strong><strong>Department of Health. Seasonal flu plan Winter 2011/12. Published May 2011. www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_127088.pdf</strong></strong></li>
    <li><strong><strong>National Institute for Health and Clinical Excellence. Amantadine, oseltamivir and zanamivir for the treatment of influenza (review of NICE technology appraisal guidance 58). Issued Feb 2009.</strong></strong></li>
    <li><strong><strong>National Institute for Health and Clinical Excellence. Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza. Issued Sept 2008.</strong></strong></li>
    <li><strong><strong>SIGN (2010) Management of sore throat and indications f or tonsillectomy www.sign.ac.uk</strong></strong></li>
    <li><strong><strong>MeReC (2006) Bulletin Volume 17 Number 3, The management of common infections in primary care www.npc.co.uk</strong></strong></li>
    <li><strong><strong>Rovers MM, Glasziou P, Appelman CL, et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet 2006; 368:1429 -1435.</strong></strong></li>
    <li><strong><strong>NICE Guidance (2010) Chronic Obstructive Pulmonary Disease www.nice.org.uk</strong></strong></li>
    <li><strong><strong>BTS (updated 2004) Guidelines for the Management of Community Acquired Pneumonia in Adults www.Brit-thoracic.org.uk</strong></strong></li>
    <li><strong><strong>HPA (2011) Guidance for public health management of meningococcal disease in the UK www.hpa.org.uk</strong></strong></li>
    <li><strong><strong>SIGN (2006) Management of suspected bacterial urinary tract infection in adults www.sign.ac.uk</strong></strong></li>
    <li><strong><strong>HPA (last reviewed 2011) Diagnosis for UTI quick reference Guide for Primary Care www.hpa.org.uk</strong></strong></li>
    <li><strong><strong>NICE (2007) urinary tract infection in children www.nice.org.uk</strong></strong></li>
    <li><strong><strong>HPA (last reviewed 2008) Diagnosis of H.pylori Quick Reference Guide for Primary Care www.hpa.org.uk</strong></strong></li>
    <li><strong><strong>NICE (2004) CG17 Dyspepsia: managing dyspepsia in adults in primary care. www.nice.org.uk</strong></strong></li>
    <li><strong><strong>British Association for Sexual Health and HIV (BASHH) Clinical Effectiveness Group Guidelines. www.bashh.org</strong></strong></li>
    <li><strong><strong>NICE. Antibiotic prescribing &ndash; especially the broad spectrum antibiotics January 2015.</strong></strong></li>
    <li><strong><strong>http://www.guysandstthomas.nhs.uk/resources/about-us/board-minutes/2014-board-papers/april/Board/cpe-briefing.pdf</strong></strong></li>
</ol>
<strong><strong><button class="btn btn-primary" data-dismiss="modal"><i class="fas fa-times fa-fw">&nbsp;</i>Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Portfolio Modal Gen Guidelines Further Reading--> </strong></strong>

<div aria-hidden="true" aria-labelledby="furtherReadingLabel" class="portfolio-modal modal fade" id="PCFurtherReading" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true">&nbsp;</span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="furtherReadingLabel"><strong><strong>Further Reading</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> <!-- Portfolio Modal - Text--> </strong></strong>

<div class="text-left">
<p><strong><strong>Department of Health. Resistance to Antibiotics and other Antimicrobial agents; action for the NHS following the Government&rsquo;s response to the House of Lords Science and Technology Select Committee report. Department of Health; 1999. (Health Service Circular: HSC (99) 049)</strong></strong></p>

<p><strong><strong>Department of Health. Hospital Pharmacy initiative for promoting prudent use of antibiotics in hospitals. London. Department of Health: 2003 (Professional letter. Chief Medical Officer: PLCMO (2003) 3)</strong></strong></p>

<p><strong><strong>Journal of hospital infection (2006) 63S, S1eS 44 Guidelines for the control and prevention of methicillin resistant Staphylococcus aureus (MRSA) in healthcare facilities.</strong></strong></p>

<p><strong><strong>JE Coia a, CG Duckworth b, DI Edwards c, M Farrington d, C Fry e, H Humphreys f *, C Mallaghan g, D R Tucker h, for the Joint Working Party of the British Society of Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association.</strong></strong></p>

<p><strong><strong>Dilip Nathwani (DN) (Chair), Marina Morgan (MM), Bob Masterton (RGM), Matthew S Dryden (MD), Barry D Cookson (BDC), Gary French (GF), Deidre Lewis (DL). Working Party Draft 2007</strong></strong></p>

<p><strong><strong>Diagnosis and Principles of Management of MRSA Infections Presenting in The Community: Guidelines for UK Practice Working Party * On Behalf Of The British Society For Antimicrobial Chemotherapy (Bsac).</strong></strong></p>

<p><strong><strong>Health Protection Agency, interim guidance on diagnosis and management of PVL - associated Staphylococcal infections in the UK, 13th march 2007.</strong></strong></p>

<p><strong><strong>Clostridium difficile infection: How to deal with the problem. Guidance from Department of Health/HPA 2008.</strong></strong></p>

<p><strong><strong>International Infection Control Council Best Infection Control Practices for patients with extended spectrum beta-Lactamase Enterobacteriaceae C Friedman, S Callery, Ajeans, P Piaskowski, L Scott (representing the International Infection Control Council) and members of the Best Practices Experts Panel and Reviewer.</strong></strong></p>

<p><strong><strong>ANTIMICROBIAL STEWARDSHIP: &ldquo;START SMART&ndash;THEN FOCUS.&rdquo; Guidance from Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) 2011</strong></strong></p>
</div>
<strong><strong><button class="btn btn-primary" data-dismiss="modal"><i class="fas fa-times fa-fw">&nbsp;</i> Close Window</button></strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!--Hospital Prophylaxis Modals--> <!-- Prophylaxis Medical Prophylaxis section--> </strong></strong>

<div aria-hidden="true" aria-labelledby="HCMedProphLabel" class="portfolio-modal modal fade " id="HCMedProph" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="HCPaedENTLabel"><strong><strong>Medical Prophylaxis</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<div class="text-left">
<h4 id="HCMedProphSection"><strong><strong><a href="#MedProphDiptheria">Diphtheria</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphSpleen">Elective or Emergency Splenectomy</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphEndocar">Endocarditis</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphHib">Haemophilus Influenza Type B (Hib)</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphMeningitis">Meningococcal Meningitis or Septicaemia</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphRheumatic">Prevention of Rheumatic Fever</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphSponBacPer">Spontaneous Bacterial Peritonitis</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphTetanusSection">Tetanus</a></strong></strong></h4>

<h4><strong><strong><a href="#MedProphWhoop">Whooping Cough (Pertussis)</a></strong></strong></h4>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphDiptheria">
<h2 class="text-center" id="MedProphDiptheriaLabel"><strong><strong>Diphtheria</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Prevention of secondary cases in non-immune patients - for close contacts, in conjunction with immunisation of susceptible individuals:</span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Adult: </strong></span><span style="color:#0000ff"><strong>Clarith<strong>romycin </strong>po 500mg bd for 7 days.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Child:</strong></span> <span style="color:#0000ff"><strong>see Children&#39;s BNF - give for 7 days.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Treat for a further 10 days if nasopharyngeal swabs positive after first 7 days of treatment.</span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphSpleen">
<h2 class="text-center" id="MedProphSpleenLabel"><strong><strong>Elective or Emergency Splenectomy</strong></strong></h2>

<p><strong><strong>For post-splenectomy prophylaxis please see section titled &#39;Surgical Prophylaxis.&#39;</strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphEndocar">
<h2 class="text-center" id="MedProphEndocarLabel"><strong><strong>Endocarditis</strong></strong></h2>

<p><strong><strong>See Dental Endocarditis Prophylaxis in section on Surgical Prophylaxis.</strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphHib">
<h2 class="text-center" id="MedProphHibLabel"><strong><strong>Haemophilus Influenzae type B (Hib)</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><strong>Haemophilus Influenzae type B (Hib) Meningitis, Epiglottitis or Other </strong><strong>Invasive Disease</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Rifampicin 600 mg od for 4 days</strong></span>;</strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Child over 3 months:</span> <span style="color:#0000ff">Rifampicin 20mg/kg&nbsp;od for 4 days, up to a maximum of 600mg daily. </span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Child between 1- 3 months:</span>&nbsp;<span style="color:#0000ff">Rifampicin 10mg/kg od for 4 days.</span></strong></strong></strong></p>

<p><strong><strong><strong>If rifampicin is contraindicated or in pregnancy/breastfeeding,</strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#0000ff">Ceftriaxone [unlicensed indication] IM or IV 1&nbsp;g od 2 days</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Child 1 month&ndash;12 years </span><span style="color:#0000ff">Ceftriaxone 50&nbsp;mg/kg (max. 1&nbsp;g) od for 2 days</span> <span style="color:#ff0000">by&nbsp;IV infusion only</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000">Give to all household members irrespective of age where there is an index case of Hib disease and a child less than 4 years.</span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Report to&nbsp;Public Health England as soon as possible (is a notifiable disease).</span></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphMeningitis">
<h2 class="text-center" id="MedProphMeningitisLabel"><strong><strong>Meningococcal Meningitis or Septicaemia</strong></strong></h2>

<p><strong><strong><span style="color:#000000"><u><strong>Indications for antibiotic prophylaxis</strong></u></span></strong></strong></p>

<p><strong><strong><span style="color:#000000">Antibiotic prophylaxis&nbsp;should be offered to the following:</span></strong></strong></p>

<ul>
    <li><strong><strong><span style="color:#000000"><strong>Close contacts </strong>-</span>&nbsp;those who have had&nbsp;prolonged close contact with the case in a household type setting during the seven days before onset of illness. Examples of such contacts would be those living and/or sleeping in the same household, pupils in the same dormitory, boy/girlfriends, or university students sharing a kitchen in a hall of residence.</strong></strong></li>
    <li><strong><strong><span style="color:#000000"><strong>Transient contacts </strong></span>-&nbsp; those who have had transient close contact with a case<span style="color:#000000"> <u><strong>only</strong></u> if </span>they have been <span style="color:#000000"><strong>directly exposed to large particle droplets/secretions from the respiratory tract of a case around the time of admission to hospital.</strong></span></strong></strong></li>
</ul>

<p><strong><strong>Close contact does<span style="color:#000000"> <u><strong>NOT</strong></u> </span>include:</strong></strong></p>

<ul>
    <li><strong><strong>staff and children attending same nursery or crche</strong></strong></li>
    <li><strong><strong>students/pupils in same school/class/tutor group</strong></strong></li>
    <li><strong><strong>work or school colleagues</strong></strong></li>
    <li><strong><strong>friends</strong></strong></li>
    <li><strong><strong>residents of nursing/residential homes</strong></strong></li>
    <li><strong><strong>kissing on cheek or mouth (intimate kissing would normally bring the contact into the close, prolonged contact category)</strong></strong></li>
    <li><strong><strong>food or drink sharing or similar low level of salivary contact</strong></strong></li>
    <li><strong><strong>attending the same social function</strong></strong></li>
    <li><strong><strong>travelling in next seat on same plane, train, bus, or car (in the absence of intense exposure to nasopharyngeal secretions).</strong></strong></li>
</ul>

<p><strong><strong><span style="color:#000000"><u><strong>Prevention of secondary cases</strong></u></span></strong></strong></p>

<p><strong><strong>Chemoprophylaxis should be prescribed following discussion with the specialist team at the PHE North West on 0344 225 0562 within office hours and via Tameside&nbsp;Hospital switchboard out of hours&ndash;ask for the PHE North West on call.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>1st line:</strong></span>&nbsp;</strong></strong></p>

<p><strong><strong><strong>Adult:<span style="color:#0000ff"> Ciprofloxacin 500mg po as a single dose</span></strong>.</strong></strong></p>

<p><strong><strong><strong>Neonate:</strong> <span style="color:#0000ff"><strong>Ciprofloxacin 30mg/kg (max. per dose 125mg) po&nbsp;for 1 dose.</strong></span></strong></strong></p>

<p><strong><strong><strong>Child 1 month to 4 years:</strong> <span style="color:#0000ff"><strong>Ciprofloxacin 30mg/kg (max. per dose 125mg) po for 1 dose.</strong></span></strong></strong></p>

<p><strong><strong><strong>Child 5 to 11 years:</strong> <span style="color:#0000ff"><strong>Ciprofloxacin 250mg po for 1 dose.</strong></span></strong></strong></p>

<p><strong><strong><strong>Child 12 to 17 years:</strong> <strong><span style="color:#0000ff">Ciprofloxacin 500mg po for 1 dose.</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Ciprofloxacin in pregnancy</strong></span></strong></strong></p>

<p><strong><strong>A single dose of ciprofloxacin 500mg po can be used for the prevention of secondary cases of meningococcal meningitis/bacteraemia in pregnancy.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Or if unable to take ciprofloxacin or if contraindicated,</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>2nd line:</strong></span></strong></strong></p>

<p><strong><strong><strong>Adult:</strong> <span style="color:#0000ff"><strong>Rifampicin 600mg po every 12 hours for 2 days.</strong></span></strong></strong></p>

<p><strong><strong><strong>Neonate to 11 months: <span style="color:#0000ff">Rifampicin 5mg/kg po every 12 hours for 2 days.</span></strong></strong></strong></p>

<p><strong><strong><strong>Child 1 to 11 years: <span style="color:#0000ff">Rifampicin 10mg/kg po every 12 hours (max. per dose 600mg), for 2 days.</span></strong></strong></strong></p>

<p><strong><strong><strong>Child 12 to 17 years:</strong> <strong><span style="color:#0000ff">Rifampicin 600mg po every 12 hours for 2 days.</span></strong></strong></strong></p>

<p><strong><strong>In addition, give rifampicin to the index case (unless they have had treatment with ceftriaxone or moxifloxacin), before discharge from hospital.</strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Or if rifampicin is contraindicated,</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>3rd line:</strong></span><span style="color:#0000ff"><strong> Ceftriaxone 250mg IM stat dose </strong></span>(<strong><span style="color:#0000ff">125mg in a child under 12yrs</span></strong>).</strong></strong></p>

<p><strong><strong>(NB not licensed for this indication).</strong></strong></p>

<p><strong><strong>Report to&nbsp;Public Health England as soon as possible (is a notifiable disease).</strong></strong></p>

<p><strong><strong>Further advice can be sought from Greater Manchester Health Protection Unit 0161 786 6710 or via switchboard out of hours.</strong></strong></p>

<p><strong><strong>For other useful numbers please see <a href="https://www.gov.uk/emergency-contacts-public-health" target="_blank"><span style="color:#0066cc">https://www.gov.uk/emergency-contacts-public-health</span></a></strong></strong></p>

<p><strong><strong><strong>References:</strong></strong></strong></p>

<p><strong><strong>Public Health England.&nbsp; Guidance for the public health management of meningococcal disease in the UK.&nbsp;February 2018. <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/688835/Public_health_management_of_meningococcal_disease_guidelines.pdf" target="_blank">Public Health Guidance PDF</a></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphRheumatic">
<h2 class="text-center" id="MedProphRheumaticLabel"><strong><strong>Prevention of Rheumatic Fever</strong></strong></h2>

<p><strong><strong><span style="color:#000000">Prevention of recurrent attacks (particularly in children):</span></strong></strong></p>

<p><strong><strong><span style="color:#0000ff"><strong>Phenoxymethylpenicillin po 250mg&nbsp;bd.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>For children under 1 year:</strong></span><span style="color:#0000ff"><strong> dose according to body weight.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><u><strong>Penicillin allergy</strong></u></span></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">Age 12 years and over: </span><span style="color:#800080">Clarithromycin&nbsp;250mg po bd.</span></strong></strong></strong></p>

<p><strong><strong><strong><span style="color:#000000">For children under 12 years:</span><span style="color:#800080"> Dose according to body weight and give half of total daily dose once daily.</span></strong></strong></strong></p>
</div>
<strong><strong> &nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphSponBacPer">
<h2 class="text-center" id="MedProphSponBacPerLabel"><strong><strong>Spontaneous Bacterial Peritonitis</strong></strong></h2>

<p><strong><strong><strong><span style="color:black">Prophylaxis after initial episode of SBP:&nbsp;</span></strong><span style="color:#800080"><strong>Ciprofloxacin 500mg po od.</strong></span></strong></strong></p>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong>&nbsp; </strong></strong>

<div class="text-left border border-info rounded px-1" id="MedProphTetanusSection">
<h2 class="text-center" id="MedProphTetanusSectionLabel"><strong><strong>Tetanus</strong></strong></h2>

<p><strong><strong>Tetanus prone wounds include:</strong></strong></p>

<p><strong><strong>wounds or burns that require surgical intervention that is delayed for more than six hours</strong></strong></p>

<p><strong><strong>wounds or burns that show a significant degree of devitalised tissue or a puncture-type injury, particularly where there has been contact with soil or manure</strong></strong></p>

<p><strong><strong>wounds containing foreign bodies</strong></strong></p>

<p><strong><strong>compound fractures</strong></strong></p>

<p><strong><strong>wounds or burns in patients who have systemic sepsis.</strong></strong></p>
<strong><strong><!--Accordian--> </strong></strong>

<div id="accordionMedProTet">
<div class="card">
<div class="card-header" id="tetanusInMedProph">
<h5 class="mb-0"><strong><strong><button aria-controls="collapsetetanusInMedProph" aria-expanded="false" class="btn btn-link collapsed" data-target="#collapsetetanusInMedProph" data-toggle="collapse" type="button">Immunisation</button></strong></strong></h5>
</div>

<div aria-labelledby="tetanusInMedProph" class="collapse" data-parent="#accordionMedProTet" id="collapsetetanusInMedProph">
<div class="card-body text-left">
<table border="1" class="table table-striped table-bordered">
    <tbody>
        <tr>
            <td><strong><strong>&nbsp;</strong></strong></td>
            <td><strong><strong><span style="color:#008000"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clean Wound</strong></span></strong></strong></td>
            <td colspan="2">
            <p><strong><strong><span style="color:#ff0000"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tetanus-prone Wound</strong></span></strong></strong></p>
            </td>
        </tr>
        <tr>
            <td><strong><strong><span style="color:#0000ff"><strong>Immunisation status</strong></span></strong></strong></td>
            <td><strong><strong><span style="color:#800080"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vaccine</strong></span></strong></strong></td>
            <td><strong><strong><span style="color:#800080"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vaccine</strong></span></strong></strong></td>
            <td><strong><strong><span style="color:#008080"><strong>&nbsp; Human&nbsp;Immunoglobulin</strong></span></strong></strong></td>
        </tr>
        <tr>
            <td>
            <p><strong><strong>Fully immunised, i.e. has received a total of five doses of vaccine at appropriate intervals</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None required</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None required</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Only if high risk*</strong></strong></p>
            </td>
        </tr>
        <tr>
            <td>
            <p><strong><strong>Primary immunisation complete, boosters incomplete but up to date</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None required</strong></strong></p>

            <p><strong><strong>(unless next dose due soon and convenient to give now)</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None required</strong></strong></p>

            <p><strong><strong>(unless next dose due soon and convenient to give now)</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Only if high risk*</strong></strong></p>
            </td>
        </tr>
        <tr>
            <td>
            <p><strong><strong>Primary immunisation incomplete or boosters not up to date</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>A reinforcing dose of vaccine and further doses as required to complete the recommended schedule (to ensure future immunity)</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>A reinforcing dose of vaccine and further doses as required to complete the recommended schedule (to ensure future immunity)</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>Yes: one dose of human tetanus immunoglobulin in a different site</strong></strong></p>
            </td>
        </tr>
        <tr>
            <td>
            <p><strong><strong>Not immunised or immunisation status not known or uncertain</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>An immediate dose of vaccine followed, if records confirm the need, by completion of a full five-dose course to ensure immunity</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>An immediate dose of vaccine followed, if records confirm the need, by completion of a full five-dose course to ensure immunity</strong></strong></p>
            </td>
            <td>
            <p><strong><strong>Yes: one dose of human tetanus immunoglobulin in a different site</strong></strong></p>
            </td>
        </tr>
    </tbody>
</table>

<p><strong><strong><strong>* </strong>High risk is regarded as heavy contamination with material likely to contain tetanus spores and/or extensive devitalised tissue.</strong></strong></p>
</div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
<strong><strong> &nbsp; </strong></strong>

<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12">
<div class="text-left border border-info rounded px-1" id="MedProphWhoop">
<h2 class="text-center" id="MedProphWhoopLabel"><strong><strong>Whooping Cough (Pertussis)</strong></strong></h2>

<p><strong><strong><strong><span style="color:#000000">Prevention of secondary cases:</span></strong></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Adult: </strong></span><span style="color:#0000ff"><strong>Clarith<strong>romycin </strong>po 500mg bd for 7 days.</strong></span></strong></strong></p>

<p><strong><strong><span style="color:#000000"><strong>Child:</strong></span> <span style="color:#0000ff"><strong>see Children&#39;s BNF - give for 7 days.</strong></span></strong></strong></p>
</div>
</div>
</div>
</div>
<br />
<strong><strong><!--floating icon--><a class="float" href="#HCMedProphSection"><i class="fa fa-arrow-up my-float">&nbsp;</i> </a><button class="btn btn-primary" data-dismiss="modal">Close Window</button></strong></strong></div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Prophylaxis MRSA Eradication--> </strong></strong>

<div aria-hidden="true" aria-labelledby="MRSAERADLabel" class="portfolio-modal modal fade " id="MRSAERAD" role="dialog" tabindex="-1">
<div class="modal-dialog modal-xl" role="document">
<div class="modal-content"><strong><strong><button aria-label="Close" class="close" data-dismiss="modal" type="button"><span aria-hidden="true"><i class="fas fa-times">&nbsp;</i></span></button> </strong></strong>

<div class="modal-body text-center">
<div class="container">
<div class="row justify-content-center">
<div class="col-lg-12"><strong><strong><!-- Portfolio Modal - Title--> </strong></strong>

<h2 class="portfolio-modal-title text-secondary text-uppercase mb-0" id="MRSAERADLabel"><strong><strong>MRSA Eradication</strong></strong></h2>
<strong><strong> <!-- Icon Divider--> </strong></strong>

<div class="divider-custom">
<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>

<div class="divider-custom-icon"><strong><strong><i class="fas fa-star">&nbsp;</i></strong></strong></div>

<div class="divider-custom-line"><strong><strong>&nbsp;</strong></strong></div>
</div>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><strong>Both nasal and skin/hair treatment must be carried out to ensure MRSA decolonisation is successful.</strong></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>&nbsp;</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><strong><u>NASAL DECOLONISATION</u></strong></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>Topical intra-nasal mupirocin or chlorhexidine can be effective for nasal decolonisation.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#0000ff"><strong>Bactroban&reg; (mupirocin) nasal ointment TDS</strong>&nbsp;<strong>for 5 days</strong></span> in both nostrils.&nbsp; If mupirocin nasal ointment is not available due to national shortage, give: <strong><span style="color:#3300ff">Octenisan nasal gel&nbsp; to be applied BD for 5 days.</span></strong></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#0000ff"><strong>Naseptin nasal cream QDS for 10 days</strong> </span>can be used where the strain of <strong>MRSA is resistant to mupirocin</strong>. <span style="color:#e74c3c"><strong>NASEPTIN CONTAINS PEANUT OIL - AVOID IN PATIENTS WITH NUT ALLERGY.</strong></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>The effectiveness of this approach is approximately 60% and may be short lived.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>&nbsp;</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#000000"><u><strong>SKIN DECOLONISATION</strong></u></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>Using disinfectants while bathing or showering has also been shown to be effective in decolonisation of skin and hair.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong><span style="color:#0000ff"><strong>Octenisan&reg; wash applied directly to the skin (body, face and hair) once daily and washed off for 5 days.</strong></span></strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>As there are concerns about development of resistance, it is recommended that topical antibiotic use should be confined to a single course of 5 days.</strong></strong></p>
<strong><strong> </strong></strong>

<p><strong><strong>For further information on the prevention and control of MRSA colonisation / infections, please refer to the Trust policy for the management of MRSA&nbsp;or contact the Infection Prevention Team.</strong></strong></p>
<strong><strong> </strong></strong></div>
</div>
</div>
</div>
<strong><strong> </strong></strong></div>
</div>
</div>
<strong><strong> <!-- Bootstrap core JS--> <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js" type="text/javascript"></script> <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/js/bootstrap.bundle.min.js" type="text/javascript"></script> <!-- Third party plugin JS--> <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery-easing/1.4.1/jquery.easing.min.js" type="text/javascript"></script> <!--Jquery CDN--> <script src="https://code.jquery.com/jquery-3.5.1.min.js" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous" type="text/javascript"></script> <!-- Core theme JS--> <script src="../js/scripts.js" type="text/javascript"></script> <script type="text/javascript">
//Primary care section
//Clicking on managing infection button.
function closePCGC() {
var x = document.getElementById("PCGeneralGuidelines");
var y = document.getElementById("managingInfectionsPC");
if(y.style.display === "none"){
y.style.display = "flex";
} else {
y.style.display = "none";
}
if(x.style.display === "flex"){
x.style.display = "none";
}
}
//Clicking on gen guidelines button
function closePCMI() {
var x = document.getElementById("managingInfectionsPC");
var y = document.getElementById("PCGeneralGuidelines");
if(y.style.display === "none"){
y.style.display = "flex";
} else {
y.style.display = "none";
}
if(x.style.display === "flex"){
x.style.display = "none";
}
}
//Intermediate care section
//Clicking on managing infection button.
function closeICGC() {
var x = document.getElementById("ICGeneralGuidelines");
var y = document.getElementById("managingInfectionsIC");
if(y.style.display === "none"){
y.style.display = "flex";
} else {
y.style.display = "none";
}
if(x.style.display === "flex"){
x.style.display = "none";
}
}
//Clicking on gen guidelines button
function closeICMI() {
var x = document.getElementById("managingInfectionsIC");
var y = document.getElementById("ICGeneralGuidelines");
if(y.style.display === "none"){
y.style.display = "flex";
} else {
y.style.display = "none";
}
if(x.style.display === "flex"){
x.style.display = "none";
}
}
//Clicking on A&E Paed button
function onlyPaedInpat() {
var a = document.getElementById("PaedInHC");
var b = document.getElementById("AdInHC");
var c = document.getElementById("HCGeneralGuidelines");
var d = document.getElementById("HCProphylaxis");
if(a.style.display === "none"){
a.style.display = "flex";
} else {
a.style.display = "none";
}
if(b.style.display === "flex"){
b.style.display = "none";
}
if(c.style.display === "flex"){
c.style.display = "none";
}
if(d.style.display === "flex"){
d.style.display = "none";
}
}
//Clicking on A&E Adults button
function onlyAdInpat() {
var a = document.getElementById("AdInHC");
var b = document.getElementById("PaedInHC");
var c = document.getElementById("HCGeneralGuidelines");
var d = document.getElementById("HCProphylaxis");
if(a.style.display === "none"){
a.style.display = "flex";
} else {
a.style.display = "none";
}
if(b.style.display === "flex"){
b.style.display = "none";
}
if(c.style.display === "flex"){
c.style.display = "none";
}
if(d.style.display === "flex"){
d.style.display = "none";
}
}
//Clicking on Hosp Guidelines button
function onlyHospGuide() {
var a = document.getElementById("HCGeneralGuidelines");
var b = document.getElementById("PaedInHC");
var c = document.getElementById("AdInHC");
var d = document.getElementById("HCProphylaxis");
if(a.style.display === "none"){
a.style.display = "flex";
} else {
a.style.display = "none";
}
if(b.style.display === "flex"){
b.style.display = "none";
}
if(c.style.display === "flex"){
c.style.display = "none";
}
if(d.style.display === "flex"){
d.style.display = "none";
}
}
//Clicking on Prophylaxis Guidelines button
function onlyProph() {
var a = document.getElementById("HCProphylaxis");
var b = document.getElementById("PaedInHC");
var c = document.getElementById("AdInHC");
var d = document.getElementById("HCGeneralGuidelines");
if(a.style.display === "none"){
a.style.display = "flex";
} else {
a.style.display = "none";
}
if(b.style.display === "flex"){
b.style.display = "none";
}
if(c.style.display === "flex"){
c.style.display = "none";
}
if(d.style.display === "flex"){
d.style.display = "none";
}
}
</script> <!--floating icon--> <a class="float " href="#page-top"> <i class="fa fa-arrow-up my-float ">&nbsp;</i> </a></strong></strong>
